{"meta":{"query_hash":"ea2d67b0c0fc","filters":{"venue":"American Journal of Clinical Oncology"},"cohort_total":196,"direct_labels_cover":1,"predictions_cover":196,"exported":196,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ea2d67b0c0fc","api":"https://metacan.xera.ac/api/v1/cohort?venue=American+Journal+of+Clinical+Oncology"},"results":[{"id":"W1854012091","doi":"10.1097/coc.0000000000000202","title":"The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Proportional hazards model; Immunohistochemistry; Epidermal growth factor receptor; Univariate analysis; Population; C-Met; Cancer; Tissue microarray; Oncology; Survival analysis; Multivariate analysis; Gastroenterology; Pathology; Receptor; Hepatocyte growth factor; Confidence interval","score_opus":0.09834555880597058,"score_gpt":0.4301980288299977,"score_spread":0.3318524700240271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1854012091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999468,0.0002888269,0.000025372387,0.00001753996,0.0000014791912,0.0000016785219,0.00007049351,0.0000014852552,0.0001250522],"genre_scores_gemma":[0.99973553,0.000072422554,0.00003988473,0.0000042588326,0.000002437543,0.0000012600951,0.000096388736,5.3288153e-7,0.000047377252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998759,0.00001631905,0.000013415763,0.000021747916,0.000041073345,0.00003141637],"domain_scores_gemma":[0.9994184,0.000117229225,0.00019514025,0.000020345795,0.00009759539,0.00015134896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021034527,0.00016940947,0.00013639769,0.00048208953,0.00028484227,0.0002505625,0.0001461091,0.00023892273,0.00079364935],"category_scores_gemma":[0.0011291659,0.00012427263,0.00015541923,0.00035001573,0.0003101353,0.00015520227,0.0001813496,0.00020340293,0.00009949047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000283123,0.0000068656236,0.99601126,0.000010057599,0.000014702265,0.00020849581,0.000030606054,0.00006234186,0.0020724304,0.00000402559,0.00003566174,0.0012603777],"study_design_scores_gemma":[0.0000068466875,0.00005290577,0.9983944,0.0000027140409,0.000016912294,0.0009082684,0.00007048833,0.00014002166,0.00029474718,0.000005539627,0.0001052198,0.0000019500167],"about_ca_topic_score_codex":0.02833544,"about_ca_topic_score_gemma":0.05293802,"teacher_disagreement_score":0.02833544,"about_ca_system_score_codex":0.00071546965,"about_ca_system_score_gemma":0.00067292113,"threshold_uncertainty_score":0.056341052},"labels":[],"label_agreement":null},{"id":"W1969233490","doi":"10.1097/coc.0b013e318256f5dc","title":"Improvements in 5-year Outcomes of Stage II/III Rectal Cancer Relative to Colon Cancer","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Colorectal cancer; Total mesorectal excision; Cancer; Internal medicine; Stage (stratigraphy); Relative survival; Perioperative; Survival rate; Rectum; Oncology; Gastroenterology; Surgery; Cancer registry","score_opus":0.09711184448178406,"score_gpt":0.5148231445701119,"score_spread":0.41771130008832785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969233490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986094,0.0005074829,0.0000701688,0.0000593291,0.000007088926,0.000005403751,0.00024828955,0.0000036044282,0.0004891989],"genre_scores_gemma":[0.99922276,0.00011369473,0.000042513315,0.000022635848,0.0000096850135,0.0000030041083,0.00045679405,0.0000011463608,0.00012778277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997868,0.000053261065,0.000019458885,0.000042011074,0.00004872078,0.000049833656],"domain_scores_gemma":[0.9989003,0.00015852967,0.00058778026,0.000039709936,0.000085183354,0.00022855196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005016544,0.00011926558,0.0001708143,0.00031030388,0.00014075298,0.0003085642,0.00010656678,0.00015632766,0.0014505569],"category_scores_gemma":[0.0015835599,0.00005305818,0.0002639513,0.00030474894,0.00014812208,0.00019274396,0.00021049977,0.0002771066,0.000120105426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094271044,0.000043414955,0.991774,0.00003645833,0.000090756934,0.000058935526,0.00003697117,0.00019057926,0.0011077223,0.000025221934,0.00020142739,0.0054917354],"study_design_scores_gemma":[0.000009976588,0.00026444433,0.9992126,0.0000044996023,0.000025095187,0.00010842294,0.000021236756,0.00005268795,0.00012273282,0.000010265389,0.00016685834,0.0000011509906],"about_ca_topic_score_codex":0.0026084622,"about_ca_topic_score_gemma":0.0061452896,"teacher_disagreement_score":0.0026084622,"about_ca_system_score_codex":0.0003796713,"about_ca_system_score_gemma":0.00035162157,"threshold_uncertainty_score":0.0051866174},"labels":[],"label_agreement":null},{"id":"W1969418055","doi":"10.1097/coc.0000000000000055","title":"Population-based Analysis of Treatment and Survival in Women Presenting With Brain Metastasis at Initial Breast Cancer Diagnosis","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université de Montréal; Hôpital Maisonneuve-Rosemont; BC Cancer Agency","funders":"","keywords":"Medicine; Brain metastasis; Breast cancer; Metastasis; Internal medicine; Radiation therapy; Oncology; Population; Cancer; Surgery","score_opus":0.05525479307048128,"score_gpt":0.4407750546448139,"score_spread":0.38552026157433267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969418055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995048,0.00016405612,0.000042634954,0.00002920128,0.0000036718643,0.000003249498,0.00012298538,0.0000025360316,0.0001268302],"genre_scores_gemma":[0.99966514,0.00005046911,0.000027280805,0.000017587325,0.0000071915288,0.000004690371,0.00019073545,7.9114477e-7,0.000036173333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962556,0.00012661601,0.000031909993,0.000101326325,0.00005852272,0.000056028304],"domain_scores_gemma":[0.99916685,0.00022117433,0.0003564829,0.000060928898,0.00006290185,0.0001317271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000473074,0.00017589847,0.00032408282,0.00073261687,0.00028312005,0.00040692557,0.00023475567,0.0005023226,0.0009864931],"category_scores_gemma":[0.002272736,0.00020392762,0.00039027186,0.00070236315,0.00023694139,0.00030214267,0.00023520915,0.0004147838,0.00019624065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011376749,0.000016589873,0.99888724,0.0000031481518,0.00004537454,0.0000622517,0.000018956385,0.00003750874,0.00009930494,0.000004081828,0.000053083182,0.0006587347],"study_design_scores_gemma":[0.0000129763075,0.00011774574,0.9989485,0.0000021011656,0.000028291444,0.00046554868,0.000075229385,0.0001937879,0.000032716056,0.000012125924,0.00010829293,0.0000027286283],"about_ca_topic_score_codex":0.0028736086,"about_ca_topic_score_gemma":0.0028524066,"teacher_disagreement_score":0.0028736086,"about_ca_system_score_codex":0.00035092534,"about_ca_system_score_gemma":0.00019516544,"threshold_uncertainty_score":0.005713761},"labels":[],"label_agreement":null},{"id":"W1972303935","doi":"10.1097/coc.0b013e318172b3b6","title":"Minimally Invasive Techniques in Management of Hepatic Neuroendocrine Metastatic Disease","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Neuroendocrine tumors; Pathology; Oncology; Surgery","score_opus":0.12094569708228022,"score_gpt":0.5212787936421702,"score_spread":0.40033309655989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972303935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016991394,0.99881077,0.00012160132,0.00020205007,0.00013498835,0.0000029945102,0.000003912784,0.0000039770175,0.000549918],"genre_scores_gemma":[0.0013183285,0.9977496,0.00020795061,0.00013327712,0.00023698006,0.000003970463,0.0000134605,0.0000011521762,0.00033527747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998331,0.00003461597,0.000023591747,0.00002250009,0.000070912625,0.000015191589],"domain_scores_gemma":[0.9996412,0.00020123133,0.00005770209,0.000011656538,0.000058597187,0.000029562916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050476997,0.0005791119,0.0010766863,0.0018184936,0.00018246575,0.00048207026,0.00077696424,0.0006707295,0.0024323252],"category_scores_gemma":[0.0008581313,0.00019089268,0.0004567574,0.0017140599,0.00057609566,0.00095049315,0.0005073591,0.0014379738,0.0013071737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007942008,0.000041859308,0.0002299574,0.0041835005,0.000048673464,0.00051664957,0.000025813353,0.00026505897,0.0008968378,0.00073741126,0.013018132,0.9799566],"study_design_scores_gemma":[0.00010669508,0.00041029326,0.0052282196,0.008184646,0.00021280457,0.018830772,0.00014060253,0.0003533682,0.0014708365,0.003950381,0.96105987,0.000051635965],"about_ca_topic_score_codex":0.0006389758,"about_ca_topic_score_gemma":0.001372619,"teacher_disagreement_score":0.0024323252,"about_ca_system_score_codex":0.00037463647,"about_ca_system_score_gemma":0.0004848731,"threshold_uncertainty_score":0.008136928},"labels":[],"label_agreement":null},{"id":"W1972848143","doi":"10.1097/00000421-200002000-00025","title":"Standard Dose (Mayo Regimen) 5-Fluorouracil and Low Dose Folinic Acid: Prohibitive Toxicity?","year":2000,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Folinic acid; Medicine; Toxicity; Regimen; Internal medicine; Gastroenterology; Fluorouracil; Population; Surgery; Chemotherapy; Creatinine","score_opus":0.04124735522247907,"score_gpt":0.42022927261315857,"score_spread":0.3789819173906795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972848143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835233,0.0064165024,0.004675278,0.0013646347,0.000052070736,0.00002626216,0.000064448075,0.000064768785,0.0038126823],"genre_scores_gemma":[0.99556315,0.0011898597,0.0019185797,0.00064385345,0.0000786911,0.000009253574,0.00006572041,0.000007697029,0.0005231852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996251,0.00016593507,0.00004203169,0.000042561715,0.00009478503,0.000029585935],"domain_scores_gemma":[0.99925023,0.0003011023,0.00024904739,0.000061438135,0.000059902562,0.00007816993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010344485,0.0000764864,0.00023111588,0.00014886289,0.00010108048,0.00029230217,0.00014922231,0.00028048226,0.00075906777],"category_scores_gemma":[0.0031760714,0.000074507545,0.00013635347,0.0002507525,0.00029866264,0.00021009431,0.00014101615,0.0002311194,0.00022003855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031472465,0.00030338875,0.5761804,0.00030763008,0.00028940864,0.005253662,0.00024022079,0.00089567655,0.017051132,0.0014444373,0.005332035,0.38955483],"study_design_scores_gemma":[0.0004480139,0.0108344685,0.8854124,0.00024381588,0.00034521153,0.061620336,0.0003204988,0.0042834445,0.010773765,0.0025856101,0.02310079,0.000031742155],"about_ca_topic_score_codex":0.0003553976,"about_ca_topic_score_gemma":0.001463186,"teacher_disagreement_score":0.0010344485,"about_ca_system_score_codex":0.00022270008,"about_ca_system_score_gemma":0.00013995414,"threshold_uncertainty_score":0.0054707527},"labels":[],"label_agreement":null},{"id":"W1978772228","doi":"10.1097/01.coc.0000225919.35003.88","title":"Is There a Detrimental Effect of Waiting for Radiotherapy for Patients With Localized Prostate Cancer?","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Hazard ratio; Radiation therapy; Prostate cancer; Confidence interval; Proportional hazards model; Multivariate analysis; Prostate; Prostate-specific antigen; Urology; Retrospective cohort study; External beam radiotherapy; Cancer; Surgery; Internal medicine","score_opus":0.02514091257903545,"score_gpt":0.4225659542720606,"score_spread":0.39742504169302517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978772228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544466,0.003509029,0.00014172317,0.00044881486,0.00003298286,0.000005701762,0.000063668595,0.0000046128066,0.00034880594],"genre_scores_gemma":[0.9989661,0.0005321016,0.00010702019,0.00014832261,0.00009476609,0.0000036002214,0.000069167836,0.0000029927462,0.00007581106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999134,0.00044535403,0.000070859125,0.000100998426,0.00013725087,0.00011163696],"domain_scores_gemma":[0.98015,0.009394016,0.008221375,0.00044852044,0.00041538285,0.0013706002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019320283,0.00022093473,0.0003515326,0.00028619083,0.0002904052,0.00047645363,0.00035141583,0.000784795,0.0026573655],"category_scores_gemma":[0.014932925,0.00016372115,0.00067671516,0.00051268603,0.00043869435,0.00059548364,0.00038562328,0.0006741195,0.0002480711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018915868,0.000100372206,0.9865226,0.0001002814,0.0001689394,0.00018689474,0.00006104958,0.00017634915,0.00038070718,0.000034207747,0.00012765198,0.0102494145],"study_design_scores_gemma":[0.00006120737,0.0020839924,0.99476445,0.000053698317,0.00033476882,0.0013347595,0.0002261079,0.00048422327,0.00021120523,0.00010268153,0.0003289082,0.000013894101],"about_ca_topic_score_codex":0.0009094389,"about_ca_topic_score_gemma":0.0013686208,"teacher_disagreement_score":0.0026573655,"about_ca_system_score_codex":0.00024761716,"about_ca_system_score_gemma":0.0005555869,"threshold_uncertainty_score":0.010217667},"labels":[],"label_agreement":null},{"id":"W19806037","doi":"10.1097/coc.0b013e3181a6500d","title":"Low Thrust Trajectory Design for CRAFTI","year":2001,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Astro and Planetary Science","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Asteroid; Payload (computing); Near-Earth object; Spacecraft; Trajectory; Aerospace engineering; Space exploration; Ion thruster; Interplanetary spaceflight; Propulsion; Thrust; Orbit (dynamics); Computer science; Astrobiology; Physics; Engineering; Astronomy; Computer security","score_opus":0.08776790651586729,"score_gpt":0.4084649225919118,"score_spread":0.3206970160760445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W19806037","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18537565,0.0012225974,0.66112834,0.001043729,0.0007328341,0.00070203684,0.0010427003,0.008668176,0.14008394],"genre_scores_gemma":[0.80095583,0.00037534168,0.15939674,0.00015913874,0.000046712114,0.00024736335,0.0010535355,0.0006342005,0.037131157],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99973506,0.000020613585,0.000010142158,0.00004526004,0.00013528153,0.000053657284],"domain_scores_gemma":[0.9995739,0.00005359576,0.00004623002,0.000108955624,0.00015323763,0.0000640484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040909613,0.0007284967,0.00038114327,0.0008176281,0.0006789089,0.0007137675,0.0010956529,0.0006977438,0.016815396],"category_scores_gemma":[0.0008730981,0.00022023606,0.00027071833,0.000574847,0.00043408602,0.00072425476,0.00080026273,0.0006147394,0.004870959],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024766184,0.00036464666,0.01230898,0.0010350615,0.00009583181,0.00081620103,0.00047282575,0.07605252,0.14067751,0.028657656,0.027839515,0.7092026],"study_design_scores_gemma":[0.0006403807,0.0059425537,0.025215363,0.0003586292,0.0002778647,0.0031784833,0.00062238117,0.37750432,0.20996064,0.01171082,0.3642558,0.00033277943],"about_ca_topic_score_codex":0.0023180644,"about_ca_topic_score_gemma":0.0041463184,"teacher_disagreement_score":0.016815396,"about_ca_system_score_codex":0.00070996606,"about_ca_system_score_gemma":0.0010633533,"threshold_uncertainty_score":0.056253076},"labels":[],"label_agreement":null},{"id":"W1981692336","doi":"10.1097/00000421-200212000-00011","title":"Subsets More Likely to Benefit From Surgery or Prophylactic Cranial Irradiation After Chemoradiation for Localized Non–Small-Cell Lung Cancer","year":2002,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Prophylactic cranial irradiation; Conventional PCI; Surgery; Retrospective cohort study; Lung cancer; Radiation therapy; Cancer; Stage (stratigraphy); Internal medicine; Oncology; Myocardial infarction","score_opus":0.07310524551789473,"score_gpt":0.41062819865696104,"score_spread":0.33752295313906633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981692336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997085,0.00006441147,0.000024823907,0.000023181894,0.0000027446147,0.000004420774,0.00003141099,6.556496e-7,0.00013984433],"genre_scores_gemma":[0.999608,0.000034327553,0.000031100117,0.0000404565,0.000017302196,0.000006998364,0.00016361648,0.0000011158845,0.000097150296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979573,0.000046704034,0.000019076208,0.000034830042,0.000032238157,0.00007144262],"domain_scores_gemma":[0.9993548,0.00017013914,0.00021244203,0.000030311598,0.000041870033,0.00019051101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001731407,0.00016042004,0.00040078964,0.0003300917,0.0003879703,0.000368947,0.00014036911,0.00030817967,0.0012822461],"category_scores_gemma":[0.0012847149,0.000110531684,0.000292986,0.00030311034,0.0002150023,0.00029006848,0.00021559413,0.00029493068,0.00018328127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010321304,0.00012285974,0.99121535,0.00000912912,0.0000463314,0.0005562944,0.000080033016,0.00017036918,0.0017552509,0.000044899334,0.00021790862,0.004749417],"study_design_scores_gemma":[0.000058534126,0.0006224656,0.9962435,0.000005835835,0.000055481978,0.0016391921,0.00019287187,0.0003897141,0.00026612205,0.00018951173,0.00032783777,0.000009037649],"about_ca_topic_score_codex":0.00068967725,"about_ca_topic_score_gemma":0.0014001429,"teacher_disagreement_score":0.0012822461,"about_ca_system_score_codex":0.00012682202,"about_ca_system_score_gemma":0.00020781392,"threshold_uncertainty_score":0.004289508},"labels":[],"label_agreement":null},{"id":"W1982142849","doi":"10.1097/coc.0b013e3181cae782","title":"Immunological Therapies Can Relieve Aromatase Inhibitor-Related Joint Symptoms in Breast Cancer Survivors","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aromatase inhibitor; Breast cancer; Aromatase; Oncology; Internal medicine; Cancer","score_opus":0.02171955216796086,"score_gpt":0.3663197050741852,"score_spread":0.34460015290622437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982142849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969374,0.0023311176,0.00004216067,0.00005826618,0.0000073600268,0.000022909511,0.000025621293,0.0000029649811,0.0005722008],"genre_scores_gemma":[0.99855775,0.0009534165,0.00007823683,0.00006244727,0.00002249281,0.000019932868,0.00004206344,5.560699e-7,0.00026303946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99993837,0.000022540733,0.000004168122,0.0000040199434,0.00001553383,0.000015389223],"domain_scores_gemma":[0.99989176,0.000030118776,0.00004638974,0.000002931435,0.0000083694895,0.000020500922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015249298,0.00008112383,0.00017573619,0.00009354703,0.000088107525,0.000084894054,0.00007020243,0.00008699855,0.0014506896],"category_scores_gemma":[0.0004886809,0.00003755513,0.00014212768,0.000110074565,0.000065607695,0.00006179339,0.00009997597,0.00011079,0.000114543975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013441431,0.0042581744,0.549244,0.0013949407,0.0004746463,0.0015451853,0.0009048694,0.0004280056,0.079600774,0.000076580654,0.0014715717,0.34715977],"study_design_scores_gemma":[0.0012224383,0.026814561,0.95910734,0.00011785142,0.0003277496,0.001939009,0.0004926899,0.00029743862,0.0056198575,0.00005352024,0.0040009953,0.000006580807],"about_ca_topic_score_codex":0.0002397257,"about_ca_topic_score_gemma":0.0005791865,"teacher_disagreement_score":0.0014506896,"about_ca_system_score_codex":0.0000555522,"about_ca_system_score_gemma":0.00011072557,"threshold_uncertainty_score":0.00485301},"labels":[],"label_agreement":null},{"id":"W1985161719","doi":"10.1097/coc.0b013e3181b4b147","title":"Population-Based Analysis of the Frequency of Anemia and its Management Before and During Chemotherapy in Patients With Malignant Lymphoma","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Anemia; Internal medicine; Vincristine; Vinblastine; CHOP; ABVD; Chemotherapy; Gastroenterology; Cyclophosphamide; Lymphoma; Rituximab; Surgery","score_opus":0.010124621850470404,"score_gpt":0.32810638917233337,"score_spread":0.31798176732186295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985161719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928325,0.00020010043,0.000040397368,0.000023665618,0.0000024959509,0.0000068176546,0.00020105994,0.0000031958398,0.00023910911],"genre_scores_gemma":[0.9996119,0.0000646902,0.000033424094,0.000013865395,0.000005623344,0.000005637638,0.00022158772,9.923018e-7,0.000042354288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992613,0.00024707595,0.000079625046,0.00014650945,0.00017880816,0.00008672761],"domain_scores_gemma":[0.99737585,0.00049296865,0.0014255886,0.00014288626,0.00030216962,0.00026063557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065569696,0.00013429638,0.0003001836,0.0009808943,0.00030072875,0.0004964813,0.00025476827,0.0004325717,0.0009211404],"category_scores_gemma":[0.003546913,0.00018781945,0.00024171513,0.001351303,0.00024527265,0.0004165749,0.00023902504,0.0003864893,0.0001587335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056182565,0.000013385354,0.9992663,0.0000029018895,0.000018357514,0.000023357945,0.000022034817,0.00002005742,0.000055292974,0.0000026400521,0.000037378253,0.0004820872],"study_design_scores_gemma":[0.0000037569914,0.000060891653,0.9995327,0.0000020171228,0.000008245906,0.00014848035,0.00006751717,0.00007206822,0.000024045261,0.00000306333,0.000075423064,0.0000016674124],"about_ca_topic_score_codex":0.0052255043,"about_ca_topic_score_gemma":0.0059136357,"teacher_disagreement_score":0.0052255043,"about_ca_system_score_codex":0.00051685947,"about_ca_system_score_gemma":0.00027845858,"threshold_uncertainty_score":0.0103901625},"labels":[],"label_agreement":null},{"id":"W1985294454","doi":"10.1097/01.coc.0000156919.04133.98","title":"On the Apparent Failure of Adjuvant Pelvic Radiotherapy to Improve Survival for Women With Uterine Sarcomas Confined to the Uterus","year":2005,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Radiation therapy; Uterine sarcoma; Bowel obstruction; Chemotherapy; Stage (stratigraphy); Surgery; Uterus; Sarcoma; Internal medicine; Pathology","score_opus":0.0837942170357247,"score_gpt":0.47037349652279087,"score_spread":0.38657927948706616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985294454","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892809,0.0076644905,0.00039511346,0.00053581444,0.000013592268,0.000008379178,0.00008415226,0.00000965702,0.0020079834],"genre_scores_gemma":[0.9971444,0.002167852,0.00014634249,0.00015355455,0.000034337754,0.000003388407,0.000069705886,0.0000020638815,0.00027829278],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985373,0.000073922616,0.000009928729,0.000012477881,0.00002809918,0.00002184963],"domain_scores_gemma":[0.9990133,0.0006966229,0.00013716966,0.000046026595,0.00004936737,0.000057392575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005797692,0.000090834095,0.00011663894,0.00018774103,0.00010384916,0.00012370726,0.00007909866,0.00014595898,0.0009871569],"category_scores_gemma":[0.0024453748,0.000039703016,0.00017350311,0.00018021332,0.00023082276,0.00012944642,0.000087841756,0.00016884906,0.00012974856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031701636,0.00016077836,0.6954794,0.00020236772,0.00023610296,0.0008020112,0.0001972759,0.001789622,0.0058124876,0.00016291997,0.0010089522,0.29097793],"study_design_scores_gemma":[0.00011629319,0.0049999645,0.9858971,0.00007228194,0.00024790244,0.0025861312,0.00013028219,0.00056119426,0.0019235987,0.00015843242,0.0033015162,0.000005269092],"about_ca_topic_score_codex":0.000633486,"about_ca_topic_score_gemma":0.0024146342,"teacher_disagreement_score":0.0009871569,"about_ca_system_score_codex":0.000112897455,"about_ca_system_score_gemma":0.00016789799,"threshold_uncertainty_score":0.0033023357},"labels":[],"label_agreement":null},{"id":"W1985876383","doi":"10.1097/00000421-200006000-00018","title":"A Phase III Study of High-Dose Intensification Without Hematopoietic Progenitor Cells Support for Patients With High-Risk Primary Breast Carcinoma","year":2000,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Etoposide; Cyclophosphamide; Breast cancer; Internal medicine; Breast carcinoma; Chemotherapy; Oncology; Survival rate; Surgery; Carcinoma; Gastroenterology; Cancer","score_opus":0.016501848803620666,"score_gpt":0.34053085781240133,"score_spread":0.3240290090087807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985876383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99430615,0.0011247165,0.00041383412,0.00023505779,0.00011058158,0.0026162844,0.0002834054,0.000038659666,0.0008713017],"genre_scores_gemma":[0.9900733,0.001712749,0.0018564651,0.0006194311,0.00022694837,0.0031777204,0.0009518576,0.000014172887,0.0013673365],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994821,0.00030483626,0.000021665253,0.00006362151,0.000039868875,0.00008792346],"domain_scores_gemma":[0.9991487,0.00020718106,0.00012395557,0.00010871709,0.000052817286,0.00035857744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016773806,0.0011093075,0.0020959487,0.00040163877,0.00034562385,0.0007791043,0.0010272582,0.000990648,0.0030039432],"category_scores_gemma":[0.0010091672,0.00044565427,0.0010845213,0.00050765957,0.001002098,0.00050942495,0.00035251488,0.0027957987,0.00053058134],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7718104,0.1232162,0.0044748387,0.00070702634,0.0011930992,0.00018238465,0.00020091627,0.0018558695,0.022075199,0.00026554862,0.0013980204,0.07262054],"study_design_scores_gemma":[0.5795163,0.41250345,0.0046618315,0.000017285267,0.00028531833,0.000078129364,0.000030061976,0.0004489323,0.0015003313,0.000097932745,0.00085057056,0.00000989816],"about_ca_topic_score_codex":0.0009264034,"about_ca_topic_score_gemma":0.0018642391,"teacher_disagreement_score":0.0030039432,"about_ca_system_score_codex":0.00072976405,"about_ca_system_score_gemma":0.001567103,"threshold_uncertainty_score":0.010049224},"labels":[],"label_agreement":null},{"id":"W1987426472","doi":"10.1097/coc.0b013e3181ec63c5","title":"Analysis of Seed Loss and Pulmonary Seed Migration in Patients Treated With Virtual Needle Guidance and Robotic Seed Delivery","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Population; Surgery","score_opus":0.01800040896527811,"score_gpt":0.33869447888821214,"score_spread":0.32069406992293403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987426472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997204,0.00008153629,0.00010879849,0.000005811699,8.152454e-7,0.0000023198568,0.000011954745,0.0000019698268,0.00006635943],"genre_scores_gemma":[0.9998306,0.000021138821,0.00007695778,0.0000051969623,0.0000025594436,0.000003073266,0.000033569428,9.704496e-7,0.000025974901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996519,0.000101327736,0.00003474747,0.00006250103,0.00008765029,0.000061788654],"domain_scores_gemma":[0.99861,0.00052385475,0.00055933313,0.00006200202,0.00007220551,0.00017249117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038758677,0.00013598005,0.0002771761,0.00045447404,0.0002059864,0.00028664165,0.00019984895,0.00025268542,0.0007809191],"category_scores_gemma":[0.002829716,0.00012985278,0.000286584,0.00034952437,0.00026693993,0.00022949008,0.00024196117,0.00026355876,0.000100636054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005277871,0.00004314041,0.99429506,0.000008286521,0.00002599766,0.00029671594,0.000052404655,0.00013368196,0.00064047537,0.000009523504,0.00003285109,0.0039341087],"study_design_scores_gemma":[0.000025074798,0.0010818393,0.9938922,0.000004258553,0.000045227753,0.0032050735,0.00013306785,0.00083126733,0.0005850331,0.000018968543,0.0001722775,0.0000057367592],"about_ca_topic_score_codex":0.0006472465,"about_ca_topic_score_gemma":0.00070516096,"teacher_disagreement_score":0.0007809191,"about_ca_system_score_codex":0.0003320799,"about_ca_system_score_gemma":0.00022958856,"threshold_uncertainty_score":0.002612412},"labels":[],"label_agreement":null},{"id":"W1987777903","doi":"10.1097/coc.0b013e3181aaca87","title":"Wide Excision or Mohs Micrographic Surgery for the Treatment of Primary Dermatofibrosarcoma Protuberans","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Dermatofibrosarcoma protuberans; Medicine; Mohs surgery; Demographics; Surgery; Retrospective cohort study; Dermatofibrosarcoma; Single Center; Surgical margin; Resection; Dermatology","score_opus":0.09294757353395929,"score_gpt":0.43076728637557304,"score_spread":0.3378197128416138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987777903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828151,0.012848008,0.0016355679,0.00014874704,0.000035478206,0.00003279577,0.000086150605,0.00006006166,0.002338073],"genre_scores_gemma":[0.99533457,0.0032568446,0.00079012854,0.000052272913,0.000054155145,0.000008736721,0.00009751078,0.0000062469144,0.0003996432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989104,0.000021828784,0.000013247355,0.00001909634,0.000029667588,0.00002513024],"domain_scores_gemma":[0.99973446,0.000051447776,0.00013095321,0.000012850493,0.000013194799,0.000056983732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001967088,0.00018946848,0.00020181478,0.0004175738,0.00024978133,0.00017149746,0.00014305729,0.00015596376,0.0026196863],"category_scores_gemma":[0.0005643519,0.00008196558,0.00023955893,0.0002640603,0.00020573653,0.00017983225,0.00018318344,0.0001680503,0.00055143883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087292603,0.00045999006,0.5167758,0.00081939006,0.00034526078,0.031950675,0.0003066451,0.0011031021,0.050546464,0.00021133314,0.003141193,0.39346728],"study_design_scores_gemma":[0.00011750757,0.0033990967,0.66940653,0.00021386548,0.00017465498,0.3060021,0.00039275628,0.0009050709,0.01104153,0.00022364974,0.008099482,0.000023687891],"about_ca_topic_score_codex":0.00022187605,"about_ca_topic_score_gemma":0.0009301229,"teacher_disagreement_score":0.0026196863,"about_ca_system_score_codex":0.00015058967,"about_ca_system_score_gemma":0.00024886755,"threshold_uncertainty_score":0.0087637305},"labels":[],"label_agreement":null},{"id":"W1988939498","doi":"10.1097/coc.0b013e31818a6c93","title":"Acute Leukemia in Patients Sixty Years of Age and Older","year":2009,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Leukemia; Acute leukemia; Induction chemotherapy; Myeloid leukemia; Univariate analysis; Internal medicine; Chemotherapy; Acute lymphocytic leukemia; Retrospective cohort study; Surgery; Cytarabine; Population; Chemotherapy regimen; Multivariate analysis; Gastroenterology; Lymphoblastic Leukemia","score_opus":0.03619018415307079,"score_gpt":0.43539085076266326,"score_spread":0.39920066660959247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988939498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960968,0.0013968649,0.00008638719,0.00016412491,0.000033031545,0.000016772075,0.0002133032,0.000008459016,0.0019843176],"genre_scores_gemma":[0.9981462,0.00088470604,0.00010872428,0.00018403062,0.00006379891,0.00001614243,0.00029618543,0.0000016874252,0.0002985102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998142,0.00003346793,0.0000175039,0.00002201574,0.00004088752,0.00007188929],"domain_scores_gemma":[0.9992987,0.00008685468,0.0003580105,0.00001255427,0.000059100475,0.00018477594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017514419,0.00017785991,0.00022923683,0.00034698108,0.0004752353,0.00033247427,0.000111228976,0.00024756807,0.0019575069],"category_scores_gemma":[0.0011757409,0.00007128266,0.0001559422,0.0006117151,0.00017980071,0.00031202417,0.00026481666,0.00025679285,0.0003037407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050880517,0.000018387713,0.9922064,0.000022482049,0.000008319494,0.0015594008,0.00021313252,0.000023140294,0.00037004118,0.000028645987,0.00041030723,0.005088867],"study_design_scores_gemma":[0.000010933362,0.0001481436,0.98695856,0.00004094097,0.000023003113,0.009489871,0.0005994732,0.00004858042,0.00010249656,0.00004880829,0.0025249345,0.000004147039],"about_ca_topic_score_codex":0.0019194438,"about_ca_topic_score_gemma":0.002965092,"teacher_disagreement_score":0.0019575069,"about_ca_system_score_codex":0.00013553319,"about_ca_system_score_gemma":0.0002986208,"threshold_uncertainty_score":0.006548524},"labels":[],"label_agreement":null},{"id":"W1989898386","doi":"10.1097/00000421-200308001-00006","title":"Role of Biologic Markers in Patient Selection and Application to Disease Prevention","year":2003,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Tamoxifen; Letrozole; Oncology; Internal medicine; Estrogen receptor; Exemestane; Biomarker; Cancer; Cancer research","score_opus":0.009047812129546872,"score_gpt":0.3526773065101224,"score_spread":0.34362949438057555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989898386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40417784,0.33418417,0.11593848,0.0580556,0.0049121045,0.001429671,0.002468567,0.0014064955,0.07742714],"genre_scores_gemma":[0.9026603,0.034950938,0.049930427,0.0045008166,0.002721286,0.0005138119,0.0008856203,0.00009798087,0.0037388736],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9932295,0.0050828196,0.0003605806,0.0003878842,0.0007889132,0.00015032785],"domain_scores_gemma":[0.97868997,0.014455397,0.002145249,0.0009891475,0.0028881829,0.0008322306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015889606,0.00091457355,0.0022120913,0.002292004,0.00051093154,0.002668624,0.0011563892,0.0014176699,0.0030815275],"category_scores_gemma":[0.039645456,0.00034672546,0.00048743666,0.0021695597,0.0007649879,0.0014485415,0.0011796734,0.0019076683,0.0014351754],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013443377,0.0003781556,0.4563303,0.00050884165,0.00025768622,0.00038418395,0.00026187729,0.002385158,0.0007876142,0.003822286,0.008394009,0.5251456],"study_design_scores_gemma":[0.00060370064,0.005096713,0.7615142,0.0030757375,0.0016646334,0.0046216603,0.0014656963,0.05358299,0.0040221885,0.042345885,0.12166818,0.0003383947],"about_ca_topic_score_codex":0.0013101241,"about_ca_topic_score_gemma":0.00093493005,"teacher_disagreement_score":0.015889606,"about_ca_system_score_codex":0.0006724345,"about_ca_system_score_gemma":0.0012782764,"threshold_uncertainty_score":0.08403325},"labels":[],"label_agreement":null},{"id":"W1994362655","doi":"10.1097/coc.0b013e3180653c0d","title":"Improved Survival, Quality of Life, and Quality-Adjusted Survival in Breast Cancer Patients Treated With Efaproxiral (Efaproxyn) Plus Whole-Brain Radiation Therapy for Brain Metastases","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Quality of life (healthcare); Oncology; Brain cancer; Overall survival; Internal medicine; Cancer","score_opus":0.1004793324465885,"score_gpt":0.45342012327607784,"score_spread":0.3529407908294893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994362655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989992,0.00066960906,0.00007364863,0.000047915448,0.0000074353625,0.000023178063,0.00004757427,0.0000022962724,0.00012923792],"genre_scores_gemma":[0.99941957,0.0002133266,0.00012282685,0.00005118276,0.000013541985,0.000028328277,0.00007922134,4.5392443e-7,0.00007152917],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99979466,0.000087634806,0.000015590407,0.000029381208,0.000038370817,0.000034400826],"domain_scores_gemma":[0.99971586,0.00007937621,0.00011520756,0.000010762469,0.000015294685,0.00006350211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004776544,0.00017983447,0.0006446344,0.00016836227,0.00012997814,0.00020293433,0.00011558633,0.00019521103,0.0012449654],"category_scores_gemma":[0.00089351635,0.00009297014,0.0005042458,0.000213453,0.00017314086,0.00016015257,0.00013766145,0.00028402277,0.000095014875],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1588154,0.011410534,0.60197824,0.00062459416,0.0037712615,0.00031749136,0.00024927087,0.002721193,0.030955443,0.00009971743,0.0011412741,0.18791562],"study_design_scores_gemma":[0.015342554,0.12039085,0.8553576,0.000062569015,0.0014314933,0.00075282436,0.00012420323,0.0020298548,0.0032226685,0.0001272226,0.0011357664,0.000022312011],"about_ca_topic_score_codex":0.00036086087,"about_ca_topic_score_gemma":0.0007381661,"teacher_disagreement_score":0.0012449654,"about_ca_system_score_codex":0.00021910816,"about_ca_system_score_gemma":0.00021319489,"threshold_uncertainty_score":0.004164815},"labels":[],"label_agreement":null},{"id":"W1996256198","doi":"10.1097/01.coc.0000180400.18021.ca","title":"Thrombocytopenia","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine","score_opus":0.08929346071015613,"score_gpt":0.5224583237547803,"score_spread":0.43316486304462415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996256198","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08107727,0.080207154,0.01653213,0.033791758,0.0068378015,0.0015050855,0.013869472,0.0029889084,0.7631904],"genre_scores_gemma":[0.6199466,0.03755095,0.006346587,0.035393205,0.0027981687,0.0004995401,0.011013118,0.00045525262,0.2859966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993487,0.000102408594,0.00006849027,0.00012053065,0.00023478299,0.00012500973],"domain_scores_gemma":[0.9989281,0.00023871615,0.000115042036,0.00012277396,0.00042089258,0.00017451994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040478216,0.00064829167,0.00092216395,0.0013601895,0.00087768235,0.00097225583,0.0005413967,0.0012868508,0.06705085],"category_scores_gemma":[0.0036293676,0.00017710024,0.0007700414,0.0009308743,0.00020792375,0.00067220035,0.00037077433,0.0016242802,0.017379224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021983196,0.000692052,0.04699628,0.0010735397,0.0003526545,0.06773986,0.0002258332,0.00040850506,0.01054733,0.0057145613,0.3557888,0.5082622],"study_design_scores_gemma":[0.0004689373,0.0011260663,0.06035277,0.0018876947,0.00046358057,0.29089195,0.00031618561,0.0012694774,0.009129545,0.008002567,0.62593955,0.00015176402],"about_ca_topic_score_codex":0.0027236715,"about_ca_topic_score_gemma":0.0026114166,"teacher_disagreement_score":0.06705085,"about_ca_system_score_codex":0.0006428782,"about_ca_system_score_gemma":0.0007276585,"threshold_uncertainty_score":0.22430742},"labels":[],"label_agreement":null},{"id":"W1998414975","doi":"10.1097/coc.0b013e31826b9b1a","title":"Dose Delivery Analysis of Weekly Versus 3-Weekly Cisplatin Concurrent With Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Nasopharyngeal carcinoma; Cisplatin; Radiation therapy; Toxicity; Mucositis; Gastroenterology; Cumulative dose; Internal medicine; Surgery; Urology; Chemotherapy","score_opus":0.0865808263449861,"score_gpt":0.4472235196646666,"score_spread":0.3606426933196805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998414975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985159,0.0006432433,0.00057672826,0.000019175504,0.0000068106065,0.000028483923,0.00002210508,0.000014180289,0.00017337533],"genre_scores_gemma":[0.99922705,0.00011096608,0.00048950705,0.00001652506,0.0000060040693,0.000015804246,0.00002957029,0.0000062582662,0.00009823187],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99943155,0.00020167073,0.00003967483,0.00008874007,0.0001805716,0.00005772786],"domain_scores_gemma":[0.999456,0.00013632543,0.0002453729,0.00004176432,0.00004746751,0.00007313472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061938603,0.00018973787,0.00044355638,0.00026478132,0.00014432467,0.00037478472,0.00035944558,0.00023387477,0.00079443847],"category_scores_gemma":[0.0013191195,0.00015351202,0.00040929462,0.00027057278,0.00019818835,0.0002554062,0.00018520579,0.00038719922,0.00015754769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06728492,0.00574574,0.24397743,0.0006233199,0.0012514254,0.00040232236,0.00061126554,0.03027402,0.273125,0.0003008747,0.00089531764,0.3755084],"study_design_scores_gemma":[0.0052255285,0.20328607,0.58049977,0.000069061585,0.0016838928,0.0023041507,0.0003421057,0.053160038,0.14789984,0.0002637876,0.0051870616,0.00007878],"about_ca_topic_score_codex":0.0014901331,"about_ca_topic_score_gemma":0.002206769,"teacher_disagreement_score":0.0014901331,"about_ca_system_score_codex":0.0011951352,"about_ca_system_score_gemma":0.0005682587,"threshold_uncertainty_score":0.008671343},"labels":[],"label_agreement":null},{"id":"W1998843791","doi":"10.1097/00000421-200008000-00018","title":"Optic Nerve Sheath Fenestration for a Reversible Optic Neuropathy in Radiation Oncology","year":2000,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Fenestration; Optic neuropathy; Radiation oncology; Surgery; Radiation therapy; Optic nerve; Radiology; Ophthalmology","score_opus":0.056901240496610106,"score_gpt":0.4443909196243589,"score_spread":0.3874896791277488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998843791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9418203,0.02692435,0.007362867,0.0027301516,0.0003127295,0.00012796483,0.00006683118,0.00023873641,0.020416053],"genre_scores_gemma":[0.9900883,0.004921268,0.0030413445,0.0003514086,0.00027511577,0.00003080917,0.000039861054,0.00002301759,0.0012288957],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99978346,0.00005435841,0.00003389047,0.000022017393,0.000050922514,0.00005539682],"domain_scores_gemma":[0.999292,0.0003016124,0.00019478166,0.00010280858,0.000025100628,0.000083669955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043018337,0.00033651412,0.0003192812,0.0007686953,0.0011349331,0.0004923205,0.0005091155,0.001024265,0.0024301843],"category_scores_gemma":[0.0023144237,0.00012872438,0.0005479293,0.000348528,0.0009410877,0.0006816458,0.00042799156,0.0008501443,0.00055863085],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009494134,0.00046278568,0.10285979,0.00085937534,0.000121830955,0.6380459,0.0008711604,0.0009475206,0.011988535,0.0016579094,0.0028659536,0.23836988],"study_design_scores_gemma":[0.000048946025,0.0006534968,0.025963468,0.00006566075,0.000035691024,0.9626366,0.00020236202,0.00028901588,0.0038367042,0.00056939345,0.005679035,0.000019504803],"about_ca_topic_score_codex":0.0006693058,"about_ca_topic_score_gemma":0.002089172,"teacher_disagreement_score":0.0024301843,"about_ca_system_score_codex":0.00036787472,"about_ca_system_score_gemma":0.0007221637,"threshold_uncertainty_score":0.008129716},"labels":[],"label_agreement":null},{"id":"W2002312553","doi":"10.1097/coc.0b013e31816fc920","title":"Meningiomas in 2009","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Meningioma; Radiation therapy; Epidemiology; Translational research; Medical physics; Pathology; Internal medicine","score_opus":0.21918867611229387,"score_gpt":0.549462012006547,"score_spread":0.3302733358942531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002312553","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010528041,0.98309934,0.00032971255,0.0018496972,0.0026696404,0.000018247541,0.00010092962,0.000043486605,0.010836044],"genre_scores_gemma":[0.008583867,0.9692257,0.00071834784,0.0018541946,0.0018780866,0.000017201835,0.00030059315,0.0000095141895,0.017412469],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998204,0.000019605879,0.000030858,0.000028098486,0.000081352744,0.000019673475],"domain_scores_gemma":[0.99983525,0.000027208143,0.000034045748,0.000006325235,0.000064180305,0.00003302027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029058303,0.0007123316,0.0006950556,0.0013980303,0.00035924194,0.000771638,0.0004228268,0.0010391902,0.00454604],"category_scores_gemma":[0.0008536983,0.00015174785,0.00033641883,0.0010799777,0.00027922823,0.00081447104,0.00059784285,0.0011788629,0.0049303295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008690729,0.00003506934,0.000665923,0.0035894744,0.000039437156,0.0036688938,0.00013990223,0.00017300383,0.0019645256,0.003340093,0.104156226,0.88214046],"study_design_scores_gemma":[0.000009834543,0.00004126806,0.00093687116,0.0009274159,0.000028011596,0.0151600065,0.00005939388,0.00003456309,0.00065545394,0.00071987254,0.9814181,0.0000092200735],"about_ca_topic_score_codex":0.003306345,"about_ca_topic_score_gemma":0.006701327,"teacher_disagreement_score":0.00454604,"about_ca_system_score_codex":0.00086814514,"about_ca_system_score_gemma":0.0015523718,"threshold_uncertainty_score":0.0152080655},"labels":[],"label_agreement":null},{"id":"W2002925242","doi":"10.1097/coc.0000000000000176","title":"Long-term Outcomes and Complications in Pediatric Ewing Sarcoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre; Pediatric Oncology Group; University of British Columbia; BC Children's Hospital; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Sarcoma; Hazard ratio; Proportional hazards model; Ewing's sarcoma; Surgery; Confidence interval; Retrospective cohort study; Internal medicine; Radiation therapy; Pelvis; Thorax (insect anatomy); Chemotherapy; Pathology","score_opus":0.1846806744650215,"score_gpt":0.4918671402861975,"score_spread":0.307186465821176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002925242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762446,0.0016883652,0.00014914342,0.000047501282,0.0000045943043,0.0000041296503,0.0001988686,0.0000035328428,0.0002793262],"genre_scores_gemma":[0.99869746,0.00063620455,0.00011778466,0.000018181905,0.000010668142,0.000006729352,0.000448148,0.0000024974586,0.00006224538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996691,0.00006336974,0.000045252564,0.00004609385,0.000098813354,0.000077369776],"domain_scores_gemma":[0.9976901,0.00036619484,0.0014248794,0.000035104335,0.00017340101,0.00031045495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003831186,0.00017763315,0.00025966528,0.0004487656,0.00030881702,0.0004216997,0.00019363404,0.00024218828,0.0006605183],"category_scores_gemma":[0.0025552278,0.000092372575,0.00028680213,0.00054352195,0.0002991434,0.00039538913,0.00036931015,0.00040518655,0.000077481855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039642306,0.000011986356,0.9959616,0.000011527903,0.000020559335,0.00052372226,0.000041164905,0.00010140062,0.00009795344,0.000016889244,0.00007429149,0.0030991652],"study_design_scores_gemma":[0.0000045950455,0.00016342224,0.9923753,0.000023747825,0.00003531976,0.006450932,0.00016871486,0.00016030784,0.000186177,0.00003083216,0.00039685957,0.0000038342655],"about_ca_topic_score_codex":0.0021825046,"about_ca_topic_score_gemma":0.003543517,"teacher_disagreement_score":0.0021825046,"about_ca_system_score_codex":0.0005067125,"about_ca_system_score_gemma":0.00046611414,"threshold_uncertainty_score":0.004339576},"labels":[],"label_agreement":null},{"id":"W2005826254","doi":"10.1097/coc.0b013e318165c01d","title":"Identifying Patients at High Risk for Neutropenic Complications During Chemotherapy for Metastatic Breast Cancer With Doxorubicin or Pegylated Liposomal Doxorubicin","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Neutropenia; Febrile neutropenia; Doxorubicin; Metastatic breast cancer; Chemotherapy; Internal medicine; Absolute neutrophil count; Oncology; Breast cancer; Surgery; Cancer; Gastroenterology","score_opus":0.07790652895789815,"score_gpt":0.4317302272727096,"score_spread":0.3538236983148114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005826254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98489153,0.00033867525,0.013638452,0.00033699864,0.000013538156,0.000081931394,0.00030514775,0.00006699116,0.00032672385],"genre_scores_gemma":[0.99191576,0.00010678085,0.006942464,0.000060980838,0.000013335741,0.00006146721,0.0006124039,0.0000052495657,0.00028154076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995596,0.00019564823,0.000031740994,0.00010539926,0.00005799495,0.00004964409],"domain_scores_gemma":[0.99801564,0.0013052182,0.00038490669,0.00004766733,0.00012257374,0.00012398302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010179324,0.00046299928,0.0007250631,0.00041544507,0.0001553979,0.00060115143,0.00054183265,0.000517434,0.0006007038],"category_scores_gemma":[0.0052480344,0.00021222989,0.00059862254,0.00025699002,0.00013440682,0.00021880919,0.00035467264,0.00057242275,0.000103065555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014648272,0.0005093853,0.8150933,0.00006818508,0.00036347375,0.00018688261,0.00008862649,0.120069854,0.0008451925,0.0001995955,0.0013308347,0.059779916],"study_design_scores_gemma":[0.0002311267,0.0007648433,0.13778447,0.000024117397,0.0002860732,0.00027666308,0.00004688679,0.85890347,0.000523849,0.0005458329,0.0005923941,0.0000202196],"about_ca_topic_score_codex":0.005626305,"about_ca_topic_score_gemma":0.005974009,"teacher_disagreement_score":0.005626305,"about_ca_system_score_codex":0.0005208545,"about_ca_system_score_gemma":0.0010061053,"threshold_uncertainty_score":0.011187077},"labels":[],"label_agreement":null},{"id":"W2008982889","doi":"10.1097/coc.0b013e31823a538e","title":"A Pragmatic Contouring Guideline for Salivary Gland Structures in Head and Neck Radiation Oncology","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Contouring; Head and neck; Radiation oncology; Salivary gland; Guideline; Head and neck cancer; Radiation therapy; Oncology; Radiology; Medical physics; Internal medicine; Surgery; Pathology","score_opus":0.07853237659563761,"score_gpt":0.5036404840520283,"score_spread":0.4251081074563907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008982889","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033638783,0.04606261,0.6183283,0.17717232,0.0135078,0.0147045795,0.0039454866,0.0039308164,0.088709354],"genre_scores_gemma":[0.050418656,0.013100862,0.90320903,0.013818892,0.0015012537,0.005749632,0.0028546578,0.00040839546,0.008938618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939786,0.002495393,0.0014074453,0.00017581502,0.0017604011,0.00018227726],"domain_scores_gemma":[0.99023926,0.0023448537,0.00074349105,0.00057944166,0.0055428077,0.00055010425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009755105,0.0011714742,0.0010522888,0.0025827806,0.0011238727,0.0017330353,0.005669416,0.0057944614,0.003584609],"category_scores_gemma":[0.020155177,0.00061534636,0.001534226,0.001790327,0.0013227358,0.0021394019,0.0016823387,0.0062155374,0.003895069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021906021,0.0006264687,0.008796976,0.0029080564,0.00007436903,0.0031615973,0.0025765598,0.007087152,0.01478112,0.011847544,0.43057463,0.51734644],"study_design_scores_gemma":[0.0003721502,0.00060239027,0.033416286,0.0076646004,0.00023219993,0.012985783,0.003071666,0.011145523,0.0053029964,0.021250548,0.9036924,0.0002634821],"about_ca_topic_score_codex":0.005967724,"about_ca_topic_score_gemma":0.01312665,"teacher_disagreement_score":0.009755105,"about_ca_system_score_codex":0.0018087882,"about_ca_system_score_gemma":0.0072578117,"threshold_uncertainty_score":0.051590562},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2010082810","doi":"10.1097/01.coc.0000071464.83271.08","title":"Effect of Capecitabine on Mean Corpuscular Volume in Patients With Metastatic Breast Cancer","year":2004,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Capecitabine; Metastatic breast cancer; Mean corpuscular volume; Breast cancer; Oncology; Internal medicine; Cancer; Colorectal cancer; Hemoglobin","score_opus":0.02125211244019987,"score_gpt":0.4226104372930836,"score_spread":0.40135832485288375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010082810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895918,0.009683858,0.00005284989,0.00009161674,0.000014847958,0.000011746463,0.00008309017,0.0000056001386,0.00046465432],"genre_scores_gemma":[0.99901426,0.0007463555,0.000065959175,0.000036534486,0.000021790496,0.0000038023,0.00006404649,0.0000010372629,0.000046234243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969864,0.0001307875,0.00003467514,0.00004376148,0.00007019597,0.000021933669],"domain_scores_gemma":[0.9983612,0.0008081682,0.0005343782,0.00003833587,0.00009693616,0.00016103244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055701216,0.0001379391,0.0004963502,0.00035026475,0.00015166843,0.00027253968,0.00013096597,0.00017199545,0.00042696384],"category_scores_gemma":[0.0038621123,0.00012076843,0.00021498406,0.00040104668,0.00013853729,0.00018268457,0.00009940654,0.00024617274,0.0000714832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030794842,0.000089059395,0.9687612,0.000099377285,0.00020629763,0.00071128877,0.00006938851,0.00016420397,0.0029174937,0.000022098346,0.00034634568,0.0235337],"study_design_scores_gemma":[0.0000589412,0.0013086322,0.99605644,0.00001750518,0.000107342414,0.0012051346,0.00003439043,0.00023461487,0.00042723666,0.000014680653,0.00053061784,0.000004373578],"about_ca_topic_score_codex":0.0009981338,"about_ca_topic_score_gemma":0.0022527934,"teacher_disagreement_score":0.0009981338,"about_ca_system_score_codex":0.00030971927,"about_ca_system_score_gemma":0.0001843622,"threshold_uncertainty_score":0.0029457808},"labels":[],"label_agreement":null},{"id":"W2010224434","doi":"10.1097/01.coc.0000264177.66369.18","title":"Prognostic Significance of Blood Transfusions in Patients With Esophageal Cancer Treated With Combined Chemoradiotherapy","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Blood transfusion and management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Esophageal cancer; Blood transfusion; Anemia; Hemoglobin; Proportional hazards model; Chemoradiotherapy; Chemotherapy; Gastroenterology; Surgery; Confidence interval; Cancer","score_opus":0.021697913088871906,"score_gpt":0.3624572559212692,"score_spread":0.3407593428323973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010224434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873596,0.0008553392,0.0000744282,0.000060643608,0.000006751307,0.0000033547688,0.00004619999,0.0000042900533,0.00021300977],"genre_scores_gemma":[0.999663,0.00012565443,0.00005426004,0.000018607489,0.000016745154,0.0000033114814,0.00007742245,0.0000011192969,0.000039858944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995913,0.00015070634,0.000054629247,0.000043588432,0.0000995958,0.000060173894],"domain_scores_gemma":[0.9969319,0.0008845927,0.0016009213,0.000072229785,0.00016999363,0.00034038222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044314726,0.00018462465,0.0002815231,0.0004459186,0.00028721668,0.0004012633,0.00018136052,0.00035467924,0.0008800053],"category_scores_gemma":[0.003916012,0.00011427004,0.00030286887,0.0005934878,0.00026627546,0.0002584947,0.0002335185,0.00045783038,0.00012113657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020645805,0.000016296382,0.9977131,0.000004843893,0.000028657558,0.00012482572,0.000016592097,0.00005943984,0.00012080307,0.000004994319,0.00005878658,0.0016451097],"study_design_scores_gemma":[0.000017529512,0.00030366558,0.9967867,0.000012209687,0.00007338168,0.0018383687,0.000071974086,0.0005443895,0.0001616593,0.000017116712,0.00016855002,0.0000044281787],"about_ca_topic_score_codex":0.0007961198,"about_ca_topic_score_gemma":0.00095891417,"teacher_disagreement_score":0.0008800053,"about_ca_system_score_codex":0.000207872,"about_ca_system_score_gemma":0.00021789566,"threshold_uncertainty_score":0.002943933},"labels":[],"label_agreement":null},{"id":"W2011633310","doi":"10.1097/01.coc.0000214929.01001.16","title":"Lymph Node-Based Prognostics: Limitations With Individualized Cancer Treatment","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Prognostics; Medicine; Cancer; Hazard ratio; Population; Oncology; Lymph node; Epidemiology; Internal medicine; Data mining; Confidence interval; Computer science","score_opus":0.05968720173358793,"score_gpt":0.39984216364182573,"score_spread":0.3401549619082378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011633310","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18954527,0.093643524,0.55770034,0.10954391,0.0028093148,0.0013861844,0.0050055664,0.0011874537,0.0391784],"genre_scores_gemma":[0.8933687,0.009295653,0.08634419,0.0059299297,0.0019860368,0.0009786536,0.0006391425,0.00013098035,0.0013267826],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9253983,0.057826523,0.0037581977,0.0034796863,0.008988413,0.00054872746],"domain_scores_gemma":[0.8267546,0.13777941,0.008058501,0.019447535,0.0070367386,0.00092320755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08074474,0.0011697337,0.0025425015,0.0023013866,0.0009126637,0.002905696,0.0027834307,0.0011171104,0.0024746682],"category_scores_gemma":[0.1446923,0.00049920427,0.0013436191,0.0021357322,0.0043218266,0.0035390412,0.0029645013,0.0037431847,0.00086018443],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015603513,0.00020733308,0.19774121,0.0034465042,0.0020036157,0.00016352824,0.0016331776,0.018363003,0.0015794649,0.027193353,0.011330674,0.7347777],"study_design_scores_gemma":[0.00073616725,0.0027941104,0.38655984,0.0057359533,0.002633729,0.003406617,0.0026508279,0.076504365,0.0047092102,0.418791,0.09491147,0.0005666644],"about_ca_topic_score_codex":0.0015912676,"about_ca_topic_score_gemma":0.0019249226,"teacher_disagreement_score":0.08074474,"about_ca_system_score_codex":0.0014545337,"about_ca_system_score_gemma":0.001953322,"threshold_uncertainty_score":0.42702413},"labels":[],"label_agreement":null},{"id":"W2012930674","doi":"10.1097/00000421-200102000-00014","title":"Osteoclastic Giant Cell Tumor of the Pancreas","year":2001,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Western University","funders":"","keywords":"Medicine; Giant cell; Pancreas; Pathology; Neoplasm; Laparotomy; Nodule (geology); Cyst; Natural history; Multinucleate; Radiology; Internal medicine","score_opus":0.1708670587541031,"score_gpt":0.5238023298579096,"score_spread":0.3529352711038065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012930674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005096445,0.98917234,0.00040868061,0.0006508705,0.00035155928,0.0000110806905,0.000028103143,0.00003478814,0.0042461054],"genre_scores_gemma":[0.030169467,0.9646828,0.00057373266,0.0006603666,0.00074421265,0.00001128583,0.000065612214,0.0000039670144,0.0030884552],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9998939,0.0000148577565,0.000017803923,0.000017197995,0.000042554813,0.000013706901],"domain_scores_gemma":[0.9998609,0.000047318077,0.00003872393,0.0000066076764,0.00002335914,0.000023060065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012909892,0.00071694155,0.0008446987,0.0018592735,0.00025397667,0.0005640655,0.0005048641,0.0007776113,0.0015772209],"category_scores_gemma":[0.00039110353,0.00017788602,0.00019802063,0.0020278832,0.00033005927,0.0008816595,0.0002889517,0.0004727616,0.0014092509],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008808343,0.000101164354,0.004021587,0.0096145095,0.00012305826,0.12655263,0.00027968545,0.00033486832,0.0058606477,0.00092750846,0.03657451,0.8155217],"study_design_scores_gemma":[0.000047887315,0.000152727,0.009623796,0.0019719487,0.00019220637,0.6307752,0.00038109976,0.00015836027,0.001326661,0.0011558908,0.35418192,0.00003224887],"about_ca_topic_score_codex":0.0010491858,"about_ca_topic_score_gemma":0.0024153742,"teacher_disagreement_score":0.0018592735,"about_ca_system_score_codex":0.00024175661,"about_ca_system_score_gemma":0.0006663212,"threshold_uncertainty_score":0.005276382},"labels":[],"label_agreement":null},{"id":"W2014560120","doi":"10.1097/coc.0b013e31825d5664","title":"Intermittent LHRH Therapy in the Management of Castrate-resistant Prostate Cancer (CRPCa)","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Capital District Health Authority","funders":"","keywords":"Medicine; Prostate cancer; Androgen deprivation therapy; Quality of life (healthcare); Randomized controlled trial; Testosterone (patch); Castration; Hormone therapy; Androgen suppression; Internal medicine; Cancer; Urology; Surgery; Gynecology; Hormone; Breast cancer","score_opus":0.14756225226109435,"score_gpt":0.5198408230466267,"score_spread":0.3722785707855324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014560120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851311,0.0138505045,0.00017683113,0.00015562563,0.000048847247,0.00015778239,0.00006356408,0.00002095917,0.00039477527],"genre_scores_gemma":[0.99681973,0.0022169785,0.0004369415,0.000109810884,0.00012682902,0.000105808336,0.00007411967,0.0000014281571,0.000108324224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996978,0.00016228705,0.000029597992,0.000027269498,0.000054867738,0.00002829153],"domain_scores_gemma":[0.9991992,0.0002921367,0.00028031433,0.000037377846,0.000019015928,0.00017199123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007539015,0.00029231887,0.00059859233,0.00023181413,0.0001960624,0.00030306785,0.00041718807,0.00037457328,0.0012418365],"category_scores_gemma":[0.0013002217,0.00013111554,0.00043786774,0.00025417894,0.0003635965,0.00021417631,0.0002344099,0.00071752566,0.00010373326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36083212,0.010811231,0.045615602,0.0029068314,0.0015602647,0.00043391268,0.00025371878,0.002152694,0.010216982,0.00025822403,0.0013119034,0.5636465],"study_design_scores_gemma":[0.22700003,0.58054966,0.1774988,0.0005161336,0.0017664188,0.0016203844,0.00016114216,0.0021965886,0.0026962813,0.0004875367,0.005465033,0.000041897325],"about_ca_topic_score_codex":0.00040536816,"about_ca_topic_score_gemma":0.00089326984,"teacher_disagreement_score":0.0012418365,"about_ca_system_score_codex":0.00023281509,"about_ca_system_score_gemma":0.00036532644,"threshold_uncertainty_score":0.0041543245},"labels":[],"label_agreement":null},{"id":"W2018978133","doi":"10.1097/coc.0b013e31819fdfc8","title":"Adenoid Cystic Breast Carcinoma","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Lumpectomy; Adenoid cystic carcinoma; Mastectomy; Surgical margin; Radiology; Malignancy; Lymph node; Breast cancer; Axillary lymph nodes; Surgery; Carcinoma; Cancer; Pathology; Internal medicine","score_opus":0.041360279461833946,"score_gpt":0.4241760238769706,"score_spread":0.38281574441513666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018978133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9208491,0.02232272,0.0020344174,0.0011270223,0.0001821145,0.0002258897,0.0024715462,0.00018999938,0.050597213],"genre_scores_gemma":[0.99404967,0.0025537608,0.00055296987,0.0001809452,0.000046486217,0.000018152221,0.0005134582,0.000006499553,0.0020781816],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99979764,0.000014877196,0.000019223828,0.000040420746,0.00007388599,0.000053951488],"domain_scores_gemma":[0.99951375,0.00010256392,0.00015811411,0.000052834068,0.000093687195,0.00007905958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014142349,0.00026040358,0.0002787024,0.0007620844,0.0005092781,0.00042890193,0.00022730199,0.00024501997,0.0069655045],"category_scores_gemma":[0.0011303148,0.00010461758,0.00013765608,0.00090161985,0.0004597939,0.00029927288,0.0003579833,0.0002641459,0.0017081172],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003338824,0.000076171586,0.6201383,0.0010706615,0.00008562355,0.24805245,0.00056334544,0.00028749197,0.022812761,0.0014417282,0.008081057,0.097056605],"study_design_scores_gemma":[0.0000388409,0.00008284083,0.18678911,0.00023237761,0.00006122331,0.7813485,0.00036448106,0.0002495631,0.0030303493,0.0006817645,0.02710209,0.000018787085],"about_ca_topic_score_codex":0.006542925,"about_ca_topic_score_gemma":0.008276833,"teacher_disagreement_score":0.0069655045,"about_ca_system_score_codex":0.00070313265,"about_ca_system_score_gemma":0.0010341874,"threshold_uncertainty_score":0.023301959},"labels":[],"label_agreement":null},{"id":"W2021090582","doi":"10.1097/coc.0000000000000084","title":"Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Saint John Regional Hospital","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Stage (stratigraphy); Radiation therapy; Chemotherapy; Oncology; Urology; Gynecology; Surgery; Cancer","score_opus":0.02309644594306763,"score_gpt":0.3847027238428795,"score_spread":0.36160627789981187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021090582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990415,0.00034287543,0.00007287572,0.000033448694,0.0000068593754,0.000008534417,0.00015106308,0.0000034576174,0.0003392894],"genre_scores_gemma":[0.9994822,0.00007316469,0.000053683427,0.000022389253,0.000008864785,0.0000064375186,0.00019913979,0.0000014753351,0.00015277912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994399,0.00021540782,0.000053476357,0.00006039784,0.00014369891,0.00008708426],"domain_scores_gemma":[0.9970765,0.000667824,0.0016512616,0.00008211305,0.00017564742,0.00034671422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001298332,0.00019372029,0.00029267638,0.00026753254,0.00015202376,0.00031385903,0.00021726749,0.00032262868,0.0017315388],"category_scores_gemma":[0.004260324,0.00009892824,0.0006018632,0.00029591873,0.00023188001,0.00031812326,0.0002802051,0.00032288316,0.00022956733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003252006,0.00042973316,0.9699804,0.0000912882,0.00035614954,0.00025074027,0.00023644287,0.0009642031,0.0015863528,0.000015724578,0.00031160493,0.022525262],"study_design_scores_gemma":[0.000043441425,0.00211757,0.9964586,0.000006707764,0.00006927278,0.00049981184,0.0001078042,0.0002128082,0.00025669372,0.0000090857275,0.0002096912,0.000008528685],"about_ca_topic_score_codex":0.00076336396,"about_ca_topic_score_gemma":0.0013964688,"teacher_disagreement_score":0.0017315388,"about_ca_system_score_codex":0.0002781113,"about_ca_system_score_gemma":0.000113000635,"threshold_uncertainty_score":0.006866336},"labels":[],"label_agreement":null},{"id":"W2021935540","doi":"10.1097/coc.0b013e31818c0926","title":"Lipoleiomyosarcoma of the Rectosigmoid Colon","year":2009,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Rectosigmoid Colon; Rectum; General surgery; Internal medicine","score_opus":0.1703578698974657,"score_gpt":0.523724642128763,"score_spread":0.3533667722312973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021935540","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037326228,0.99318624,0.00022881947,0.00028207482,0.00010869841,0.000008309406,0.000016513302,0.000012729923,0.0024240322],"genre_scores_gemma":[0.023276191,0.97432137,0.0006353651,0.00021916897,0.00027293322,0.000011097853,0.000051701805,0.0000018342488,0.0012102154],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99988043,0.00002284922,0.000024918008,0.000019869287,0.000041037547,0.00001092306],"domain_scores_gemma":[0.9998242,0.00005949584,0.000060651124,0.000004206667,0.00003326572,0.00001814159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020891457,0.00038574336,0.0005402672,0.0015947677,0.00017026387,0.0003244603,0.00033842726,0.00041778822,0.0015605103],"category_scores_gemma":[0.0005852442,0.00013024178,0.00016881396,0.0014202482,0.00021837465,0.00050753716,0.00021509724,0.0003407214,0.0011150956],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075996926,0.000051798423,0.0044113686,0.011725047,0.00009747958,0.019840673,0.00014170432,0.0003662004,0.006103189,0.0005803237,0.012045728,0.9445605],"study_design_scores_gemma":[0.000070112284,0.00037312962,0.0245683,0.009970174,0.00038534004,0.34561896,0.000658373,0.00034802398,0.003963601,0.0010758223,0.6129194,0.000048653863],"about_ca_topic_score_codex":0.0010332617,"about_ca_topic_score_gemma":0.001982733,"teacher_disagreement_score":0.0015947677,"about_ca_system_score_codex":0.00023119764,"about_ca_system_score_gemma":0.00082150596,"threshold_uncertainty_score":0.005220413},"labels":[],"label_agreement":null},{"id":"W2024642727","doi":"10.1097/01.coc.0000139487.56328.5e","title":"Radiotherapy-Induced ID Reaction","year":2005,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radiation therapy; Skin reaction; Dermatology; Surgery","score_opus":0.07078119933036933,"score_gpt":0.468992687439074,"score_spread":0.39821148810870466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024642727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8811907,0.029009087,0.01623649,0.0011291604,0.0005925466,0.00036646414,0.00046694308,0.0011124854,0.06989609],"genre_scores_gemma":[0.9933663,0.002252074,0.00093746313,0.0006799197,0.000104229635,0.000022680711,0.000081263046,0.000049075585,0.0025069374],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997603,0.00007034539,0.000018935014,0.00004619386,0.00004796439,0.00005623463],"domain_scores_gemma":[0.9993291,0.00023224768,0.00019182806,0.00016406718,0.000039622253,0.0000431708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025001244,0.00040521284,0.00045613002,0.00028795426,0.00038520352,0.00032855355,0.00027557847,0.0006779792,0.003082653],"category_scores_gemma":[0.0012374794,0.00015421082,0.0007159253,0.00028354605,0.0005411671,0.00027152122,0.0004138022,0.0010994305,0.0010060142],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017563526,0.00037368276,0.06783378,0.0026510223,0.00028698522,0.6898154,0.001079803,0.0019701158,0.11986769,0.0030632839,0.006710324,0.10459154],"study_design_scores_gemma":[0.00010535733,0.0011794394,0.0464599,0.00011475333,0.00017214824,0.8984249,0.00014078175,0.00054283184,0.03189112,0.00059870025,0.020342903,0.000027096992],"about_ca_topic_score_codex":0.00043003046,"about_ca_topic_score_gemma":0.00055940665,"teacher_disagreement_score":0.003082653,"about_ca_system_score_codex":0.00048042773,"about_ca_system_score_gemma":0.00020732015,"threshold_uncertainty_score":0.010312557},"labels":[],"label_agreement":null},{"id":"W2027298049","doi":"10.1097/coc.0b013e31819e902d","title":"Primary Tumor Resection in Patients Presenting With Metastatic Colorectal Cancer","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Colorectal cancer; Chemotherapy; Surgery; Cancer; Cohort; Radiation therapy; Cancer registry; Primary tumor; Retrospective cohort study; Resection; Internal medicine; Metastasis","score_opus":0.039402056543300944,"score_gpt":0.4231073212999518,"score_spread":0.3837052647566509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027298049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99829847,0.00038969633,0.000040408548,0.00014526151,0.0000071025374,0.000014091554,0.00043234334,0.0000059388476,0.00066673063],"genre_scores_gemma":[0.9992091,0.00021903693,0.00006427501,0.00006280321,0.000009720339,0.0000055410287,0.00032000555,0.0000014841656,0.00010808559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996896,0.000022204675,0.000013929734,0.00004737381,0.000107081156,0.00011981317],"domain_scores_gemma":[0.99930453,0.000049992977,0.0002730765,0.00001379601,0.00011691701,0.0002417476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014767067,0.00021490843,0.0002770519,0.0004887438,0.00093223975,0.00047622752,0.00037549282,0.0003475636,0.0019132831],"category_scores_gemma":[0.0011312562,0.00014878286,0.000210907,0.0011721719,0.00037247044,0.0001687607,0.00026919282,0.00043422633,0.00017142683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002298801,0.000015224593,0.99786466,0.000013479292,0.000008147669,0.00025808145,0.00006307079,0.000026474889,0.00016142026,0.0000071618706,0.00023285941,0.0013264205],"study_design_scores_gemma":[0.000005417413,0.00004424472,0.9978314,0.000011098745,0.000008625644,0.0013357463,0.0002884205,0.00009352737,0.000045564386,0.000009172709,0.00032361285,0.000003091557],"about_ca_topic_score_codex":0.47624585,"about_ca_topic_score_gemma":0.58741474,"teacher_disagreement_score":0.47624585,"about_ca_system_score_codex":0.002341334,"about_ca_system_score_gemma":0.0036898453,"threshold_uncertainty_score":0.9469476},"labels":[],"label_agreement":null},{"id":"W2029339227","doi":"10.1097/coc.0b013e318199fb84","title":"S9511","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Regimen; Neutropenia; Gastroenterology; Internal medicine; Bolus (digestion); Toxicity; Surgery; Perforation; Stomach; Performance status; Chemotherapy","score_opus":0.06832863086102609,"score_gpt":0.4826672435239714,"score_spread":0.4143386126629453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029339227","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6939655,0.015860727,0.001736208,0.00665408,0.0027763394,0.005543414,0.013491189,0.0006552383,0.25931734],"genre_scores_gemma":[0.71962863,0.004757239,0.0032016905,0.008797762,0.0012070264,0.0036761055,0.02140512,0.00014974749,0.23717669],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971515,0.00011375477,0.000022839453,0.00004517242,0.00005527842,0.000047712678],"domain_scores_gemma":[0.99973387,0.00004482861,0.000036160403,0.000015920967,0.00003491928,0.00013432812],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054260244,0.00048646075,0.0005837877,0.00025241115,0.00026682415,0.0004905068,0.00032697368,0.000889662,0.12456946],"category_scores_gemma":[0.00051477406,0.00011300764,0.00041368246,0.00027338992,0.00025271988,0.00024886685,0.00024946718,0.0009719896,0.020360392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1533515,0.011605293,0.013124312,0.001750149,0.0005013553,0.00057643105,0.00011147728,0.0010352319,0.01991543,0.002913837,0.11912906,0.67598605],"study_design_scores_gemma":[0.23414613,0.23490167,0.030076824,0.00084318116,0.00073621876,0.0015404276,0.00012436091,0.0017368236,0.010271238,0.0016829217,0.4838952,0.000045005676],"about_ca_topic_score_codex":0.00036118767,"about_ca_topic_score_gemma":0.0010451807,"teacher_disagreement_score":0.8754305,"about_ca_system_score_codex":0.00029611122,"about_ca_system_score_gemma":0.00079268526,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2029370731","doi":"10.1097/00000421-200010000-00012","title":"Acute Spontaneous Tumor Lysis Syndrome in Adenocarcinoma of the Lung","year":2000,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Tumor lysis syndrome; Adenocarcinoma; Lung; Adenocarcinoma of the lung; Lysis; Pathology; Internal medicine; Oncology; Chemotherapy; Immunology; Cancer","score_opus":0.02485707856460666,"score_gpt":0.37952115369733314,"score_spread":0.35466407513272646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029370731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98521703,0.004479651,0.0028272236,0.001111967,0.00015702515,0.000089908,0.00008722845,0.00013783007,0.0058921003],"genre_scores_gemma":[0.9979988,0.0009123416,0.00027485704,0.00019542342,0.0002502621,0.000010829447,0.000040547216,0.000005435997,0.0003115189],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997372,0.00005385431,0.000039438848,0.000044169083,0.000050678893,0.000074717485],"domain_scores_gemma":[0.99855155,0.0004260455,0.000480578,0.000108360306,0.000096672586,0.00033685943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026286463,0.000769931,0.00053376606,0.0009780462,0.00093849865,0.00075447577,0.00050983543,0.0017823117,0.0013083334],"category_scores_gemma":[0.0028004078,0.00041302052,0.00041539496,0.0007336491,0.0010504904,0.0009232602,0.0006303888,0.001509788,0.00044840918],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010349195,0.000060263876,0.050949723,0.00004928107,0.000018474462,0.94336253,0.0001700063,0.00016382062,0.0019177874,0.0003449582,0.00027680406,0.0025829512],"study_design_scores_gemma":[0.000027136784,0.00019862644,0.019740064,0.000012734496,0.000014813143,0.9780109,0.00010218993,0.0003389844,0.00087624684,0.00017098829,0.00049723167,0.000010084956],"about_ca_topic_score_codex":0.0011073168,"about_ca_topic_score_gemma":0.0011474824,"teacher_disagreement_score":0.0017823117,"about_ca_system_score_codex":0.00057271356,"about_ca_system_score_gemma":0.0007144279,"threshold_uncertainty_score":0.004376769},"labels":[],"label_agreement":null},{"id":"W2030403305","doi":"10.1097/coc.0b013e318282a830","title":"Sex-based Disparities in Colorectal Cancer Screening","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Sigmoidoscopy; Demography; Fecal occult blood; Colonoscopy; Cohort; Colorectal cancer; Confounding; Population; Logistic regression; Gerontology; Odds ratio; Cancer; Internal medicine; Environmental health","score_opus":0.06352729270048085,"score_gpt":0.4281057249179441,"score_spread":0.3645784322174632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030403305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917454,0.003558876,0.00014674877,0.0005729786,0.000022896334,0.000007235506,0.0005688464,0.0000069280713,0.0033700482],"genre_scores_gemma":[0.9991178,0.00047328728,0.00004055708,0.00006096845,0.000015385527,0.0000018330304,0.00016096554,0.0000011349711,0.00012809169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999742,0.000057117515,0.000018798284,0.00006662778,0.000049661106,0.00006573596],"domain_scores_gemma":[0.9994124,0.00013954502,0.00026855664,0.000026772643,0.000056007222,0.000096684445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038888454,0.00010173175,0.00016302358,0.0005850652,0.00019972627,0.00029528548,0.00012650352,0.00016518746,0.0030526067],"category_scores_gemma":[0.0014031109,0.000061489605,0.00019394336,0.00050599186,0.00020528662,0.00021259283,0.00028368612,0.00016592832,0.00013898079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062177016,0.000027886314,0.9900513,0.00004378752,0.00008475482,0.000060023067,0.00020209103,0.00006377308,0.00020919264,0.0003172281,0.0003926217,0.008485213],"study_design_scores_gemma":[0.0000047188987,0.000029394476,0.9984316,0.000027458724,0.000028257045,0.00013458125,0.0001488104,0.00009825004,0.00004898619,0.0003171127,0.0007284253,0.0000023573612],"about_ca_topic_score_codex":0.0070744622,"about_ca_topic_score_gemma":0.010664543,"teacher_disagreement_score":0.0070744622,"about_ca_system_score_codex":0.00022015878,"about_ca_system_score_gemma":0.0002715041,"threshold_uncertainty_score":0.014066577},"labels":[],"label_agreement":null},{"id":"W2030878921","doi":"10.1097/coc.0b013e3181b0c370","title":"Does a Three-Field Electron/Minitangent Photon Technique Offer Dosimetric Advantages to a Multifield, Photon-Only Technique for Accelerated Partial Breast Irradiation?","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Nuclear medicine; Dosimetry; Breast cancer; Irradiation; Radiation therapy; Photon; Radiology; Cancer; Optics; Internal medicine; Physics","score_opus":0.0231191773281977,"score_gpt":0.40161043696538057,"score_spread":0.3784912596371829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030878921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941479,0.0019477494,0.0028945934,0.00017971823,0.000016977492,0.00002088098,0.000017487157,0.000028098322,0.0007466197],"genre_scores_gemma":[0.9955804,0.00065150147,0.0034085973,0.00007154815,0.00002805296,0.000018088307,0.000019238181,0.0000089546675,0.00021380141],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998116,0.000085951164,0.000010108845,0.000026638698,0.0000487048,0.00001696014],"domain_scores_gemma":[0.9994411,0.00028105095,0.0001524352,0.000057422625,0.000021689111,0.00004636215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006467899,0.00011441898,0.00020502762,0.00014400012,0.000061969484,0.00020004589,0.0002155444,0.00027996182,0.0018776897],"category_scores_gemma":[0.0013028973,0.000096982505,0.00022256718,0.0001463566,0.00021568622,0.00030668953,0.00012259904,0.00021941925,0.00023011805],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017440105,0.0017349734,0.19753426,0.00096716866,0.00058527524,0.0006279907,0.00034816013,0.002922525,0.21853407,0.00075860525,0.00062981877,0.55791706],"study_design_scores_gemma":[0.0026990096,0.062807865,0.79172325,0.0001941729,0.001011758,0.022054221,0.0006294683,0.008074354,0.09747058,0.0010407962,0.012213156,0.00008135308],"about_ca_topic_score_codex":0.00017714332,"about_ca_topic_score_gemma":0.00050726655,"teacher_disagreement_score":0.0018776897,"about_ca_system_score_codex":0.00009220106,"about_ca_system_score_gemma":0.0001433111,"threshold_uncertainty_score":0.006281495},"labels":[],"label_agreement":null},{"id":"W2031270583","doi":"10.1097/coc.0b013e31807a2f49","title":"Neuroendocrine Tumors of the Gastrointestinal Tract","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Gastrointestinal tract; Neuroendocrine tumors; Internal medicine; Pathology; Gastroenterology","score_opus":0.08907959381622788,"score_gpt":0.4520346795353134,"score_spread":0.3629550857190855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031270583","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98271424,0.013601463,0.00060740556,0.00025941685,0.000025207873,0.00001971986,0.0003300791,0.000026832005,0.0024156456],"genre_scores_gemma":[0.994239,0.0043421094,0.00046476076,0.00009518548,0.000051958756,0.00000907323,0.00027108012,0.000003084192,0.00052381237],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991786,0.00001663192,0.000014048609,0.0000120826935,0.000024931991,0.000014386673],"domain_scores_gemma":[0.9995938,0.000077329576,0.00021747805,0.000012541963,0.0000444196,0.000054448225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014382762,0.00013224283,0.00014946752,0.00020791838,0.00016903576,0.00023309939,0.00015014704,0.00011563484,0.0011021553],"category_scores_gemma":[0.000682232,0.000055673536,0.000089268695,0.00042810457,0.00015610378,0.00018194871,0.00015628265,0.00012787862,0.0003337621],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020364384,0.000029849538,0.9175002,0.00039216445,0.000081980106,0.022828585,0.00022039379,0.00037114092,0.0066846283,0.00015083657,0.0018934424,0.049643144],"study_design_scores_gemma":[0.000034066208,0.00029500702,0.80647683,0.00022923171,0.00008552172,0.17395008,0.00034756644,0.00032959788,0.0022199778,0.0001922443,0.015827067,0.000012905459],"about_ca_topic_score_codex":0.00077067345,"about_ca_topic_score_gemma":0.0014172136,"teacher_disagreement_score":0.0011021553,"about_ca_system_score_codex":0.0001714319,"about_ca_system_score_gemma":0.0002575262,"threshold_uncertainty_score":0.0036870837},"labels":[],"label_agreement":null},{"id":"W2031688279","doi":"10.1097/coc.0000000000000169","title":"Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Radiosurgery; Dose fractionation; Medical physics; Radiation therapy; Radiology","score_opus":0.18220526878716964,"score_gpt":0.5007683855363978,"score_spread":0.31856311674922816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031688279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97359383,0.013190515,0.0021241638,0.0010970361,0.000045728513,0.00009889349,0.0009353927,0.00010130049,0.008813134],"genre_scores_gemma":[0.9917847,0.0049235076,0.0014440037,0.00039773734,0.000032836622,0.00003755289,0.0005588648,0.000014831258,0.0008059449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927515,0.000264819,0.00010296187,0.00008098088,0.00019257654,0.00008352703],"domain_scores_gemma":[0.9974058,0.0006975978,0.0012616803,0.00009732198,0.0002543246,0.00028327538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091770024,0.00014984969,0.00021250527,0.0005690164,0.00020737412,0.00023203815,0.0002807889,0.00024555952,0.0042213285],"category_scores_gemma":[0.0036809933,0.00010375958,0.0003177901,0.0010286375,0.00022618622,0.0003579193,0.00038696118,0.00032910216,0.0007143142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031568663,0.00013461283,0.8107204,0.0014305519,0.00010941576,0.00045537585,0.0006134716,0.0007023881,0.0034521983,0.00016094215,0.0054293126,0.17647561],"study_design_scores_gemma":[0.000046766825,0.0013061153,0.9740941,0.00051056343,0.00010307103,0.004610802,0.0008543185,0.0004989323,0.0027053482,0.0001846039,0.015068902,0.000016451258],"about_ca_topic_score_codex":0.0031460808,"about_ca_topic_score_gemma":0.0062880307,"teacher_disagreement_score":0.0042213285,"about_ca_system_score_codex":0.0005599545,"about_ca_system_score_gemma":0.0007567526,"threshold_uncertainty_score":0.014121711},"labels":[],"label_agreement":null},{"id":"W2033010643","doi":"10.1097/coc.0b013e3181b20641","title":"The Contents and Readability of Informed Consent Forms for Oncology Clinical Trials","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Readability; Informed consent; Clinical trial; Oncology; MEDLINE; Internal medicine; Medical physics; Family medicine; Alternative medicine; Pathology","score_opus":0.8287529717556347,"score_gpt":0.7598991608982333,"score_spread":0.06885381085740139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033010643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5455733,0.031559236,0.13600688,0.016222969,0.00414221,0.1920163,0.02032507,0.0020305,0.052123632],"genre_scores_gemma":[0.71152025,0.0047429046,0.13346288,0.0051576253,0.0011978766,0.13570432,0.005558808,0.0004060773,0.002249279],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.3530298,0.47128493,0.13573764,0.0056438018,0.031777263,0.0025266171],"domain_scores_gemma":[0.08975417,0.6938136,0.1269913,0.045766782,0.041725226,0.0019488251],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.521247,0.0012725348,0.0024277652,0.009204176,0.0018726572,0.0065477714,0.0017479389,0.0032947892,0.006933042],"category_scores_gemma":[0.78794163,0.00095053075,0.0035765008,0.006303343,0.0035414854,0.006040561,0.0023611642,0.002675298,0.0021101746],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031368915,0.001874505,0.10780133,0.024806084,0.002248207,0.0011876551,0.033343453,0.0036774739,0.0048599862,0.012638364,0.048492894,0.72770125],"study_design_scores_gemma":[0.01503075,0.020855581,0.5202156,0.058658928,0.0035457315,0.007847817,0.021257006,0.024104828,0.024058754,0.05243731,0.2498162,0.0021715185],"about_ca_topic_score_codex":0.00046520354,"about_ca_topic_score_gemma":0.0005817597,"teacher_disagreement_score":0.47875297,"about_ca_system_score_codex":0.0038696076,"about_ca_system_score_gemma":0.0063938377,"threshold_uncertainty_score":0.5903877},"labels":[],"label_agreement":null},{"id":"W2033387468","doi":"10.1097/01.coc.0000260950.44761.74","title":"Can Serum Markers Be Used to Predict Acute and Late Toxicity in Patients With Lung Cancer?","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pulmonary function testing; Internal medicine; Radiation therapy; Lung cancer; Gastroenterology; Stage (stratigraphy); Pulmonary fibrosis; Lung; Cancer; White blood cell; Pneumonitis; Pulmonary toxicity; DLCO; Oncology; Surgery; Diffusing capacity","score_opus":0.01786665297264441,"score_gpt":0.40190118580411016,"score_spread":0.38403453283146577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033387468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863783,0.009060436,0.0015692076,0.0009403289,0.00010859559,0.00009909283,0.0004801874,0.000044894434,0.001318895],"genre_scores_gemma":[0.9972644,0.0008453793,0.00092885946,0.00019933675,0.000101834645,0.000051831117,0.00040799563,0.000003953283,0.00019642811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993345,0.0003278401,0.00007105425,0.000071157185,0.00013372253,0.00006177092],"domain_scores_gemma":[0.997317,0.001138566,0.0007631442,0.00012914979,0.00028934018,0.00036277427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014404977,0.0007100651,0.0010631938,0.00075831945,0.00018733637,0.0009036095,0.00039452486,0.0009974735,0.0008509471],"category_scores_gemma":[0.007675185,0.00025673435,0.00041823633,0.00074225955,0.00042941573,0.00076942454,0.000338472,0.00068319566,0.00043333296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015261922,0.00013806102,0.97003573,0.00005708171,0.00011672976,0.000054496842,0.000013030711,0.00035142916,0.0005872615,0.00001858999,0.00023929679,0.026862161],"study_design_scores_gemma":[0.0005463366,0.005390493,0.98315054,0.00010082779,0.00050491025,0.0008894306,0.0001316783,0.0046478645,0.0022628172,0.00030770907,0.0020318527,0.000035383793],"about_ca_topic_score_codex":0.00042381365,"about_ca_topic_score_gemma":0.0006392691,"teacher_disagreement_score":0.0014404977,"about_ca_system_score_codex":0.00019574392,"about_ca_system_score_gemma":0.00039821403,"threshold_uncertainty_score":0.0076181293},"labels":[],"label_agreement":null},{"id":"W2034338399","doi":"10.1097/coc.0b013e31819d3684","title":"Optimal Equations for Describing the Relationship Between Prostate Volume, Number of Sources, and Total Activity in Permanent Prostate Brachytherapy","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Nomogram; Brachytherapy; Medicine; Prostate; Linear equation; Volume (thermodynamics); Prostate brachytherapy; Nuclear medicine; Statistics; Mathematics; Radiation therapy; Surgery; Oncology; Mathematical analysis; Internal medicine","score_opus":0.13860465488506815,"score_gpt":0.44171375617570857,"score_spread":0.3031091012906404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034338399","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15910736,0.00045619742,0.8358582,0.00038633432,0.000026146734,0.0003570178,0.0005060818,0.000947871,0.002354782],"genre_scores_gemma":[0.6669079,0.00043911766,0.32915175,0.00014939059,0.000039989955,0.0006594144,0.00074555655,0.00028437653,0.0016224169],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9970624,0.001590173,0.00024098378,0.00034864602,0.00062757725,0.00013026783],"domain_scores_gemma":[0.9771772,0.018398715,0.0017078137,0.00081202143,0.00179482,0.00010939835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006538686,0.00095786323,0.00069583923,0.0015732123,0.00030391826,0.0012674575,0.001161,0.0006490082,0.0018187611],"category_scores_gemma":[0.05516679,0.000666439,0.001054256,0.0010723236,0.0005723979,0.00185101,0.0007271757,0.00089331757,0.0006287517],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004995753,0.0003615626,0.121385664,0.0004091762,0.00027375683,0.00028158203,0.0004954279,0.63693315,0.005029362,0.017044326,0.0042342907,0.21305206],"study_design_scores_gemma":[0.00009624406,0.0002185879,0.016909055,0.000067648245,0.00013371317,0.00032778934,0.00008829274,0.967124,0.0039688186,0.009215634,0.0018023325,0.000047997062],"about_ca_topic_score_codex":0.0039896625,"about_ca_topic_score_gemma":0.0035345424,"teacher_disagreement_score":0.006538686,"about_ca_system_score_codex":0.001364913,"about_ca_system_score_gemma":0.001975935,"threshold_uncertainty_score":0.03458029},"labels":[],"label_agreement":null},{"id":"W2037321725","doi":"10.1097/01.coc.0000258084.55036.9e","title":"A Population-Based Analysis of Second Primary Cancers After Irradiation for Rectal Cancer","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Cancer registry; Prostate cancer; Population; Cancer; Internal medicine; Incidence (geometry); Colorectal cancer; Cohort; Confidence interval; Oncology; Prostate; Epidemiology; Gynecology; Urology","score_opus":0.04742313306440697,"score_gpt":0.45107602988796874,"score_spread":0.40365289682356176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037321725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885607,0.00020642724,0.00032657312,0.000014419802,0.0000040124037,0.000008290031,0.00037071016,0.0000073741917,0.00020613018],"genre_scores_gemma":[0.9993807,0.000060045833,0.000115219904,0.0000075039293,0.0000044490607,0.000007130717,0.0002965314,0.000001850678,0.0001265938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960643,0.000110198765,0.000022788128,0.00013417656,0.000077861885,0.00004866134],"domain_scores_gemma":[0.99930084,0.0001540712,0.00025298548,0.000121944766,0.00008407944,0.00008603549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006468173,0.00021706456,0.00034377506,0.00063788,0.00020435565,0.0003760334,0.00023462679,0.00032151287,0.0016910125],"category_scores_gemma":[0.0016204594,0.00024086371,0.00084799837,0.00064027304,0.0001399927,0.00018217874,0.00029109322,0.00042681387,0.00020853545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029075367,0.00002750676,0.9966354,0.000014383793,0.000264603,0.00012123481,0.000030098172,0.00012969572,0.0007441509,0.000010701652,0.00009045582,0.0016411002],"study_design_scores_gemma":[0.00001028778,0.00017086898,0.99880636,0.0000017930976,0.00007243063,0.000468313,0.000027978956,0.00017225741,0.00012155974,0.000008169805,0.00013737031,0.0000025840484],"about_ca_topic_score_codex":0.002371262,"about_ca_topic_score_gemma":0.0029426378,"teacher_disagreement_score":0.002371262,"about_ca_system_score_codex":0.00021455914,"about_ca_system_score_gemma":0.00028861195,"threshold_uncertainty_score":0.005657017},"labels":[],"label_agreement":null},{"id":"W2037683381","doi":"10.1097/01.coc.0000175290.65929.3b","title":"Acute Proctocolitis With Commencement of Neoadjuvant Chemoradiation for Rectal Cancer","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"","keywords":"Medicine; Colorectal cancer; Neoadjuvant therapy; Chemotherapy; Oncology; Internal medicine; Cancer; Surgery","score_opus":0.05996344512944724,"score_gpt":0.4813663481641092,"score_spread":0.421402903034662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037683381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597031,0.005387128,0.0011424051,0.009737986,0.0007652758,0.00017219798,0.0003673103,0.000119760865,0.022604883],"genre_scores_gemma":[0.99601257,0.0009904819,0.00028777754,0.000822259,0.0008334639,0.00001674611,0.00021116108,0.000008185036,0.0008173881],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995977,0.0001214423,0.00006597019,0.00004364312,0.00008892656,0.000082336235],"domain_scores_gemma":[0.9967591,0.0013994644,0.0007698768,0.00014981201,0.00017234575,0.0007494609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000300549,0.00029095533,0.00044798816,0.00059436663,0.0007470228,0.0004468978,0.00032400156,0.0007696705,0.0025433698],"category_scores_gemma":[0.006026249,0.00017348524,0.00037507495,0.0006512685,0.00048128096,0.0006538822,0.0002711567,0.001701781,0.0003097801],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049467585,0.00050732115,0.4490845,0.0002445187,0.00009282584,0.4904069,0.00041358155,0.00051446934,0.0028990626,0.0005923014,0.008721412,0.04157649],"study_design_scores_gemma":[0.00044783938,0.0024233276,0.56357175,0.00023954913,0.00013262268,0.41933832,0.00064796774,0.0014043775,0.0016714096,0.0008672416,0.00918425,0.00007127842],"about_ca_topic_score_codex":0.002470285,"about_ca_topic_score_gemma":0.0058710217,"teacher_disagreement_score":0.0025433698,"about_ca_system_score_codex":0.0006607424,"about_ca_system_score_gemma":0.00085956004,"threshold_uncertainty_score":0.008508384},"labels":[],"label_agreement":null},{"id":"W2038083383","doi":"10.1097/01.coc.0000203757.52100.fa","title":"Metastatic Synovial Sarcoma of the Foot to the Throat","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Foot (prosody); Synovial sarcoma; Internal medicine; Throat; Sarcoma; General surgery; Family medicine; Oncology; Surgery; Pathology","score_opus":0.13523882103533955,"score_gpt":0.4547688675458058,"score_spread":0.31953004651046624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038083383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8373187,0.013463392,0.004233288,0.010330639,0.0010933526,0.00022623691,0.0013765334,0.00031587298,0.13164185],"genre_scores_gemma":[0.9882421,0.0020404693,0.00040829138,0.0007413341,0.00024816833,0.00000909032,0.000108661414,0.000011430373,0.008190422],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99983275,0.000010753129,0.000008906576,0.00002488144,0.000046094672,0.00007646983],"domain_scores_gemma":[0.99970204,0.000046261088,0.000031929787,0.000021268079,0.000029161538,0.00016922072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000095087926,0.00042412,0.00037260447,0.00056276756,0.00088072586,0.0006202269,0.0003674547,0.0005710824,0.010519169],"category_scores_gemma":[0.000849703,0.00022882762,0.00027507788,0.0004467555,0.0005647369,0.00037917646,0.00033314538,0.0007356983,0.0016532991],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019349255,0.00007190845,0.010138165,0.0001391429,0.000026062895,0.9605784,0.00009621047,0.00025744038,0.005079281,0.00078911573,0.0050236084,0.017607184],"study_design_scores_gemma":[0.00009358347,0.00027162922,0.02801548,0.00012090118,0.000030296058,0.95851654,0.0003414654,0.00082720694,0.0011676189,0.00071860215,0.009876809,0.000019979814],"about_ca_topic_score_codex":0.017091645,"about_ca_topic_score_gemma":0.034022886,"teacher_disagreement_score":0.017091645,"about_ca_system_score_codex":0.0018412295,"about_ca_system_score_gemma":0.0015722085,"threshold_uncertainty_score":0.035190165},"labels":[],"label_agreement":null},{"id":"W2038286567","doi":"10.1097/00000421-200102000-00012","title":"Malignant Lymphoma of Mucosa-Associated Lymphoid Tissue of the Lacrimal Gland","year":2001,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Queen Elizabeth II Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Lacrimal gland; MALT lymphoma; Radiation therapy; Lymphoma; Pathology; Mucosa-associated lymphoid tissue; Lymphatic system; Lacrimal apparatus; Salivary gland; Thyroid; Radiology; Internal medicine","score_opus":0.1181665783926455,"score_gpt":0.47604372562490727,"score_spread":0.35787714723226177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038286567","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000955354,0.99718994,0.0001302825,0.00012788232,0.000108900174,0.000005478156,0.000014584069,0.000013765017,0.001453753],"genre_scores_gemma":[0.006651236,0.9917354,0.00022127769,0.00015192901,0.00017870276,0.000007496043,0.000038387665,0.0000015447156,0.0010140899],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9998672,0.00002278314,0.000022772867,0.00002158754,0.00005244314,0.000013214081],"domain_scores_gemma":[0.9998067,0.00006876139,0.000046027406,0.000006888264,0.000050140603,0.000021434063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021314326,0.0006192381,0.000970674,0.0022274642,0.00020165551,0.00050682214,0.000581049,0.00045318142,0.0020938027],"category_scores_gemma":[0.00050467905,0.00015214556,0.0002209716,0.0029711272,0.00027045724,0.00069678586,0.00018951745,0.00032427348,0.0016719437],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067571724,0.00006217085,0.0020401878,0.011290808,0.00008307771,0.004356848,0.000087877015,0.00020692394,0.0026360254,0.00030966214,0.023434896,0.95542395],"study_design_scores_gemma":[0.000052827345,0.00022060948,0.021105824,0.006201841,0.0003903896,0.07565971,0.00033281665,0.00020505294,0.0021252795,0.0011566322,0.8925203,0.00002877618],"about_ca_topic_score_codex":0.0012048933,"about_ca_topic_score_gemma":0.002097475,"teacher_disagreement_score":0.0022274642,"about_ca_system_score_codex":0.00033585692,"about_ca_system_score_gemma":0.0006868882,"threshold_uncertainty_score":0.00700444},"labels":[],"label_agreement":null},{"id":"W2039440309","doi":"10.1097/01.coc.0000236006.54867.f7","title":"Metastatic Midgut Carcinoid to the Heart Demonstrated on Cardiac Magnetic Resonance Imaging","year":2009,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Magnetic resonance imaging; Midgut; Carcinoid Heart Disease; Radiology; Cardiac magnetic resonance; Carcinoid syndrome; Cardiology; Internal medicine","score_opus":0.05700696874890271,"score_gpt":0.45941140065302044,"score_spread":0.40240443190411773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039440309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85402757,0.010632274,0.0021949916,0.017265407,0.0017023218,0.000354497,0.0021763302,0.00017439312,0.11147221],"genre_scores_gemma":[0.9717084,0.006395236,0.0017764019,0.0028091632,0.0016820497,0.000057976555,0.0009018758,0.00003159516,0.014637333],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9999361,0.0000065805084,0.000009397969,0.000016434753,0.000015410807,0.000016038312],"domain_scores_gemma":[0.99974114,0.00010880116,0.000024849021,0.00001522497,0.000026575188,0.00008333232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011997197,0.00022362352,0.00030287897,0.0007045446,0.00028060476,0.0002822479,0.0002817927,0.0006920657,0.010896195],"category_scores_gemma":[0.0011070631,0.00015070314,0.00015254955,0.00021959294,0.00016801938,0.0004911199,0.00025592835,0.0006066201,0.0013929264],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031273218,0.00010100737,0.040547915,0.0001212581,0.000015596113,0.9052137,0.0001646795,0.00023175674,0.010784158,0.000817335,0.016454834,0.025235137],"study_design_scores_gemma":[0.00016950666,0.00037014092,0.10243533,0.00018850848,0.00007932912,0.86844635,0.0002904768,0.00089283666,0.0042471886,0.0012418239,0.021587294,0.000051203202],"about_ca_topic_score_codex":0.001167182,"about_ca_topic_score_gemma":0.0024810762,"teacher_disagreement_score":0.010896195,"about_ca_system_score_codex":0.0002593367,"about_ca_system_score_gemma":0.00031625776,"threshold_uncertainty_score":0.03645146},"labels":[],"label_agreement":null},{"id":"W2039779593","doi":"10.1097/01.coc.0000143049.05090.12","title":"The Effects of Age and Comorbidity on Treatment and Outcomes in Women With Endometrial Cancer","year":2005,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Comorbidity; Endometrial cancer; Cohort; Cancer; Lymphadenectomy; Population; Internal medicine; Cancer registry; Hysterectomy; Charlson comorbidity index; Incidence (geometry); Surgery; Gynecology","score_opus":0.05067664852646503,"score_gpt":0.4393041282844591,"score_spread":0.38862747975799405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039779593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817216,0.0012476627,0.000027613461,0.00010320952,0.000005560039,0.0000035677997,0.0001467222,0.0000012897842,0.0002921439],"genre_scores_gemma":[0.9994097,0.00032879095,0.000029735656,0.000026817776,0.0000104074825,0.000002968566,0.00015744765,5.704176e-7,0.00003362843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936074,0.00025104138,0.000058263504,0.00006644034,0.00013150886,0.00013202181],"domain_scores_gemma":[0.99718875,0.00077965565,0.001394717,0.000075495314,0.00018434606,0.00037698195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005746687,0.00011838247,0.0002557449,0.00047989064,0.00035636066,0.00042437456,0.00020372104,0.00032870646,0.00069493434],"category_scores_gemma":[0.0045388388,0.00013243059,0.00031396467,0.00083031633,0.00028568783,0.0002620946,0.00035745473,0.00033858398,0.000083149374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006861456,0.000007760302,0.99852836,0.000004187375,0.000030345858,0.00003646257,0.000018505329,0.000028790482,0.000023639554,0.0000037549385,0.00004469477,0.0012049421],"study_design_scores_gemma":[0.0000024339618,0.000030135101,0.99964035,0.0000041987314,0.000013729181,0.00013276754,0.000039187296,0.000063959145,0.000006711474,0.000008546816,0.00005674081,0.0000011992719],"about_ca_topic_score_codex":0.013651917,"about_ca_topic_score_gemma":0.026029,"teacher_disagreement_score":0.013651917,"about_ca_system_score_codex":0.0005603699,"about_ca_system_score_gemma":0.0004135041,"threshold_uncertainty_score":0.027144909},"labels":[],"label_agreement":null},{"id":"W2046401073","doi":"10.1097/coc.0b013e318165c036","title":"A Comparison of Treatment Outcomes by Radiochemotherapy and Postoperative Radiotherapy in Locally Advanced Squamous Cell Carcinomas of Head and Neck","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Neck dissection; Radiation therapy; Surgery; Stage (stratigraphy); Concomitant; Port (circuit theory); Head and neck; Head and neck cancer; Adjuvant; Retrospective cohort study; Hazard ratio; Oncology; Cancer; Internal medicine","score_opus":0.06438859198682809,"score_gpt":0.4560576032786439,"score_spread":0.39166901129181586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046401073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988809,0.00073770666,0.000060395963,0.000027900069,0.0000032811906,0.000008000046,0.00009769894,0.0000014865107,0.00018253889],"genre_scores_gemma":[0.99961555,0.0001004488,0.000021898155,0.000014159831,0.0000041975586,0.000004990851,0.00016996749,7.240875e-7,0.00006799747],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996717,0.00009486496,0.000029080089,0.000055379696,0.000077894,0.00007110643],"domain_scores_gemma":[0.9990639,0.00023123121,0.0004467874,0.000025442481,0.00011056855,0.0001221499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041874257,0.00011330112,0.00028741857,0.00030528137,0.00016248909,0.00025376654,0.00016396378,0.00029178537,0.0006825813],"category_scores_gemma":[0.00139327,0.00006480716,0.0003272194,0.0003729135,0.00022418305,0.00015122538,0.00016137476,0.00017527348,0.00008436724],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012389419,0.000051716106,0.99004793,0.00003429259,0.00013204584,0.00008917277,0.000048854865,0.00019885875,0.00060505106,0.0000096133435,0.000099904864,0.0074436334],"study_design_scores_gemma":[0.000027295177,0.00043280405,0.9987915,0.0000059021345,0.000045893266,0.00022031732,0.00005007183,0.00012227065,0.00012705542,0.000006449293,0.00016798815,0.000002370034],"about_ca_topic_score_codex":0.008783234,"about_ca_topic_score_gemma":0.017781923,"teacher_disagreement_score":0.008783234,"about_ca_system_score_codex":0.00085537275,"about_ca_system_score_gemma":0.00047373484,"threshold_uncertainty_score":0.01746422},"labels":[],"label_agreement":null},{"id":"W2047293775","doi":"10.1097/coc.0b013e31805c13f0","title":"The Influence of Mentorship on Research Productivity in Oncology","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Mentoring and Academic Development","field":"Psychology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Association for Cancer Research","keywords":"Mentorship; Medicine; Productivity; Medical education; Translational research; Clinical Oncology; Oncology; Family medicine; Internal medicine; Pathology; Cancer","score_opus":0.247257875317649,"score_gpt":0.5920795632103625,"score_spread":0.3448216878927135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047293775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917916,0.0012387667,0.0005400529,0.0024288292,0.00008827907,0.000036122365,0.00007867399,0.000028774717,0.0037687926],"genre_scores_gemma":[0.9990336,0.00021674654,0.00020380123,0.000080308586,0.00007037409,0.00001432515,0.000029408384,0.0000043494515,0.000347108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9793042,0.013995392,0.0007433814,0.0005126073,0.0034707508,0.0019736064],"domain_scores_gemma":[0.74135584,0.14813098,0.050846256,0.006955611,0.015881341,0.036829956],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017431283,0.00027049566,0.00024169392,0.0014801712,0.0012415602,0.0024708288,0.0007604807,0.00055975385,0.003438653],"category_scores_gemma":[0.15361522,0.00014322285,0.00044359316,0.0007704822,0.0010991477,0.0009822082,0.0024537877,0.0009984561,0.00042587848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064191106,0.001000795,0.8202964,0.0001837232,0.00014612418,0.00025801122,0.0033879024,0.00023751002,0.0005778436,0.0002732103,0.0021803023,0.17081629],"study_design_scores_gemma":[0.00003713593,0.0010263642,0.9917414,0.00014209167,0.000049582406,0.0004037829,0.0031240068,0.00035351657,0.00045471673,0.00027776827,0.0023712816,0.000018352368],"about_ca_topic_score_codex":0.001563449,"about_ca_topic_score_gemma":0.0019262305,"teacher_disagreement_score":0.98256874,"about_ca_system_score_codex":0.0015908517,"about_ca_system_score_gemma":0.002359637,"threshold_uncertainty_score":0.09218657},"labels":[],"label_agreement":null},{"id":"W2052762622","doi":"10.1097/coc.0b013e3181574084","title":"Sorafenib for Metastatic Renal Cancer","year":2008,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sorafenib; Rash; Internal medicine; Adverse effect; Population; Placebo; Common Terminology Criteria for Adverse Events; Oncology; Surgery; Cancer; Cohort; Gastroenterology; Hepatocellular carcinoma; Pathology","score_opus":0.22788009951966287,"score_gpt":0.5035995736530775,"score_spread":0.27571947413341463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052762622","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94884986,0.0426765,0.0009820744,0.001136087,0.00012711696,0.00010320766,0.0002631803,0.00011856549,0.0057434137],"genre_scores_gemma":[0.99160063,0.0052753002,0.00073956494,0.00024087793,0.00021412462,0.000044636152,0.000342296,0.000004298591,0.0015383128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991393,0.00003329692,0.000005700008,0.000011285402,0.000020696052,0.000014987274],"domain_scores_gemma":[0.99984825,0.000035164205,0.00004138834,0.0000061583196,0.000016931059,0.000052142437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022128153,0.00012749764,0.000314396,0.00011212232,0.00019086049,0.00017539854,0.00010808079,0.00011588066,0.0025359555],"category_scores_gemma":[0.00043244511,0.000027255835,0.00015181514,0.00014291672,0.00008166872,0.00009406307,0.00014133437,0.00020390526,0.00031509245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012540069,0.0015631893,0.059727047,0.0015336125,0.00040169456,0.003778777,0.00016341083,0.0014645588,0.03372071,0.0006547657,0.026244668,0.85820764],"study_design_scores_gemma":[0.013742498,0.043286808,0.6146432,0.00046652433,0.00094666437,0.069994345,0.0002020244,0.0076102866,0.032637127,0.0018821958,0.21453962,0.000048702233],"about_ca_topic_score_codex":0.00033184097,"about_ca_topic_score_gemma":0.0007071013,"teacher_disagreement_score":0.0025359555,"about_ca_system_score_codex":0.0002161748,"about_ca_system_score_gemma":0.0003460292,"threshold_uncertainty_score":0.008483648},"labels":[],"label_agreement":null},{"id":"W2053643895","doi":"10.1097/coc.0000000000000099","title":"Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Aegera Therapeutics (Canada)","funders":"Chinese University of Hong Kong; University of Hong Kong","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Clinical endpoint; Internal medicine; Adverse effect; Response Evaluation Criteria in Solid Tumors; Oncology; Combination therapy; Randomized controlled trial; Surgery; Phases of clinical research; Gastroenterology; Clinical trial","score_opus":0.014248113666293308,"score_gpt":0.31433472358678255,"score_spread":0.30008660992048924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053643895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244565,0.001455253,0.00075670343,0.000471314,0.0002751327,0.003118056,0.00056347554,0.00008078364,0.00083365367],"genre_scores_gemma":[0.98910975,0.0012116345,0.0021971231,0.0006774703,0.0003154047,0.0036913774,0.0008102877,0.000018797218,0.0019681768],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994259,0.0003439304,0.000033489563,0.00009310644,0.000038688075,0.00006493669],"domain_scores_gemma":[0.99920803,0.00016043065,0.0001959119,0.000059306436,0.000042967196,0.0003333594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018336315,0.0016864007,0.0028719108,0.00039694642,0.00033917063,0.00077276054,0.0007310775,0.0010720663,0.004518316],"category_scores_gemma":[0.0011373352,0.0006763816,0.0011484491,0.00035203533,0.0010089331,0.0008329683,0.0004654566,0.0023366115,0.00079027936],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95520234,0.014591885,0.0011961677,0.00037937585,0.00081283366,0.000079212004,0.000067478206,0.00070873287,0.010232775,0.00012782004,0.00077815296,0.015823368],"study_design_scores_gemma":[0.9271716,0.070301786,0.0009613161,0.000008083535,0.00017117408,0.0000421654,0.000009804136,0.00031055565,0.0006188087,0.00005724325,0.0003398833,0.000007606739],"about_ca_topic_score_codex":0.0005125319,"about_ca_topic_score_gemma":0.0014784541,"teacher_disagreement_score":0.004518316,"about_ca_system_score_codex":0.0007079452,"about_ca_system_score_gemma":0.0014127358,"threshold_uncertainty_score":0.015115321},"labels":[],"label_agreement":null},{"id":"W2056504493","doi":"10.1097/coc.0b013e31828aab2a","title":"Outcomes of Small Cell Lung Cancer Patients Treated With Cisplatin-Etoposide Versus Carboplatin-Etoposide","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Carboplatin; Internal medicine; Population; Gastroenterology; Cisplatin; Retrospective cohort study; Chemotherapy; Surgery","score_opus":0.05152157600792551,"score_gpt":0.4453391437418046,"score_spread":0.3938175677338791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056504493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993174,0.00031947272,0.00002858639,0.000026486694,0.0000038277176,0.0000065915065,0.000060269038,0.0000014306601,0.00023604407],"genre_scores_gemma":[0.9996959,0.00006096988,0.000016881322,0.000020530711,0.0000074515965,0.0000050804624,0.00015866003,4.4065186e-7,0.00003402523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975234,0.00007193786,0.000035817233,0.00004365457,0.00005258054,0.00004362702],"domain_scores_gemma":[0.99933535,0.00016988307,0.00027023588,0.000018130886,0.00006179207,0.00014456754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002866537,0.00010497323,0.00035411245,0.00029534628,0.0001731861,0.00037157262,0.00010766162,0.0002015194,0.00052973314],"category_scores_gemma":[0.0015064721,0.000066899556,0.00032362924,0.00033086608,0.00018626235,0.00029233252,0.0002082662,0.00023712649,0.000096126794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002034117,0.00015316764,0.98816967,0.000033327207,0.00015312953,0.00023954525,0.00007626273,0.00039580226,0.0007667433,0.00001965831,0.00012660764,0.007831959],"study_design_scores_gemma":[0.00015669172,0.0029338752,0.9940339,0.000015461274,0.00012542368,0.0011002913,0.00017532264,0.0005064099,0.00044133773,0.00004347688,0.00046216213,0.0000057024026],"about_ca_topic_score_codex":0.0007703299,"about_ca_topic_score_gemma":0.0016369022,"teacher_disagreement_score":0.0007703299,"about_ca_system_score_codex":0.00039382986,"about_ca_system_score_gemma":0.00023780481,"threshold_uncertainty_score":0.002857387},"labels":[],"label_agreement":null},{"id":"W2056948196","doi":"10.1097/coc.0b013e31818b9486","title":"Bladder Conservation Treatment in the Elderly Population","year":2009,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cystectomy; Univariate analysis; Bladder cancer; Radiation therapy; Surgery; Chemotherapy; Carcinoma; Medical record; Cancer; Multivariate analysis; Internal medicine","score_opus":0.08724261910795172,"score_gpt":0.4652728854638044,"score_spread":0.3780302663558527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056948196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920846,0.0061121485,0.00026533328,0.00028352725,0.00003644037,0.000011516521,0.00008296325,0.000008243007,0.0011151959],"genre_scores_gemma":[0.99723697,0.0018444607,0.00016651113,0.00020085307,0.00011752786,0.000013665133,0.00016827176,0.0000013371904,0.000250345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998921,0.000034849814,0.0000065952786,0.000014976602,0.00001837539,0.000033171447],"domain_scores_gemma":[0.9997576,0.00003451272,0.000093610455,0.000009447813,0.000022367847,0.00008251346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002374498,0.00010570923,0.00017239082,0.00019018451,0.00023751523,0.00016145495,0.0000868082,0.00015436308,0.0007686265],"category_scores_gemma":[0.00075219834,0.000030761395,0.00022011157,0.00020485175,0.00012163093,0.00013531599,0.00015514767,0.00012381394,0.0001305672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007597415,0.00037081525,0.86746395,0.00017037764,0.00023037304,0.0026079293,0.00037559122,0.0006898193,0.0031671645,0.000114324954,0.0022485359,0.12180134],"study_design_scores_gemma":[0.00018710186,0.0045989715,0.96945256,0.0001861873,0.00027730715,0.013260142,0.0005803793,0.000664098,0.001237702,0.00013455149,0.009409553,0.000011539457],"about_ca_topic_score_codex":0.00062413415,"about_ca_topic_score_gemma":0.0011523613,"teacher_disagreement_score":0.0007686265,"about_ca_system_score_codex":0.00012469865,"about_ca_system_score_gemma":0.00022249208,"threshold_uncertainty_score":0.0025713444},"labels":[],"label_agreement":null},{"id":"W2057110064","doi":"10.1097/01.coc.0000180384.40865.f7","title":"A Spermatocytic Seminoma With Rhabdomyosarcoma Transformation and Extensive Metastases","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Rhabdomyosarcoma; Seminoma; Transformation (genetics); Malignant transformation; Radiology; Pathology; Internal medicine; Sarcoma; Chemotherapy","score_opus":0.04173647213736187,"score_gpt":0.42705227651371597,"score_spread":0.3853158043763541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057110064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95617616,0.001508647,0.0021901568,0.0057402165,0.00057987566,0.0003144013,0.00097158324,0.0002564437,0.032262553],"genre_scores_gemma":[0.9934714,0.00036414078,0.00080548675,0.00085136335,0.00043898512,0.000019402449,0.00019287781,0.000032928845,0.003823456],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996178,0.000043720815,0.000044713895,0.000094501826,0.0000914325,0.00010788773],"domain_scores_gemma":[0.9988508,0.0003675339,0.00013194539,0.00007203802,0.00008913171,0.00048853544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003640599,0.0007815996,0.000765618,0.0022532083,0.0014920109,0.0007235783,0.00091070315,0.0025235214,0.0056651896],"category_scores_gemma":[0.0021227014,0.0004440795,0.00080361526,0.00074507407,0.0006618826,0.0008518172,0.0006510414,0.0018473126,0.0011060402],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016279667,0.00006037159,0.008770981,0.000021028703,0.000008903774,0.98647076,0.0001280807,0.00008019253,0.0015742113,0.00039328178,0.0004694983,0.0018598278],"study_design_scores_gemma":[0.00009514839,0.0004527434,0.034079578,0.0000129273085,0.000034491102,0.9597884,0.00020183834,0.0005049771,0.0017647424,0.0006291858,0.002403881,0.00003212684],"about_ca_topic_score_codex":0.0038364453,"about_ca_topic_score_gemma":0.005241188,"teacher_disagreement_score":0.0056651896,"about_ca_system_score_codex":0.00092053413,"about_ca_system_score_gemma":0.00080257404,"threshold_uncertainty_score":0.018951952},"labels":[],"label_agreement":null},{"id":"W2059793948","doi":"10.1097/01.coc.0000195092.25516.19","title":"Examining Time Intervals Between Diagnosis and Treatment in the Management of Patients With Limited Stage Small Cell Lung Cancer","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Lung cancer; Confidence interval; Odds ratio; Stage (stratigraphy); Internal medicine; Radiation therapy; Proportional hazards model; Chemotherapy; Cancer; Logistic regression; Oncology","score_opus":0.09451095105498074,"score_gpt":0.44607742118003774,"score_spread":0.351566470125057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059793948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758255,0.0017046402,0.0002007769,0.00011034208,0.000012529077,0.000010607219,0.00013982347,0.0000036563997,0.00023515233],"genre_scores_gemma":[0.99926347,0.00021405928,0.00020868266,0.000025022806,0.000029364726,0.000012844843,0.00020554865,0.00000150808,0.000039424598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984818,0.00067584653,0.00019729271,0.0001903134,0.0003185484,0.0001361588],"domain_scores_gemma":[0.98254895,0.0071639046,0.008945471,0.00018960936,0.00044315588,0.000708925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020718134,0.00015755805,0.00030762397,0.0009520552,0.00020097906,0.0004261652,0.00038822816,0.0005026816,0.0007632625],"category_scores_gemma":[0.01718286,0.00013432084,0.00041182415,0.0012702843,0.00020043345,0.00054586946,0.00042067104,0.000606843,0.00011903652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009322305,0.0000561479,0.99479526,0.00002678425,0.000044588105,0.00008419479,0.000050427847,0.00017879401,0.00013294967,0.000010979976,0.000054249256,0.0036334966],"study_design_scores_gemma":[0.0000305855,0.00072292803,0.9978288,0.00001635565,0.000052779716,0.0002907567,0.0001437302,0.00054939016,0.000099410994,0.000022460492,0.00023784295,0.000004880104],"about_ca_topic_score_codex":0.0020615621,"about_ca_topic_score_gemma":0.0031804119,"teacher_disagreement_score":0.0020718134,"about_ca_system_score_codex":0.0004196389,"about_ca_system_score_gemma":0.00051446306,"threshold_uncertainty_score":0.010956943},"labels":[],"label_agreement":null},{"id":"W2061574831","doi":"10.1097/coc.0b013e3181ec60b8","title":"Integrating Radioembolization (90Y Microspheres) Into Current Treatment Options for Liver Tumors","year":2010,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nordion (Canada)","funders":"","keywords":"Medicine; Microsphere; Selective internal radiation therapy; Liver cancer; Radiology; Toxicity; Hepatocellular carcinoma; Internal medicine","score_opus":0.2800039921853348,"score_gpt":0.5061857362013176,"score_spread":0.2261817440159828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061574831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010430379,0.9989874,0.00011479076,0.000099893754,0.00006551024,0.000004131689,0.0000069273715,0.0000043114223,0.0006127653],"genre_scores_gemma":[0.0005056045,0.998845,0.00018891075,0.000083225874,0.000074246884,0.0000043259297,0.00001588501,8.8785055e-7,0.00028199045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981314,0.00003240421,0.000030043484,0.00003610789,0.00007508111,0.000013295187],"domain_scores_gemma":[0.9997454,0.00012861,0.000044056065,0.000007819849,0.000055946755,0.000018101207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005459962,0.0008089164,0.0015133179,0.0033416443,0.00024272782,0.0007589068,0.0007181033,0.0009429672,0.0025055027],"category_scores_gemma":[0.00050371833,0.00030961208,0.00046065313,0.0034162481,0.00054692273,0.0014702043,0.0005709523,0.0014837881,0.0021038703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044726246,0.00005980354,0.0002022042,0.0119164605,0.000072918156,0.00025787242,0.00004931838,0.00027732056,0.0021806734,0.001295252,0.011681663,0.97196186],"study_design_scores_gemma":[0.000033314664,0.00015168612,0.0020427313,0.0035305098,0.00018925844,0.0044003804,0.00009134876,0.0001150373,0.001159657,0.001627204,0.98663217,0.000026721846],"about_ca_topic_score_codex":0.0013452133,"about_ca_topic_score_gemma":0.002438147,"teacher_disagreement_score":0.0033416443,"about_ca_system_score_codex":0.0005726019,"about_ca_system_score_gemma":0.0007409084,"threshold_uncertainty_score":0.008381784},"labels":[],"label_agreement":null},{"id":"W2064927794","doi":"10.1097/coc.0b013e3181beac33","title":"A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Lapatinib; Medicine; Internal medicine; Prostate cancer; Rash; Oncology; Clinical endpoint; Cancer; Prostate-specific antigen; Breast cancer; Population; Phases of clinical research; Adverse effect; Clinical trial; Trastuzumab","score_opus":0.09440197135542061,"score_gpt":0.5517576730823424,"score_spread":0.45735570172692175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064927794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080336,0.0015255266,0.0005949782,0.00061081303,0.00016730228,0.0033105074,0.0009735444,0.00014457377,0.00186938],"genre_scores_gemma":[0.9884477,0.0011703571,0.0013531771,0.0009675288,0.00022256853,0.0030375794,0.0025706918,0.000035733705,0.0021946416],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99935764,0.00038452202,0.000022833658,0.0000866247,0.0000493169,0.000099033474],"domain_scores_gemma":[0.9991843,0.000104557424,0.00014516167,0.00005896485,0.000047216214,0.0004597685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023326944,0.0019240498,0.001443039,0.0004176198,0.00047700285,0.00090193085,0.00092006684,0.0013605839,0.00506074],"category_scores_gemma":[0.0009930204,0.00060232537,0.0009993088,0.00045950979,0.0010194732,0.00075662637,0.00045304943,0.0032552273,0.00094585825],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79008484,0.078800015,0.0054654055,0.0007792028,0.0010287439,0.00037471746,0.00022975425,0.0026867657,0.03974107,0.0003587289,0.006230963,0.0742197],"study_design_scores_gemma":[0.7812954,0.21026565,0.004471267,0.00002048804,0.00013568107,0.00018461671,0.000023222878,0.0008259559,0.0017246822,0.00012931871,0.0009059364,0.000017747467],"about_ca_topic_score_codex":0.0009210825,"about_ca_topic_score_gemma":0.0018979062,"teacher_disagreement_score":0.00506074,"about_ca_system_score_codex":0.0007589759,"about_ca_system_score_gemma":0.002023967,"threshold_uncertainty_score":0.016929865},"labels":[],"label_agreement":null},{"id":"W2065008784","doi":"10.1097/coc.0b013e3181e841ec","title":"Prospective Evaluation of a 12-Week Walking Exercise Program and Its Effect on Fatigue in Prostate Cancer Patients Undergoing Radical External Beam Radiotherapy","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Tolerability; Prospective cohort study; External beam radiotherapy; Quality of life (healthcare); Physical therapy; Radiation therapy; Adverse effect; Surgery; Internal medicine; Cancer","score_opus":0.047203938295134924,"score_gpt":0.4465187186582216,"score_spread":0.3993147803630867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065008784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99945503,0.00014934187,0.00007108207,0.0000134769625,0.0000057082693,0.00016958776,0.000044120792,0.0000071376026,0.000084476625],"genre_scores_gemma":[0.9988902,0.000113670445,0.00028648184,0.000047369802,0.000022253756,0.00029078824,0.00016835377,0.0000019428155,0.00017884951],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993956,0.00030716945,0.000048451468,0.00007898626,0.00007370415,0.00009600428],"domain_scores_gemma":[0.9989973,0.00017157593,0.00030537837,0.00006532741,0.00012080605,0.0003397152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014873417,0.0006552325,0.00067308825,0.00028178035,0.00040549837,0.0002894902,0.00029073487,0.0005142468,0.0010231015],"category_scores_gemma":[0.0016517681,0.00030344576,0.0006281006,0.00028312788,0.00030874106,0.00024283593,0.00025592078,0.00059080555,0.00023735857],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22702585,0.13137291,0.47657922,0.0008214971,0.0022299993,0.00023954902,0.000957221,0.0016630939,0.015172757,0.000045111232,0.00064667105,0.14324616],"study_design_scores_gemma":[0.009950329,0.45735624,0.5303703,0.000023338747,0.00030605646,0.00008396962,0.00011317683,0.00044907292,0.00086680445,0.000012403191,0.00044702343,0.000021348973],"about_ca_topic_score_codex":0.0010367902,"about_ca_topic_score_gemma":0.0017973644,"teacher_disagreement_score":0.0014873417,"about_ca_system_score_codex":0.00021114321,"about_ca_system_score_gemma":0.0005175087,"threshold_uncertainty_score":0.007865906},"labels":[],"label_agreement":null},{"id":"W2065940966","doi":"10.1097/coc.0b013e3182568f7a","title":"Randomized Feasibility Study of De-escalated (Every 12 wk) Versus Standard (Every 3 to 4 wk) Intravenous Pamidronate in Women With Low-risk Bone Metastases From Breast Cancer","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Regional Municipality of Durham; University Health Network; St. Michael's Hospital; Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Bone pain; Bisphosphonate; Surgery; N-terminal telopeptide; Confidence interval; Bone disease; Internal medicine; Cancer; Osteoporosis; Alkaline phosphatase","score_opus":0.050315859666884274,"score_gpt":0.42938422032831985,"score_spread":0.37906836066143557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065940966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909019,0.00032355663,0.00053060194,0.00031170787,0.00020760635,0.007039195,0.00015667289,0.000026565705,0.0005021042],"genre_scores_gemma":[0.9876566,0.00027222335,0.0023447624,0.00055672706,0.00024491214,0.008041203,0.00018887768,0.000008087315,0.00068660127],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99623626,0.0028083813,0.00018928981,0.00033042175,0.00016973622,0.00026590223],"domain_scores_gemma":[0.9948832,0.0020910471,0.0011535106,0.00050801394,0.00035128556,0.0010130353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059977453,0.0011255913,0.001932065,0.0005037779,0.00052098633,0.0008365099,0.001134846,0.0019503689,0.004293097],"category_scores_gemma":[0.0065215137,0.0010030007,0.0011150616,0.0003911531,0.001570043,0.0010228091,0.00073128456,0.0022122094,0.0007369712],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9514791,0.035481144,0.001853201,0.00013599353,0.0002349361,0.000036465375,0.00008394458,0.00023158509,0.0027621281,0.00008173556,0.00015668097,0.0074631106],"study_design_scores_gemma":[0.61262226,0.38355973,0.002641006,0.000010715417,0.00012476055,0.000024534873,0.00003367894,0.0003061833,0.00028306703,0.00007229772,0.00031238078,0.0000093619965],"about_ca_topic_score_codex":0.0006954319,"about_ca_topic_score_gemma":0.0011255661,"teacher_disagreement_score":0.0059977453,"about_ca_system_score_codex":0.00081481534,"about_ca_system_score_gemma":0.002336455,"threshold_uncertainty_score":0.031719506},"labels":[],"label_agreement":null},{"id":"W2067425644","doi":"10.1097/01.coc.0000091359.11281.f4","title":"Influence of Oxygen on the Radiosensitivity of Human Glioma Cell Lines","year":2003,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Radiosensitivity; ERCC1; Radioresistance; Glioma; Cell culture; Biology; Clonogenic assay; DNA repair; Cancer research; Molecular biology; Nucleotide excision repair; Medicine; Genetics; Gene; Radiation therapy; Internal medicine","score_opus":0.03153943899472396,"score_gpt":0.3750174377133877,"score_spread":0.34347799871866375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067425644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991859,0.00314846,0.0022609266,0.000086152984,0.000035236808,0.00007770176,0.00083298574,0.000055036882,0.001644428],"genre_scores_gemma":[0.9876102,0.0022965337,0.003976737,0.00010273477,0.000016046544,0.000115166156,0.003566761,0.000035404846,0.0022805121],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996178,0.000106506806,0.00004386561,0.000049448663,0.00012290958,0.000059527025],"domain_scores_gemma":[0.9997279,0.00008988137,0.00003610044,0.000037930728,0.000069836584,0.000038349343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035521167,0.00038665105,0.00038226275,0.0003587243,0.00022548425,0.00039628893,0.00026027724,0.00020515041,0.0013607136],"category_scores_gemma":[0.00029649737,0.00011016486,0.000305762,0.00030248796,0.00014449279,0.00014168832,0.00024277133,0.00038494932,0.00033632392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005503006,0.00012964972,0.0014099791,0.000090866604,0.000033838896,0.00011695242,0.00014958627,0.00018408183,0.99376726,0.000114608454,0.00020151027,0.0032512664],"study_design_scores_gemma":[0.0000356698,0.0018609551,0.014907298,0.000015166794,0.00006288896,0.00048030194,0.00012687682,0.00070525997,0.9773971,0.000039707058,0.004355053,0.000013796912],"about_ca_topic_score_codex":0.0033423286,"about_ca_topic_score_gemma":0.003920052,"teacher_disagreement_score":0.0033423286,"about_ca_system_score_codex":0.00027731352,"about_ca_system_score_gemma":0.00017350377,"threshold_uncertainty_score":0.006645739},"labels":[],"label_agreement":null},{"id":"W2070107163","doi":"10.1097/01.coc.0000200044.81711.57","title":"A Phase I Dose Finding Study of Cisplatin, Gemcitabine, and Weekly Docetaxel for Patients With Advanced Transitional Cell Cancer","year":2006,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Cisplatin; Oncology; Internal medicine; Chemotherapy","score_opus":0.03829447789951697,"score_gpt":0.4331444057135976,"score_spread":0.3948499278140806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070107163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618775,0.0009855432,0.00054267485,0.0001876547,0.00005403079,0.0013502057,0.00015557877,0.000031986885,0.000504553],"genre_scores_gemma":[0.992136,0.0008225358,0.0032858097,0.00042357878,0.00009654059,0.0020429003,0.0005420237,0.00002011387,0.00063055777],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991823,0.00043489627,0.00006424448,0.00011608747,0.00009340762,0.00010915032],"domain_scores_gemma":[0.998774,0.00018920492,0.0002524276,0.000120500394,0.00007065312,0.00059323123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016483574,0.0008779287,0.0019900089,0.00040019653,0.0005604238,0.0006682816,0.0010874755,0.0011309615,0.0020665152],"category_scores_gemma":[0.0015414577,0.00054548896,0.0013117783,0.00057931046,0.0008940115,0.00069042336,0.00041608873,0.0031999894,0.00051450916],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5492193,0.1427686,0.042472053,0.000833619,0.0018196255,0.00053020194,0.00083020906,0.005809038,0.05029483,0.00030855674,0.003357569,0.20175639],"study_design_scores_gemma":[0.29625127,0.67486376,0.018797224,0.000031903663,0.0004550499,0.00061012444,0.00007890376,0.0015581781,0.005013688,0.00014740601,0.0021641715,0.000028362016],"about_ca_topic_score_codex":0.00064275047,"about_ca_topic_score_gemma":0.001577718,"teacher_disagreement_score":0.0020665152,"about_ca_system_score_codex":0.0010096051,"about_ca_system_score_gemma":0.0019610082,"threshold_uncertainty_score":0.008717418},"labels":[],"label_agreement":null},{"id":"W2070148052","doi":"10.1097/01.coc.0000245473.41035.c4","title":"Simultaneous Infield Boost With Helical Tomotherapy for Patients With 1 to 3 Brain Metastases","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Tomotherapy; Medicine; Radiosurgery; Nuclear medicine; Radiation therapy; Radiation treatment planning; Imaging phantom; Stereotaxis; Stereotactic radiation therapy; Dose fractionation; Radiology","score_opus":0.017801389357539377,"score_gpt":0.4166439268012715,"score_spread":0.3988425374437321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070148052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887455,0.00013616061,0.009771693,0.000036453188,0.000005565823,0.00008105167,0.00010625498,0.00008076702,0.0010366464],"genre_scores_gemma":[0.99544346,0.000042271855,0.004121259,0.000007189707,0.0000025159711,0.000026617894,0.00005905201,0.0000057930583,0.00029186887],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99996185,0.000009783017,0.0000013592709,0.000009652144,0.000009914103,0.000007518546],"domain_scores_gemma":[0.99995637,0.000013235238,0.000015303473,0.000005626934,0.0000022567156,0.0000072369053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103484286,0.00026769305,0.00015362361,0.00008113311,0.000101280006,0.00013045345,0.0002239852,0.00017015966,0.0010212736],"category_scores_gemma":[0.00019551336,0.000102286096,0.00025449344,0.00006899855,0.00015991666,0.00007304481,0.00011656868,0.00015211018,0.00016029434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005808825,0.0019962466,0.09510523,0.0002882353,0.00018534125,0.0027834338,0.00029539905,0.44130594,0.3887066,0.0013368384,0.0010968662,0.061091024],"study_design_scores_gemma":[0.0018553238,0.031229055,0.12477093,0.00003861708,0.00035059877,0.008215389,0.00014436666,0.5767246,0.24791735,0.0018501326,0.0068330434,0.000070613925],"about_ca_topic_score_codex":0.004144374,"about_ca_topic_score_gemma":0.0038680257,"teacher_disagreement_score":0.004144374,"about_ca_system_score_codex":0.00041719666,"about_ca_system_score_gemma":0.00038087106,"threshold_uncertainty_score":0.008240521},"labels":[],"label_agreement":null},{"id":"W2076298506","doi":"10.1097/coc.0b013e31815e456d","title":"Antineoplastic Properties of Bacteriocins","year":2008,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Bacteriocin; Colicin; Antimicrobial; Bacteria; Microbiology; Medicine; Peptide; Antimicrobial peptides; Pharmacology; Biology; Biochemistry; Escherichia coli; Gene; Genetics","score_opus":0.20098938294223406,"score_gpt":0.4178537484140202,"score_spread":0.2168643654717861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076298506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00097301905,0.99640155,0.00023381483,0.00012869108,0.00008940769,0.0000058255946,0.000021374839,0.000011491713,0.0021348582],"genre_scores_gemma":[0.004091833,0.9935033,0.00031699272,0.00011087081,0.00009253413,0.000010497082,0.000042746055,0.0000018852313,0.0018293187],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999006,0.000013413574,0.00000869512,0.000018577228,0.00004714977,0.000011535192],"domain_scores_gemma":[0.99990726,0.000034966797,0.00001546743,0.000003148984,0.000028152963,0.000010963721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021618778,0.0005958808,0.00090110843,0.0012683137,0.0001834061,0.000554132,0.00048806317,0.00060599396,0.002451254],"category_scores_gemma":[0.00024205529,0.0001571576,0.00026137565,0.0009659193,0.0002534447,0.0005244031,0.00033752833,0.00087407907,0.0015359304],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009786645,0.00011582228,0.00018622424,0.00782427,0.00004515842,0.0004447092,0.00005468115,0.00034793938,0.020211259,0.0017914928,0.009382031,0.9594985],"study_design_scores_gemma":[0.000034775483,0.00023277444,0.0017631477,0.0013879219,0.000060981958,0.003704819,0.00005823686,0.00012837641,0.0099343145,0.0011174846,0.9815554,0.000021771593],"about_ca_topic_score_codex":0.0004946494,"about_ca_topic_score_gemma":0.0008174415,"teacher_disagreement_score":0.002451254,"about_ca_system_score_codex":0.0003095982,"about_ca_system_score_gemma":0.00027913004,"threshold_uncertainty_score":0.008200228},"labels":[],"label_agreement":null},{"id":"W2077590802","doi":"10.1097/coc.0b013e3181b2043f","title":"A Phase I Study of Flavopiridol in Combination With Gemcitabine and Irinotecan in Patients With Metastatic Cancer","year":2010,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Gemcitabine; Irinotecan; Oncology; Internal medicine; Cancer; Phases of clinical research; Chemotherapy; Colorectal cancer","score_opus":0.02715845203865139,"score_gpt":0.4104983521347776,"score_spread":0.3833399000961262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077590802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940916,0.0016104295,0.00031625075,0.00041423814,0.000111362046,0.0020970048,0.00036949664,0.000040812603,0.00094874186],"genre_scores_gemma":[0.99088365,0.0020521765,0.0014400696,0.00063126476,0.00022142168,0.0021246194,0.0011418237,0.000018211262,0.0014866649],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995172,0.00021893361,0.00002335207,0.00008522995,0.000045969864,0.00010931381],"domain_scores_gemma":[0.9991579,0.000099874895,0.00010931465,0.000055165572,0.000060776303,0.00051700027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014364783,0.0014664495,0.0025992403,0.0005667136,0.0007698125,0.00081905705,0.00092200626,0.0011123774,0.0029831622],"category_scores_gemma":[0.00097643316,0.0007569243,0.0013900064,0.00060071587,0.0010547412,0.0008217593,0.00037214637,0.0031439594,0.0006980145],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62848294,0.18819733,0.013859039,0.001321122,0.0017279882,0.0007522417,0.00067026465,0.0029011322,0.06084199,0.00029361012,0.004399228,0.096553124],"study_design_scores_gemma":[0.36921278,0.6103863,0.01404064,0.00003711197,0.0003880778,0.00033513806,0.00008294944,0.00081050064,0.0024066924,0.00009405734,0.0021802692,0.000025399928],"about_ca_topic_score_codex":0.0016266303,"about_ca_topic_score_gemma":0.0043310886,"teacher_disagreement_score":0.0029831622,"about_ca_system_score_codex":0.001260227,"about_ca_system_score_gemma":0.002387206,"threshold_uncertainty_score":0.009979665},"labels":[],"label_agreement":null},{"id":"W2078978524","doi":"10.1097/01.coc.0000258081.70643.3d","title":"Correlation Between Saliva Production and Quality of Life Measurements in Head and Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Medicine; Saliva; Head and neck cancer; Radiation therapy; Quality of life (healthcare); Grading (engineering); Internal medicine; Toxicity; Head and neck; Cancer; Surgery","score_opus":0.1268325691945153,"score_gpt":0.43849231888889506,"score_spread":0.31165974969437976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078978524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999012,0.00055759633,0.00013143265,0.000015263378,0.0000029244209,0.000010410686,0.000121898825,0.000005424573,0.00014303648],"genre_scores_gemma":[0.9995523,0.00007896196,0.000101983045,0.00001100581,0.0000039473903,0.000011900028,0.00019106545,0.0000015792474,0.00004731764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996488,0.00011311536,0.00003501782,0.000056232435,0.000104677085,0.000042150743],"domain_scores_gemma":[0.9988166,0.0003845954,0.0005051833,0.00007154507,0.00014185299,0.0000802815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006910556,0.00019029934,0.00041507417,0.0004196275,0.00016774995,0.0004141625,0.00016379157,0.0002841601,0.0006124011],"category_scores_gemma":[0.0028503013,0.00014539114,0.00023572956,0.00035074994,0.00022991626,0.00024436557,0.00024337227,0.0002843265,0.00012821134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007844991,0.000082743536,0.9847692,0.000039945593,0.000114670715,0.00010033418,0.00010643668,0.00021608411,0.0040388587,0.000005918082,0.00010782677,0.009633285],"study_design_scores_gemma":[0.000014683771,0.00052641955,0.99793017,0.0000026388234,0.000044062803,0.0003942176,0.000037171896,0.00020277011,0.00066888676,0.000006101093,0.00016876234,0.0000041498015],"about_ca_topic_score_codex":0.0008439288,"about_ca_topic_score_gemma":0.0006684249,"teacher_disagreement_score":0.0008439288,"about_ca_system_score_codex":0.00025349428,"about_ca_system_score_gemma":0.00017813011,"threshold_uncertainty_score":0.0036547184},"labels":[],"label_agreement":null},{"id":"W2079094353","doi":"10.1097/01.coc.0000256103.21797.e5","title":"Oral Versus Intravenous Administration of Vinorelbine as a Single Agent for the First-Line Treatment of Metastatic Nonsmall Cell Lung Carcinoma (NSCLC)","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Hôpital Charles-Le Moyne; McGill University; Royal Victoria Hospital","funders":"","keywords":"Vinorelbine; Medicine; Internal medicine; Chemotherapy; Gastroenterology; Carcinoma; Surgery","score_opus":0.10356668326748363,"score_gpt":0.4792282221413577,"score_spread":0.37566153887387405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079094353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99570966,0.0022110622,0.00027109252,0.00019649013,0.00019650513,0.0003852039,0.00012203445,0.000025971312,0.000881952],"genre_scores_gemma":[0.99662375,0.0012175496,0.0005145645,0.00012456987,0.00018166618,0.00031435472,0.00013368909,0.0000057917027,0.00088411686],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997298,0.000105930376,0.000020573843,0.00004761914,0.000031706008,0.00006428569],"domain_scores_gemma":[0.999483,0.000160835,0.00011194882,0.000023502409,0.000013054193,0.00020758407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005470818,0.0004612672,0.0010850907,0.00026906224,0.00020131066,0.0004936678,0.0003688035,0.00063164876,0.003895394],"category_scores_gemma":[0.0010410899,0.0002180744,0.00039595924,0.00018723548,0.0005195091,0.00040117442,0.00023505131,0.0011683039,0.0003621695],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6852886,0.0194935,0.006631082,0.00097067485,0.00062713266,0.00016422464,0.0001411698,0.0018395962,0.024460847,0.00048503114,0.0016475008,0.25825062],"study_design_scores_gemma":[0.29999784,0.66115963,0.0199459,0.00015519027,0.0007797369,0.00044872146,0.00010541979,0.0027739273,0.008738429,0.0003825843,0.0054649357,0.000047674148],"about_ca_topic_score_codex":0.00028855746,"about_ca_topic_score_gemma":0.0009146873,"teacher_disagreement_score":0.003895394,"about_ca_system_score_codex":0.00040532564,"about_ca_system_score_gemma":0.00050760654,"threshold_uncertainty_score":0.013031423},"labels":[],"label_agreement":null},{"id":"W2082636073","doi":"10.1097/coc.0000000000000193","title":"Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"FOLFIRINOX; Medicine; Gemcitabine; Internal medicine; Performance status; Regimen; Oncology; Pancreatic cancer; Chemotherapy; Irinotecan; Gastroenterology; Cancer; Colorectal cancer","score_opus":0.30297252008093706,"score_gpt":0.559154466054304,"score_spread":0.2561819459733669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082636073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986351,0.0005835394,0.000069142814,0.00009579062,0.000008653413,0.000054847897,0.00007806104,0.0000026447074,0.00047219387],"genre_scores_gemma":[0.9995034,0.000094549505,0.000076179735,0.000058621416,0.000013022428,0.000031115134,0.00014425248,4.7676187e-7,0.00007835066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959713,0.00016120411,0.000059821894,0.00007154788,0.000051878193,0.00005849489],"domain_scores_gemma":[0.99927,0.00022329972,0.00025050706,0.000025933365,0.000032598033,0.00019753643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007247708,0.00013679286,0.00044968995,0.00025458276,0.00029022587,0.00039098272,0.00015584126,0.00030898573,0.0015288237],"category_scores_gemma":[0.0021173873,0.00007389421,0.0004175623,0.00024309955,0.00017006963,0.000266178,0.00025666165,0.00026070417,0.00016654159],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055430975,0.0010494796,0.8708982,0.00022495129,0.00022872158,0.0007096616,0.00028622252,0.0007135464,0.005191054,0.00015349622,0.0009675722,0.06414605],"study_design_scores_gemma":[0.002843032,0.012556264,0.97482944,0.00010555103,0.0003153956,0.002564943,0.00040254567,0.0015225484,0.0017160678,0.00025851314,0.0028697958,0.0000159273],"about_ca_topic_score_codex":0.0005718365,"about_ca_topic_score_gemma":0.0017595651,"teacher_disagreement_score":0.0015288237,"about_ca_system_score_codex":0.00046892132,"about_ca_system_score_gemma":0.00055430154,"threshold_uncertainty_score":0.005114436},"labels":[],"label_agreement":null},{"id":"W2083379775","doi":"10.1097/coc.0b013e3181131d62","title":"Angiosarcomas of the Breast","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Angiosarcoma; Breast cancer; Mastectomy; Radiation therapy; Incidence (geometry); Breast carcinoma; Population; Hemangiosarcoma; Cancer registry; Adjuvant therapy; Cancer; Surgery; Oncology; Internal medicine","score_opus":0.04150870458100532,"score_gpt":0.42823016395404523,"score_spread":0.3867214593730399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083379775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97569126,0.017496563,0.0011271439,0.00012180285,0.000026336913,0.000049628918,0.0004368455,0.000070295355,0.004980145],"genre_scores_gemma":[0.99002224,0.0077578817,0.0007941743,0.00007476743,0.00007539776,0.000015520778,0.00031981597,0.0000047024514,0.0009354823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981683,0.000029072053,0.00002648265,0.000034025612,0.00006184614,0.00003179825],"domain_scores_gemma":[0.99910754,0.00020404134,0.00048281316,0.00003598855,0.000113032766,0.000056491892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026674833,0.00018847245,0.00012527204,0.0013594714,0.00021908144,0.0002723859,0.00017496273,0.00012258922,0.001450405],"category_scores_gemma":[0.00084515923,0.00011019533,0.0001458114,0.0011434931,0.00020602018,0.00026804113,0.00015578869,0.00012787119,0.0004328066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012811349,0.00006811698,0.8406249,0.0006180443,0.000107797634,0.037005275,0.00041306915,0.00020195832,0.016766127,0.00023171822,0.0026947146,0.10114003],"study_design_scores_gemma":[0.00001792628,0.00020887541,0.7299475,0.00033109065,0.0001119125,0.25260198,0.00029747788,0.00020490572,0.00389812,0.00014219282,0.01222869,0.000009190929],"about_ca_topic_score_codex":0.0015532833,"about_ca_topic_score_gemma":0.003225762,"teacher_disagreement_score":0.0015532833,"about_ca_system_score_codex":0.00024736184,"about_ca_system_score_gemma":0.0003854173,"threshold_uncertainty_score":0.004852116},"labels":[],"label_agreement":null},{"id":"W2086540370","doi":"10.1097/01.coc.0000021042.55557.2b","title":"Cost Utility Analysis of First-Line Hormonal Therapy in Advanced Breast Cancer","year":2003,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tamoxifen; Letrozole; Anastrozole; Randomized controlled trial; Oncology; Breast cancer; Internal medicine; Clinical trial; Antiestrogen; Cancer","score_opus":0.04048766813107931,"score_gpt":0.42129993607378313,"score_spread":0.38081226794270384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086540370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91752017,0.014774372,0.051473204,0.0034205024,0.00016890587,0.000811528,0.0023974942,0.00013833649,0.009295509],"genre_scores_gemma":[0.99300367,0.0013346771,0.0042825155,0.00012525308,0.000024344972,0.00017992084,0.00042232437,0.000010188632,0.00061707513],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9958497,0.003567647,0.00008713341,0.0001070806,0.00022489122,0.0001635733],"domain_scores_gemma":[0.9820663,0.016392723,0.0005797084,0.00022617384,0.0004510732,0.00028404885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071439287,0.001188618,0.001737032,0.0018687395,0.00028178116,0.0014880565,0.0010344816,0.001178191,0.0021654838],"category_scores_gemma":[0.022446336,0.0006924219,0.0027593079,0.0016678157,0.00052460434,0.0011496843,0.00064504676,0.0011698835,0.0001046525],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001910483,0.00018425753,0.0053256713,0.00035960868,0.00097555877,0.00012570017,0.00002549075,0.9740148,0.00012093969,0.004945478,0.00060371653,0.011408293],"study_design_scores_gemma":[0.0004010351,0.00079043466,0.0043009426,0.00009786276,0.00076841866,0.00007965229,0.00005843663,0.98787725,0.00011483544,0.0049964823,0.0004827678,0.000031918407],"about_ca_topic_score_codex":0.020477222,"about_ca_topic_score_gemma":0.0086479755,"teacher_disagreement_score":0.020477222,"about_ca_system_score_codex":0.005889912,"about_ca_system_score_gemma":0.0030407521,"threshold_uncertainty_score":0.042734444},"labels":[],"label_agreement":null},{"id":"W2087772648","doi":"10.1097/01.coc.0000138965.97476.0f","title":"Preliminary Reliability and Validity Testing of a New Skin Toxicity Assessment Tool (STAT) in Breast Cancer Patients Undergoing Radiotherapy","year":2004,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Toxicity; Radiation therapy; Breast cancer; Acute toxicity; Surgery; Internal medicine; Cancer","score_opus":0.042995942553570046,"score_gpt":0.42978023574963425,"score_spread":0.3867842931960642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087772648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271715,0.00033491614,0.004964451,0.00008547616,0.00007293065,0.00026611565,0.00020653527,0.000035240428,0.0013170806],"genre_scores_gemma":[0.9948698,0.00010064835,0.0042569526,0.000046431094,0.00003059778,0.00020864114,0.0002854287,0.00001040641,0.00019106497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.989867,0.00490326,0.0013165589,0.0006120361,0.0029959297,0.00030524636],"domain_scores_gemma":[0.9548155,0.028926274,0.004997741,0.00186663,0.008747251,0.0006466031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014429734,0.00042402724,0.00052218203,0.0012799754,0.0003328317,0.0007297839,0.0005022924,0.00049875735,0.0008501196],"category_scores_gemma":[0.041334175,0.00030496082,0.0010308066,0.000838923,0.0006536729,0.0006874986,0.0009940668,0.0006182442,0.00033295326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009449224,0.0002291846,0.95194954,0.0001792525,0.00022695756,0.00006928915,0.0011606511,0.0009571195,0.0017509555,0.00012572946,0.00043814295,0.041968208],"study_design_scores_gemma":[0.00011316884,0.0036217896,0.9846272,0.000094194475,0.00013415646,0.00046258894,0.00076951506,0.0072934222,0.0011133392,0.00020629409,0.0015315453,0.000032901455],"about_ca_topic_score_codex":0.0008140109,"about_ca_topic_score_gemma":0.0013709442,"teacher_disagreement_score":0.014429734,"about_ca_system_score_codex":0.00042136316,"about_ca_system_score_gemma":0.0005279437,"threshold_uncertainty_score":0.07631266},"labels":[],"label_agreement":null},{"id":"W2090589423","doi":"10.1097/01.coc.0000178031.69209.47","title":"A Multicenter Phase II Study of “Adjuvant” Irinotecan Following Resection of Colorectal Hepatic Metastases","year":2005,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Mount Sinai Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Irinotecan; Internal medicine; Colorectal cancer; Regimen; Tolerability; Gastroenterology; Hepatectomy; Univariate analysis; Adjuvant therapy; Chemotherapy; Toxicity; Oncology; Surgery; Adjuvant; Cancer; Multivariate analysis; Resection; Adverse effect","score_opus":0.1306705066118074,"score_gpt":0.4518752882036163,"score_spread":0.3212047815918089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090589423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99740136,0.0008801589,0.00036621705,0.00014859886,0.000042845928,0.0006740305,0.00013838804,0.0000314834,0.000316968],"genre_scores_gemma":[0.995017,0.00074271654,0.001247139,0.00028603416,0.00009677053,0.00092460116,0.0009884059,0.000014363395,0.0006829457],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99940574,0.00036458657,0.000025224579,0.00008107864,0.000048387676,0.00007502511],"domain_scores_gemma":[0.99916387,0.00013139295,0.00019479309,0.00007128889,0.000051281586,0.0003874352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017848086,0.0010081327,0.0012869133,0.00023785017,0.00033301456,0.0005165809,0.0006081403,0.00064773957,0.0014486312],"category_scores_gemma":[0.0009947811,0.00037811973,0.00063087925,0.0002778823,0.0008578851,0.0004269111,0.0002059644,0.0016646096,0.0004034104],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6775037,0.06772634,0.034873303,0.0008403551,0.0016076567,0.0007731964,0.0004303566,0.0033178627,0.09725122,0.00017656293,0.003326355,0.11217317],"study_design_scores_gemma":[0.32969266,0.62161976,0.03465261,0.000031309835,0.0005052691,0.00087901886,0.00008569021,0.0015484749,0.008391186,0.00009599017,0.002473333,0.000024793855],"about_ca_topic_score_codex":0.0007643189,"about_ca_topic_score_gemma":0.0018714658,"teacher_disagreement_score":0.0017848086,"about_ca_system_score_codex":0.0005928792,"about_ca_system_score_gemma":0.0013266723,"threshold_uncertainty_score":0.009439051},"labels":[],"label_agreement":null},{"id":"W2091417780","doi":"10.1097/01.coc.0000258125.97090.3f","title":"Survival Differences Observed in Metastatic Breast Cancer Patients Treated With Capecitabine When Compared With Vinorelbine After Pretreatment With Anthracycline and Taxane","year":2007,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Statistics Canada; Alberta Cancer Foundation; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Vinorelbine; Capecitabine; Medicine; Anthracycline; Taxane; Metastatic breast cancer; Internal medicine; Oncology; Chemotherapy; Breast cancer; Cancer; Surgery; Colorectal cancer","score_opus":0.0626830552519413,"score_gpt":0.40415889236326363,"score_spread":0.34147583711132234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091417780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993228,0.0003059995,0.000033913126,0.000014485767,0.0000015778583,0.0000048477905,0.00013555124,0.000001473532,0.0001794254],"genre_scores_gemma":[0.99959713,0.0000880414,0.000036247566,0.000008239412,0.0000028237534,0.0000037958496,0.00021554384,5.68471e-7,0.00004759344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997949,0.000033050823,0.000025538773,0.000046315712,0.00005277887,0.000047480575],"domain_scores_gemma":[0.99928844,0.00019363913,0.00033794108,0.000018724106,0.0000740634,0.00008710164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002809691,0.00009999332,0.0001774818,0.00044491867,0.00020315232,0.0002202495,0.00010935863,0.00015610972,0.001071687],"category_scores_gemma":[0.0014555516,0.000065373366,0.00025623353,0.00044254845,0.00016306182,0.00013459817,0.00011860743,0.00017173178,0.00009077262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005581615,0.000029061088,0.9934681,0.000020144007,0.0000532006,0.00031381127,0.00009282925,0.00008628979,0.0010174392,0.000016078686,0.00007256558,0.0042723594],"study_design_scores_gemma":[0.000017153787,0.00030977407,0.9981628,0.000006157203,0.00004104667,0.0007718221,0.000083055376,0.000090524925,0.00028015047,0.000011946003,0.0002230338,0.0000025454017],"about_ca_topic_score_codex":0.0040869107,"about_ca_topic_score_gemma":0.0082526365,"teacher_disagreement_score":0.0040869107,"about_ca_system_score_codex":0.00050709903,"about_ca_system_score_gemma":0.00044311013,"threshold_uncertainty_score":0.008126259},"labels":[],"label_agreement":null},{"id":"W2092816732","doi":"10.1097/coc.0b013e3182868e82","title":"Rare Presentations of Primary Melanoma and Special Populations","year":2013,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Institute on Minority Health and Health Disparities; National Center for Research Resources; National Cancer Institute","keywords":"Medicine; Melanoma; Mucosal melanoma; Genitourinary system; Dermatology; Head and neck; Internal medicine; Surgery; Cancer research","score_opus":0.18486749970874297,"score_gpt":0.4858452699134193,"score_spread":0.3009777702046763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092816732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005765851,0.98787737,0.00039942426,0.00050255546,0.00019430736,0.0000090916465,0.00003547432,0.000019086345,0.0051967665],"genre_scores_gemma":[0.054639578,0.9422571,0.00065857254,0.00055160245,0.00055563985,0.000012131844,0.00009434834,0.000004974822,0.0012260339],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978155,0.000047506303,0.000034073444,0.00004283307,0.00006123763,0.000032747805],"domain_scores_gemma":[0.9997154,0.00011435238,0.000086394466,0.000009283825,0.000043130196,0.00003135228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022884201,0.00041435144,0.0006231991,0.0015661787,0.00025312474,0.000573729,0.00032119916,0.0006167264,0.0018945778],"category_scores_gemma":[0.0009059009,0.00013053507,0.00028921434,0.0011860795,0.00031298082,0.00063381036,0.000498809,0.00062538276,0.0005064732],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075445896,0.00007436027,0.018542064,0.012758485,0.00018377526,0.029176634,0.000765967,0.00048383436,0.004293976,0.0033382217,0.031583562,0.8987236],"study_design_scores_gemma":[0.000018844905,0.00010030532,0.026720231,0.0088920705,0.00025263114,0.47375497,0.0013163182,0.00018420965,0.0016645709,0.0031318627,0.48392493,0.00003915595],"about_ca_topic_score_codex":0.0007950106,"about_ca_topic_score_gemma":0.0014470574,"teacher_disagreement_score":0.0018945778,"about_ca_system_score_codex":0.00019985293,"about_ca_system_score_gemma":0.00043852776,"threshold_uncertainty_score":0.0063379407},"labels":[],"label_agreement":null},{"id":"W2094784241","doi":"10.1097/01.coc.0000054890.69365.3e","title":"Tolerance of Radiotherapy and Chemotherapy in Elderly Patients With Bladder Cancer","year":2004,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Cystectomy; Radiation therapy; Bladder cancer; Chemotherapy; Surgery; Neutropenia; Toxicity; Urinary bladder; Urology; Retrospective cohort study; Urinary system; Cancer; Internal medicine","score_opus":0.025108387793313806,"score_gpt":0.397683006252059,"score_spread":0.3725746184587452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094784241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981029,0.0010976649,0.00012845712,0.00003261528,0.0000055476617,0.000004423066,0.000058121455,0.000002404784,0.00056778814],"genre_scores_gemma":[0.9992798,0.00031354988,0.00009000952,0.000076762524,0.000018579436,0.0000053118147,0.000102301776,0.000001444155,0.00011236938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997638,0.000083178275,0.000035319594,0.000022928627,0.000058168167,0.000036639736],"domain_scores_gemma":[0.9989077,0.00024176201,0.0005816103,0.000039172024,0.00007805308,0.00015183428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043032918,0.00010986043,0.00031605127,0.00033370004,0.00021812369,0.00028256295,0.000086895074,0.00018118024,0.0006224405],"category_scores_gemma":[0.0021061492,0.00006896875,0.00024494057,0.00043625705,0.00012969994,0.00024166811,0.00018385872,0.00019470784,0.00013760818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049896474,0.000043362674,0.9853919,0.00002272567,0.000045577715,0.0006398587,0.00012603808,0.00011671468,0.00084548315,0.000016530768,0.00009037394,0.012162453],"study_design_scores_gemma":[0.000020396772,0.0015383324,0.9905027,0.000018333641,0.00007565603,0.0059547108,0.00017128195,0.00023245544,0.0003967939,0.000048287697,0.0010346555,0.0000062930003],"about_ca_topic_score_codex":0.0005471355,"about_ca_topic_score_gemma":0.0011734779,"teacher_disagreement_score":0.0006224405,"about_ca_system_score_codex":0.00015367812,"about_ca_system_score_gemma":0.00015007604,"threshold_uncertainty_score":0.0022758245},"labels":[],"label_agreement":null},{"id":"W2281671786","doi":"10.1097/coc.0000000000000274","title":"A Meta-Analysis of the Association Between Radiation Therapy and Survival for Surgically Resected Soft-Tissue Sarcoma","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Queen's University","funders":"","keywords":"Medicine; Odds ratio; Hazard ratio; Confidence interval; Soft tissue sarcoma; Radiation therapy; Confounding; Meta-analysis; Internal medicine; Population; Sarcoma; Surgery; Soft tissue; Pathology","score_opus":0.32452958089877754,"score_gpt":0.521202957292902,"score_spread":0.19667337639412447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2281671786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056019383,0.9929576,0.00037415454,0.00019223205,0.00015501693,0.00019789091,0.00026095207,0.000018836794,0.00024142065],"genre_scores_gemma":[0.15656543,0.83839315,0.0022729165,0.00073200284,0.00025609648,0.00072712585,0.0006151749,0.000025992173,0.00041221525],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9940713,0.0032604209,0.0013490638,0.0005261019,0.0006088117,0.00018421229],"domain_scores_gemma":[0.98781466,0.009257516,0.0015841943,0.000294217,0.00085861125,0.00019090441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009605356,0.0025381916,0.01435564,0.0056209634,0.0006106191,0.0026124015,0.0016988767,0.0021928605,0.003127073],"category_scores_gemma":[0.027822489,0.0011492755,0.031007135,0.0056217555,0.0005054527,0.0012620119,0.0010822879,0.0019499933,0.00029452352],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003819023,0.000048700087,0.003466122,0.3410238,0.6309489,0.00022826849,0.00008633197,0.00061380386,0.00034898423,0.00015625547,0.00091995974,0.018339733],"study_design_scores_gemma":[0.0006535284,0.00023563667,0.0027449313,0.015921975,0.9786567,0.00011865269,0.000028303688,0.00015341933,0.00011735817,0.000143674,0.0012084651,0.000017281529],"about_ca_topic_score_codex":0.0059527503,"about_ca_topic_score_gemma":0.012242549,"teacher_disagreement_score":0.01435564,"about_ca_system_score_codex":0.0024903775,"about_ca_system_score_gemma":0.0029964736,"threshold_uncertainty_score":0.050798595},"labels":[],"label_agreement":null},{"id":"W2312366830","doi":"10.1097/coc.0b013e318210f9ce","title":"Impact and Feasibility of a Comprehensive Geriatric Assessment in the Oncology Setting","year":2011,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Geriatric oncology; MEDLINE; Oncology; Medical physics; Intensive care medicine; Internal medicine; Cancer","score_opus":0.18752569596741567,"score_gpt":0.5315478851114135,"score_spread":0.34402218914399785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312366830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954619,0.000322094,0.00025080764,0.0011781154,0.000030050263,0.0003579116,0.00013336612,0.00002012746,0.002245693],"genre_scores_gemma":[0.9988141,0.00008529322,0.0007171598,0.00014039694,0.000028215321,0.00008561675,0.0000589407,0.0000016659659,0.00006860807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900662,0.0065778717,0.00061503035,0.0005242986,0.0013328253,0.0008838048],"domain_scores_gemma":[0.97504413,0.010728717,0.0046798917,0.0009826258,0.0025101788,0.0060543586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0094707385,0.00031072306,0.00028235692,0.0005820955,0.000996433,0.0014058716,0.0006931921,0.0008782876,0.0026565518],"category_scores_gemma":[0.041965745,0.00024287876,0.00044747622,0.0005163279,0.00056337775,0.0009940095,0.0025108901,0.0009159353,0.0003686617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014679787,0.0019194592,0.9197546,0.00020066326,0.000048369297,0.0010046874,0.0012832184,0.00089306437,0.000787334,0.00009777261,0.0012100689,0.07133277],"study_design_scores_gemma":[0.0001935772,0.0059156413,0.9858073,0.00019185859,0.00004837303,0.0013079522,0.0023913046,0.002393745,0.0002611642,0.00008017467,0.0013751268,0.000033837096],"about_ca_topic_score_codex":0.009510408,"about_ca_topic_score_gemma":0.01702509,"teacher_disagreement_score":0.009510408,"about_ca_system_score_codex":0.0019644324,"about_ca_system_score_gemma":0.0057843747,"threshold_uncertainty_score":0.050086677},"labels":[],"label_agreement":null},{"id":"W2312903109","doi":"10.1097/coc.0b013e3182439068","title":"Impact of Asian Ethnicity on Colorectal Cancer Screening","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Vietnamese; Demography; Odds; Logistic regression; Ethnic group; Odds ratio; Confounding; Population; Multivariate analysis; Gerontology; Cohort; Environmental health; Internal medicine","score_opus":0.1101335112731579,"score_gpt":0.5045825546756414,"score_spread":0.3944490434024835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312903109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918356,0.0011066075,0.0001278508,0.0004781419,0.000033821147,0.000007584845,0.00032226832,0.000007980957,0.006080125],"genre_scores_gemma":[0.99894625,0.00044118165,0.00008573881,0.0000921688,0.00001687058,0.0000035306616,0.00010136036,0.0000035414596,0.00030936656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938715,0.0002175096,0.00006410072,0.00006617234,0.00013808318,0.0001269813],"domain_scores_gemma":[0.99791044,0.0004007745,0.00092174055,0.00012014147,0.00023027805,0.00041656633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078230066,0.00017142356,0.00016125462,0.00048396946,0.00045771868,0.0006652434,0.00017489685,0.00014558912,0.0044744294],"category_scores_gemma":[0.0029364843,0.00008069917,0.0004348309,0.00070291356,0.00032404513,0.00045717275,0.00072321016,0.0003339451,0.00031853662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010345598,0.000038610448,0.9903336,0.00004979187,0.000091874754,0.0002677391,0.00025455086,0.000039205497,0.00035739728,0.00013218651,0.0001644236,0.008167115],"study_design_scores_gemma":[0.0000029879109,0.00007533162,0.9973103,0.000048476963,0.00007813567,0.00055953045,0.0007147967,0.00009558849,0.00012480162,0.000096849464,0.00088853383,0.0000047184203],"about_ca_topic_score_codex":0.008595887,"about_ca_topic_score_gemma":0.013351686,"teacher_disagreement_score":0.008595887,"about_ca_system_score_codex":0.00025544857,"about_ca_system_score_gemma":0.00059062004,"threshold_uncertainty_score":0.017091691},"labels":[],"label_agreement":null},{"id":"W2312995441","doi":"10.1097/coc.0000000000000184","title":"A Patient-centered Approach to Evaluate the Information Needs of Women With Ductal Carcinoma In Situ","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; Queen's University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Timeline; Focus group; Ductal carcinoma; Set (abstract data type); Family medicine; Cancer; Internal medicine; Breast cancer","score_opus":0.15238951793087577,"score_gpt":0.42794872088618696,"score_spread":0.2755592029553112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312995441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99133766,0.00031530065,0.0014883803,0.0008903567,0.000027294636,0.0017475983,0.00075528433,0.00004623607,0.003391949],"genre_scores_gemma":[0.9836481,0.0003531755,0.010676889,0.00062089955,0.000033669065,0.0033078692,0.00043031838,0.0000093695635,0.0009196275],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9943329,0.0041471506,0.00041992482,0.00019564388,0.0005863769,0.00031800018],"domain_scores_gemma":[0.99020314,0.00488667,0.0018840393,0.0002594625,0.0018394138,0.00092723675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009509816,0.0003707079,0.0004896725,0.002200002,0.0010811533,0.0010888039,0.00052375544,0.00063617853,0.003940609],"category_scores_gemma":[0.017836338,0.00020560631,0.0007347948,0.0012235391,0.00051338144,0.0016680651,0.0018303015,0.0008712224,0.00039258727],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003535725,0.0059900195,0.6606049,0.0024994847,0.00031521491,0.0011491464,0.099796526,0.0011400732,0.004868454,0.0012285806,0.0082493145,0.21062252],"study_design_scores_gemma":[0.0016636143,0.02906669,0.7193724,0.00093366514,0.0006241319,0.002962033,0.19301379,0.0074460884,0.008115545,0.0023039205,0.034204267,0.0002937881],"about_ca_topic_score_codex":0.00077077735,"about_ca_topic_score_gemma":0.0016313958,"teacher_disagreement_score":0.009509816,"about_ca_system_score_codex":0.0015240418,"about_ca_system_score_gemma":0.0021261747,"threshold_uncertainty_score":0.050293326},"labels":[],"label_agreement":null},{"id":"W2313859996","doi":"10.1097/00000421-200202000-00015","title":"A Phase II Study of Etoposide, Doxorubicin, and Carboplatin in the Treatment of Advanced Gastric Cancer","year":2002,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Etoposide; Carboplatin; Regimen; Gastroenterology; Internal medicine; Leukopenia; Nausea; Toxicity; Progressive disease; Surgery; Phases of clinical research; Chemotherapy; Vomiting; Doxorubicin; Cisplatin","score_opus":0.08909568021714441,"score_gpt":0.467989818956733,"score_spread":0.37889413873958855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313859996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98467237,0.003533914,0.0015493646,0.0005708296,0.00023764015,0.0074718734,0.0005022364,0.00007367093,0.0013880905],"genre_scores_gemma":[0.9698777,0.005459694,0.00801854,0.0015292899,0.00038288385,0.008697849,0.003082185,0.00003875444,0.0029129935],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99867755,0.0008029861,0.00007454204,0.00013687584,0.0001516196,0.00015640211],"domain_scores_gemma":[0.9988955,0.00016324247,0.00014277137,0.000091525246,0.00007597912,0.00063095836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036802078,0.001773839,0.002519892,0.0008712532,0.00053566566,0.0008557147,0.0010865389,0.001389303,0.0014993522],"category_scores_gemma":[0.0012495249,0.00084664597,0.0012658078,0.0008445067,0.0013392415,0.00067544845,0.00048507005,0.003615295,0.00038853346],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47845796,0.24748065,0.01430727,0.00128012,0.0021683192,0.00088261074,0.00066154345,0.00558077,0.10148364,0.0007621641,0.0038542598,0.14308068],"study_design_scores_gemma":[0.57929265,0.4013647,0.009670685,0.00003495092,0.00027801216,0.00044979528,0.000047443216,0.0014732075,0.004499633,0.00013626865,0.0027221753,0.000030472878],"about_ca_topic_score_codex":0.0010940733,"about_ca_topic_score_gemma":0.0017639515,"teacher_disagreement_score":0.0036802078,"about_ca_system_score_codex":0.0007682222,"about_ca_system_score_gemma":0.0021421541,"threshold_uncertainty_score":0.019463062},"labels":[],"label_agreement":null},{"id":"W2313979980","doi":"10.1097/coc.0000000000000077","title":"Primary and Radiation-induced Breast Angiosarcoma","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Histopathology; Malignancy; Grading (engineering); Breast cancer; Angiosarcoma; Adjuvant radiotherapy; Radiation therapy; Context (archaeology); Radiology; Oncology; Surgery; Internal medicine; Cancer; Pathology","score_opus":0.0729620257128847,"score_gpt":0.41371646145324054,"score_spread":0.34075443574035585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313979980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835384,0.0006097985,0.0000960426,0.000017732511,0.000003981155,0.000009676417,0.000111118075,0.000005277212,0.0007925801],"genre_scores_gemma":[0.99960023,0.00011756485,0.000050227012,0.000007884215,0.000008917864,0.0000045204997,0.0000871806,0.0000014270663,0.00012196606],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99973804,0.000060446862,0.000030743195,0.00003798755,0.000065136,0.000067572844],"domain_scores_gemma":[0.9980521,0.00050342816,0.0008951421,0.00012600145,0.0001805528,0.0002426947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004420364,0.0001544043,0.00016983775,0.0004905211,0.00026237514,0.000253195,0.00015456148,0.00017782599,0.0034994273],"category_scores_gemma":[0.002061776,0.00010642451,0.00017017931,0.00034138534,0.00027789315,0.00018298984,0.00024035762,0.00016323356,0.0004718236],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021204731,0.000023142658,0.99158704,0.00003377081,0.000019457377,0.0028982023,0.00006128778,0.00006190415,0.00093316345,0.00001926059,0.000116171395,0.004034543],"study_design_scores_gemma":[0.000015125444,0.0003570664,0.9540833,0.000014829269,0.000047518875,0.04349243,0.00015578403,0.0001331187,0.000937308,0.00004168597,0.00071747025,0.00000428506],"about_ca_topic_score_codex":0.00074003683,"about_ca_topic_score_gemma":0.001345747,"teacher_disagreement_score":0.0034994273,"about_ca_system_score_codex":0.00028405502,"about_ca_system_score_gemma":0.00026051333,"threshold_uncertainty_score":0.01170671},"labels":[],"label_agreement":null},{"id":"W2314709406","doi":"10.1097/coc.0b013e3182143cce","title":"Wait Times in Diagnostic Evaluation and Treatment for Patients With Stage III Non-Small Cell Lung Cancer in British Columbia","year":2011,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Lung cancer; Neoplasm staging; Oncology; Cancer; Intensive care medicine; Internal medicine","score_opus":0.04201635644396122,"score_gpt":0.39316747585261536,"score_spread":0.3511511194086541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314709406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930847,0.00028693106,0.000022547985,0.00006923187,0.0000041490903,0.0000037387867,0.00006586889,0.0000020701682,0.00023693305],"genre_scores_gemma":[0.9997017,0.000071032104,0.000026204221,0.00002157302,0.0000024520837,0.0000030186438,0.000081390106,8.6901053e-7,0.00009161414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967,0.000057210113,0.00002618543,0.000054681663,0.00008028146,0.00011151665],"domain_scores_gemma":[0.9985145,0.000337822,0.00066492526,0.000021761467,0.00013284206,0.00032822465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024731492,0.000117341195,0.00015744347,0.00035716654,0.00067018444,0.00041976292,0.0003517562,0.00032889517,0.0013305467],"category_scores_gemma":[0.0024082966,0.00014894553,0.00014363561,0.0005292005,0.00023001056,0.00014508895,0.0002510678,0.00041678897,0.00009965758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001882375,0.000036008973,0.9960962,0.000013657535,0.000014360952,0.0002752503,0.00014081904,0.000102318656,0.0002883817,0.000014307542,0.00021105418,0.0026194549],"study_design_scores_gemma":[0.000011800372,0.000095727286,0.9987155,0.00001008279,0.000011425408,0.00029498088,0.00031258035,0.00024228416,0.000074439595,0.000009564748,0.00021739806,0.0000042609186],"about_ca_topic_score_codex":0.32692644,"about_ca_topic_score_gemma":0.40501916,"teacher_disagreement_score":0.67307353,"about_ca_system_score_codex":0.003162559,"about_ca_system_score_gemma":0.0022327292,"threshold_uncertainty_score":0.65004706},"labels":[],"label_agreement":null},{"id":"W2318711118","doi":"10.1097/coc.0000000000000034","title":"A Phase I Study of Tomotherapy in Patients With Primary Benign and Low-grade Brain Tumors","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; London Health Sciences Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Tomotherapy; Nausea; Quality of life (healthcare); Radiation therapy; Statistical significance; Performance status; Neurotoxicity; Toxicity; Whole brain radiotherapy; Internal medicine; Surgery; Nuclear medicine; Overall survival; Metastasis; Brain metastasis; Cancer","score_opus":0.029548250902858512,"score_gpt":0.41319229308486044,"score_spread":0.38364404218200193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318711118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958692,0.0008891423,0.000265503,0.000119076525,0.000045738572,0.0018494047,0.00031269435,0.000021448117,0.0006277535],"genre_scores_gemma":[0.9910748,0.001290118,0.0014604778,0.0004470296,0.00016640771,0.0030502337,0.0013277907,0.000013201769,0.001169825],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99952114,0.00019712195,0.000023840032,0.00006779247,0.000056622797,0.00013348294],"domain_scores_gemma":[0.999371,0.000068679925,0.00013091222,0.00006130227,0.000055184286,0.000312949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00123066,0.0011662046,0.0018446125,0.00036659042,0.00056716724,0.0006610703,0.0006456197,0.00081713777,0.0023543043],"category_scores_gemma":[0.0007899029,0.00042562018,0.001015745,0.00046780918,0.00082387467,0.00047777756,0.00028231088,0.001568887,0.0005290905],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6383,0.15277609,0.056606706,0.0009946788,0.001863898,0.0007261779,0.000602373,0.002346297,0.043668557,0.00021494828,0.0027450474,0.09915519],"study_design_scores_gemma":[0.23681039,0.7176251,0.039416336,0.000024544412,0.00037819622,0.0006055088,0.00009054153,0.0007352404,0.002505904,0.000093378476,0.0016972297,0.000017663539],"about_ca_topic_score_codex":0.002763071,"about_ca_topic_score_gemma":0.006290152,"teacher_disagreement_score":0.002763071,"about_ca_system_score_codex":0.0012590423,"about_ca_system_score_gemma":0.0021918516,"threshold_uncertainty_score":0.009135067},"labels":[],"label_agreement":null},{"id":"W2319098184","doi":"10.1097/coc.0000000000000192","title":"Stage IIIC Endometrial Cancer","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Endometrial cancer; Proportional hazards model; Stage (stratigraphy); Internal medicine; Chemotherapy; Oncology; Cohort; Cancer; Urology; Gynecology","score_opus":0.228678672495576,"score_gpt":0.5295284305313788,"score_spread":0.3008497580358028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319098184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811942,0.009553651,0.00065819337,0.00038296578,0.000054191638,0.00008142604,0.0010452853,0.000023983404,0.0070061646],"genre_scores_gemma":[0.9953047,0.0018644483,0.00060342054,0.00027782517,0.000056597113,0.00002838777,0.00077284867,0.0000046903406,0.001087187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987924,0.00002059567,0.000009455038,0.000027015109,0.000025195142,0.000038533846],"domain_scores_gemma":[0.99982625,0.000030258847,0.000086674656,0.000011543238,0.000020652065,0.000024681201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022764836,0.000174309,0.00031134757,0.0001782222,0.0003275618,0.00029954722,0.00012281854,0.00015767047,0.0023931502],"category_scores_gemma":[0.0006106281,0.00006791199,0.00016231101,0.00029649088,0.00015879497,0.000086331216,0.00017995524,0.00012379173,0.00050025596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023383506,0.000019652118,0.96025974,0.00014984379,0.000044491873,0.0013362727,0.000069390524,0.00013156194,0.0028696558,0.000120781,0.0016416084,0.033123184],"study_design_scores_gemma":[0.000051321535,0.0003290684,0.96293443,0.0001419029,0.00009822336,0.019760838,0.00019446593,0.00027517515,0.0010576702,0.00018978713,0.014960851,0.0000061389837],"about_ca_topic_score_codex":0.0036698407,"about_ca_topic_score_gemma":0.007882586,"teacher_disagreement_score":0.0036698407,"about_ca_system_score_codex":0.00033649022,"about_ca_system_score_gemma":0.0005362634,"threshold_uncertainty_score":0.008005917},"labels":[],"label_agreement":null},{"id":"W2319511858","doi":"10.1097/00000421-200112000-00014","title":"Thymidylate Synthase Expression in Stage II and III Colon Cancer","year":2001,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Thymidylate synthase; Chemotherapy; Internal medicine; Adjuvant; Colorectal cancer; Grading (engineering); Fluorouracil; Stage (stratigraphy); Gastroenterology; Adjuvant therapy; Adjuvant chemotherapy; Retrospective cohort study; Surgery; Oncology; Cancer","score_opus":0.07275299460736473,"score_gpt":0.4744815850383554,"score_spread":0.4017285904309907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319511858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956626,0.00016453346,0.00003266671,0.0000044118187,0.0000013528887,0.0000030564206,0.00007220218,0.0000010037663,0.00015453187],"genre_scores_gemma":[0.99966097,0.000048425616,0.000039125334,0.000005853052,0.0000028866064,0.0000043801597,0.00018188039,6.9598474e-7,0.00005580849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997991,0.000039324375,0.000027125394,0.000037900776,0.000040364714,0.000056110595],"domain_scores_gemma":[0.99930894,0.00013955093,0.00029337246,0.00003374789,0.000065338194,0.00015907153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020291071,0.00018304969,0.00026821546,0.00064650946,0.00025095316,0.00027411996,0.00011174587,0.00025895672,0.00077166554],"category_scores_gemma":[0.00087406114,0.00015375213,0.00026236038,0.0004923475,0.00021524639,0.00019339527,0.00024822488,0.00021660168,0.00015599083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001576463,0.0000059017802,0.9980964,0.0000050960725,0.000013036505,0.00014966432,0.000025778974,0.000012961122,0.0007185176,0.0000029642777,0.0000186506,0.0007933641],"study_design_scores_gemma":[0.000005433315,0.0001236499,0.9984334,0.0000021191609,0.0000133830645,0.0010548875,0.000057426252,0.000052342428,0.00015060256,0.0000053227404,0.000099715624,0.000001782269],"about_ca_topic_score_codex":0.0015555937,"about_ca_topic_score_gemma":0.0022528782,"teacher_disagreement_score":0.0015555937,"about_ca_system_score_codex":0.00019393447,"about_ca_system_score_gemma":0.00015512385,"threshold_uncertainty_score":0.0030931234},"labels":[],"label_agreement":null},{"id":"W2319904351","doi":"10.1097/01.coc.0000077940.05196.86","title":"Inducible Nitric Oxide Synthase and Nitrotyrosine in Mice With Radiation-Induced Lung Damage","year":2003,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Nitrotyrosine; Nitric oxide synthase; Pathology; Lung; Nitric oxide; Medicine; Immunostaining; Respiratory epithelium; Pathogenesis; Immunohistochemistry; Epithelium; Molecular biology; Andrology; Biology; Endocrinology; Internal medicine","score_opus":0.03604392762972686,"score_gpt":0.3931742984545507,"score_spread":0.35713037082482385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319904351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961273,0.001598292,0.001421976,0.00010105226,0.00002160312,0.000041991163,0.0001451841,0.000066674045,0.0004759595],"genre_scores_gemma":[0.99276334,0.0012973695,0.0022407228,0.00010404078,0.000019476778,0.00012499775,0.00047609952,0.000025405829,0.0029485826],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99977547,0.00006049555,0.000019687643,0.000048163918,0.000045974375,0.00005023639],"domain_scores_gemma":[0.9996495,0.000033446337,0.00014491701,0.00003321556,0.00002640741,0.00011239113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041850776,0.0006594153,0.00042972146,0.00064292597,0.00025783255,0.00024688424,0.00024588633,0.0006265527,0.0015343912],"category_scores_gemma":[0.00018624282,0.0002875523,0.00034732695,0.00019256577,0.0004390347,0.00034331178,0.00024626573,0.0011090302,0.00023074707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014275601,0.0003985845,0.0019178455,0.00006092825,0.000012410323,0.0002433203,0.000044211036,0.00007228243,0.99338055,0.00015455011,0.00005549671,0.002232309],"study_design_scores_gemma":[0.000529834,0.016588628,0.09568366,0.00009145064,0.00014300873,0.005489635,0.00021314458,0.002054068,0.87455696,0.00045973988,0.004150418,0.0000393498],"about_ca_topic_score_codex":0.00025783625,"about_ca_topic_score_gemma":0.0005425613,"teacher_disagreement_score":0.0015343912,"about_ca_system_score_codex":0.00024479418,"about_ca_system_score_gemma":0.00022750862,"threshold_uncertainty_score":0.0051330924},"labels":[],"label_agreement":null},{"id":"W2320487245","doi":"10.1097/coc.0b013e318248da66","title":"Factors Associated With Suboptimal Colorectal Cancer Screening in US Immigrants","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Sigmoidoscopy; Odds ratio; Fecal occult blood; Confidence interval; Colonoscopy; Demography; Residence; Colorectal cancer; Odds; Immigration; Logistic regression; Gerontology; Internal medicine; Cancer","score_opus":0.12137843319455338,"score_gpt":0.4349463914394331,"score_spread":0.3135679582448797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320487245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99921703,0.00021489509,0.000027917737,0.00011219325,0.0000059120925,0.0000050710787,0.000072349656,0.0000017521004,0.00034285785],"genre_scores_gemma":[0.9996948,0.000085878455,0.000041795065,0.00004191173,0.0000075425037,0.000004003342,0.00008277791,9.784823e-7,0.000040388386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995035,0.00015833566,0.00007093395,0.00007100949,0.00009500262,0.00010134207],"domain_scores_gemma":[0.9980458,0.0003331791,0.0010252054,0.000064314154,0.00020225628,0.00032925222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007213435,0.00019874318,0.0002716372,0.0006297859,0.00052203645,0.00060860324,0.00026645273,0.00042537335,0.0014802488],"category_scores_gemma":[0.0044268626,0.00016621653,0.0002908616,0.0009557696,0.00039069584,0.00032093775,0.0005552526,0.00046230975,0.00011496385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018479202,0.000013196064,0.99930227,0.0000058597575,0.000012706178,0.000043241336,0.000065953274,0.000019576684,0.000027694045,0.000010637612,0.000045971774,0.00043443442],"study_design_scores_gemma":[0.0000022881836,0.000038445953,0.9990238,0.000013383598,0.000015807587,0.00015171789,0.00048254555,0.00013011147,0.000015185025,0.000020954038,0.000102460865,0.0000033443364],"about_ca_topic_score_codex":0.019243529,"about_ca_topic_score_gemma":0.022454515,"teacher_disagreement_score":0.019243529,"about_ca_system_score_codex":0.00043944226,"about_ca_system_score_gemma":0.0007268771,"threshold_uncertainty_score":0.038263083},"labels":[],"label_agreement":null},{"id":"W2320599978","doi":"10.1097/coc.0b013e3181f47583","title":"Radioembolization for the Treatment of Liver Tumors","year":2010,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nordion (Canada)","funders":"","keywords":"Medicine; Microsphere; Embolization; Radiology; Concomitant; Selective internal radiation therapy; Liver function; Magnetic resonance imaging; Nuclear medicine; Hepatocellular carcinoma; Surgery; Internal medicine","score_opus":0.3324402411097796,"score_gpt":0.49262732612599613,"score_spread":0.16018708501621653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320599978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089299385,0.9985506,0.00012742406,0.00012293407,0.0000913578,0.000005486096,0.000011402296,0.000006709396,0.0009948015],"genre_scores_gemma":[0.0007571446,0.99836844,0.00017229721,0.00008936377,0.00009626582,0.0000059618787,0.00002903517,0.0000015258195,0.00047990985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976605,0.000042751035,0.000032818578,0.00003894219,0.00010363432,0.00001580849],"domain_scores_gemma":[0.99965894,0.00015414317,0.00006552172,0.000013449525,0.000078549165,0.000029380019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050825096,0.0009990609,0.0016157196,0.0038387056,0.00031629574,0.0006949208,0.0007679207,0.0007806226,0.003754149],"category_scores_gemma":[0.0007075432,0.00019726889,0.0005418055,0.0044999667,0.00058296754,0.0010946346,0.00047555953,0.0013637772,0.0033401612],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042773056,0.00007489664,0.0003206814,0.011502857,0.00009414134,0.00029517914,0.000043371867,0.0002676482,0.000999161,0.0010702895,0.025225205,0.96006376],"study_design_scores_gemma":[0.000026731355,0.000105638486,0.0027233667,0.004676829,0.00019546403,0.0063082096,0.00008519644,0.0001229123,0.0006165248,0.0015617919,0.98355365,0.000023710645],"about_ca_topic_score_codex":0.0012320036,"about_ca_topic_score_gemma":0.002166397,"teacher_disagreement_score":0.0038387056,"about_ca_system_score_codex":0.00061386026,"about_ca_system_score_gemma":0.00094203063,"threshold_uncertainty_score":0.012558818},"labels":[],"label_agreement":null},{"id":"W2320853964","doi":"10.1097/00000421-200212001-00003","title":"Efficacy of Bisphosphonates in the Management of Skeletal Complications of Bone Metastases and Selection of Clinical Endpoints","year":2002,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Zoledronic acid; Clinical trial; Bisphosphonate; Breast cancer; Prostate cancer; Multiple myeloma; Bone metastasis; Oncology; Clinical endpoint; Internal medicine; Cancer; Surgery; Osteoporosis","score_opus":0.19155596160046878,"score_gpt":0.539495382071859,"score_spread":0.3479394204713902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320853964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019876647,0.99888045,0.00019630542,0.00016413903,0.000071036724,0.000021551434,0.0000082371325,0.0000027447904,0.00045680767],"genre_scores_gemma":[0.0020649654,0.996581,0.000792656,0.00021393588,0.000099744415,0.000044913933,0.000018168204,0.0000014510623,0.00018322411],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962114,0.001816831,0.0006375383,0.00027216267,0.0010101488,0.000051911913],"domain_scores_gemma":[0.99461067,0.00433052,0.00048110145,0.0000841469,0.00043568743,0.000057822675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006907269,0.0008914456,0.004068754,0.0033737477,0.00027037758,0.0011893604,0.0010867785,0.0012574261,0.0010633356],"category_scores_gemma":[0.007643739,0.00029875606,0.0011459433,0.0034150209,0.00080172595,0.0009570905,0.00039055062,0.0011423477,0.00048763814],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031484733,0.000079234895,0.00049582106,0.041518684,0.00041552936,0.00009841589,0.00006700023,0.00035390325,0.00095316663,0.0033034307,0.0038833048,0.9485167],"study_design_scores_gemma":[0.0010052156,0.0025091514,0.018350078,0.09130606,0.0047924696,0.004697246,0.00055288366,0.00087868737,0.004126867,0.013714356,0.85791826,0.0001486778],"about_ca_topic_score_codex":0.0010285754,"about_ca_topic_score_gemma":0.002225962,"teacher_disagreement_score":0.006907269,"about_ca_system_score_codex":0.0011265181,"about_ca_system_score_gemma":0.0018340016,"threshold_uncertainty_score":0.03652954},"labels":[],"label_agreement":null},{"id":"W2322229085","doi":"10.1097/coc.0000000000000107","title":"Function Preservation After Conservative Resection and Radiotherapy for Soft-tissue Sarcoma of the Distal Extremity","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Wound dehiscence; Surgery; Amputation; Soft tissue sarcoma; Adverse effect; Complication; Soft tissue; Sarcoma; Dehiscence; Radiation therapy; Forefoot; Cellulitis; Lymphedema; Current Procedural Terminology; Ankle; Cancer; Breast cancer; Internal medicine","score_opus":0.055735465324442714,"score_gpt":0.416092564456979,"score_spread":0.3603570991325363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322229085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990038,0.00053042796,0.00015435112,0.00001882328,0.000005055691,0.000007918298,0.000026632233,0.0000063043603,0.00024678346],"genre_scores_gemma":[0.9996165,0.000094881885,0.000057125275,0.000020408874,0.000007853478,0.000006415344,0.00010072902,9.1225087e-7,0.0000951179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998368,0.00004620718,0.000014110456,0.000022471611,0.00004685666,0.000033634748],"domain_scores_gemma":[0.999703,0.000058243895,0.00012158199,0.000017306762,0.000016637956,0.00008322265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032707717,0.00019114076,0.00032131275,0.00021574403,0.0001658769,0.00017468401,0.00014366547,0.00012097947,0.00086135115],"category_scores_gemma":[0.00090130075,0.00004592146,0.00023382617,0.00019239106,0.00022769153,0.00013981781,0.0002371663,0.00017383762,0.00019329922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070424955,0.0021224534,0.79510045,0.00025724177,0.00037652862,0.0021757043,0.00041737626,0.0024524785,0.011757093,0.000055888646,0.0007479569,0.17749439],"study_design_scores_gemma":[0.00030933946,0.019662227,0.9714289,0.000022131488,0.00012364371,0.00504546,0.00019014372,0.0007045813,0.0017225004,0.00006129353,0.0007198088,0.00000996165],"about_ca_topic_score_codex":0.00052260497,"about_ca_topic_score_gemma":0.001286855,"teacher_disagreement_score":0.00086135115,"about_ca_system_score_codex":0.00019971293,"about_ca_system_score_gemma":0.00022719364,"threshold_uncertainty_score":0.0028814673},"labels":[],"label_agreement":null},{"id":"W2324258684","doi":"10.1097/coc.0000000000000091","title":"Asian Versus Non-Asian Outcomes in Nasopharyngeal Carcinoma: A North American Population-based Analysis","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Nasopharyngeal carcinoma; Internal medicine; Proportional hazards model; Hazard ratio; Stage (stratigraphy); Survival analysis; Multivariate analysis; Population; Retrospective cohort study; Oncology; Radiation therapy; Confidence interval","score_opus":0.049414887521933654,"score_gpt":0.43132924567618386,"score_spread":0.38191435815425023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324258684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993735,0.000109501336,0.000048678958,0.000021305561,0.0000024040364,0.000004705147,0.0001992087,0.0000015743068,0.00023915716],"genre_scores_gemma":[0.99957377,0.00007230794,0.000041191142,0.000013687296,0.000005611408,0.000005375349,0.00022532075,0.0000015477697,0.00006114024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995784,0.00011638373,0.000035871126,0.000111071815,0.00009447755,0.00006377539],"domain_scores_gemma":[0.99925214,0.00012119695,0.00030366742,0.00007066228,0.00012131745,0.00013102779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000969569,0.00019483673,0.0002560865,0.00063203205,0.00040819895,0.00050368835,0.00027990257,0.00026413912,0.0010739947],"category_scores_gemma":[0.0011181233,0.00020763844,0.0004850307,0.0009882654,0.0002660207,0.0003538823,0.00037092937,0.00033540625,0.00016323512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008758972,0.000014363616,0.99881244,0.000005582042,0.00007523801,0.000038078946,0.00007729058,0.000025820531,0.00010473293,0.000010576936,0.00005593566,0.00069237617],"study_design_scores_gemma":[0.000006279114,0.000051650317,0.99917775,0.0000029439414,0.00005259795,0.00011030184,0.00023856116,0.00016501971,0.000025710948,0.000012519491,0.00015412644,0.0000024561941],"about_ca_topic_score_codex":0.02072617,"about_ca_topic_score_gemma":0.030569442,"teacher_disagreement_score":0.02072617,"about_ca_system_score_codex":0.0003835341,"about_ca_system_score_gemma":0.0005462377,"threshold_uncertainty_score":0.04121107},"labels":[],"label_agreement":null},{"id":"W2327192765","doi":"10.1097/coc.0000000000000284","title":"Age Bias in Time From Diagnosis Comparisons of Prostate Cancer Treatment","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Prostatectomy; Prostate cancer; Observational study; Randomized controlled trial; Hazard ratio; Radiation therapy; Cohort; Survival analysis; Cohort study; Proportional hazards model; Prostate; Epidemiology; Cancer; Oncology; Surgery; Internal medicine; Confidence interval","score_opus":0.13724191495587953,"score_gpt":0.46373678657197276,"score_spread":0.32649487161609325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327192765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6985304,0.08910022,0.16018535,0.006974961,0.006686528,0.003548077,0.012325384,0.00044307043,0.022206072],"genre_scores_gemma":[0.97465605,0.0028736917,0.015775668,0.0016776128,0.0006266196,0.0012213229,0.0016063437,0.00007819609,0.0014846281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.82226247,0.14092971,0.012820788,0.009708249,0.0126244575,0.0016543583],"domain_scores_gemma":[0.7338974,0.19657461,0.03861975,0.02276692,0.006955056,0.001186269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14876583,0.0005583916,0.0013268295,0.0014726131,0.0006744087,0.0018597097,0.0012724851,0.001098153,0.0031642187],"category_scores_gemma":[0.26346394,0.00032465678,0.0032989962,0.0019660832,0.0010799165,0.0015926386,0.0019122907,0.0015632705,0.0003357316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019617803,0.00028631775,0.7093131,0.005557396,0.026961371,0.00026384828,0.0029327546,0.0049530775,0.0017760785,0.02418087,0.006406309,0.19775113],"study_design_scores_gemma":[0.0024935496,0.009586454,0.8770719,0.0023282836,0.013131051,0.0009831763,0.0010236669,0.008102268,0.0070447074,0.03175491,0.046250205,0.00022978481],"about_ca_topic_score_codex":0.0020936052,"about_ca_topic_score_gemma":0.0022552651,"teacher_disagreement_score":0.14876583,"about_ca_system_score_codex":0.000992825,"about_ca_system_score_gemma":0.001411082,"threshold_uncertainty_score":0.7867583},"labels":[],"label_agreement":null},{"id":"W2328073063","doi":"10.1097/00000421-200002000-00012","title":"Pyomyositis After Chemotherapy for Breast Cancer","year":2000,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Infectious Diseases and Tuberculosis","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Pyomyositis; Medicine; Myositis; Malignancy; Chemotherapy; Venous thrombosis; Breast cancer; Complication; Thrombosis; Surgery; Cancer; Internal medicine; Abscess","score_opus":0.022095474975394408,"score_gpt":0.43398240162820045,"score_spread":0.411886926652806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328073063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9012002,0.05830074,0.0017581809,0.0023300534,0.00036198285,0.0002011506,0.0002424713,0.00023655762,0.035368692],"genre_scores_gemma":[0.98669785,0.00938518,0.00028232034,0.0010516663,0.0002037542,0.00002715909,0.00011962429,0.000016662183,0.0022158616],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997409,0.000066271044,0.000024068671,0.000021677768,0.000061767176,0.00008537741],"domain_scores_gemma":[0.99911135,0.00025694474,0.0003364591,0.000050438746,0.00006206362,0.00018275554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018898025,0.00035104985,0.00045657373,0.00044379025,0.0008569762,0.00044149862,0.00018886804,0.00079706137,0.002515246],"category_scores_gemma":[0.0026168844,0.00015772806,0.0003476884,0.00061688246,0.0003755082,0.00029649425,0.000529692,0.00088306866,0.0005864998],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000974293,0.00020734897,0.1138005,0.00069805444,0.00010703541,0.7942328,0.00088536245,0.0004507831,0.0073514776,0.00045472785,0.004871435,0.07596617],"study_design_scores_gemma":[0.00007544955,0.0005936519,0.12265968,0.00030337073,0.000084455736,0.862781,0.00031566765,0.00026028368,0.0017572534,0.00032800427,0.010819803,0.000021443648],"about_ca_topic_score_codex":0.0015815151,"about_ca_topic_score_gemma":0.0022472718,"teacher_disagreement_score":0.002515246,"about_ca_system_score_codex":0.00056038325,"about_ca_system_score_gemma":0.000420469,"threshold_uncertainty_score":0.008414388},"labels":[],"label_agreement":null},{"id":"W2328785997","doi":"10.1097/coc.0000000000000155","title":"Locally Advanced Malignant Myoepithelioma of the Parotid Gland Treated With Radiotherapy","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Island University; BC Cancer Agency","funders":"","keywords":"Medicine; Myoepithelioma; Radiation therapy; Parotid gland; Salivary gland; Surgery; Parotidectomy; Retrospective cohort study; Radiology; Pathology; Immunohistochemistry; Myoepithelial cell","score_opus":0.025323506714727113,"score_gpt":0.37068422629497727,"score_spread":0.34536071958025016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328785997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899927,0.0023768398,0.0011819514,0.00023460636,0.000044451288,0.00006252033,0.0000678798,0.000086257234,0.005952862],"genre_scores_gemma":[0.99835086,0.0005223083,0.00030484077,0.00010365742,0.000052664902,0.000011981116,0.000063404405,0.000008946747,0.00058131845],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9998492,0.000017206641,0.000012947691,0.000030142837,0.000033296135,0.00005717662],"domain_scores_gemma":[0.9997787,0.000039507533,0.00006937889,0.000029639483,0.000014057535,0.000068768575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001442351,0.0004850541,0.0006437423,0.00041631647,0.00074614346,0.00034974923,0.0004873326,0.0006959069,0.0013777799],"category_scores_gemma":[0.0005386783,0.00021645323,0.00074205303,0.00049346953,0.00044393918,0.00035245993,0.00043169156,0.0006429055,0.00056946644],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036071715,0.00026667817,0.076957524,0.00022014078,0.000121894285,0.8795138,0.0006772977,0.00081066135,0.022431308,0.00021136922,0.0004953045,0.017933272],"study_design_scores_gemma":[0.00009186337,0.0010634408,0.08813557,0.000050247614,0.00011238528,0.904127,0.00021867051,0.00051530707,0.0036035897,0.00016475182,0.0018960512,0.000021096801],"about_ca_topic_score_codex":0.00075752713,"about_ca_topic_score_gemma":0.0017332591,"teacher_disagreement_score":0.0013777799,"about_ca_system_score_codex":0.0005412687,"about_ca_system_score_gemma":0.0004812415,"threshold_uncertainty_score":0.0046091676},"labels":[],"label_agreement":null},{"id":"W2329158748","doi":"10.1097/00000421-200110000-00020","title":"Interstitial Fluid Pressure in Cervical Cancer","year":2001,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Angiogenesis; Oxygenation; Perfusion; Radiation therapy; Radioresistance; Hypoxia (environmental); Tumor hypoxia; Cervical cancer; Cancer; Internal medicine; Pathology; Cancer research; Oxygen","score_opus":0.08403186207789642,"score_gpt":0.47538515284573357,"score_spread":0.39135329076783715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329158748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78434527,0.18983011,0.0029389136,0.0038747112,0.0003708199,0.00014254844,0.0010905792,0.00015943032,0.017247574],"genre_scores_gemma":[0.9802003,0.017704604,0.0006662691,0.00022944255,0.00016955425,0.00006801559,0.00024758145,0.000007387844,0.00070687634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997671,0.00008185557,0.00002221826,0.000036572794,0.00006051674,0.00003179712],"domain_scores_gemma":[0.99950933,0.00017196094,0.00016540036,0.000029396082,0.00006295283,0.000061047744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003158004,0.00017906775,0.00047599812,0.0006661758,0.00039761755,0.0006934795,0.00029176896,0.00049921253,0.0008938067],"category_scores_gemma":[0.0025030226,0.00013803357,0.00022613103,0.0008002357,0.00044387107,0.00041412248,0.00042309734,0.0006770442,0.00017204859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038421063,0.00036536192,0.5709892,0.0019816891,0.00028126317,0.008700054,0.00086066814,0.0021521065,0.052050754,0.0043110303,0.007963137,0.34650266],"study_design_scores_gemma":[0.00016913486,0.0015991093,0.911888,0.00031746615,0.00041341316,0.017484015,0.00065086584,0.003438991,0.01784148,0.0051751044,0.04093351,0.00008899114],"about_ca_topic_score_codex":0.005379531,"about_ca_topic_score_gemma":0.0026214372,"teacher_disagreement_score":0.005379531,"about_ca_system_score_codex":0.0012426357,"about_ca_system_score_gemma":0.0010591324,"threshold_uncertainty_score":0.010696411},"labels":[],"label_agreement":null},{"id":"W2329439009","doi":"10.1097/coc.0b013e31829e19fb","title":"Outcome of Adjuvant Therapy in Biliary Tract Cancers","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Hazard ratio; Biliary tract cancer; Radiation therapy; Confidence interval; Surgery; Proportional hazards model; Chemotherapy; Internal medicine; Biliary tract; Oncology; Gemcitabine","score_opus":0.11798332655424212,"score_gpt":0.4637876789343794,"score_spread":0.3458043523801373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329439009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98840755,0.010421006,0.00018723005,0.0001856997,0.000014423649,0.000009413975,0.00015163117,0.0000082328515,0.00061487575],"genre_scores_gemma":[0.99873644,0.0009066507,0.000076463744,0.00002842665,0.000020905958,0.0000034899865,0.00017188747,0.0000012322552,0.000054409673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999468,0.00023929159,0.00007872298,0.00005233005,0.000104872764,0.00005676555],"domain_scores_gemma":[0.9976305,0.00072005886,0.0012525677,0.000062363455,0.00015246974,0.0001820772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010886586,0.00012691758,0.00033200328,0.00039927245,0.00012849271,0.00031332148,0.00011498938,0.00014451967,0.0006626033],"category_scores_gemma":[0.0043843198,0.00005158104,0.00033484504,0.000532502,0.00017213573,0.00018931284,0.0002254677,0.00019015641,0.00008987685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091263966,0.000062633975,0.9566431,0.00016841147,0.00022981741,0.00029159064,0.00004068746,0.00047375984,0.00056398753,0.000026710579,0.00030099967,0.04028571],"study_design_scores_gemma":[0.00004364325,0.000824772,0.9951047,0.000058776655,0.00018298233,0.0019593097,0.00004666212,0.00039705622,0.00049242296,0.000054892556,0.0008299198,0.00000504122],"about_ca_topic_score_codex":0.0004564451,"about_ca_topic_score_gemma":0.0008539216,"teacher_disagreement_score":0.0010886586,"about_ca_system_score_codex":0.00030354672,"about_ca_system_score_gemma":0.00024983063,"threshold_uncertainty_score":0.005757451},"labels":[],"label_agreement":null},{"id":"W2331674475","doi":"10.1097/coc.0b013e3182467a13","title":"Phase I Trial of AEG35156 an Antisense Oligonucleotide to XIAP Plus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma","year":2012,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Medicine; Gemcitabine; Pancreatic ductal adenocarcinoma; Oncology; Adenocarcinoma; Pancreatic cancer; Internal medicine; Cancer research; XIAP; Chemotherapy; Pancreatic carcinoma; Cancer; Apoptosis","score_opus":0.03633009900065996,"score_gpt":0.3926177608916083,"score_spread":0.35628766189094835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331674475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540615,0.0015579815,0.0002308727,0.00021529496,0.00008746066,0.0010643206,0.00024321495,0.000057693574,0.0011369953],"genre_scores_gemma":[0.9935754,0.0015512515,0.0010365294,0.00035287737,0.00011123313,0.0009881795,0.0009012642,0.0000130675435,0.0014702586],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9998092,0.00007173319,0.000015367834,0.0000394637,0.000022392309,0.000041824605],"domain_scores_gemma":[0.9997297,0.000039011476,0.000049278642,0.00001710567,0.000014749526,0.00015019228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066880655,0.0012276863,0.0016375864,0.0002937409,0.0003237305,0.00058238383,0.00054702733,0.00086853985,0.0023482698],"category_scores_gemma":[0.00045584203,0.00033132697,0.000784309,0.00032574128,0.0005937571,0.00049189886,0.00028573742,0.002152486,0.00048473052],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5790254,0.06276997,0.012363042,0.0017205672,0.001790655,0.001023889,0.0004950751,0.006482259,0.15917856,0.00046832775,0.0045600147,0.17012225],"study_design_scores_gemma":[0.34768862,0.6214088,0.01270218,0.00006422328,0.0004647501,0.00064089865,0.000069921785,0.0017100641,0.011579935,0.00017180681,0.003474143,0.00002455431],"about_ca_topic_score_codex":0.0007563312,"about_ca_topic_score_gemma":0.0020086963,"teacher_disagreement_score":0.0023482698,"about_ca_system_score_codex":0.0008391488,"about_ca_system_score_gemma":0.0011433205,"threshold_uncertainty_score":0.007855773},"labels":[],"label_agreement":null},{"id":"W2331897577","doi":"10.1097/coc.0000000000000281","title":"Chemotherapy is of Value in Second Line and Beyond, Relapsed High-grade, Serous Epithelial Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Etoposide; Serous fluid; Hazard ratio; Internal medicine; Proportional hazards model; Chemotherapy; Progression-free survival; Population; Univariate analysis; Oncology; Ovarian cancer; Surgery; Multivariate analysis; Confidence interval; Cancer","score_opus":0.03879162495960458,"score_gpt":0.40089231286677424,"score_spread":0.36210068790716965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331897577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97318834,0.023741938,0.0002943792,0.0006237124,0.000034048928,0.000022109412,0.00018271587,0.000028861503,0.0018840367],"genre_scores_gemma":[0.99603695,0.0032163607,0.00026792544,0.000078541365,0.000044295957,0.0000052950163,0.00013994865,0.0000019334436,0.00020880862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998386,0.000077689394,0.000015376272,0.000017971064,0.00003266732,0.000017661767],"domain_scores_gemma":[0.9989792,0.00041088535,0.0003894527,0.000039409813,0.00007015642,0.00011096798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040707766,0.00011822905,0.00033739125,0.00039627912,0.00013876389,0.00035894188,0.00014122686,0.00021165096,0.0011022084],"category_scores_gemma":[0.002143908,0.000054270527,0.00022235869,0.00035046483,0.00020709354,0.00022343511,0.00017900646,0.00026098842,0.000097665004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00509972,0.00013902623,0.80823845,0.00053831626,0.00017379821,0.0007240422,0.00010651809,0.0008517664,0.004963117,0.00009715578,0.0010879214,0.17798011],"study_design_scores_gemma":[0.00025599502,0.004639748,0.97537065,0.0002694212,0.00036012332,0.005119918,0.00017748804,0.0010028797,0.0038984693,0.00025078043,0.008641143,0.000013423391],"about_ca_topic_score_codex":0.00076054165,"about_ca_topic_score_gemma":0.0023924194,"teacher_disagreement_score":0.0011022084,"about_ca_system_score_codex":0.00045094313,"about_ca_system_score_gemma":0.00033144417,"threshold_uncertainty_score":0.0036872625},"labels":[],"label_agreement":null},{"id":"W2332772114","doi":"10.1097/00000421-200308001-00005","title":"Emerging Role of Aromatase Inhibitors in the Adjuvant Setting","year":2003,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Exemestane; Anastrozole; Medicine; Tamoxifen; Letrozole; Breast cancer; Oncology; Aromatase inhibitor; Internal medicine; Aromatase; Metastatic breast cancer; Adjuvant therapy; Selective estrogen receptor modulator; Pharmacology; Cancer","score_opus":0.028193737216965196,"score_gpt":0.43078381918006087,"score_spread":0.40259008196309565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332772114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029059893,0.95396847,0.0010964066,0.033105545,0.0013715171,0.000015718493,0.000093367096,0.000039613333,0.0074034734],"genre_scores_gemma":[0.031146647,0.93760276,0.0026496912,0.018265722,0.008031833,0.000051091527,0.00018421661,0.000019219127,0.0020488244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990283,0.00032127154,0.00009398184,0.00017194066,0.00025515357,0.00012935649],"domain_scores_gemma":[0.99235123,0.0043033827,0.00074268394,0.0001717868,0.0014813468,0.0009496106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004590773,0.00040839764,0.0008608506,0.00090214313,0.00032294443,0.0020842645,0.00094015576,0.0017409314,0.0061946926],"category_scores_gemma":[0.008492098,0.00024281719,0.0006007565,0.00092629256,0.0014859538,0.003204906,0.0014424676,0.0044584177,0.0016598279],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041458115,0.0001723631,0.0034070483,0.0024473977,0.00007753603,0.0004990337,0.00015903187,0.00052899495,0.0014034942,0.023172684,0.04128126,0.92643666],"study_design_scores_gemma":[0.00024196842,0.0010586056,0.005988596,0.005458943,0.0001712181,0.00243214,0.00046262293,0.001172296,0.00084932306,0.028638957,0.9534651,0.0000601605],"about_ca_topic_score_codex":0.00095789105,"about_ca_topic_score_gemma":0.0029604153,"teacher_disagreement_score":0.0061946926,"about_ca_system_score_codex":0.0013480566,"about_ca_system_score_gemma":0.0021308954,"threshold_uncertainty_score":0.02427864},"labels":[],"label_agreement":null},{"id":"W2333432525","doi":"10.1097/coc.0000000000000140","title":"Dose-escalated Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Inoperable or Unresectable Non-Small Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Radiation therapy; Lung cancer; Toxicity; Chemotherapy; Nuclear medicine; Cumulative dose; Cumulative incidence; Dose fractionation; Oncology; Internal medicine; Cohort","score_opus":0.043467876988290965,"score_gpt":0.4170678090021223,"score_spread":0.37359993201383135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333432525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949227,0.0018564835,0.0018704794,0.000057158548,0.000028809018,0.0003059268,0.000069073,0.0000824885,0.00080691586],"genre_scores_gemma":[0.9956232,0.0007802532,0.0026438243,0.000059122467,0.00003349741,0.0001601462,0.00023767304,0.0000104121555,0.00045199582],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998142,0.000055670214,0.000021450012,0.00003425513,0.000041751326,0.000032702028],"domain_scores_gemma":[0.99986935,0.000018885947,0.000048859794,0.000026558504,0.000008496448,0.00002784263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033005737,0.0004767001,0.0006723118,0.00028485857,0.0002993762,0.00020882016,0.00058385805,0.0001763894,0.000857812],"category_scores_gemma":[0.0005131373,0.00015483983,0.0004585167,0.00036232246,0.00024953068,0.00015035951,0.000332819,0.00048743436,0.00021940943],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018507509,0.010679289,0.10519976,0.0017745646,0.0013666985,0.002364224,0.0008617819,0.022660326,0.16485973,0.00034531276,0.002917095,0.66846377],"study_design_scores_gemma":[0.020014444,0.13574456,0.7028327,0.00026313186,0.0019587507,0.010778662,0.00015509983,0.02904649,0.07439294,0.00085306336,0.02386639,0.00009373045],"about_ca_topic_score_codex":0.0008514041,"about_ca_topic_score_gemma":0.0033379684,"teacher_disagreement_score":0.000857812,"about_ca_system_score_codex":0.000591077,"about_ca_system_score_gemma":0.0005009892,"threshold_uncertainty_score":0.004288614},"labels":[],"label_agreement":null},{"id":"W2333456198","doi":"10.1097/00000421-200210000-00019","title":"Carboplatin and Vinblastine for the Treatment of Metastatic Transitional Cell Carcinoma of the Urothelial Tract","year":2002,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vinblastine; Carboplatin; Transitional cell carcinoma; Urothelial carcinoma; Transitional Cell; Metastatic Urothelial Carcinoma; Chemotherapy; Oncology; Urology; Carcinoma; Internal medicine; Cisplatin; Bladder cancer; Cancer","score_opus":0.09289857469421467,"score_gpt":0.3973515386408462,"score_spread":0.30445296394663157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333456198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8761759,0.11977574,0.0008392469,0.00045550824,0.00012283753,0.00019153286,0.0001607871,0.000045842764,0.0022326557],"genre_scores_gemma":[0.97139716,0.02562214,0.0012915289,0.00023450519,0.00015155051,0.00007418016,0.00038960515,0.0000067047035,0.0008326349],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997365,0.00008781368,0.000030875868,0.000031574775,0.00007552958,0.000037631602],"domain_scores_gemma":[0.9998487,0.000027375581,0.000043086322,0.000008788993,0.000011653455,0.000060390747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038402015,0.00023722259,0.00049483194,0.0005078892,0.00030142913,0.00024517236,0.00037711393,0.00031427163,0.00087237416],"category_scores_gemma":[0.00041847644,0.00011149073,0.00034389668,0.0007055794,0.00029661867,0.00011716924,0.0002296571,0.00048493504,0.00020151038],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01815947,0.0014251713,0.13851492,0.0035937214,0.00090839644,0.00845736,0.00036952438,0.0024178077,0.050602734,0.00030424204,0.0058693625,0.7693773],"study_design_scores_gemma":[0.0066402336,0.04340906,0.741649,0.0008474663,0.0020579689,0.06803936,0.00035935536,0.003875734,0.022144359,0.0005680508,0.1103254,0.00008404792],"about_ca_topic_score_codex":0.0029435572,"about_ca_topic_score_gemma":0.0117222015,"teacher_disagreement_score":0.0029435572,"about_ca_system_score_codex":0.00084598316,"about_ca_system_score_gemma":0.0009431613,"threshold_uncertainty_score":0.0061380863},"labels":[],"label_agreement":null},{"id":"W2333550047","doi":"10.1097/coc.0b013e3182a533ea","title":"Pancreatectomy Versus Conservative Management for Pancreatic Cancer","year":2013,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Pancreatic cancer; Pancreatectomy; Cohort; Occult; Cancer; Population; Surgery; Pancreas; Stage (stratigraphy); Survival analysis; Internal medicine; Pathology","score_opus":0.15983487796767606,"score_gpt":0.5218794553148332,"score_spread":0.3620445773471571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333550047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95565623,0.039628234,0.0006379105,0.00097429147,0.00057096215,0.00020324934,0.00018596734,0.000024402145,0.0021186906],"genre_scores_gemma":[0.9914192,0.0068389284,0.00037030957,0.00043466003,0.00040574707,0.000119754695,0.00011912036,0.0000028329705,0.00028940025],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99932575,0.00035782924,0.00008452492,0.00009635179,0.0000938911,0.000041587828],"domain_scores_gemma":[0.9982889,0.0009680791,0.00045782095,0.000052268366,0.000037049333,0.00019583141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001336061,0.00023831462,0.0008206231,0.00034281955,0.00017628465,0.00039412768,0.00029287595,0.00039209917,0.0030941349],"category_scores_gemma":[0.0029447721,0.0000770775,0.0007414808,0.0003785233,0.00049765065,0.00039101928,0.00032554695,0.000644612,0.00018319498],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43899617,0.006739403,0.08050044,0.0070254127,0.0052815084,0.0005910128,0.00021363261,0.0024046795,0.0024645284,0.0014603928,0.0018727751,0.45245013],"study_design_scores_gemma":[0.16377541,0.3710622,0.42561725,0.0039809514,0.007414356,0.0028039147,0.00080203975,0.0049919463,0.0040336996,0.00441165,0.010989729,0.00011678287],"about_ca_topic_score_codex":0.00025822446,"about_ca_topic_score_gemma":0.00061729446,"teacher_disagreement_score":0.0030941349,"about_ca_system_score_codex":0.00033423337,"about_ca_system_score_gemma":0.00053978106,"threshold_uncertainty_score":0.010350943},"labels":[],"label_agreement":null},{"id":"W2333789445","doi":"10.1097/coc.0b013e318209d36c","title":"Real-world Impact of Availability of Adjuvant Therapy on Outcomes in Patients With Resected Pancreatic Adenocarcinoma","year":2011,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Gemcitabine; Adjuvant therapy; Pancreatic cancer; Referral; Adenocarcinoma; Cancer; Internal medicine; Surgery; General surgery; Family medicine","score_opus":0.12946154596548323,"score_gpt":0.4731822632168055,"score_spread":0.34372071725132225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333789445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976078,0.00089838647,0.000028653607,0.00024553234,0.000009788557,0.0000044699223,0.0005377998,0.0000035311368,0.000664039],"genre_scores_gemma":[0.99925345,0.00022537554,0.000035338548,0.000029512865,0.000012388646,0.0000028989837,0.0003982309,0.0000012536563,0.000041394735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992067,0.00023646536,0.00014173175,0.000109453205,0.00017879838,0.0001268907],"domain_scores_gemma":[0.99125683,0.0017424934,0.005146605,0.00015816884,0.0006265583,0.0010693098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009969159,0.000105938496,0.00017568929,0.0006705678,0.00029712505,0.0008681576,0.0003068744,0.00033280475,0.0012572459],"category_scores_gemma":[0.00809388,0.00010130078,0.00023746496,0.0011540744,0.00029183546,0.00055691204,0.00045418664,0.00054409495,0.0001551135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015300563,0.000017159735,0.9973488,0.00001286242,0.000021568105,0.00006830721,0.000031281754,0.00007720808,0.000031698983,0.0000075413914,0.0001476911,0.0020829432],"study_design_scores_gemma":[0.000006315985,0.00008371947,0.9988864,0.000014628844,0.000021418175,0.00029456776,0.0002081933,0.00016697402,0.000038775797,0.000017474438,0.00025790976,0.0000035602714],"about_ca_topic_score_codex":0.0072273496,"about_ca_topic_score_gemma":0.011407853,"teacher_disagreement_score":0.0072273496,"about_ca_system_score_codex":0.0010390646,"about_ca_system_score_gemma":0.00060964626,"threshold_uncertainty_score":0.014370561},"labels":[],"label_agreement":null},{"id":"W2334974730","doi":"10.1097/coc.0b013e31820dbdcc","title":"A Phase II Trial of Erlotinib as Maintenance Treatment After Gemcitabine Plus Platinum-based Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma","year":2011,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Erlotinib; Medicine; Gemcitabine; Carboplatin; Internal medicine; Chemotherapy; Oncology; Progressive disease; Regimen; Nasopharyngeal carcinoma; Erlotinib Hydrochloride; Cisplatin; Gastroenterology; Cancer; Radiation therapy; Epidermal growth factor receptor","score_opus":0.08404970786032828,"score_gpt":0.41959301545087513,"score_spread":0.33554330759054685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334974730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955978,0.0013330929,0.00023785404,0.0003012457,0.000101195124,0.001244884,0.00036710597,0.000053373504,0.0007634927],"genre_scores_gemma":[0.9933275,0.0009754156,0.0008211066,0.0005012034,0.00014363238,0.001782156,0.001152266,0.000016747985,0.0012799178],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99958485,0.0002031441,0.000026424948,0.00008284382,0.000029354653,0.00007338814],"domain_scores_gemma":[0.9991424,0.00015870667,0.0002077131,0.000094495175,0.00004966314,0.0003469684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017797531,0.0014906425,0.0021634148,0.00038135026,0.0004079702,0.0010388067,0.0009219096,0.0011989533,0.0029244048],"category_scores_gemma":[0.0012248836,0.00057711016,0.001008735,0.00041945814,0.00088400935,0.00089660863,0.0003333258,0.002942761,0.0006761662],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88612914,0.03145845,0.006146058,0.00055073365,0.0008139723,0.00023410241,0.00021295417,0.0011913228,0.020057457,0.000111065565,0.0018221574,0.051272586],"study_design_scores_gemma":[0.74108636,0.24743195,0.0074826605,0.000027972077,0.0003001631,0.00021975694,0.000036371017,0.0010097018,0.0014425331,0.00007030925,0.00087277597,0.00001929693],"about_ca_topic_score_codex":0.0006120889,"about_ca_topic_score_gemma":0.0016043863,"teacher_disagreement_score":0.0029244048,"about_ca_system_score_codex":0.0007945849,"about_ca_system_score_gemma":0.0012683982,"threshold_uncertainty_score":0.009783149},"labels":[],"label_agreement":null},{"id":"W2340840224","doi":"10.1097/coc.0000000000000215","title":"ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma","year":2015,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Appropriate Use Criteria; Guideline; Medical physics; Positron emission tomography; Radiation therapy; Diffuse large B-cell lymphoma; Appropriateness criteria; Multidisciplinary approach; Lymphoma; Radiology; Internal medicine; Pathology","score_opus":0.17736043082327232,"score_gpt":0.5224009550491343,"score_spread":0.34504052422586196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340840224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016666632,0.91647744,0.00522331,0.012550753,0.006063591,0.0016212107,0.0038616296,0.0003282806,0.052207157],"genre_scores_gemma":[0.039026905,0.87038815,0.03695468,0.013467816,0.0044691158,0.0033451838,0.014879434,0.0001719248,0.017296778],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994165,0.0015883058,0.0014933315,0.0002198276,0.002273318,0.0002603042],"domain_scores_gemma":[0.9935813,0.0017751434,0.0012632612,0.00017157395,0.002935914,0.0002729711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032511742,0.0012593493,0.001966537,0.0057789916,0.0006944124,0.0018091963,0.0020548073,0.0014872631,0.0076180734],"category_scores_gemma":[0.010018913,0.0003393,0.00205975,0.0048234942,0.0009647001,0.0012586352,0.0012482812,0.002196719,0.004656332],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011763573,0.000046423516,0.0031301274,0.022513825,0.0002551306,0.0008551202,0.00018816997,0.00047533325,0.0009871279,0.005742955,0.5388275,0.42686066],"study_design_scores_gemma":[0.00010258398,0.000065418244,0.008299095,0.01596389,0.00033880633,0.006508762,0.00019115815,0.00023920556,0.00035604322,0.0035020371,0.9643954,0.000037621856],"about_ca_topic_score_codex":0.004335485,"about_ca_topic_score_gemma":0.007382129,"teacher_disagreement_score":0.0076180734,"about_ca_system_score_codex":0.001910154,"about_ca_system_score_gemma":0.0048012123,"threshold_uncertainty_score":0.02548498},"labels":[],"label_agreement":null},{"id":"W2432804309","doi":"10.1097/coc.0000000000000294","title":"ACR Appropriateness Criteria® Hodgkin Lymphoma—Unfavorable Clinical Stage I and II","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Guideline; Stage (stratigraphy); Appropriate Use Criteria; Intensive care medicine; Delphi method; Medical physics; Internal medicine; Pathology","score_opus":0.19357822069068492,"score_gpt":0.5475453707828247,"score_spread":0.3539671500921398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432804309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016775258,0.88827914,0.009851861,0.024512695,0.009581449,0.0037839122,0.010888546,0.00048734865,0.05093747],"genre_scores_gemma":[0.02382709,0.84945804,0.05747081,0.019737571,0.004693477,0.007136418,0.022138396,0.0002028073,0.0153354695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994713,0.0014005715,0.0015172833,0.00020868905,0.001932424,0.0002279432],"domain_scores_gemma":[0.9900816,0.0029087544,0.0016935776,0.00019879783,0.0048075574,0.00030968044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039899675,0.001100298,0.0022164425,0.0056907563,0.0006711982,0.001506515,0.0026711293,0.0015662964,0.0061991],"category_scores_gemma":[0.013302947,0.0003899314,0.0029044806,0.0049825157,0.00076591276,0.0012421204,0.001178663,0.0022437207,0.0032935243],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012161957,0.00004725794,0.003195719,0.031489145,0.0004106532,0.00040590824,0.00020168771,0.00054096873,0.00047415154,0.0069094454,0.5562159,0.3999876],"study_design_scores_gemma":[0.00013348038,0.00006674106,0.008576806,0.037758734,0.00083243963,0.0022838905,0.0001940832,0.0003201857,0.0002545433,0.0051828944,0.9443476,0.000048604954],"about_ca_topic_score_codex":0.010561341,"about_ca_topic_score_gemma":0.018459642,"teacher_disagreement_score":0.010561341,"about_ca_system_score_codex":0.0024871766,"about_ca_system_score_gemma":0.008044865,"threshold_uncertainty_score":0.021101177},"labels":[],"label_agreement":null},{"id":"W2434288623","doi":"10.1097/coc.0000000000000307","title":"Cost-effectiveness of Management Options for Small Renal Mass","year":2016,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Renal mass; Nephrectomy; Cost effectiveness; Surgery; Variety (cybernetics); Intensive care medicine; General surgery; Medical physics; Kidney; Risk analysis (engineering); Internal medicine","score_opus":0.3131896401851001,"score_gpt":0.5322940023700894,"score_spread":0.2191043621849893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434288623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009281632,0.99801147,0.000066316985,0.00028920083,0.000047635775,0.000035097695,0.00015773514,0.0000018652648,0.00046242532],"genre_scores_gemma":[0.023207534,0.9755962,0.0004680548,0.00029554014,0.00009556164,0.000085146334,0.0001627589,0.0000028232846,0.00008651194],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958883,0.0018898412,0.0009852967,0.00022632601,0.0008707166,0.00013966831],"domain_scores_gemma":[0.98977226,0.008025419,0.0015203943,0.00007451637,0.00051312894,0.00009424299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039067785,0.0011546336,0.004444652,0.007737786,0.00029565478,0.002387207,0.0010410572,0.0012758261,0.0047344654],"category_scores_gemma":[0.016940385,0.0005379589,0.0055834535,0.0068256063,0.0003913816,0.0016257849,0.0006510944,0.0012462063,0.00022541784],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012622527,0.00012139574,0.0031566175,0.5126405,0.022377482,0.00028908052,0.000093676834,0.0014596944,0.00027251712,0.0026961153,0.006410242,0.44922042],"study_design_scores_gemma":[0.0021642148,0.001712336,0.03134658,0.65864736,0.13170773,0.004373225,0.0009062595,0.0020133308,0.0013304031,0.0077178827,0.15788296,0.00019778978],"about_ca_topic_score_codex":0.003605264,"about_ca_topic_score_gemma":0.0077780187,"teacher_disagreement_score":0.007737786,"about_ca_system_score_codex":0.0031132216,"about_ca_system_score_gemma":0.0034977498,"threshold_uncertainty_score":0.022588134},"labels":[],"label_agreement":null},{"id":"W2468525182","doi":"10.1097/coc.0000000000000310","title":"Secondary Surgery Versus Chemotherapy for Recurrent Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"National Cancer Institute","keywords":"Medicine; Debulking; Hazard ratio; Chemotherapy; Ovarian cancer; Surgery; Proportional hazards model; Confidence interval; Survival analysis; Cancer; Internal medicine","score_opus":0.13024568978278558,"score_gpt":0.4824705152351497,"score_spread":0.3522248254523641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468525182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97811586,0.01393228,0.0017560228,0.002518613,0.0003606977,0.00011470139,0.0003940855,0.00005867896,0.002749053],"genre_scores_gemma":[0.9973978,0.0011948204,0.00038084987,0.00027449618,0.00014943338,0.000032438864,0.0002458112,0.000004639583,0.00031965825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987618,0.0006590224,0.00012282048,0.00019192697,0.00017386,0.00009063256],"domain_scores_gemma":[0.99644536,0.0013793859,0.0013056389,0.00016303272,0.00019682782,0.0005097626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016199203,0.00019366782,0.00069331867,0.00037632583,0.00016135028,0.00041204563,0.0003149216,0.0002870746,0.0037127323],"category_scores_gemma":[0.00799607,0.00007730805,0.0011356004,0.0002807533,0.00026782093,0.00029224527,0.00049223023,0.0004766935,0.00030517083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039375775,0.0012836492,0.55706465,0.0021010158,0.0039047392,0.0004724,0.00032414502,0.0053936453,0.00248766,0.0016455149,0.005017606,0.38092923],"study_design_scores_gemma":[0.0054223933,0.04914193,0.89062244,0.0015622696,0.0036957061,0.0047251205,0.00041288882,0.01968565,0.004822813,0.0035334746,0.016318548,0.000056768287],"about_ca_topic_score_codex":0.0008620638,"about_ca_topic_score_gemma":0.0016818903,"teacher_disagreement_score":0.0037127323,"about_ca_system_score_codex":0.00064329006,"about_ca_system_score_gemma":0.00063977594,"threshold_uncertainty_score":0.012420356},"labels":[],"label_agreement":null},{"id":"W2519254806","doi":"10.1097/coc.0000000000000329","title":"Stereotactic Ablative Radiotherapy (SABR) for Large Renal Tumors","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; SABR volatility model; Common Terminology Criteria for Adverse Events; Renal cell carcinoma; Nephrectomy; Response Evaluation Criteria in Solid Tumors; Ablative case; Progressive disease; Confidence interval; Radiation therapy; Nausea; Pneumonitis; Surgery; Adverse effect; Radiology; Internal medicine; Kidney; Chemotherapy; Lung","score_opus":0.07778116298228616,"score_gpt":0.4458222962025069,"score_spread":0.36804113322022075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519254806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98442405,0.006410541,0.0061326935,0.00015760615,0.000017489565,0.00009019369,0.00018740646,0.00014303598,0.0024369638],"genre_scores_gemma":[0.995497,0.0013643726,0.0025001701,0.000065038446,0.000043342716,0.000020511014,0.0001546375,0.000015843292,0.00033915538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973494,0.00006005148,0.00003053765,0.00005320236,0.00009005257,0.00003116785],"domain_scores_gemma":[0.99943644,0.00014396575,0.00027247253,0.000044179083,0.000032724078,0.00007017388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005521365,0.00023170629,0.00037465757,0.0006069671,0.00047165743,0.00034986294,0.00037086516,0.00022155704,0.001427969],"category_scores_gemma":[0.000939823,0.000091725145,0.00043293717,0.00067986036,0.00045644297,0.00028563093,0.00031419194,0.00023612117,0.00044750926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001049395,0.00055430486,0.68079674,0.0011715139,0.00042009656,0.018238273,0.00040337996,0.0039764936,0.06821322,0.0006334902,0.0022628885,0.22228019],"study_design_scores_gemma":[0.00020359311,0.004256813,0.6807502,0.00017380329,0.00030105843,0.25248024,0.00045062316,0.0052522155,0.043213353,0.0006780899,0.012187004,0.000053002863],"about_ca_topic_score_codex":0.0005564765,"about_ca_topic_score_gemma":0.0019364429,"teacher_disagreement_score":0.001427969,"about_ca_system_score_codex":0.00050550135,"about_ca_system_score_gemma":0.00082211214,"threshold_uncertainty_score":0.004777074},"labels":[],"label_agreement":null},{"id":"W2547683025","doi":"10.1097/coc.0000000000000342","title":"Impact of Postoperative Adjuvant Chemotherapy Following Long-course Chemoradiotherapy in Stage II Rectal Cancer","year":2016,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Memorial University of Newfoundland; University of Ottawa; University of Calgary; BC Cancer Agency; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Medicine; Lymphovascular invasion; Perineural invasion; Carcinoembryonic antigen; Internal medicine; Colorectal cancer; Oxaliplatin; Oncology; Stage (stratigraphy); Regimen; Chemoradiotherapy; Univariate analysis; Chemotherapy; Multivariate analysis; Surgery; Cancer; Metastasis","score_opus":0.05552703053806801,"score_gpt":0.5047770831299755,"score_spread":0.4492500525919075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547683025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826247,0.0012600715,0.00006443225,0.000077231816,0.000010650059,0.0000036976464,0.00006844937,0.000002818655,0.00025024373],"genre_scores_gemma":[0.99956244,0.00017402825,0.00006295712,0.00002462645,0.000010756776,0.000002080592,0.00010667148,7.362153e-7,0.00005560357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996177,0.00018190338,0.000054651064,0.000034495388,0.00006263661,0.000048500882],"domain_scores_gemma":[0.998395,0.00050283835,0.0007773053,0.00005296582,0.00007974394,0.00019213131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006381092,0.000097339034,0.00016427206,0.00015161654,0.000107537984,0.000336577,0.0001452854,0.00012299599,0.0006783104],"category_scores_gemma":[0.0029705693,0.000044727673,0.00024638243,0.00022998029,0.00016405495,0.00020233903,0.00019799703,0.00016968655,0.00006487425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002563635,0.00014570601,0.96565074,0.00009753706,0.00015942672,0.00013774869,0.000038038987,0.00043861507,0.001295678,0.000022929693,0.0002394836,0.0292105],"study_design_scores_gemma":[0.000051876472,0.0019746295,0.9950899,0.000037607027,0.00015303429,0.0006035677,0.000075804724,0.00065972,0.00064712303,0.000023525708,0.00067917,0.000004024521],"about_ca_topic_score_codex":0.0009386193,"about_ca_topic_score_gemma":0.0038317665,"teacher_disagreement_score":0.0009386193,"about_ca_system_score_codex":0.000329309,"about_ca_system_score_gemma":0.0003698903,"threshold_uncertainty_score":0.0033746958},"labels":[],"label_agreement":null},{"id":"W2603488693","doi":"10.1097/coc.0000000000000385","title":"Predictive Impact of Clinical Benefit in Chemotherapy-treated Advanced Pancreatic Cancer Patients in Northern Alberta","year":2017,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Covenant Health; University of Alberta; University of Manitoba","funders":"","keywords":"Medicine; Internal medicine; Chemotherapy; Pancreatic cancer; Disease; Quality of life (healthcare); Cancer; Performance status; Clinical endpoint; Oncology; Clinical trial; Surgery","score_opus":0.06483734788493076,"score_gpt":0.5155751278823387,"score_spread":0.45073777999740794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603488693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863714,0.00017997353,0.000023373064,0.000074964904,0.0000031527468,0.0000077422665,0.00019268919,0.000002447474,0.00087853696],"genre_scores_gemma":[0.9994492,0.00008683264,0.000046965437,0.000023392497,0.00000352744,0.0000028883658,0.00022075756,0.000001008773,0.00016542496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997447,0.00005181741,0.000015973123,0.00003053262,0.000085029315,0.00007204304],"domain_scores_gemma":[0.9993337,0.000101253274,0.00022425728,0.000015605305,0.00014749316,0.00017772299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034339182,0.00014398803,0.00018498112,0.0004936854,0.0005311873,0.0005194836,0.0003828001,0.00023770847,0.0011523465],"category_scores_gemma":[0.0012918309,0.00008867792,0.00020676662,0.0010001337,0.0003343825,0.00014831882,0.0003732501,0.0002826141,0.00010261661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023458242,0.000023046052,0.9973454,0.000008661106,0.000011406317,0.00013181401,0.00008501573,0.0001220666,0.00016922689,0.000015877931,0.00015962964,0.0016933416],"study_design_scores_gemma":[0.000014037066,0.000057339454,0.9988619,0.0000063649104,0.000013498747,0.00018827296,0.0002804756,0.0002487088,0.00004501398,0.0000142987365,0.00026763344,0.0000024642031],"about_ca_topic_score_codex":0.50069165,"about_ca_topic_score_gemma":0.65268236,"teacher_disagreement_score":0.49930835,"about_ca_system_score_codex":0.003173428,"about_ca_system_score_gemma":0.0022238067,"threshold_uncertainty_score":0.9955546},"labels":[],"label_agreement":null},{"id":"W2790914546","doi":"10.1097/coc.0000000000000435","title":"Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Radiosurgery; Toxicity; Radiology; Ascites; Cohort; Magnetic resonance imaging; Nuclear medicine; Target lesion; Radiation therapy; Surgery; Internal medicine","score_opus":0.15870054531556246,"score_gpt":0.41966979684214756,"score_spread":0.2609692515265851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790914546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842412,0.009550379,0.0038351705,0.00023043985,0.00003734582,0.00008153499,0.00011111889,0.00012974461,0.0017830956],"genre_scores_gemma":[0.9949116,0.0028862583,0.0013530432,0.000054327415,0.000036771973,0.000023873568,0.00017338412,0.000009511068,0.0005512257],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999205,0.000022503236,0.000006970214,0.000007100074,0.000025710806,0.000017252467],"domain_scores_gemma":[0.9999044,0.000017716136,0.000040194947,0.000008511871,0.000008090303,0.000021128772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017394057,0.00017986448,0.00021411976,0.00033273714,0.00021336877,0.00010274124,0.00013377403,0.00014740619,0.0016953078],"category_scores_gemma":[0.000216988,0.00006994537,0.0002774291,0.00028803633,0.00019327158,0.00009068299,0.00016275766,0.00015456663,0.0005439008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065877917,0.00079558033,0.27458873,0.0020283863,0.0004444601,0.005255372,0.0003890921,0.0063708434,0.2216501,0.00077560736,0.006410449,0.47470367],"study_design_scores_gemma":[0.0015231008,0.018175833,0.7856813,0.00028497254,0.00043819728,0.04601998,0.000286473,0.010624418,0.10702995,0.0011421781,0.028726563,0.000067049106],"about_ca_topic_score_codex":0.0010381176,"about_ca_topic_score_gemma":0.0023523609,"teacher_disagreement_score":0.0016953078,"about_ca_system_score_codex":0.00035367507,"about_ca_system_score_gemma":0.00041181454,"threshold_uncertainty_score":0.005671382},"labels":[],"label_agreement":null},{"id":"W2792603138","doi":"10.1097/coc.0000000000000429","title":"Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Chugai Pharmaceutical; National Institutes of Health; Astellas Pharma; University of Pennsylvania; Ariad Pharmaceuticals; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Pembrolizumab; Discontinuation; Internal medicine; Response Evaluation Criteria in Solid Tumors; Adverse effect; Gastroenterology; Carcinoma; Surgery; Oncology; Progressive disease; Cancer; Disease; Immunotherapy","score_opus":0.08574078329257076,"score_gpt":0.4604282430723585,"score_spread":0.3746874597797878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792603138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8934705,0.090518855,0.0016760408,0.0023864764,0.0002587577,0.0010490061,0.00040527363,0.00014308094,0.010092038],"genre_scores_gemma":[0.9761139,0.019360956,0.0012842788,0.0007496314,0.00016698995,0.00028604857,0.00037600592,0.000006782146,0.0016554006],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998994,0.000030353898,0.000010992384,0.000013276201,0.00002587576,0.000020102922],"domain_scores_gemma":[0.99992037,0.000014655471,0.000023331231,0.000004797063,0.000011178786,0.000025561983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038569575,0.0001976147,0.00040191645,0.000207784,0.00027073768,0.00020312557,0.0001768542,0.00019649153,0.0014353225],"category_scores_gemma":[0.00026743385,0.00006664321,0.00031401828,0.00017564005,0.00012247004,0.00014295202,0.00017670925,0.00055737357,0.00040241788],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018784488,0.00248936,0.02318546,0.002348941,0.00056809146,0.0022699388,0.0002559616,0.001197897,0.094820715,0.00063042884,0.011341785,0.8421069],"study_design_scores_gemma":[0.06737168,0.09511032,0.3973344,0.0021073932,0.0020708407,0.025802147,0.0004277523,0.0078012655,0.054294128,0.0019841997,0.34559944,0.000096429256],"about_ca_topic_score_codex":0.0005549306,"about_ca_topic_score_gemma":0.0018736209,"teacher_disagreement_score":0.0014353225,"about_ca_system_score_codex":0.00038249954,"about_ca_system_score_gemma":0.00045284157,"threshold_uncertainty_score":0.0048015714},"labels":[],"label_agreement":null},{"id":"W2800002034","doi":"10.1097/coc.0000000000000448","title":"Mohs Micrographic Surgery Volume and Payment Patterns Among Dermatologists in the Medicare Population, 2013","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Reimbursement; Medicare Part B; Decile; Payment; Population; Family medicine; Health care; Finance; Environmental health; Statistics","score_opus":0.05118055452259984,"score_gpt":0.41532199879458953,"score_spread":0.3641414442719897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800002034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618065,0.00044862743,0.00007160836,0.00032232414,0.00000452212,0.000012647295,0.0022947104,0.000010328407,0.0006546654],"genre_scores_gemma":[0.9974504,0.00026944873,0.00016469155,0.00012353322,0.000017700117,0.000014722581,0.0017531142,0.000002639505,0.00020368991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991394,0.00013044661,0.00011726951,0.0001377034,0.00031633582,0.00015874782],"domain_scores_gemma":[0.9961415,0.000264852,0.0028303047,0.000063786356,0.00035532724,0.0003442702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080158765,0.00013105216,0.000146675,0.0016093549,0.00032997524,0.00054923125,0.00033551484,0.00026151128,0.001637143],"category_scores_gemma":[0.0030919383,0.00014288102,0.0004006105,0.0020669953,0.00021072307,0.00041645556,0.00058724877,0.00033142552,0.00027551097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001344362,0.0000134567035,0.9977718,0.0000059688255,0.000019822373,0.000017318856,0.000044021457,0.00003857376,0.000057316327,0.000020072508,0.0004913204,0.0015068194],"study_design_scores_gemma":[0.000001722671,0.000010247602,0.99942756,0.000006246266,0.0000062361714,0.0001049869,0.00010102762,0.000113821436,0.000025813823,0.000006192546,0.00019519527,0.0000011020983],"about_ca_topic_score_codex":0.035789136,"about_ca_topic_score_gemma":0.053343534,"teacher_disagreement_score":0.035789136,"about_ca_system_score_codex":0.0015117127,"about_ca_system_score_gemma":0.0010687287,"threshold_uncertainty_score":0.07116163},"labels":[],"label_agreement":null},{"id":"W2801876087","doi":"10.1097/coc.0000000000000451","title":"Nivolumab in the Treatment of Metastatic Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Nivolumab; Medicine; Renal cell carcinoma; Quality-adjusted life year; Willingness to pay; Cost effectiveness; Oncology; Cost–utility analysis; Everolimus; Cost–benefit analysis; Cohort; Quality of life (healthcare); Internal medicine; Cancer; Intensive care medicine; Immunotherapy; Risk analysis (engineering); Nursing","score_opus":0.10691684125219736,"score_gpt":0.4359489687321487,"score_spread":0.32903212747995136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801876087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84947455,0.10711624,0.009347784,0.0065149227,0.00039131477,0.000762109,0.0018885771,0.00015579216,0.024348726],"genre_scores_gemma":[0.99109745,0.005711334,0.0013728166,0.00040593036,0.00005755011,0.000054111606,0.00027131048,0.000006629396,0.0010229204],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.999438,0.0003248962,0.000018764216,0.00003716169,0.0001344398,0.000046867193],"domain_scores_gemma":[0.99961936,0.00020865348,0.0000688504,0.000013840938,0.000057444642,0.00003185507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011546039,0.00020794338,0.00031080245,0.00024062177,0.00016222715,0.0005066364,0.00036466413,0.00031153669,0.0013139572],"category_scores_gemma":[0.0019725712,0.00009696873,0.00073310116,0.00027037578,0.00016769639,0.00017381075,0.00020981807,0.00046384215,0.00009680529],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015403021,0.0008718888,0.054840293,0.0030954506,0.0036752902,0.0009955715,0.00011057761,0.46452895,0.009345044,0.0074886982,0.01527474,0.42437044],"study_design_scores_gemma":[0.011192855,0.012627706,0.14117666,0.0035934094,0.007109585,0.0040272186,0.00028096116,0.6215716,0.025484249,0.021458404,0.15122256,0.00025480104],"about_ca_topic_score_codex":0.04841716,"about_ca_topic_score_gemma":0.088064834,"teacher_disagreement_score":0.04841716,"about_ca_system_score_codex":0.003773124,"about_ca_system_score_gemma":0.0034850885,"threshold_uncertainty_score":0.09627068},"labels":[],"label_agreement":null},{"id":"W2811214182","doi":"10.1097/coc.0000000000000474","title":"Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bevacizumab; Irinotecan; Internal medicine; Capecitabine; Oncology; Colorectal cancer; Oxaliplatin; Chemotherapy; Progression-free survival; Vascular endothelial growth factor; Gastroenterology; Placental growth factor; Surgery; Cancer","score_opus":0.022705154419738784,"score_gpt":0.41521285634739813,"score_spread":0.3925077019276593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811214182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992193,0.0003889817,0.000068874586,0.000037154485,0.0000043826485,0.000007935498,0.000074942676,0.0000023140726,0.00019612105],"genre_scores_gemma":[0.9996463,0.000064697546,0.000079470505,0.000014287233,0.000011877064,0.000008459248,0.00012064705,5.951634e-7,0.000053577973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979156,0.000063692096,0.00002250731,0.000037623267,0.000046784975,0.00003781507],"domain_scores_gemma":[0.99877626,0.0003602216,0.00055781624,0.00002447578,0.000085453146,0.0001957576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004654546,0.00018060277,0.00025832935,0.00031717174,0.00018342394,0.0003191321,0.00014970859,0.00033230794,0.0007302706],"category_scores_gemma":[0.001732233,0.00008793563,0.00018047642,0.00041362314,0.00016486285,0.00021583786,0.00017129269,0.00046501664,0.00011007394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001338656,0.000065204964,0.9937452,0.000015037255,0.000031355903,0.00010022098,0.000023940667,0.00015584649,0.0010000378,0.000011993913,0.00007201545,0.0034403522],"study_design_scores_gemma":[0.000048053378,0.0008092846,0.9968541,0.000005379724,0.000046735775,0.00059918314,0.00003893426,0.0008909851,0.0003406104,0.000032238044,0.00033037862,0.000004053543],"about_ca_topic_score_codex":0.00047615217,"about_ca_topic_score_gemma":0.00062594656,"teacher_disagreement_score":0.0007302706,"about_ca_system_score_codex":0.0002786833,"about_ca_system_score_gemma":0.00021215666,"threshold_uncertainty_score":0.0024615526},"labels":[],"label_agreement":null},{"id":"W2893411854","doi":"10.1097/coc.0000000000000483","title":"Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non–Small Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Cohort; Oncology; Hazard ratio; Cancer; Lung cancer; Metastasis; Multivariate analysis; Proportional hazards model; Confidence interval","score_opus":0.12714203529253765,"score_gpt":0.5401090070464296,"score_spread":0.41296697175389196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893411854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99950504,0.00017487537,0.00002975614,0.000017028558,0.0000031024442,0.0000041588683,0.00015473207,0.0000011399787,0.000110230896],"genre_scores_gemma":[0.9994356,0.000040958617,0.000020244668,0.0000097479815,0.0000069092694,0.00000335381,0.00044467434,8.068927e-7,0.00003768556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994566,0.0001159686,0.00008354291,0.00015541416,0.000107085194,0.00008135424],"domain_scores_gemma":[0.9979963,0.00043473253,0.00090801314,0.000110113,0.00020305524,0.0003477603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010084362,0.00016416605,0.00036868118,0.0008190582,0.000198881,0.0004103567,0.0003979095,0.00035689303,0.0008440647],"category_scores_gemma":[0.0029070433,0.00010765526,0.0004110223,0.0005753011,0.00024873353,0.00040063536,0.00049275294,0.0002987156,0.00015260716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024251924,0.00002225833,0.99812406,0.000009161234,0.000056495253,0.00007189175,0.000024437833,0.000046541096,0.00019144148,0.000008598307,0.000040828054,0.0011617744],"study_design_scores_gemma":[0.000010497228,0.00017052624,0.9990602,0.0000033133276,0.00001911745,0.0003533185,0.00007178618,0.00016744579,0.00005696643,0.000016681024,0.00006795911,0.0000020499713],"about_ca_topic_score_codex":0.000982899,"about_ca_topic_score_gemma":0.0018280203,"teacher_disagreement_score":0.0010084362,"about_ca_system_score_codex":0.00033457542,"about_ca_system_score_gemma":0.00024468964,"threshold_uncertainty_score":0.005333185},"labels":[],"label_agreement":null},{"id":"W2900369182","doi":"10.1097/coc.0000000000000489","title":"Role of Stereotactic Body Radiation Therapy in Early Stage Small Cell Lung Cancer in the Era of Lung Cancer Screening","year":2018,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Lung cancer; Stage (stratigraphy); Radiation therapy; Cancer; Lung cancer screening; Oncology; Chemotherapy; Radiology; Metastasis; Internal medicine","score_opus":0.10745501994803246,"score_gpt":0.5305652655606843,"score_spread":0.4231102456126518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900369182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027607416,0.9992939,0.000018214709,0.00019464351,0.00003547938,0.000013321667,0.00003209207,9.673643e-7,0.00013520314],"genre_scores_gemma":[0.008962645,0.99001795,0.00017870335,0.000547418,0.00011486849,0.000058136236,0.00006078046,0.0000021659039,0.000057263143],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99251986,0.0034267148,0.0023921938,0.00043352964,0.001082555,0.00014519278],"domain_scores_gemma":[0.9690007,0.02376421,0.004757084,0.00028732148,0.0019812349,0.00020955397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077740857,0.000566235,0.0044732103,0.005503237,0.00030942823,0.0022369418,0.0012269609,0.0017359606,0.0025023846],"category_scores_gemma":[0.030913835,0.00051181257,0.0046829805,0.005681633,0.0007664436,0.0025850872,0.00085123256,0.001114019,0.00024511322],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035068023,0.000032950164,0.0012714643,0.8588146,0.0041573104,0.00017042922,0.00018474212,0.00017252471,0.00021132587,0.0005461844,0.0022307308,0.13185717],"study_design_scores_gemma":[0.00023025028,0.00033319442,0.007472845,0.92687714,0.025625218,0.0008420667,0.00037474438,0.00012061531,0.00027648537,0.00088110135,0.036926582,0.00003961715],"about_ca_topic_score_codex":0.0072613684,"about_ca_topic_score_gemma":0.014210009,"teacher_disagreement_score":0.0077740857,"about_ca_system_score_codex":0.0027746612,"about_ca_system_score_gemma":0.006532219,"threshold_uncertainty_score":0.041113794},"labels":[],"label_agreement":null},{"id":"W2902720924","doi":"10.1097/coc.0000000000000500","title":"Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer","year":2018,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Gemcitabine; Medicine; FOLFIRINOX; Chemotherapy; Internal medicine; Oncology; Pancreatic cancer; Cancer; Irinotecan","score_opus":0.09085758571509699,"score_gpt":0.5029794401867757,"score_spread":0.41212185447167865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902720924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892044,0.00037481272,0.00004722968,0.00006389578,0.000004888323,0.0000073530723,0.0002818222,0.000002425843,0.00029717913],"genre_scores_gemma":[0.9992847,0.00011066969,0.00002499343,0.00002928185,0.000009226807,0.000005799739,0.00046825764,9.127816e-7,0.00006623494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975914,0.00003473609,0.00002577559,0.000067425186,0.000059595768,0.000053413714],"domain_scores_gemma":[0.99868125,0.00016071288,0.00077484665,0.00003804955,0.000094232215,0.0002508616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031155482,0.00014740408,0.00028884126,0.00031883435,0.00021796318,0.00045801263,0.00017254375,0.00029423134,0.0011824246],"category_scores_gemma":[0.001743377,0.00007533286,0.00032462986,0.000572243,0.00017624634,0.00030830927,0.00021175893,0.00045198898,0.00013123412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022406933,0.000037282436,0.9971915,0.0000113575925,0.000041795858,0.00006441797,0.000019202484,0.00008254913,0.00012385723,0.000006802443,0.00013270907,0.002064557],"study_design_scores_gemma":[0.00003431066,0.0002818121,0.9985197,0.000011716621,0.000029362047,0.000491239,0.00008197978,0.00022952887,0.000075495154,0.00002300883,0.00021853477,0.0000033338908],"about_ca_topic_score_codex":0.0027638793,"about_ca_topic_score_gemma":0.0046530203,"teacher_disagreement_score":0.0027638793,"about_ca_system_score_codex":0.0005711717,"about_ca_system_score_gemma":0.0004855322,"threshold_uncertainty_score":0.0054955482},"labels":[],"label_agreement":null},{"id":"W2907792399","doi":"10.1097/coc.0000000000000510","title":"Factors Influencing Clinical and Setting Pathways After Discharge From an Acute Palliative/Supportive Care Unit","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Palliative care; Referral; Delirium; Hospital admission; Emergency medicine; Acute care; Intensive care medicine; Acute hospital; Health care; Internal medicine; Nursing","score_opus":0.2317270329303146,"score_gpt":0.538092441989873,"score_spread":0.30636540905955845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907792399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887735,0.0001935833,0.00012463253,0.0002169459,0.000010428539,0.000024974976,0.000096224554,0.0000052556443,0.0004505011],"genre_scores_gemma":[0.9995297,0.00008493768,0.00011893649,0.000029020277,0.0000058452324,0.000007752875,0.0001402123,0.0000014654769,0.0000821106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988458,0.00037484674,0.00024582792,0.00011179896,0.00021819811,0.00020349378],"domain_scores_gemma":[0.99193734,0.0015946823,0.003986943,0.00012631076,0.00079546025,0.001559216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005861005,0.00018420597,0.00019643609,0.00050701445,0.00062881457,0.0010909396,0.00033214482,0.00042551308,0.0035286744],"category_scores_gemma":[0.015177326,0.00008545008,0.00027425197,0.00054264825,0.0002768164,0.00049351394,0.0008014998,0.00072488753,0.0003401784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010108361,0.000100422076,0.9952768,0.000024040028,0.000023961244,0.00026384697,0.00043922584,0.00009441819,0.00013697028,0.000029336827,0.00015656406,0.00335328],"study_design_scores_gemma":[0.000008652593,0.00024651564,0.99519026,0.00005951257,0.000012602673,0.00074311614,0.0028448696,0.00034979064,0.00011072816,0.000106069056,0.00031747526,0.00001037824],"about_ca_topic_score_codex":0.0032689467,"about_ca_topic_score_gemma":0.0035399778,"teacher_disagreement_score":0.0035286744,"about_ca_system_score_codex":0.00049471145,"about_ca_system_score_gemma":0.0012153056,"threshold_uncertainty_score":0.01180464},"labels":[],"label_agreement":null},{"id":"W2908711030","doi":"10.1097/coc.0000000000000490","title":"MGMT Testing in Glioblastomas","year":2018,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Epigenetics; DNA methylation; Oncology; Methylation; EPIC; Bioinformatics; Gene; Genetics; Biology","score_opus":0.2533946580244729,"score_gpt":0.5438179933644874,"score_spread":0.2904233353400145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908711030","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002049078,0.99834394,0.00009932772,0.0004756919,0.000119696866,0.000003676512,0.000013892304,0.0000053026665,0.0007335424],"genre_scores_gemma":[0.0025149216,0.99644876,0.00021409486,0.00025543652,0.00015503279,0.000004858162,0.000041518513,0.0000013967841,0.00036402163],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997583,0.000056394612,0.00004800791,0.00003412559,0.00008413605,0.000019062745],"domain_scores_gemma":[0.9995623,0.0001928438,0.000079703816,0.000014192389,0.00012349374,0.000027427313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000624104,0.0005520615,0.00094609533,0.0032555428,0.00019475668,0.0006491109,0.00073807716,0.0009365349,0.0011058695],"category_scores_gemma":[0.0015390861,0.00020368706,0.0004974105,0.0019140862,0.00051822764,0.0008359298,0.0004934039,0.0013353779,0.0007237618],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000499199,0.000025522671,0.0010032471,0.00956984,0.000071691866,0.0005070883,0.00007358178,0.00024446344,0.0008701351,0.0021170333,0.028848311,0.9566191],"study_design_scores_gemma":[0.000026835254,0.00010865377,0.006518639,0.013286266,0.00029294554,0.013562547,0.00017781538,0.00026598744,0.0018030459,0.005214468,0.9587054,0.000037257952],"about_ca_topic_score_codex":0.002568993,"about_ca_topic_score_gemma":0.0040958775,"teacher_disagreement_score":0.0032555428,"about_ca_system_score_codex":0.0005932528,"about_ca_system_score_gemma":0.001049702,"threshold_uncertainty_score":0.005108118},"labels":[],"label_agreement":null},{"id":"W2910133491","doi":"10.1097/coc.0000000000000513","title":"Survival Implications of De Novo Versus Recurrent Metastatic Non–Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cohort; Internal medicine; Oncology; Retrospective cohort study; Lung cancer; Cancer; Performance status; Multivariate analysis; Stage (stratigraphy); Radiation therapy; Disease","score_opus":0.08079565904110957,"score_gpt":0.517913950960586,"score_spread":0.43711829191947643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910133491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998137,0.0011418168,0.000052730255,0.00009165308,0.0000064220585,0.0000020496714,0.00016752527,0.0000019691129,0.00039886977],"genre_scores_gemma":[0.9996245,0.00014076622,0.000016470514,0.000010954894,0.000007403868,0.0000012974795,0.00015087816,6.895779e-7,0.00004710889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996661,0.00010318631,0.00003430844,0.000071895236,0.00006234492,0.000062145475],"domain_scores_gemma":[0.99786323,0.00066635123,0.00092512084,0.00006163007,0.00016348813,0.00032026888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009130708,0.00013649384,0.00018547988,0.0003929186,0.00018625756,0.0004366735,0.00021211438,0.00023180949,0.0012709589],"category_scores_gemma":[0.0035985708,0.00006558861,0.00028179595,0.0003094433,0.00026181884,0.00031729334,0.00034588427,0.0002553463,0.00011631352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004521426,0.000018405242,0.99069464,0.000034530076,0.00006654101,0.00031492193,0.00010718787,0.00017840682,0.0008527933,0.0000901268,0.00015671557,0.0070334827],"study_design_scores_gemma":[0.000010646751,0.00023405685,0.9973683,0.000015955042,0.00006404241,0.001192552,0.0001353784,0.00030460928,0.00023029279,0.00011388758,0.000326273,0.0000041062117],"about_ca_topic_score_codex":0.000964509,"about_ca_topic_score_gemma":0.0020389336,"teacher_disagreement_score":0.0012709589,"about_ca_system_score_codex":0.00043390604,"about_ca_system_score_gemma":0.00021713991,"threshold_uncertainty_score":0.0048288107},"labels":[],"label_agreement":null},{"id":"W2911948934","doi":"10.1097/coc.0000000000000523","title":"Dual Modality Radiation With External Beam Radiation Therapy and Transarterial Radioembolization for Hepatocellular Carcinoma With Gross Vascular Invasion","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"National Cancer Institute","keywords":"Medicine; Hepatocellular carcinoma; Proportional hazards model; Radiation therapy; External beam radiation; Hazard ratio; External beam radiotherapy; Nuclear medicine; Internal medicine; Surgery; Confidence interval; Radiology; Brachytherapy","score_opus":0.07422255893670243,"score_gpt":0.33393653532564405,"score_spread":0.2597139763889416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911948934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99402773,0.0040319036,0.0010286978,0.00013069884,0.000022189104,0.000031730637,0.000047844664,0.000015208518,0.00066407176],"genre_scores_gemma":[0.99779403,0.0009054777,0.0007018114,0.00005434563,0.00004649253,0.00002081163,0.00009459742,0.0000027579017,0.00037957242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977916,0.00006794623,0.000020007366,0.000040572322,0.000049554706,0.000042675096],"domain_scores_gemma":[0.9996271,0.0000912909,0.00015667717,0.000022861654,0.00001926722,0.00008275533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000484719,0.00014131996,0.00033482048,0.00029165938,0.00014319814,0.00022808136,0.0001817708,0.00016782116,0.0011343866],"category_scores_gemma":[0.0007020078,0.00007933972,0.00040713022,0.00023555769,0.00024318486,0.00024023847,0.00032130725,0.00029369493,0.00020922933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013554937,0.0011079848,0.7319312,0.0005380571,0.00085569086,0.0014418579,0.00012980663,0.0015190456,0.02506374,0.00018489119,0.0007856347,0.22288716],"study_design_scores_gemma":[0.0009844516,0.022344364,0.9406924,0.00014429925,0.000660699,0.013452485,0.00021061355,0.0032653303,0.0133928275,0.00029476767,0.0045293462,0.000028458819],"about_ca_topic_score_codex":0.00043503215,"about_ca_topic_score_gemma":0.0016968773,"teacher_disagreement_score":0.0011343866,"about_ca_system_score_codex":0.00041337937,"about_ca_system_score_gemma":0.0004365499,"threshold_uncertainty_score":0.0037949085},"labels":[],"label_agreement":null},{"id":"W2912542243","doi":"10.1097/coc.0000000000000512","title":"Metformin Use and Kidney Cancer Survival Outcomes","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Health Sciences Centre; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hazard ratio; Meta-analysis; Metformin; Confidence interval; Publication bias; Internal medicine; Cancer; Oncology; Kidney cancer; Proportional hazards model; Relative risk","score_opus":0.2496114612423718,"score_gpt":0.5258678647893239,"score_spread":0.27625640354695213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912542243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01899001,0.97808444,0.00053701707,0.0007096762,0.00017359665,0.00011124243,0.0008017594,0.000013623827,0.0005786643],"genre_scores_gemma":[0.52332044,0.46975186,0.002678677,0.0014034474,0.0007099913,0.0004653511,0.0012593619,0.00001871372,0.00039219766],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.9937543,0.0029236388,0.001617205,0.00064030447,0.0008471936,0.00021743852],"domain_scores_gemma":[0.9861953,0.00847411,0.004149699,0.0002607465,0.000777895,0.00014223777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009508406,0.0010993441,0.003935983,0.003535236,0.00039154803,0.0019425073,0.00093782373,0.0011805603,0.0016674045],"category_scores_gemma":[0.021940757,0.00048129013,0.0136574535,0.0039680554,0.0004607306,0.001066579,0.0009523732,0.0012881083,0.00011564421],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006045311,0.00011036835,0.0882139,0.38226837,0.43445733,0.0002377318,0.00022299765,0.002457144,0.00071038515,0.00063619355,0.0026710024,0.08196923],"study_design_scores_gemma":[0.0016967362,0.0010032866,0.08300875,0.06494183,0.8352968,0.00063746504,0.00014645784,0.0014231162,0.0010599344,0.0014600831,0.009230773,0.000094721225],"about_ca_topic_score_codex":0.0028661445,"about_ca_topic_score_gemma":0.005617143,"teacher_disagreement_score":0.009508406,"about_ca_system_score_codex":0.0015662734,"about_ca_system_score_gemma":0.0021490862,"threshold_uncertainty_score":0.050285816},"labels":[],"label_agreement":null},{"id":"W2917225635","doi":"10.1097/coc.0000000000000530","title":"Effects of Social and Contextual Factors Including Marital Status and Children on the Use of Palliative Chemotherapy in Metastatic Colorectal Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Odds ratio; Colorectal cancer; Chemotherapy; Marital status; Performance status; Confidence interval; Oncology; Cancer; Cohort; Population","score_opus":0.11866741414800781,"score_gpt":0.45659374509340894,"score_spread":0.33792633094540114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917225635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991178,0.00039544387,0.000022262244,0.00010187962,0.000006142399,0.0000031423838,0.000082661434,0.0000011619892,0.00026938203],"genre_scores_gemma":[0.9997874,0.0000974953,0.000018856595,0.000013389563,0.000004196999,0.0000017088095,0.000046614605,4.9839383e-7,0.000029949368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952483,0.00023005591,0.000037999012,0.000042101525,0.00006865204,0.00009632495],"domain_scores_gemma":[0.99730945,0.00067230477,0.0011213911,0.000076508804,0.00017978705,0.000640689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000534474,0.0001797796,0.00018687127,0.0003449523,0.0004239571,0.00044816433,0.00024530492,0.00019411577,0.0014113918],"category_scores_gemma":[0.0044303946,0.00009744936,0.000493236,0.00045077148,0.0002893801,0.00023593598,0.00058639806,0.00044992063,0.000060989423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007579634,0.000024466277,0.9981371,0.0000071258596,0.00008456403,0.00004024531,0.000045893958,0.00006665673,0.00003464278,0.0000074870977,0.000040818388,0.001435077],"study_design_scores_gemma":[0.0000024126632,0.000067181245,0.9994955,0.000006764042,0.000026491769,0.00004798888,0.00014492175,0.00011909677,0.000013932796,0.00000912912,0.000064491906,0.0000020857012],"about_ca_topic_score_codex":0.018738624,"about_ca_topic_score_gemma":0.045737114,"teacher_disagreement_score":0.018738624,"about_ca_system_score_codex":0.0006225654,"about_ca_system_score_gemma":0.000606732,"threshold_uncertainty_score":0.037259102},"labels":[],"label_agreement":null},{"id":"W2929106448","doi":"10.1097/coc.0000000000000533","title":"Adjuvant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (TKIs) in Resected Non–Small Cell Lung Cancer (NSCLC)","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Odds ratio; Lung cancer; Epidermal growth factor receptor; Adjuvant; Randomized controlled trial; Subgroup analysis; Confidence interval; Cancer","score_opus":0.08513669810114843,"score_gpt":0.49292264131819974,"score_spread":0.4077859432170513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2929106448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046373844,0.95179576,0.00034544253,0.00021251055,0.0002167621,0.00034077503,0.00021373371,0.000010181942,0.00049101847],"genre_scores_gemma":[0.33389223,0.6615139,0.0015724998,0.00087971496,0.00038504944,0.0006684287,0.0005075143,0.0000061215123,0.00057455915],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99892825,0.00047647554,0.00032067738,0.00010224219,0.00012908241,0.000043303753],"domain_scores_gemma":[0.99800485,0.0013962652,0.00040805258,0.000043143496,0.00008665491,0.000061008894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003067223,0.0005803052,0.0034586953,0.0008569718,0.00016776197,0.0005776211,0.00032818166,0.0008291063,0.0016855499],"category_scores_gemma":[0.003333575,0.0002088576,0.0029232302,0.0011516787,0.00029098697,0.00054088526,0.00028830775,0.001122562,0.00017769141],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08055359,0.0012430392,0.0057636346,0.3351776,0.017840477,0.00037481994,0.0001551102,0.0019884186,0.006405635,0.00074689364,0.002667965,0.54708284],"study_design_scores_gemma":[0.24325691,0.1667593,0.08280158,0.15696043,0.24328938,0.00463628,0.0004948002,0.0036590074,0.011435799,0.0043196864,0.08217732,0.00020945228],"about_ca_topic_score_codex":0.0008416513,"about_ca_topic_score_gemma":0.0023079892,"teacher_disagreement_score":0.0034586953,"about_ca_system_score_codex":0.0005752871,"about_ca_system_score_gemma":0.0011526764,"threshold_uncertainty_score":0.016221225},"labels":[],"label_agreement":null},{"id":"W2953134807","doi":"10.1097/coc.0000000000000562","title":"Can Statins be Protagonists in Our Approach to Cancer Treatment?","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Foothills; Medicine; Family medicine; Cartography","score_opus":0.048891188786232366,"score_gpt":0.4296239645610091,"score_spread":0.3807327757747767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953134807","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031251938,0.20639667,0.0017878975,0.76680315,0.011873228,0.00003628752,0.00011701574,0.00009782823,0.0097627295],"genre_scores_gemma":[0.09315876,0.52903694,0.012139272,0.29185268,0.055940267,0.00029095417,0.0002811456,0.00014402246,0.017156009],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99772865,0.00090117706,0.00025890535,0.00023600188,0.0006548872,0.00022039498],"domain_scores_gemma":[0.9954401,0.0017255759,0.00052989594,0.000263693,0.001160657,0.0008801015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006296984,0.000781706,0.0014499727,0.00095253345,0.0013738347,0.0038154852,0.0014147189,0.0040741735,0.006480896],"category_scores_gemma":[0.008468678,0.0004071904,0.00085849233,0.000731579,0.0033366056,0.005786355,0.002261355,0.013717217,0.004024884],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002503571,0.000793395,0.007293858,0.0015484557,0.00048614267,0.0014042918,0.0006988927,0.00095103896,0.0033469135,0.046156395,0.29229942,0.6425177],"study_design_scores_gemma":[0.0009606418,0.0011455016,0.0046767537,0.0042667612,0.00036318382,0.0017525788,0.0016875922,0.00069847394,0.0012185087,0.083471715,0.8995829,0.00017533469],"about_ca_topic_score_codex":0.0021354295,"about_ca_topic_score_gemma":0.010041181,"teacher_disagreement_score":0.006480896,"about_ca_system_score_codex":0.0018408457,"about_ca_system_score_gemma":0.003983324,"threshold_uncertainty_score":0.03330201},"labels":[],"label_agreement":null},{"id":"W2961148344","doi":"10.1097/coc.0000000000000571","title":"Long-Term Vitamin K Antagonists and Cancer Risk","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; NOSM University; Laurentian University; Institute of Health Services and Policy Research; Health Sciences North","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); Hazard ratio; Confidence interval; Cancer; Internal medicine; Meta-analysis; Vitamin k; Observational study; Randomized controlled trial; Oncology","score_opus":0.12233796374679566,"score_gpt":0.5178873721666691,"score_spread":0.39554940841987346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961148344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0109198075,0.98625445,0.0005021775,0.0005130166,0.0001295586,0.00007601105,0.0011472352,0.000010422231,0.00044730701],"genre_scores_gemma":[0.37067014,0.6220769,0.0027701687,0.0011040043,0.00054408226,0.00040040593,0.0019772567,0.00001782807,0.00043923224],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933508,0.0022651977,0.0021263934,0.0010494279,0.0010054141,0.00020285562],"domain_scores_gemma":[0.979007,0.0137946345,0.0052443356,0.00039153625,0.0013883549,0.00017408167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067453696,0.00078273355,0.0032674025,0.002802675,0.00035340645,0.0017469033,0.00081005145,0.0011157459,0.002031888],"category_scores_gemma":[0.022806557,0.0005834628,0.010521235,0.004054309,0.0004270096,0.0009287206,0.00081990595,0.0013534583,0.00014354552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003976123,0.00007650214,0.1281902,0.37612146,0.41095793,0.0002199998,0.00024665231,0.0016698262,0.0007885257,0.0008404613,0.0031567193,0.073755585],"study_design_scores_gemma":[0.0014546963,0.0007273263,0.12899697,0.09813542,0.7475468,0.0010715318,0.00023066718,0.0011161274,0.0008758851,0.0019524934,0.01779057,0.00010152942],"about_ca_topic_score_codex":0.0057314583,"about_ca_topic_score_gemma":0.009777595,"teacher_disagreement_score":0.0067453696,"about_ca_system_score_codex":0.0012159293,"about_ca_system_score_gemma":0.002071641,"threshold_uncertainty_score":0.03567332},"labels":[],"label_agreement":null},{"id":"W2963197408","doi":"10.1097/coc.0000000000000579","title":"Statins as Potential Therapeutics for Lung Cancer","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Lung cancer; Statin; Malignancy; Cancer; Downregulation and upregulation; Oncology; Adjuvant; Chemotherapy; Bioinformatics; Internal medicine; Pharmacology","score_opus":0.10720463013442146,"score_gpt":0.5318358649780958,"score_spread":0.4246312348436743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963197408","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009352188,0.9988469,0.000062651845,0.00028015,0.00019243911,0.000003439728,0.000013515715,0.0000051611623,0.00050223013],"genre_scores_gemma":[0.00047481945,0.99865544,0.00010872064,0.00019012188,0.0001793338,0.0000050544095,0.000023165407,0.0000010518407,0.00036229537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998116,0.000036601705,0.00003153466,0.000030369358,0.00006812356,0.000021714],"domain_scores_gemma":[0.99963903,0.00019466894,0.000042280288,0.0000100599045,0.00007879902,0.00003517901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061714504,0.00071524095,0.0011767582,0.002443646,0.0002999479,0.0009746003,0.00077419344,0.001154329,0.003364543],"category_scores_gemma":[0.00082744105,0.00023195076,0.0005814232,0.0015951359,0.00040476787,0.0012581414,0.0006823696,0.0025660146,0.0016221498],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009790625,0.00008124148,0.00016571918,0.012598069,0.00009510718,0.00026173578,0.000052782827,0.00029740148,0.001644018,0.0042619854,0.028213033,0.95223093],"study_design_scores_gemma":[0.00002504446,0.00012545515,0.00063418737,0.0030203422,0.00011680609,0.0010488135,0.00004580225,0.000092242655,0.00051337614,0.0020821448,0.99227977,0.000016170767],"about_ca_topic_score_codex":0.0006906416,"about_ca_topic_score_gemma":0.001914427,"teacher_disagreement_score":0.003364543,"about_ca_system_score_codex":0.0006087367,"about_ca_system_score_gemma":0.0009825587,"threshold_uncertainty_score":0.011255503},"labels":[],"label_agreement":null},{"id":"W2963703029","doi":"10.1097/coc.0000000000000577","title":"Association Between Smoking and Survival Benefit of Immunotherapy in Advanced Malignancies","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Confidence interval; Internal medicine; Immunotherapy; Meta-analysis; Randomized controlled trial; Oncology; Clinical trial; Cancer","score_opus":0.11228883707839485,"score_gpt":0.4767912794818843,"score_spread":0.3645024424034895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963703029","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019862603,0.9973526,0.00012848388,0.00016164623,0.000060162125,0.000022996623,0.00011709865,0.000004311614,0.00016649581],"genre_scores_gemma":[0.08468762,0.9130766,0.000694936,0.000632093,0.00027268135,0.00009180586,0.0003371616,0.000009274177,0.00019796714],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968284,0.0017047118,0.00065708207,0.0003616258,0.00035112083,0.000096925985],"domain_scores_gemma":[0.9889836,0.009078321,0.0012442349,0.00015260998,0.00043308598,0.000108150125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052345446,0.0011869435,0.006310805,0.0025435875,0.00025577637,0.0014660319,0.0009343379,0.0013504268,0.002350597],"category_scores_gemma":[0.014794232,0.00059943757,0.013203263,0.002813596,0.00038211883,0.0007428023,0.000614597,0.001317897,0.00019174388],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034354446,0.000072899216,0.014974535,0.4684477,0.3842494,0.00015635617,0.000081472994,0.001300811,0.0008278999,0.0005151857,0.0022885813,0.123649694],"study_design_scores_gemma":[0.00091008894,0.00070859154,0.026113471,0.06385053,0.8939299,0.00042033856,0.00006816996,0.0006269523,0.00050913286,0.0011267837,0.011693562,0.000042438278],"about_ca_topic_score_codex":0.0027739122,"about_ca_topic_score_gemma":0.0058166664,"teacher_disagreement_score":0.006310805,"about_ca_system_score_codex":0.0009342142,"about_ca_system_score_gemma":0.0017233586,"threshold_uncertainty_score":0.027683198},"labels":[],"label_agreement":null},{"id":"W2969467201","doi":"10.1097/coc.0000000000000584","title":"The Role of Partial Breast Radiation in the Previously Radiated Breast","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Radiation therapy; Mastectomy; Radiology; Cancer; Nuclear medicine; Internal medicine","score_opus":0.01145468675319999,"score_gpt":0.35199994752706704,"score_spread":0.34054526077386704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969467201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959863,0.00285981,0.00016978655,0.00004316889,0.0000068232075,0.000005588161,0.00004751445,0.0000064229234,0.0008746946],"genre_scores_gemma":[0.9989526,0.0005483074,0.00011054781,0.000027450633,0.000020776308,0.000003370111,0.00009800421,0.0000039100496,0.00023506446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997943,0.00006107867,0.000016997106,0.000038029524,0.00004473898,0.00004485809],"domain_scores_gemma":[0.9993049,0.00023036619,0.0002787431,0.00005961603,0.000049884366,0.000076433535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044278352,0.00017259047,0.00022122628,0.00042739345,0.00018950389,0.00050775293,0.00027809007,0.00020517097,0.0023833378],"category_scores_gemma":[0.0016078141,0.00009278088,0.00032320994,0.0003712511,0.00037786135,0.000323699,0.00024420835,0.00019045672,0.00027142285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045056854,0.00003575079,0.9541768,0.00009168249,0.000117484866,0.0014959892,0.00010144553,0.00033333746,0.0028523314,0.000073632,0.00013590326,0.040135037],"study_design_scores_gemma":[0.000015207629,0.00051557407,0.97546333,0.000046641842,0.000115975956,0.020030916,0.00015795685,0.00030344768,0.0013910447,0.000063309606,0.00189133,0.000005257982],"about_ca_topic_score_codex":0.00059935986,"about_ca_topic_score_gemma":0.0014113185,"teacher_disagreement_score":0.0023833378,"about_ca_system_score_codex":0.0003087855,"about_ca_system_score_gemma":0.00033708903,"threshold_uncertainty_score":0.007973075},"labels":[],"label_agreement":null},{"id":"W2972579615","doi":"10.1097/coc.0000000000000600","title":"Clinical Outcomes of Surgically Unresectable Endometrial Cancers","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Radiation therapy; Chemotherapy; Histology; Stage (stratigraphy); Multivariate analysis; Endometrial cancer; Internal medicine; Proportional hazards model; Surgery; Odds ratio; Cancer; Oncology","score_opus":0.0918264800486993,"score_gpt":0.48334566626677505,"score_spread":0.39151918621807574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972579615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884784,0.0005810498,0.00005717151,0.00004843747,0.0000054298507,0.0000043646974,0.0001050197,0.0000021866474,0.00034842052],"genre_scores_gemma":[0.99955994,0.000132686,0.000035909,0.000014992659,0.00000907682,0.0000035330731,0.0001793684,7.397719e-7,0.0000637037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999806,0.00004019467,0.00003408344,0.000029723287,0.00004837323,0.000041653428],"domain_scores_gemma":[0.9988323,0.00017712431,0.00070230954,0.000025251155,0.000105807216,0.00015721658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000243059,0.00013659787,0.00020154344,0.00038429335,0.0002530046,0.00031576699,0.0001565523,0.00017738061,0.001033585],"category_scores_gemma":[0.002511682,0.00006759663,0.00019431225,0.00035469662,0.00025203865,0.00023709438,0.0002934685,0.00020720059,0.00017318064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110240675,0.000017649696,0.9946603,0.000018681198,0.000020445987,0.00063571555,0.00006520006,0.00008544483,0.00030458608,0.000013438903,0.00009942324,0.003968869],"study_design_scores_gemma":[0.000012645821,0.00024823917,0.99343675,0.000018923398,0.000028857323,0.005112415,0.00025587378,0.00017373609,0.00023377319,0.00004613767,0.00042784936,0.0000047919866],"about_ca_topic_score_codex":0.0005913171,"about_ca_topic_score_gemma":0.0014155667,"teacher_disagreement_score":0.001033585,"about_ca_system_score_codex":0.0002533568,"about_ca_system_score_gemma":0.00026346004,"threshold_uncertainty_score":0.0034576654},"labels":[],"label_agreement":null},{"id":"W2973123957","doi":"10.1097/coc.0000000000000599","title":"Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada","funders":"National Cancer Institute","keywords":"Medicine; Nelfinavir; Gemcitabine; Chemoimmunotherapy; Pancreatic cancer; Internal medicine; FOLFIRINOX; Adenocarcinoma; Oncology; Surgery; Gastroenterology; Cancer; Irinotecan; Immunotherapy; Immunology","score_opus":0.04319597588248913,"score_gpt":0.45250995121326015,"score_spread":0.409313975330771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973123957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200696,0.0012592945,0.0004327857,0.000395274,0.00021712409,0.003304678,0.00072599645,0.00007503722,0.0015828462],"genre_scores_gemma":[0.9872348,0.001007372,0.0015349776,0.00078604935,0.00018960102,0.004290059,0.001727166,0.000031016138,0.003198962],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996164,0.0001772669,0.000021026677,0.00008420374,0.000027431935,0.000073744195],"domain_scores_gemma":[0.99937385,0.00008817835,0.00010825403,0.000068941685,0.00003655011,0.00032419286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013451377,0.0015318168,0.0017769708,0.00039491337,0.00049166096,0.00083412917,0.0009471601,0.0013410668,0.004598052],"category_scores_gemma":[0.00076174457,0.0007085152,0.00090738194,0.00035431542,0.0010566098,0.000715853,0.00032841606,0.003302625,0.0008658156],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8678221,0.074241124,0.0025392016,0.00038895398,0.00065797806,0.00008893392,0.00013351966,0.0008428414,0.024464998,0.00019152802,0.001773399,0.026855556],"study_design_scores_gemma":[0.7026933,0.28857866,0.0032574171,0.000027656533,0.00023897251,0.00008735222,0.00003152953,0.0005933601,0.0029991155,0.00012392589,0.0013539818,0.000014722311],"about_ca_topic_score_codex":0.0010712082,"about_ca_topic_score_gemma":0.0029656247,"teacher_disagreement_score":0.004598052,"about_ca_system_score_codex":0.0011820332,"about_ca_system_score_gemma":0.0019274013,"threshold_uncertainty_score":0.015381992},"labels":[],"label_agreement":null},{"id":"W2984732432","doi":"10.1097/coc.0000000000000625","title":"Real-world Outcomes Among Patients Treated With Gemcitabine-based Therapy Post-FOLFIRINOX Failure in Advanced Pancreatic Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; CancerCare Manitoba","funders":"","keywords":"Medicine; Gemcitabine; FOLFIRINOX; Internal medicine; Interquartile range; Regimen; Proportional hazards model; Pancreatic cancer; Population; Survival analysis; Oncology; Gastroenterology; Surgery; Chemotherapy; Cancer; Irinotecan","score_opus":0.03950336415771432,"score_gpt":0.4347694346585533,"score_spread":0.39526607050083895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984732432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99902594,0.00024262888,0.000023567509,0.000055406606,0.0000028133206,0.0000051565517,0.00044762404,0.0000017237451,0.00019525253],"genre_scores_gemma":[0.9993906,0.0000685636,0.000020290878,0.000015307538,0.0000039818397,0.0000040549103,0.0004653052,4.6359233e-7,0.000031400134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995609,0.00011741782,0.00005473621,0.00009207665,0.00008425771,0.00009070032],"domain_scores_gemma":[0.99786586,0.0002508811,0.0012765422,0.000057228004,0.00017900174,0.00037058396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005978514,0.00013647588,0.00026968683,0.000504099,0.00029677793,0.00077374757,0.000292709,0.000346031,0.00080365775],"category_scores_gemma":[0.0026763156,0.0000986684,0.000367585,0.0009969994,0.00025088736,0.00039402343,0.00037099727,0.00049114757,0.00013044511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022264094,0.000025109242,0.9983088,0.000009175845,0.000046215388,0.000034533175,0.00003776691,0.00010622603,0.000036260833,0.000008119253,0.00010370535,0.001061555],"study_design_scores_gemma":[0.000012426462,0.00013589193,0.99916935,0.0000069035696,0.00002407249,0.00011764683,0.00013395913,0.0002217923,0.000027361599,0.000015891974,0.0001305105,0.0000041902667],"about_ca_topic_score_codex":0.020301426,"about_ca_topic_score_gemma":0.025142474,"teacher_disagreement_score":0.020301426,"about_ca_system_score_codex":0.001500865,"about_ca_system_score_gemma":0.0007323264,"threshold_uncertainty_score":0.04036653},"labels":[],"label_agreement":null},{"id":"W2994379966","doi":"10.1097/coc.0000000000000650","title":"Analysis of Heterogeneity in Survival Benefit of Immunotherapy in Oncology According to Patient Demographics and Performance Status","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Confidence interval; Meta-analysis; Randomized controlled trial; Subgroup analysis; Oncology","score_opus":0.1313721123070089,"score_gpt":0.4929832975669688,"score_spread":0.3616111852599599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994379966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0329099,0.95778537,0.0042440626,0.00074111245,0.0007731563,0.00086068455,0.001504569,0.00009204871,0.0010891851],"genre_scores_gemma":[0.8187196,0.16948996,0.004289687,0.0020050653,0.0007421828,0.002178301,0.0017622225,0.000080479826,0.0007324372],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.9783795,0.012634133,0.0048878607,0.0021658621,0.0015071379,0.00042556896],"domain_scores_gemma":[0.9546927,0.038875766,0.003998365,0.0013151696,0.0008629605,0.0002550162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030656299,0.0024453748,0.012366581,0.004365571,0.00039635427,0.0027885959,0.0016067604,0.0019289725,0.002686457],"category_scores_gemma":[0.055958483,0.0010291943,0.052247938,0.0037269406,0.0009064202,0.0016423778,0.0012830702,0.0020482186,0.00024383399],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041760807,0.000021959113,0.0057875006,0.054082174,0.92835313,0.00007390225,0.000036206737,0.00058578356,0.00022760566,0.00013164264,0.0002961838,0.0062279166],"study_design_scores_gemma":[0.0016035342,0.00036685925,0.006061309,0.0032788317,0.98671687,0.000069327856,0.000023668961,0.00035913743,0.0001607587,0.00057706144,0.00076575077,0.000016835684],"about_ca_topic_score_codex":0.0029582502,"about_ca_topic_score_gemma":0.0039806454,"teacher_disagreement_score":0.030656299,"about_ca_system_score_codex":0.0017284538,"about_ca_system_score_gemma":0.0017691507,"threshold_uncertainty_score":0.16212791},"labels":[],"label_agreement":null},{"id":"W2994816936","doi":"10.1097/coc.0000000000000655","title":"Molecular Determinants of Statin-sensitivity in Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Foothills; Family medicine; Gerontology; Library science; Cartography","score_opus":0.029869205101394205,"score_gpt":0.42211075749555327,"score_spread":0.3922415523941591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994816936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96232045,0.023996059,0.00027220804,0.0035555973,0.000086583925,0.000037590635,0.0006668589,0.000020959085,0.009043621],"genre_scores_gemma":[0.9926857,0.0045709847,0.00024344756,0.00021873254,0.00005604508,0.000009717854,0.0003275267,0.0000027112758,0.0018850898],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998808,0.00002295459,0.000008404046,0.000012456413,0.000035562873,0.000039824576],"domain_scores_gemma":[0.99976367,0.000034088043,0.00008646738,0.000010429156,0.00004657693,0.000058709422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015816466,0.00012633512,0.00018510535,0.0006353811,0.000278517,0.00045544395,0.00017583792,0.00025910267,0.0021597985],"category_scores_gemma":[0.00042534637,0.00015356709,0.00012007223,0.00078476506,0.00019854508,0.00009586069,0.00018984915,0.00036200948,0.00034658238],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010352527,0.00015511567,0.9036523,0.000121412086,0.00017931053,0.0010473145,0.00012749093,0.0005163915,0.03717643,0.0016912401,0.0040843524,0.050213408],"study_design_scores_gemma":[0.000019959436,0.00007585894,0.99155045,0.000028343198,0.000052230796,0.0006712797,0.00010847924,0.00047162865,0.0028518694,0.0004254066,0.0037347323,0.000009726812],"about_ca_topic_score_codex":0.015214132,"about_ca_topic_score_gemma":0.020087589,"teacher_disagreement_score":0.015214132,"about_ca_system_score_codex":0.00087630027,"about_ca_system_score_gemma":0.0006924523,"threshold_uncertainty_score":0.030251205},"labels":[],"label_agreement":null},{"id":"W2995696129","doi":"10.1097/coc.0000000000000630","title":"Targeting the Mevalonate Pathway for Treating Lung Cancer","year":2019,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Lung cancer; Mevalonate pathway; Cancer; Signal transduction; Cancer research; Lung; Cancer cell; Bioinformatics; Limiting; Treatment of lung cancer; Pharmacology; Enzyme; Oncology; Cell biology; Internal medicine; Biology; Biochemistry; Biosynthesis","score_opus":0.07649159286793035,"score_gpt":0.4788333153143113,"score_spread":0.40234172244638094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995696129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016654459,0.9973936,0.00016598708,0.00046768584,0.00031415175,0.000006333603,0.000025597696,0.000015362684,0.0014447162],"genre_scores_gemma":[0.00085857336,0.99746644,0.00021444354,0.0002733051,0.00018316928,0.000006513204,0.00004117182,0.0000019795295,0.0009544008],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987733,0.000019151612,0.000016451504,0.000020716503,0.000052493266,0.00001389574],"domain_scores_gemma":[0.99985933,0.00004995728,0.000022674389,0.0000043039568,0.000044765788,0.000018975139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028419858,0.0005430841,0.00067749666,0.0018005035,0.00025270614,0.0006238632,0.0005403818,0.00075114425,0.004121408],"category_scores_gemma":[0.00041653082,0.00014024215,0.0004986231,0.0010369088,0.00024117,0.00082301465,0.00046858704,0.0019464013,0.0022954447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006752599,0.00007944996,0.00015207351,0.012172369,0.000077527904,0.0002196007,0.00004324454,0.0002549255,0.003088568,0.00244529,0.04177237,0.93962705],"study_design_scores_gemma":[0.000014766942,0.000084103354,0.0005241043,0.0020473395,0.00007829604,0.0013798061,0.000027370008,0.00007237293,0.00065791095,0.0012163793,0.9938875,0.000010079181],"about_ca_topic_score_codex":0.00067873776,"about_ca_topic_score_gemma":0.0018706403,"teacher_disagreement_score":0.004121408,"about_ca_system_score_codex":0.0004838945,"about_ca_system_score_gemma":0.0006604868,"threshold_uncertainty_score":0.013787448},"labels":[],"label_agreement":null},{"id":"W2996673269","doi":"10.1097/coc.0000000000000657","title":"Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Lung cancer; Guideline; Chemotherapy; Radiation therapy; Proportional hazards model; Stage (stratigraphy); Cancer; Oncology; Surgery; Confidence interval","score_opus":0.1688143842316305,"score_gpt":0.5700223225478211,"score_spread":0.4012079383161906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996673269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6192308,0.3434174,0.0011530054,0.008966932,0.0002394823,0.00040169526,0.020563371,0.000041965868,0.0059853937],"genre_scores_gemma":[0.95867735,0.03506269,0.001314639,0.0012280714,0.00009115217,0.0001251928,0.0034110995,0.000005483974,0.000084357875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98245054,0.006930435,0.00462701,0.0011765991,0.0045015365,0.0003137668],"domain_scores_gemma":[0.9111303,0.030940661,0.04141091,0.0017692838,0.013913303,0.00083553366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010975275,0.000118345,0.0005362876,0.00318844,0.00027425692,0.0014584847,0.00082886504,0.00055826147,0.00038165922],"category_scores_gemma":[0.0710314,0.0001745177,0.0007397943,0.006843486,0.0004509268,0.0007046027,0.00037139197,0.00050118,0.000051171544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017782432,0.00004010336,0.8980454,0.01356907,0.002900224,0.00010097861,0.0008894804,0.0004978299,0.00011845947,0.00031330975,0.004604385,0.07874301],"study_design_scores_gemma":[0.00006634118,0.00013439603,0.97411865,0.010588493,0.0014910615,0.00042167908,0.0011496494,0.0005814074,0.00012569416,0.00011585984,0.011174689,0.000032109052],"about_ca_topic_score_codex":0.10632569,"about_ca_topic_score_gemma":0.23657463,"teacher_disagreement_score":0.10632569,"about_ca_system_score_codex":0.0040345583,"about_ca_system_score_gemma":0.008738839,"threshold_uncertainty_score":0.21141362},"labels":[],"label_agreement":null},{"id":"W3003778095","doi":"10.1097/coc.0000000000000633","title":"Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"National Cancer Institute","keywords":"Medicine; Gemcitabine; Erlotinib; Hazard ratio; Internal medicine; Pancreatic cancer; Oncology; Adverse effect; Chemotherapy; Confidence interval; Surgery; Cancer; Epidermal growth factor receptor","score_opus":0.1517376473785678,"score_gpt":0.522276700143894,"score_spread":0.3705390527653263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003778095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89347625,0.01636302,0.001849687,0.02821501,0.0016150065,0.009753935,0.016882872,0.00015823104,0.031686004],"genre_scores_gemma":[0.9486713,0.0036453055,0.0027685948,0.013220924,0.0013661254,0.0077736434,0.009004583,0.00012426585,0.0134253455],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934649,0.005115889,0.0004118755,0.00034857434,0.0004483,0.00021042522],"domain_scores_gemma":[0.99201375,0.0036854944,0.0020523334,0.00063439173,0.0005778955,0.001036119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011125874,0.00061704864,0.0012417447,0.00028743388,0.00035660533,0.0007922231,0.00081879215,0.001463843,0.010088915],"category_scores_gemma":[0.009608358,0.00024675694,0.0026743577,0.0003047626,0.0005143194,0.00057044893,0.0005685688,0.0014666734,0.0012533601],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6928092,0.010113292,0.031788506,0.0028563975,0.005973029,0.00009439048,0.00024370095,0.0028854483,0.007649185,0.00088923884,0.03849696,0.20620066],"study_design_scores_gemma":[0.3467804,0.31272048,0.2080707,0.0015990774,0.014415997,0.00037284175,0.0002750356,0.0022297662,0.016697211,0.002263498,0.09446663,0.00010844779],"about_ca_topic_score_codex":0.00085577025,"about_ca_topic_score_gemma":0.003974291,"teacher_disagreement_score":0.011125874,"about_ca_system_score_codex":0.0015942605,"about_ca_system_score_gemma":0.001658553,"threshold_uncertainty_score":0.058839977},"labels":[],"label_agreement":null},{"id":"W3012066456","doi":"10.1097/coc.0000000000000685","title":"Twitter","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Marketing buzz; Medicine; Scopus; Radiation oncology; Impact factor; Citation; Bibliometrics; Clinical Oncology; Library science; Internal medicine; MEDLINE; World Wide Web; Radiation therapy","score_opus":0.4525055894671902,"score_gpt":0.6121880681730625,"score_spread":0.15968247870587227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012066456","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010287823,0.0025461814,0.0059950342,0.02155351,0.0046784976,0.0013833689,0.13317879,0.0056312517,0.8147456],"genre_scores_gemma":[0.13467275,0.0056016482,0.012707983,0.017704602,0.0074613714,0.0032890188,0.14919303,0.0031021165,0.6662675],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749976,0.00063137227,0.0003167756,0.00049594615,0.0007256732,0.00033042303],"domain_scores_gemma":[0.9927886,0.0019092784,0.0012077068,0.00082758215,0.0023316275,0.00093512365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002012767,0.0009697127,0.0006448965,0.0035376374,0.0019715307,0.0066260365,0.0010703309,0.0018276967,0.2618404],"category_scores_gemma":[0.016111828,0.00032313872,0.0006017691,0.0036171747,0.00060409814,0.0072977673,0.0040202686,0.0013431574,0.23278116],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000166229,0.000038215643,0.007082944,0.00089577277,0.000025674903,0.00016491699,0.0006712961,0.00016695903,0.00045608924,0.013322878,0.8386267,0.13838233],"study_design_scores_gemma":[0.000022798145,0.000029926214,0.005090446,0.00029879605,0.000016003629,0.00012718719,0.00081413705,0.00043837968,0.00025689043,0.0030415219,0.9898335,0.000030378123],"about_ca_topic_score_codex":0.0033860288,"about_ca_topic_score_gemma":0.0036113672,"teacher_disagreement_score":0.2618404,"about_ca_system_score_codex":0.001135787,"about_ca_system_score_gemma":0.001970195,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W3014500359","doi":"10.1097/coc.0000000000000691","title":"A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":250,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Welichem Biotech (Canada); SignalChem (Canada); Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Sanofi; GlaxoSmithKline; Servier; Pfizer; Eli Lilly and Company; Genentech; PTC Therapeutics; American Association for Cancer Research","keywords":"Medicine; Tolerability; Cmax; Discontinuation; Internal medicine; Pharmacokinetics; Nausea; Adverse effect; Dosing; Cohort; Vomiting; Gastroenterology; Response Evaluation Criteria in Solid Tumors; Pharmacology; Phases of clinical research; Toxicity","score_opus":0.027762532162020494,"score_gpt":0.37617253892835273,"score_spread":0.3484100067663322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014500359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629265,0.0006437175,0.0003833922,0.00022697459,0.000043422802,0.0011288514,0.00046990867,0.000046658697,0.00076421694],"genre_scores_gemma":[0.9912411,0.0010333647,0.0016649993,0.0005319798,0.000075026575,0.0012929409,0.0021589352,0.000020250367,0.0019814027],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99971217,0.00012622548,0.0000117711925,0.0000584966,0.00004051794,0.00005080092],"domain_scores_gemma":[0.99947137,0.00007769427,0.000105947336,0.00004008943,0.000051869883,0.000253103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088460505,0.0010554086,0.0011724421,0.0002745879,0.0003584259,0.0005712539,0.00047846185,0.0008766631,0.0023800884],"category_scores_gemma":[0.0005886856,0.00039401592,0.00077138434,0.00027120762,0.0005580442,0.00051710237,0.00021530528,0.0018701999,0.0005428168],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41730314,0.12184282,0.03008394,0.0014394629,0.0016121258,0.001231744,0.0008731013,0.007067,0.24066879,0.0004775614,0.01034425,0.16705608],"study_design_scores_gemma":[0.23919614,0.7128725,0.031205822,0.00002902722,0.00031077446,0.0009756791,0.00007092891,0.0022407419,0.008685156,0.00014360591,0.0042350115,0.000034683035],"about_ca_topic_score_codex":0.0007587727,"about_ca_topic_score_gemma":0.0021858653,"teacher_disagreement_score":0.0023800884,"about_ca_system_score_codex":0.00065472844,"about_ca_system_score_gemma":0.0015042064,"threshold_uncertainty_score":0.007962227},"labels":[],"label_agreement":null},{"id":"W3018565988","doi":"10.1097/coc.0000000000000694","title":"The Population-based Impact of Adjuvant Chemotherapy on Outcomes in T2N0M0 Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Internal medicine; Interquartile range; Hazard ratio; Lung cancer; Oncology; Proportional hazards model; Chemotherapy; Population; Cohort; Confidence interval","score_opus":0.04726510851326197,"score_gpt":0.4697619957226392,"score_spread":0.4224968872093772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018565988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821115,0.0006987322,0.000059404272,0.00015690319,0.000009875835,0.0000062832064,0.0003379293,0.000003866057,0.0005158935],"genre_scores_gemma":[0.9995671,0.00011603132,0.000021042008,0.000020860844,0.000007448861,0.000001845925,0.00021479843,9.986712e-7,0.00004978404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992962,0.00018511622,0.000048537193,0.0001591185,0.00014230206,0.00016874856],"domain_scores_gemma":[0.9982035,0.0003982944,0.00072393444,0.00014920808,0.00022443173,0.00030058817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010866931,0.00020252085,0.00025980917,0.0005700347,0.00040286066,0.0006849999,0.00040886,0.00040029862,0.00077558536],"category_scores_gemma":[0.003997359,0.00014333884,0.00067161827,0.0010309558,0.00038985984,0.00037154427,0.00043070447,0.0005508628,0.000081372375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011777421,0.000015424868,0.9981548,0.000005590381,0.000102092316,0.00001993484,0.000016675365,0.0001107442,0.000049844824,0.00000979143,0.00007055749,0.001326724],"study_design_scores_gemma":[0.0000043719992,0.000043929445,0.9994985,0.0000029026714,0.000047440477,0.000028919276,0.000040113464,0.00020873592,0.000024414629,0.000016996632,0.000081898455,0.000001797807],"about_ca_topic_score_codex":0.09179072,"about_ca_topic_score_gemma":0.1437455,"teacher_disagreement_score":0.09179072,"about_ca_system_score_codex":0.0017269687,"about_ca_system_score_gemma":0.001642123,"threshold_uncertainty_score":0.18251288},"labels":[],"label_agreement":null},{"id":"W3020350434","doi":"10.1097/coc.0000000000000703","title":"Characterizing Urban-Rural Differences in Colon Cancer Outcomes","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Confidence interval; Hazard ratio; Proportional hazards model; Residence; Colorectal cancer; Demography; Rural area; Population; Cancer; Multivariate analysis; Surgery; Internal medicine; Environmental health","score_opus":0.28341152782406254,"score_gpt":0.5104588487067819,"score_spread":0.2270473208827194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020350434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980217,0.00016389895,0.0001725746,0.00015808058,0.0000035499168,0.000013808804,0.0006032197,0.000003952099,0.0008590603],"genre_scores_gemma":[0.9995208,0.000041758747,0.000055210035,0.000023176128,0.0000044277276,0.0000039051647,0.0002492681,0.000001219453,0.00010027342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996007,0.00008039135,0.000018852517,0.0000843688,0.000071477756,0.00014424136],"domain_scores_gemma":[0.99900216,0.00011208924,0.0005924603,0.000035602105,0.00013609522,0.000121538586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050846563,0.00015363006,0.00013719362,0.0008909421,0.00048954994,0.000649588,0.0003434303,0.00016609373,0.0016793694],"category_scores_gemma":[0.0017268157,0.00007942359,0.0001813036,0.0013396377,0.0005198581,0.00031587086,0.00075111666,0.00022242802,0.00012782034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003463636,0.00001639159,0.9965827,0.000018024097,0.000023968532,0.00004617294,0.00030091516,0.000117118885,0.00010437085,0.000098538345,0.00024082902,0.0024163513],"study_design_scores_gemma":[0.0000019608228,0.000015980717,0.9983942,0.000008802082,0.000006765242,0.00005654553,0.0009063927,0.00018438471,0.000029035114,0.0000706714,0.00032316425,0.0000020473622],"about_ca_topic_score_codex":0.17417194,"about_ca_topic_score_gemma":0.3291658,"teacher_disagreement_score":0.17417194,"about_ca_system_score_codex":0.0012163405,"about_ca_system_score_gemma":0.0016807425,"threshold_uncertainty_score":0.34631628},"labels":[],"label_agreement":null},{"id":"W3025456390","doi":"10.1097/coc.0000000000000705","title":"Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Clinical trial; Clinical endpoint; Renal cell carcinoma; Intensive care medicine; Surrogate endpoint; Internal medicine; Disease; Oncology","score_opus":0.23265778802584905,"score_gpt":0.5115335604306447,"score_spread":0.27887577240479566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025456390","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08644417,0.21879221,0.29490337,0.069060184,0.014350307,0.23011966,0.030364756,0.0014515062,0.054513805],"genre_scores_gemma":[0.36915165,0.010990534,0.22501245,0.032875996,0.002347801,0.34440562,0.012165735,0.0007009092,0.0023493164],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.1124187,0.6821646,0.15860923,0.009626017,0.03552256,0.0016588584],"domain_scores_gemma":[0.17970395,0.5910497,0.13019821,0.04553951,0.050144486,0.0033642321],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.66625017,0.0025599722,0.0069011184,0.0078856135,0.0032403832,0.011702398,0.007137428,0.009284376,0.0041927425],"category_scores_gemma":[0.76255053,0.0016986262,0.012743586,0.012187707,0.004865997,0.008502105,0.0073832367,0.009675972,0.0015306642],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06767892,0.0012294368,0.0988726,0.18024866,0.076562874,0.00059778703,0.007988682,0.012424838,0.002880674,0.10577335,0.07935027,0.36639196],"study_design_scores_gemma":[0.06690999,0.010535948,0.14253104,0.17229454,0.03990106,0.0011067549,0.0019628599,0.02265892,0.009628611,0.20478205,0.32627207,0.0014162523],"about_ca_topic_score_codex":0.0015044148,"about_ca_topic_score_gemma":0.0019522615,"teacher_disagreement_score":0.66625017,"about_ca_system_score_codex":0.0075602424,"about_ca_system_score_gemma":0.01681393,"threshold_uncertainty_score":0.411573},"labels":[],"label_agreement":null},{"id":"W3025793877","doi":"10.1097/coc.0000000000000706","title":"ACR–ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Medical physics; Radiation oncology; Timeline; Documentation; Radiosurgery; Workflow; Stereotactic radiation therapy; Medical physicist; Radiation therapy; Nuclear medicine; Radiology; Database; Computer science","score_opus":0.11296292720294071,"score_gpt":0.47217885969907764,"score_spread":0.3592159324961369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025793877","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0300343,0.017248102,0.27574244,0.03252748,0.008091343,0.00980584,0.010603274,0.012333639,0.6036136],"genre_scores_gemma":[0.23771538,0.014561401,0.60334533,0.015247518,0.0024279386,0.011240295,0.029422076,0.006270526,0.07976948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.89916176,0.025949314,0.014780511,0.003905171,0.054168265,0.00203492],"domain_scores_gemma":[0.7537345,0.02837418,0.021637268,0.014930126,0.17792185,0.0034020273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04662303,0.0014436906,0.00095470937,0.0060066013,0.0024295857,0.0065211644,0.0047766343,0.0038230033,0.013172731],"category_scores_gemma":[0.12698689,0.0006312161,0.0016006747,0.0033700974,0.0022807613,0.003525051,0.0037085565,0.00362082,0.020618731],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041226402,0.0005176283,0.016675195,0.002676067,0.00009013227,0.00026888106,0.0016177512,0.007338332,0.008749548,0.034075994,0.4404254,0.48715273],"study_design_scores_gemma":[0.00007642356,0.00043377237,0.014890344,0.0022439342,0.000079386424,0.0011454562,0.0006177399,0.0024283407,0.0073444257,0.006745658,0.96384275,0.00015170834],"about_ca_topic_score_codex":0.012792988,"about_ca_topic_score_gemma":0.011972023,"teacher_disagreement_score":0.04662303,"about_ca_system_score_codex":0.0075561074,"about_ca_system_score_gemma":0.025262747,"threshold_uncertainty_score":0.24656916},"labels":[],"label_agreement":null},{"id":"W3030965370","doi":"10.1097/coc.0000000000000716","title":"Population-based Treatment Patterns and Outcomes for Stage III Non–Small Cell Lung Cancer Patients","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Alberta Health Services","funders":"","keywords":"Medicine; Stage (stratigraphy); Cancer registry; Internal medicine; Population; Chemoradiotherapy; Radiation therapy; Confidence interval; Cohort; Lung cancer; Cancer; Medical record; Palliative care; Oncology","score_opus":0.05548615419366075,"score_gpt":0.43925876907400935,"score_spread":0.3837726148803486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030965370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996576,0.00030474053,0.00008139534,0.00016519688,0.0000047319063,0.000019591465,0.00204716,0.000007731491,0.00079335866],"genre_scores_gemma":[0.99867487,0.00009103127,0.000050556722,0.000029944786,0.0000027988683,0.0000061342794,0.0010855688,0.0000016488019,0.000057346544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993913,0.00004653481,0.0000496239,0.00013165921,0.00018871546,0.00019211462],"domain_scores_gemma":[0.9988495,0.00007876916,0.0004912764,0.000044992907,0.00025693254,0.0002785138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004914887,0.00019087229,0.0002317969,0.0008936968,0.00090886286,0.0006864906,0.00060179835,0.00030477016,0.0011377665],"category_scores_gemma":[0.0016468578,0.00014462981,0.0004124435,0.002291317,0.00042576485,0.0002614584,0.00043233097,0.0004560146,0.00011770844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018212026,0.0000067848723,0.9989868,0.00000412711,0.000018029055,0.000018704874,0.000045295055,0.00005416638,0.000046473717,0.000014959674,0.00018023324,0.0006062857],"study_design_scores_gemma":[0.0000027032015,0.000013262779,0.99928683,0.0000049714367,0.000009432608,0.00005970656,0.00019717404,0.00017036658,0.000021153093,0.000017245018,0.00021421193,0.000003047002],"about_ca_topic_score_codex":0.67624915,"about_ca_topic_score_gemma":0.75837994,"teacher_disagreement_score":0.67624915,"about_ca_system_score_codex":0.0053232927,"about_ca_system_score_gemma":0.0057393303,"threshold_uncertainty_score":0.651315},"labels":[],"label_agreement":null},{"id":"W3031320380","doi":"10.1097/coc.0000000000000704","title":"The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Proportional hazards model; Chemotherapy; Hazard ratio; Internal medicine; Propensity score matching; Oncology; Urology; Surgery; Confidence interval","score_opus":0.05299939664535952,"score_gpt":0.38595632455785617,"score_spread":0.33295692791249665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031320380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979843,0.0010930403,0.00016826381,0.00011876155,0.000011443859,0.0000056147715,0.00019303855,0.000004317654,0.00042127902],"genre_scores_gemma":[0.99950504,0.00015726038,0.000055820867,0.000032671127,0.000014792976,0.0000040242376,0.00014248677,0.0000012739937,0.00008663194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994987,0.00023138107,0.000033095777,0.000110008186,0.000064091495,0.00006268771],"domain_scores_gemma":[0.99836594,0.00061468827,0.0006516964,0.00011212901,0.00008023679,0.00017525943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008642438,0.00017394622,0.00026267546,0.00018605894,0.00013699663,0.00033029375,0.00021493567,0.00021698448,0.0012599126],"category_scores_gemma":[0.0032322588,0.0000986113,0.0007134216,0.00026676155,0.00022008763,0.00032464997,0.00029020457,0.0003922485,0.00011750501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011205379,0.000052985735,0.9919652,0.000027276463,0.0002626142,0.000026839421,0.000014479624,0.0002769986,0.00023308411,0.000025790527,0.00012574531,0.005868576],"study_design_scores_gemma":[0.00004389528,0.0007152159,0.9971204,0.000014346272,0.00027925617,0.00011474047,0.000042203577,0.0011092398,0.00023095204,0.000058080466,0.00026777852,0.000003873776],"about_ca_topic_score_codex":0.0014465372,"about_ca_topic_score_gemma":0.0030148777,"teacher_disagreement_score":0.0014465372,"about_ca_system_score_codex":0.00031149184,"about_ca_system_score_gemma":0.00032704943,"threshold_uncertainty_score":0.0045706034},"labels":[],"label_agreement":null},{"id":"W3080188819","doi":"10.1097/coc.0000000000000757","title":"Cancer Management During the COVID-19 Pandemic in the United States","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Pandemic; Specialty; Family medicine; Coronavirus disease 2019 (COVID-19); MEDLINE; Cancer; Radiation oncology; Radiation therapy; Disease; Internal medicine; Infectious disease (medical specialty)","score_opus":0.3017747871706211,"score_gpt":0.5751222812276002,"score_spread":0.2733474940569791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080188819","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97474414,0.002939818,0.00020451249,0.014671731,0.0001367671,0.00007661046,0.0012026504,0.000021101314,0.0060026473],"genre_scores_gemma":[0.99390864,0.0015186943,0.00023398909,0.003162675,0.00013871516,0.000035536228,0.00059424,0.0000035429282,0.00040388244],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99925333,0.00026356633,0.00007273196,0.000104220984,0.0001126226,0.00019345053],"domain_scores_gemma":[0.9977653,0.00029618028,0.0012669504,0.00004321009,0.00017740464,0.00045087907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006652434,0.00008659225,0.00010717038,0.00030681674,0.0008203619,0.00061000517,0.00027522954,0.00056853716,0.0017275901],"category_scores_gemma":[0.0036334672,0.0001235149,0.0001863208,0.0005192682,0.00024967585,0.0006810062,0.00088212715,0.0007494493,0.00011714388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052139334,0.00011585104,0.9646488,0.00008010721,0.00003637483,0.0004145323,0.0015816804,0.00023487561,0.00027991994,0.00023019216,0.0100514805,0.022274137],"study_design_scores_gemma":[0.0000128086185,0.00010679383,0.98330575,0.0002024271,0.000022196049,0.0005514061,0.0067937016,0.0004627883,0.000143021,0.0002409895,0.008146636,0.000011507265],"about_ca_topic_score_codex":0.030263135,"about_ca_topic_score_gemma":0.06537693,"teacher_disagreement_score":0.030263135,"about_ca_system_score_codex":0.0014221708,"about_ca_system_score_gemma":0.001977809,"threshold_uncertainty_score":0.06017393},"labels":[],"label_agreement":null},{"id":"W3082718662","doi":"10.1097/coc.0000000000000754","title":"Eligibility for Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Sorafenib; Hepatocellular carcinoma; Internal medicine; Proportional hazards model; Oncology; Surgery","score_opus":0.12563893260768216,"score_gpt":0.39175020678182276,"score_spread":0.2661112741741406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082718662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922645,0.003652837,0.00024663363,0.00057932414,0.00002984721,0.00008511181,0.0013144553,0.000013844851,0.0018135718],"genre_scores_gemma":[0.9965857,0.0007891573,0.00027826577,0.00029321882,0.000069719004,0.00007456632,0.0015934401,0.000004312405,0.00031153532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993709,0.00019419049,0.00010255376,0.00008135557,0.00013956024,0.00011149955],"domain_scores_gemma":[0.9976508,0.00056818046,0.0011839967,0.000060882823,0.00017793475,0.00035831687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008663619,0.0001368333,0.0004600219,0.00055973843,0.00038885043,0.0005843357,0.0002618461,0.0003142219,0.0022395188],"category_scores_gemma":[0.0024589193,0.000069994945,0.0002888228,0.0009309159,0.00022596915,0.00032447485,0.00033968178,0.00039351892,0.0003499827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008433959,0.00009467568,0.97761554,0.00016938524,0.000046907928,0.000493139,0.00011445231,0.00013626539,0.000767091,0.000060027574,0.0015225668,0.01813652],"study_design_scores_gemma":[0.00010077941,0.0004528861,0.9916232,0.00013076836,0.000045358913,0.0024491455,0.000278392,0.00045234483,0.00044359863,0.00013342676,0.0038771036,0.000013000702],"about_ca_topic_score_codex":0.0024865875,"about_ca_topic_score_gemma":0.006463468,"teacher_disagreement_score":0.0024865875,"about_ca_system_score_codex":0.00060122024,"about_ca_system_score_gemma":0.0012187858,"threshold_uncertainty_score":0.007491946},"labels":[],"label_agreement":null},{"id":"W3083996699","doi":"10.1097/coc.0000000000000756","title":"Is There a Role for Statins and Metformin in Cancer Therapy?","year":2020,"lang":"en","type":"editorial","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Metformin; Family medicine; Cancer; Alternative medicine; Cancer therapy; Oncology; MEDLINE; Internal medicine; Pathology; Law","score_opus":0.041764502572484916,"score_gpt":0.4437940500946438,"score_spread":0.40202954752215886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083996699","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055720622,0.023134386,0.000100765086,0.068520494,0.9054053,0.000016579888,0.000045065324,0.00004545686,0.0026762767],"genre_scores_gemma":[0.00070305436,0.022844722,0.00012435486,0.031235674,0.93771803,0.000017153141,0.000033367254,0.000022379763,0.007301255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982218,0.00035891298,0.00024087064,0.00017814836,0.0008643615,0.00013582715],"domain_scores_gemma":[0.9875218,0.0056149145,0.0005246621,0.00025913923,0.0038930597,0.002186381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005578071,0.002368116,0.0024515104,0.0018239242,0.0020210056,0.0040229117,0.002821805,0.00884088,0.011267391],"category_scores_gemma":[0.015203614,0.00078646967,0.0014798971,0.0007738298,0.0015392906,0.0031403825,0.0007362356,0.019661868,0.007056635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007109066,0.000011995085,0.00003062439,0.00022274503,0.000017362667,0.00011554779,0.000008548238,0.000026371137,0.000041204705,0.00037929864,0.9872241,0.011851117],"study_design_scores_gemma":[0.00009770075,0.00004346917,0.00029664367,0.0006168853,0.000070189446,0.00027387604,0.00003971055,0.0001336258,0.00007621847,0.0010816947,0.99725467,0.000015352502],"about_ca_topic_score_codex":0.0025962119,"about_ca_topic_score_gemma":0.008115541,"teacher_disagreement_score":0.011267391,"about_ca_system_score_codex":0.0023853104,"about_ca_system_score_gemma":0.0024957268,"threshold_uncertainty_score":0.037693202},"labels":[],"label_agreement":null},{"id":"W3089262302","doi":"10.1097/coc.0000000000000766","title":"Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bladder cancer; Hazard ratio; Internal medicine; Proportional hazards model; Epidemiology; Cancer; Stage (stratigraphy); Urology; Relative risk; Gastroenterology; Confidence interval","score_opus":0.053662678147619436,"score_gpt":0.40163046573874844,"score_spread":0.347967787591129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089262302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997451,0.0015499393,0.00013529116,0.0001241762,0.0000235982,0.000004099579,0.0003808277,0.00000516215,0.00032588397],"genre_scores_gemma":[0.9992293,0.00024766655,0.000052630523,0.000027482234,0.000038584825,0.0000030255883,0.00030481844,0.0000015918447,0.00009480245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891543,0.00045341108,0.00008986118,0.00021915995,0.00015652293,0.00016563742],"domain_scores_gemma":[0.99662125,0.0010190043,0.0014758991,0.00025522526,0.00023433723,0.00039426264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001858043,0.00042235182,0.00042257374,0.0005754895,0.00023147996,0.0005574429,0.0004565548,0.00059473584,0.0010830278],"category_scores_gemma":[0.005557412,0.00023607122,0.0012764059,0.00055782427,0.0002392681,0.00072361314,0.0006483658,0.00070064334,0.000207456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002366873,0.000017283672,0.9985091,0.000008092887,0.00012972153,0.000016566219,0.0000098912915,0.00010248917,0.0000492204,0.000007848392,0.000047956426,0.00086506875],"study_design_scores_gemma":[0.000009930624,0.0001807946,0.9987161,0.000008845326,0.00014308347,0.00009972444,0.000041777286,0.00059981534,0.000059785303,0.000026321606,0.000110293775,0.000003586899],"about_ca_topic_score_codex":0.0031732905,"about_ca_topic_score_gemma":0.0040268092,"teacher_disagreement_score":0.0031732905,"about_ca_system_score_codex":0.0002720716,"about_ca_system_score_gemma":0.0003348246,"threshold_uncertainty_score":0.009826362},"labels":[],"label_agreement":null},{"id":"W3089314974","doi":"10.1097/coc.0000000000000763","title":"Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba; Canadian Mennonite University","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Odds ratio; Population; Confidence interval; Cohort; Internal medicine; Oncology; Retrospective cohort study; Prostate-specific antigen; Gynecology; Hormone therapy; Cancer; Urology; Breast cancer","score_opus":0.12694714096734777,"score_gpt":0.44492201640483353,"score_spread":0.31797487543748576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089314974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99789846,0.00008798446,0.000059987542,0.000023536377,0.0000015973993,0.000030323738,0.001628618,0.0000055682767,0.00026391802],"genre_scores_gemma":[0.99884987,0.000039811333,0.000077691664,0.000012442051,0.0000023103842,0.000015337004,0.00094024895,8.9828035e-7,0.000061454535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991998,0.000111373774,0.00009463697,0.0001829988,0.00026701644,0.00014413579],"domain_scores_gemma":[0.9978428,0.00017003294,0.0011003838,0.0001397637,0.00044328326,0.00030368887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009999541,0.00027239628,0.00024792473,0.0015220236,0.00059128186,0.000692249,0.0010971978,0.0003859657,0.00081614876],"category_scores_gemma":[0.0026162323,0.0002717548,0.0006003163,0.0023116947,0.00033232028,0.00032723875,0.0005855346,0.00049949007,0.00016053434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030455229,0.000017504635,0.9993699,0.0000044147987,0.000029494919,0.000010039296,0.000025881647,0.00004952573,0.000035468005,0.0000050332305,0.00005756635,0.00036470807],"study_design_scores_gemma":[0.0000036851604,0.00003574201,0.99952304,0.000002455642,0.000011803033,0.00004138727,0.0000805839,0.00020948032,0.000018855171,0.0000029503362,0.00006805242,0.0000020270984],"about_ca_topic_score_codex":0.40502012,"about_ca_topic_score_gemma":0.4681476,"teacher_disagreement_score":0.40502012,"about_ca_system_score_codex":0.003530638,"about_ca_system_score_gemma":0.00324774,"threshold_uncertainty_score":0.80532527},"labels":[],"label_agreement":null},{"id":"W3093548028","doi":"10.1097/coc.0000000000000773","title":"Outcome of Locally Advanced Esophageal Cancer Patients Treated With Perioperative Chemotherapy and Chemoradiotherapy Followed by Surgery","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"","keywords":"Medicine; Perioperative; Esophageal cancer; Hazard ratio; Chemoradiotherapy; Chemotherapy; Neoadjuvant therapy; Esophagectomy; Proportional hazards model; Cancer; Internal medicine; Surgery; Radiation therapy; Positron emission tomography; Gastroenterology; Nuclear medicine; Confidence interval","score_opus":0.047929063335342435,"score_gpt":0.42944304758274027,"score_spread":0.38151398424739785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093548028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992762,0.00031607546,0.00003721355,0.00003743685,0.0000036311048,0.0000051376423,0.00008796489,0.0000016714961,0.00023469879],"genre_scores_gemma":[0.99951196,0.00012596343,0.000028059214,0.000022571188,0.000008115328,0.0000049119444,0.0002493567,8.2217514e-7,0.000048253278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978477,0.000065311724,0.000027430697,0.000036221954,0.000042458316,0.000043830823],"domain_scores_gemma":[0.99946934,0.000083020896,0.00026578899,0.000015222616,0.00005545742,0.00011121232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003259149,0.00013838887,0.00025216292,0.00032814598,0.00026188977,0.00033011776,0.00013674618,0.0001934198,0.0008073567],"category_scores_gemma":[0.0010180381,0.00008743727,0.0003282064,0.00037823187,0.0002191443,0.00019425242,0.00022281923,0.00025709198,0.00015914088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002887193,0.000038512728,0.9961987,0.000014612137,0.000057981313,0.00043154426,0.000054450742,0.0001160679,0.0003611247,0.00000943894,0.00010891452,0.0023199061],"study_design_scores_gemma":[0.000038595408,0.0007286379,0.99556124,0.000019788704,0.000085870044,0.002505876,0.00020007376,0.00026410088,0.00021613065,0.000019551555,0.00035398683,0.0000061238734],"about_ca_topic_score_codex":0.001866585,"about_ca_topic_score_gemma":0.0030304645,"teacher_disagreement_score":0.001866585,"about_ca_system_score_codex":0.0004043115,"about_ca_system_score_gemma":0.0003645588,"threshold_uncertainty_score":0.0037114024},"labels":[],"label_agreement":null},{"id":"W3104600821","doi":"10.1097/coc.0000000000000775","title":"Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma","year":2020,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Stereotactic radiotherapy; Enucleation; Confidence interval; Radiation therapy; Internal medicine; Oncology; Surgery","score_opus":0.3280721946622167,"score_gpt":0.49513510739544503,"score_spread":0.16706291273322832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104600821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067643505,0.9914745,0.00044141,0.00018737627,0.00018686127,0.00023785161,0.0003737229,0.000020298121,0.00031370227],"genre_scores_gemma":[0.22321437,0.7712377,0.0020624874,0.0011306641,0.00037461703,0.00093009707,0.0006748453,0.00003783433,0.00033742344],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98906344,0.0055803205,0.0029982147,0.0010037437,0.0010903956,0.00026384555],"domain_scores_gemma":[0.981428,0.01387159,0.0030271679,0.00043320365,0.0010442698,0.00019567467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013128091,0.0025187992,0.017075855,0.0050375187,0.00064704166,0.0030097351,0.0019330336,0.0023081945,0.0027751576],"category_scores_gemma":[0.03250129,0.0011434876,0.03561777,0.00556828,0.00070679345,0.0015921434,0.0011472912,0.0018897059,0.00024332658],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031076188,0.00003371445,0.002570138,0.30064413,0.6822143,0.00012461856,0.000067472414,0.00055247627,0.00024861196,0.00011455147,0.0004007852,0.009921521],"study_design_scores_gemma":[0.0005404723,0.00020983482,0.0022129624,0.014853047,0.9808189,0.0000641829,0.000025626672,0.00012427596,0.00009382998,0.00011201782,0.0009308904,0.000013944253],"about_ca_topic_score_codex":0.0055311737,"about_ca_topic_score_gemma":0.011551238,"teacher_disagreement_score":0.017075855,"about_ca_system_score_codex":0.0024512736,"about_ca_system_score_gemma":0.0029380918,"threshold_uncertainty_score":0.0694288},"labels":[],"label_agreement":null},{"id":"W3113817951","doi":"10.1097/coc.0000000000000777","title":"Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database","year":2020,"lang":"en","type":"letter","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Neuroendocrine tumors; Colorectal cancer; Oncology; Internal medicine; Database; General surgery; Cancer","score_opus":0.06803966288764587,"score_gpt":0.41078314383523173,"score_spread":0.3427434809475859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113817951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88492197,0.0027869863,0.0015638765,0.08168633,0.00092074316,0.00011169862,0.007131814,0.00007313681,0.020803435],"genre_scores_gemma":[0.9740189,0.0011915667,0.0021090773,0.015403781,0.0010494468,0.000047614918,0.0038473897,0.000026012438,0.0023063454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989079,0.00019623464,0.00026763277,0.00016842372,0.00027802293,0.00018172222],"domain_scores_gemma":[0.99592304,0.0016562495,0.0007956695,0.00031596498,0.0007334841,0.0005756115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009821703,0.00013836817,0.0003335108,0.0011256202,0.00075250113,0.0009394053,0.00038274992,0.0013307881,0.0015193607],"category_scores_gemma":[0.0051944763,0.00013162776,0.00018647559,0.0018656239,0.00033282663,0.0007384448,0.00058888656,0.0009140008,0.0005207902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037758308,0.000077891855,0.7659853,0.00011171515,0.000043851123,0.10492397,0.00094360445,0.00041111346,0.0060137315,0.002224454,0.07471841,0.04416832],"study_design_scores_gemma":[0.00007598275,0.00014024673,0.5099841,0.00037835503,0.00015699028,0.36051205,0.003687242,0.0045334096,0.0040097283,0.0041445233,0.11230831,0.000069068505],"about_ca_topic_score_codex":0.0055053486,"about_ca_topic_score_gemma":0.013990918,"teacher_disagreement_score":0.0055053486,"about_ca_system_score_codex":0.0010639871,"about_ca_system_score_gemma":0.0010797329,"threshold_uncertainty_score":0.010946631},"labels":[],"label_agreement":null},{"id":"W3115667044","doi":"10.1097/coc.0000000000000789","title":"Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Gallbladder cancer; Internal medicine; Hazard ratio; Gallbladder; Biliary tract; Gastroenterology; Population; Chemotherapy; Surgery; Survival analysis; Confidence interval","score_opus":0.04834031077639483,"score_gpt":0.38259637408280156,"score_spread":0.3342560633064067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115667044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711585,0.0024035622,0.00006827029,0.00010150429,0.000011479779,0.000009323307,0.00007632809,0.0000035140904,0.00021015276],"genre_scores_gemma":[0.9989479,0.00072246173,0.000073781164,0.00005602023,0.000017830589,0.0000074718714,0.00014176789,7.9447705e-7,0.000031904274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997576,0.00010186565,0.00002795533,0.000036001464,0.000043151886,0.000033411598],"domain_scores_gemma":[0.9983026,0.0004036633,0.0009843856,0.00006305744,0.000058983653,0.00018720598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007432568,0.00016512352,0.000328972,0.00027049385,0.0001507579,0.0004298134,0.00015128538,0.000266873,0.0008776338],"category_scores_gemma":[0.0021193034,0.00008909444,0.000556503,0.0002727432,0.00018478968,0.00026365853,0.000261213,0.00035370994,0.000086133114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066098897,0.00049072865,0.96612984,0.00019480541,0.00061277347,0.00026879582,0.0000903286,0.0007296145,0.0017103987,0.00005409592,0.00041616234,0.022692643],"study_design_scores_gemma":[0.0007499621,0.0074186614,0.98631734,0.00006519569,0.00043133553,0.0018288174,0.00012406893,0.0010281274,0.0005952952,0.00011181598,0.0013153035,0.000014107222],"about_ca_topic_score_codex":0.000376869,"about_ca_topic_score_gemma":0.0009628027,"teacher_disagreement_score":0.0008776338,"about_ca_system_score_codex":0.00036865412,"about_ca_system_score_gemma":0.000304236,"threshold_uncertainty_score":0.0039307475},"labels":[],"label_agreement":null},{"id":"W3132127201","doi":"10.1097/coc.0000000000000799","title":"Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ramucirumab; Hazard ratio; Internal medicine; Proportional hazards model; Odds ratio; Cancer registry; Confidence interval; Retrospective cohort study; Cohort; Paclitaxel; Cancer; Oncology; Chemotherapy","score_opus":0.05346937309322012,"score_gpt":0.44030375532445065,"score_spread":0.3868343822312305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132127201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728537,0.0017821266,0.000037187114,0.0000897825,0.0000046610744,0.00000649333,0.0003891403,0.0000028506736,0.0004023903],"genre_scores_gemma":[0.99904376,0.00045175635,0.000036650483,0.00002623612,0.000008367913,0.0000025600598,0.00038162465,8.4814656e-7,0.000048255657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958366,0.00007554353,0.000049719012,0.00007309302,0.000144866,0.00007309609],"domain_scores_gemma":[0.998752,0.0001433235,0.00080770545,0.000030731448,0.00014046521,0.0001257405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046796683,0.00009553063,0.00022507057,0.00049012754,0.00022548642,0.00046927496,0.00029881133,0.00015574502,0.00057843927],"category_scores_gemma":[0.0018561321,0.00009288879,0.00033640602,0.0011679989,0.00019909294,0.00021025524,0.00022187627,0.00025471774,0.0000723459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009047164,0.000008920549,0.99730515,0.000026865788,0.0000591272,0.000101571786,0.000033566994,0.00007258192,0.000082062674,0.000009522664,0.00011357051,0.0020966185],"study_design_scores_gemma":[0.000007841306,0.00005052611,0.9987004,0.000022498383,0.00006073909,0.0004621595,0.00014182687,0.00017785071,0.00005245818,0.0000069517573,0.00031423714,0.0000025897418],"about_ca_topic_score_codex":0.047761377,"about_ca_topic_score_gemma":0.09976438,"teacher_disagreement_score":0.047761377,"about_ca_system_score_codex":0.0011654245,"about_ca_system_score_gemma":0.0012468529,"threshold_uncertainty_score":0.09496677},"labels":[],"label_agreement":null},{"id":"W3140522824","doi":"10.1097/coc.0000000000000812","title":"Clinical Uncertainty and Equipoise in the Management of Recurrent Glioblastoma","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Alberta; University of Alberta Hospital; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre","funders":"","keywords":"Medicine; Clinical equipoise; Confidence interval; Glioblastoma; Randomized controlled trial; Magnetic resonance imaging; MEDLINE; Surgery; Physical therapy; Internal medicine; Radiology","score_opus":0.0746135353584897,"score_gpt":0.470644307905219,"score_spread":0.3960307725467293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140522824","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.092074014,0.88971484,0.0045025228,0.009126918,0.00040184378,0.00036638518,0.00082541886,0.00001849615,0.0029695462],"genre_scores_gemma":[0.88370484,0.10596271,0.0052021565,0.0033625113,0.00062512764,0.00055241736,0.0005018148,0.000018971645,0.000069563495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.58400184,0.28786224,0.0828492,0.011772142,0.032257333,0.0012571856],"domain_scores_gemma":[0.18877053,0.69797784,0.08896479,0.008367533,0.014842329,0.0010769961],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.25761876,0.0006135292,0.0041641854,0.013160117,0.0009713406,0.0048921467,0.0023506058,0.0018671438,0.000935053],"category_scores_gemma":[0.54031634,0.0010522392,0.005702727,0.008884811,0.006447021,0.005421094,0.004359318,0.002137423,0.000102507845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002776225,0.000107579115,0.26927525,0.3161447,0.047973663,0.00052725285,0.023116734,0.0029272793,0.0006334931,0.0073689097,0.0041174274,0.32503146],"study_design_scores_gemma":[0.0008470611,0.0020908138,0.36517996,0.48214436,0.048954878,0.0031301999,0.02161369,0.0029361374,0.0022127181,0.030630842,0.039495125,0.0007642648],"about_ca_topic_score_codex":0.005015469,"about_ca_topic_score_gemma":0.006844011,"teacher_disagreement_score":0.25761876,"about_ca_system_score_codex":0.004259519,"about_ca_system_score_gemma":0.007502023,"threshold_uncertainty_score":0.91548824},"labels":[],"label_agreement":null},{"id":"W3165150297","doi":"10.1097/coc.0000000000000834","title":"Real-world Patterns of Adjuvant Chemotherapy Following Neoadjuvant Chemoradiation for Patients With Resected Rectal Adenocarcinoma","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Oxaliplatin; Hazard ratio; Internal medicine; Proportional hazards model; Chemotherapy; Oncology; Colorectal cancer; Odds ratio; Regimen; Surgery; Confidence interval; Cancer","score_opus":0.04186623095062805,"score_gpt":0.41075068191978464,"score_spread":0.36888445096915656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165150297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991954,0.0002855801,0.00006670443,0.00006237985,0.0000031910943,0.0000045249994,0.00019701805,0.0000022145482,0.00018290884],"genre_scores_gemma":[0.9996332,0.00007781706,0.00006350758,0.000012823104,0.00000288226,0.0000022093407,0.00017688822,7.662953e-7,0.00002986988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917704,0.00025568754,0.00015016511,0.00014095813,0.00017828193,0.000097751574],"domain_scores_gemma":[0.9965592,0.00051830686,0.0023672224,0.00012420154,0.00021719509,0.000213961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005798385,0.00010438579,0.00016471735,0.00067446876,0.00022404779,0.00047021266,0.0003149567,0.00026002823,0.0005967882],"category_scores_gemma":[0.003860106,0.00012878797,0.00023951166,0.0011514341,0.00029242618,0.0003102258,0.00032160236,0.00024918714,0.000107345884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047449306,0.00000566121,0.99902785,0.0000052998053,0.00002204734,0.00003821275,0.000035461748,0.000050253144,0.000087217886,0.0000053839017,0.00003124467,0.00064387574],"study_design_scores_gemma":[0.0000025646714,0.000032506257,0.998882,0.0000056960153,0.000012940299,0.00035075672,0.00023991357,0.00021883246,0.00006774246,0.000010354035,0.00017373257,0.0000029421242],"about_ca_topic_score_codex":0.013203877,"about_ca_topic_score_gemma":0.030317165,"teacher_disagreement_score":0.013203877,"about_ca_system_score_codex":0.00066832197,"about_ca_system_score_gemma":0.00069138466,"threshold_uncertainty_score":0.026254058},"labels":[],"label_agreement":null},{"id":"W3180861062","doi":"10.1097/coc.0000000000000850","title":"Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MacEwan University; University of Alberta","funders":"","keywords":"Capecitabine; Medicine; Concomitant; Internal medicine; Chemoradiotherapy; Hazard ratio; Oncology; Colorectal cancer; Fluorouracil; Cancer; Radiation therapy; Surgery; Confidence interval","score_opus":0.07194702185611679,"score_gpt":0.43029819684358467,"score_spread":0.3583511749874679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180861062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414575,0.0048380652,0.00014406664,0.000077421915,0.000022433465,0.000028338873,0.000084199695,0.000007344739,0.0006523989],"genre_scores_gemma":[0.99810445,0.001234035,0.00025595247,0.000046269517,0.000030064077,0.000016235685,0.00011369341,0.0000017913694,0.0001973781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964094,0.00010167316,0.000066428816,0.000062614534,0.000092537484,0.000035781424],"domain_scores_gemma":[0.9991565,0.00018528885,0.00045486217,0.000035879177,0.000044682776,0.00012280424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038549025,0.00013007672,0.0003714975,0.00023973736,0.00023292523,0.0002747301,0.00016358275,0.00013388006,0.0007955938],"category_scores_gemma":[0.0012389985,0.0001143747,0.0003583712,0.000356648,0.00017507722,0.00021804571,0.00021566506,0.00031468418,0.00011107836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010568771,0.0007410859,0.87230426,0.0006466551,0.0008663631,0.0015179007,0.00014734211,0.00047561823,0.021747349,0.000058414345,0.00044212546,0.09048408],"study_design_scores_gemma":[0.00024507465,0.018267492,0.9648334,0.00010839224,0.00076157757,0.00488285,0.00014684699,0.00065317727,0.005661286,0.000033447886,0.004392256,0.0000141825685],"about_ca_topic_score_codex":0.000604453,"about_ca_topic_score_gemma":0.0032830953,"teacher_disagreement_score":0.0007955938,"about_ca_system_score_codex":0.000398387,"about_ca_system_score_gemma":0.00044316586,"threshold_uncertainty_score":0.0028904676},"labels":[],"label_agreement":null},{"id":"W3187087408","doi":"10.1097/coc.0000000000000857","title":"A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non–Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Alberta Health Services","funders":"","keywords":"Medicine; Internal medicine; Anaplastic lymphoma kinase; Oncology; Lung cancer; Population; Chemotherapy; Targeted therapy; Cancer registry; Radiation therapy; Immunotherapy; Cancer; Cohort; Stage (stratigraphy)","score_opus":0.03589171005346983,"score_gpt":0.4420942888196092,"score_spread":0.4062025787661394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187087408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979557,0.00012559135,0.000050586415,0.00006674835,0.0000036716563,0.000022932034,0.0013928304,0.0000029289304,0.00037902783],"genre_scores_gemma":[0.9987729,0.00007155901,0.00006155361,0.000039815066,0.000004069568,0.000011587795,0.00093776995,0.0000012086384,0.00009951721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992317,0.000077733064,0.000071576585,0.00022296199,0.00018888246,0.00020704538],"domain_scores_gemma":[0.99870765,0.00011639651,0.0005334657,0.00008899112,0.00028601458,0.00026744237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005816596,0.00027967824,0.00035104298,0.0010611214,0.0012137139,0.0006436258,0.0008195751,0.00049917476,0.0011472448],"category_scores_gemma":[0.0017687996,0.0003118273,0.0004969112,0.0026484318,0.00048453052,0.00040525303,0.0005257454,0.0006080768,0.00017787771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029916982,0.000015145235,0.99930644,0.0000044662315,0.00002657283,0.000021766811,0.000050669765,0.000020507707,0.000052626252,0.000007939066,0.00010305931,0.00036098075],"study_design_scores_gemma":[0.000008018674,0.000042347645,0.99924743,0.000004311426,0.000016358015,0.00009011275,0.00024396199,0.00011045195,0.000016286163,0.000010306791,0.00020677278,0.0000037149025],"about_ca_topic_score_codex":0.59872127,"about_ca_topic_score_gemma":0.6621845,"teacher_disagreement_score":0.59872127,"about_ca_system_score_codex":0.0052723438,"about_ca_system_score_gemma":0.0051271357,"threshold_uncertainty_score":0.8072839},"labels":[],"label_agreement":null},{"id":"W3190815019","doi":"10.1097/coc.0000000000000856","title":"Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"FOLFIRINOX; Medicine; Hazard ratio; Internal medicine; Interquartile range; Confidence interval; Oncology; Pancreatic cancer; Progression-free survival; Olaparib; Chemotherapy; Gastroenterology; Surgery; Cancer; Irinotecan","score_opus":0.028545416360479522,"score_gpt":0.3923611423485976,"score_spread":0.36381572598811807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190815019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991714,0.00039462378,0.000017627237,0.000047375182,0.0000032978576,0.0000033027677,0.00014327542,0.0000024104918,0.00021670494],"genre_scores_gemma":[0.9997241,0.00005645688,0.000017410295,0.000009122608,0.0000035764394,0.0000011396025,0.00013287773,4.3511108e-7,0.000054896183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983823,0.000024877161,0.000014957069,0.000030554966,0.00004861032,0.00004276407],"domain_scores_gemma":[0.99839395,0.00022068313,0.00077649206,0.000045003533,0.00015727383,0.00040662018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031533377,0.00012963849,0.00019665046,0.0003747649,0.00024889936,0.0004830203,0.0002803427,0.00026904145,0.0008244755],"category_scores_gemma":[0.001552739,0.00007520925,0.00018195288,0.0006209246,0.00023131384,0.00016357198,0.00015701963,0.00039371688,0.00007626042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028055205,0.00001880616,0.9980009,0.0000046172568,0.000017655535,0.00004314534,0.000017543518,0.00007421776,0.000132109,0.0000042020442,0.00007182718,0.0013344057],"study_design_scores_gemma":[0.000012269319,0.00008273499,0.99938035,0.0000034722182,0.000012780224,0.00015498909,0.0000352943,0.0001551596,0.000047654143,0.0000047413223,0.000108728804,0.0000018698926],"about_ca_topic_score_codex":0.03312923,"about_ca_topic_score_gemma":0.04524033,"teacher_disagreement_score":0.03312923,"about_ca_system_score_codex":0.00096348947,"about_ca_system_score_gemma":0.00070505176,"threshold_uncertainty_score":0.06587279},"labels":[],"label_agreement":null},{"id":"W3200804649","doi":"10.1097/coc.0000000000000866","title":"Trends in Diagnosis and Treatment of Metastatic Cancer in the United States","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Centre for Family Medicine","funders":"National Cancer Institute","keywords":"Medicine; Epidemiology; Internal medicine; Cancer; Incidence (geometry); Colorectal cancer; Oncology; Cancer registry; Surveillance, Epidemiology, and End Results; Metastatic breast cancer; Prostate; Metastasis; Prostate cancer; Kidney cancer; Breast cancer","score_opus":0.1264741920221116,"score_gpt":0.4957059781453322,"score_spread":0.3692317861232206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200804649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8942725,0.04130202,0.0015170715,0.0070661623,0.00031817704,0.0000669004,0.042924397,0.00031941896,0.012213361],"genre_scores_gemma":[0.96161675,0.012112543,0.0011563011,0.0012318074,0.00022777477,0.000058380585,0.022256237,0.0000230442,0.0013171828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993038,0.00009410482,0.00011325559,0.00016063741,0.00024048665,0.00008762722],"domain_scores_gemma":[0.99765646,0.00020478466,0.0013893652,0.000042117754,0.0005135906,0.00019375165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052976044,0.0001796069,0.00023484633,0.0014723662,0.00019381431,0.00048827188,0.00029376356,0.0003288281,0.0014943079],"category_scores_gemma":[0.002720838,0.0001297091,0.00047311772,0.002238837,0.00015829864,0.00043557823,0.0002979397,0.00064745103,0.00026128796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007293601,0.000057501635,0.9683616,0.00024984384,0.00015129002,0.000074206844,0.00006699556,0.00051410333,0.00029967912,0.00032307353,0.011738122,0.018090596],"study_design_scores_gemma":[0.000009634779,0.000055274904,0.99017966,0.00014554459,0.000056682606,0.0004177487,0.00017308294,0.00065811037,0.00015950638,0.00008058044,0.008056469,0.000007731315],"about_ca_topic_score_codex":0.033274565,"about_ca_topic_score_gemma":0.053414505,"teacher_disagreement_score":0.033274565,"about_ca_system_score_codex":0.0012662925,"about_ca_system_score_gemma":0.0012119157,"threshold_uncertainty_score":0.06616175},"labels":[],"label_agreement":null},{"id":"W3204935647","doi":"10.1097/coc.0000000000000869","title":"Stereotactic Body Radiotherapy for Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Prostate cancer; Citation; Specialty; Radiation oncology; Bibliometrics; Medical physics; Oncology; Cancer; Radiation therapy; Family medicine; Internal medicine; Library science","score_opus":0.06958080656621164,"score_gpt":0.4855860037090525,"score_spread":0.4160051971428409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204935647","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037519295,0.9345732,0.0028525926,0.002491496,0.00049209164,0.0001241994,0.0034136865,0.00025485424,0.018278595],"genre_scores_gemma":[0.22548337,0.75636035,0.007366866,0.0010464413,0.0012633372,0.00010180764,0.004207114,0.000047309022,0.0041233846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990926,0.0001816366,0.000106448824,0.00007799609,0.00048339754,0.00005785326],"domain_scores_gemma":[0.9983871,0.0005865686,0.00051154225,0.00005074815,0.00039609772,0.00006798875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014947932,0.0003181882,0.00046834326,0.0062098876,0.00022138853,0.00096752966,0.00037252242,0.0003921369,0.005502251],"category_scores_gemma":[0.0024510426,0.00008070054,0.0007289919,0.010427294,0.0003470021,0.0006646652,0.00041291048,0.0003019739,0.0013103854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023949458,0.00009608975,0.03631721,0.018927043,0.00038982581,0.0005083424,0.00021297553,0.0005426222,0.0032860173,0.0014918078,0.019294862,0.9186937],"study_design_scores_gemma":[0.00011018792,0.0014025907,0.47555453,0.019582225,0.0013606333,0.016623352,0.0010089647,0.0012246524,0.008763596,0.0035612932,0.47073185,0.00007605957],"about_ca_topic_score_codex":0.0023403305,"about_ca_topic_score_gemma":0.0040695,"teacher_disagreement_score":0.0062098876,"about_ca_system_score_codex":0.0009615398,"about_ca_system_score_gemma":0.0025506953,"threshold_uncertainty_score":0.018406868},"labels":[],"label_agreement":null},{"id":"W3206694174","doi":"10.1097/coc.0000000000000867","title":"Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"","keywords":"Radiation therapy; Prophylactic cranial irradiation; Brain metastasis; Neurocognitive; Lung cancer; Radiosurgery; Central nervous system; Conventional PCI; Chemotherapy","score_opus":0.11089184346273195,"score_gpt":0.5429156578752207,"score_spread":0.4320238144124887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206694174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016233665,0.9968829,0.00007436411,0.0003859376,0.00009621843,0.00002072571,0.00003702475,0.000003173466,0.0008763508],"genre_scores_gemma":[0.020399604,0.9782799,0.00031042498,0.00048369437,0.0001599637,0.000041983894,0.00007107701,0.0000017286042,0.00025176216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995136,0.00021950001,0.00008568963,0.0000464469,0.00011149517,0.000023238485],"domain_scores_gemma":[0.99876547,0.00082287256,0.0002059327,0.000027121809,0.00014454754,0.000034015517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011329391,0.00022264932,0.000980005,0.0006881282,0.00018431737,0.00048655027,0.00039887987,0.0005479601,0.0020032628],"category_scores_gemma":[0.0032750193,0.000094764946,0.0010208781,0.0007289342,0.00023816424,0.0004083947,0.00022290826,0.0008045619,0.00036993017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007893858,0.00021536178,0.0023431114,0.07600624,0.0009518188,0.00016312626,0.00009674216,0.00034235296,0.0015899603,0.0011708454,0.006623091,0.90970784],"study_design_scores_gemma":[0.0014798208,0.011580379,0.06478578,0.13599662,0.011092869,0.0045162425,0.00054313004,0.0005343408,0.007958876,0.0048881797,0.75653905,0.00008465282],"about_ca_topic_score_codex":0.0010429055,"about_ca_topic_score_gemma":0.0027577195,"teacher_disagreement_score":0.0020032628,"about_ca_system_score_codex":0.00029437782,"about_ca_system_score_gemma":0.00075592875,"threshold_uncertainty_score":0.006701529},"labels":[],"label_agreement":null},{"id":"W4200621966","doi":"10.1097/coc.0000000000000882","title":"Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"FOLFIRINOX; Pancreatic cancer; Palliative chemotherapy; Chemotherapy; Population; Palliative care; Young adult; MEDLINE","score_opus":0.05427993787854053,"score_gpt":0.46352425922381213,"score_spread":0.4092443213452716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200621966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896646,0.00043323298,0.00004714599,0.00006310413,0.0000033637966,0.000006045688,0.00015313108,0.0000015397266,0.00032595918],"genre_scores_gemma":[0.9994541,0.0001735202,0.00004073333,0.00003815133,0.0000070111137,0.0000046318273,0.00021554035,7.263017e-7,0.00006553453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997093,0.00006787064,0.000053043135,0.00005688191,0.00006916546,0.000043817614],"domain_scores_gemma":[0.9987685,0.00012992164,0.0007991053,0.0000331842,0.00009965543,0.00016954045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036327064,0.00011995904,0.0002215281,0.00042322362,0.00022673857,0.00031188855,0.0001235586,0.0002182945,0.0007456995],"category_scores_gemma":[0.0019749412,0.000085398606,0.00026708248,0.0006428944,0.00013973037,0.00026603593,0.00024071331,0.00026305116,0.00013432276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063833824,0.000016415253,0.99819356,0.0000054209045,0.000022562772,0.000053454824,0.000036603305,0.000033516953,0.00008987703,0.000005966044,0.000053368633,0.0014254708],"study_design_scores_gemma":[0.000007215942,0.000082528306,0.99906725,0.000008953337,0.000016481707,0.0003635191,0.00011897742,0.00012748684,0.00003510455,0.000014241776,0.000156743,0.0000015459589],"about_ca_topic_score_codex":0.0032000015,"about_ca_topic_score_gemma":0.005962058,"teacher_disagreement_score":0.0032000015,"about_ca_system_score_codex":0.0003139036,"about_ca_system_score_gemma":0.00023189769,"threshold_uncertainty_score":0.006362736},"labels":[],"label_agreement":null},{"id":"W4210423488","doi":"10.1097/coc.0000000000000891","title":"The Prognostic Impact of Radiotherapy Delays in Oropharynx Carcinoma and the Role of p16 Status","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Positive Living North","funders":"","keywords":"Radiation therapy; Carcinoma; Retrospective cohort study; Risk factor; Karnofsky Performance Status; Overall survival","score_opus":0.030904148224827913,"score_gpt":0.4320641685821482,"score_spread":0.4011600203573203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210423488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983701,0.0010845851,0.000117086056,0.000017570437,0.0000056382914,0.0000048867573,0.0002186077,0.0000023820016,0.00017917267],"genre_scores_gemma":[0.99967957,0.00012427324,0.000039954793,0.0000036964,0.0000039642255,0.000002750032,0.00011021692,0.0000010852099,0.0000345832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968946,0.000056939556,0.00005147373,0.000074404896,0.00006831502,0.000059467227],"domain_scores_gemma":[0.9976908,0.0005167445,0.0014475207,0.000097981836,0.00008907083,0.00015789681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005636802,0.00013840063,0.00019796229,0.0003844187,0.00016373317,0.00028986638,0.00023354522,0.00018641975,0.00097104075],"category_scores_gemma":[0.0027400963,0.00012463862,0.00034827142,0.0006673714,0.00019855113,0.00025544077,0.0002557983,0.000230291,0.00010763678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034376085,0.000008665382,0.99672395,0.000019204832,0.000039733764,0.00007993928,0.00001705668,0.00016179505,0.00042541948,0.000008852909,0.000031111933,0.0021404568],"study_design_scores_gemma":[0.0000094567995,0.00017712242,0.99801135,0.000009707706,0.00005373028,0.000722482,0.000077748395,0.00029690049,0.00028434923,0.000017830123,0.0003360672,0.0000031394636],"about_ca_topic_score_codex":0.0023819176,"about_ca_topic_score_gemma":0.0032822078,"teacher_disagreement_score":0.0023819176,"about_ca_system_score_codex":0.00034454087,"about_ca_system_score_gemma":0.0004376432,"threshold_uncertainty_score":0.0047361255},"labels":[],"label_agreement":null},{"id":"W4214511738","doi":"10.1097/coc.0000000000000900","title":"Use of “Repurposed” Drugs in the Treatment of Epithelial Ovarian Cancer","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical trial; Ovarian cancer; Observational study; Epithelial ovarian cancer; Randomized controlled trial; Nonsteroidal; MEDLINE","score_opus":0.054969698660248714,"score_gpt":0.4009150864410306,"score_spread":0.3459453877807819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214511738","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00095602067,0.99834883,0.000056528836,0.00013393619,0.000049883998,0.00005422267,0.00016114581,0.000002869435,0.00023643365],"genre_scores_gemma":[0.017887155,0.9806903,0.00038033063,0.00056466507,0.00008118793,0.00011283562,0.00019041657,0.0000032357111,0.00008989882],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9954922,0.0016774995,0.001685364,0.00036807996,0.0006865672,0.000090219466],"domain_scores_gemma":[0.9887531,0.008047359,0.0023011733,0.00021460965,0.00059056195,0.00009325077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038952555,0.0005156782,0.0039642598,0.0035677939,0.00026084765,0.0012249902,0.0008178997,0.0009770772,0.0033204546],"category_scores_gemma":[0.012421023,0.00034279207,0.00413439,0.003932414,0.00048904837,0.00094887894,0.00064293755,0.0006285575,0.0002515415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050262775,0.000032720476,0.0012119724,0.8509368,0.012097593,0.00009920224,0.000092341164,0.00010162964,0.0003921486,0.0003949669,0.002006607,0.13213138],"study_design_scores_gemma":[0.0012921961,0.0010290713,0.017288856,0.75449663,0.119944625,0.0014238558,0.0003233275,0.0001822523,0.0009437914,0.0011890364,0.101812795,0.00007370783],"about_ca_topic_score_codex":0.0021817696,"about_ca_topic_score_gemma":0.007181494,"teacher_disagreement_score":0.0039642598,"about_ca_system_score_codex":0.00089081394,"about_ca_system_score_gemma":0.0028485723,"threshold_uncertainty_score":0.020600319},"labels":[],"label_agreement":null},{"id":"W4224240457","doi":"10.1097/coc.0000000000000906","title":"Changes in Survival Outcomes of Patients With Neuroendocrine Neoplasms Over the Past 15 Years","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Confidence interval; Internal medicine; Survival analysis; Comorbidity; Cohort study; Population; Cohort","score_opus":0.043241115950161335,"score_gpt":0.41578084862906867,"score_spread":0.37253973267890733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224240457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691075,0.0010868746,0.00007788984,0.00027846778,0.000015168292,0.000004164797,0.0011312772,0.000007063079,0.0004882827],"genre_scores_gemma":[0.99881124,0.00024551954,0.000039386767,0.00004115882,0.0000116445835,0.0000025161426,0.0007776067,9.883416e-7,0.00006988269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952877,0.00006433826,0.000050315462,0.00010106223,0.00011969535,0.00013581692],"domain_scores_gemma":[0.99727756,0.00023507369,0.0015964839,0.00007779629,0.00039314837,0.0004199063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000705378,0.00016373146,0.0002153326,0.0008311392,0.00047532344,0.0007200087,0.0004280142,0.00032619562,0.00083747617],"category_scores_gemma":[0.0031841192,0.00009879889,0.00038034166,0.0013452248,0.0004243701,0.00045268098,0.00042146738,0.00048236278,0.00011850942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022137268,0.000004231096,0.9990158,0.0000063894536,0.00002467072,0.000028032024,0.000036416794,0.000058144,0.000027362377,0.0000080096315,0.000089906986,0.0006788089],"study_design_scores_gemma":[0.0000016264391,0.000019345256,0.9993168,0.000007996305,0.000018235687,0.00013521823,0.00012318678,0.00011443997,0.00001681396,0.000017602873,0.00022594508,0.0000027404562],"about_ca_topic_score_codex":0.08538041,"about_ca_topic_score_gemma":0.1473718,"teacher_disagreement_score":0.08538041,"about_ca_system_score_codex":0.0017427688,"about_ca_system_score_gemma":0.001587906,"threshold_uncertainty_score":0.16976684},"labels":[],"label_agreement":null},{"id":"W4254975047","doi":"10.1097/01.coc.0000214931.01062.01","title":"Natural History and Chemotherapy Effectiveness for Advanced Adenocarcinoma of the Small Bowel: A Retrospective Review of 113 Cases","year":2006,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Irinotecan; Chemotherapy; Regimen; Retrospective cohort study; Adenocarcinoma; Internal medicine; Gemcitabine; Oncology; Chemotherapy regimen; Cancer; Medical record; Proportional hazards model; Surgery; Colorectal cancer","score_opus":0.11064317117632977,"score_gpt":0.480968717011261,"score_spread":0.3703255458349312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254975047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025670853,0.9730525,0.00014179922,0.000093816816,0.00003792802,0.00004490306,0.00021290134,0.000009147543,0.0007361095],"genre_scores_gemma":[0.09263204,0.9059384,0.00045117605,0.00015648507,0.00008982043,0.000058427315,0.0003920809,0.0000054740462,0.00027611523],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989925,0.0001862052,0.0003978842,0.00013284369,0.00025213804,0.0000384694],"domain_scores_gemma":[0.9977841,0.0010811121,0.0007755649,0.00007800612,0.00022117305,0.000060207676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009523709,0.00035578985,0.00097190525,0.004534429,0.0003360805,0.000595215,0.0007071731,0.0004872959,0.0011642794],"category_scores_gemma":[0.00278258,0.00030573053,0.0005703627,0.0064545455,0.00050085696,0.00069265487,0.00033856247,0.00026764942,0.0004220166],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004158975,0.000107417276,0.2351715,0.053823408,0.0009893436,0.035988823,0.0013389578,0.00027810395,0.0026303409,0.00035609765,0.009120239,0.6597799],"study_design_scores_gemma":[0.000096415904,0.00084144704,0.5345718,0.029442687,0.005168423,0.2861083,0.0019693102,0.0002257329,0.0014851177,0.00033667736,0.13966857,0.00008546734],"about_ca_topic_score_codex":0.0013998962,"about_ca_topic_score_gemma":0.0021730722,"teacher_disagreement_score":0.004534429,"about_ca_system_score_codex":0.00040636945,"about_ca_system_score_gemma":0.00096056104,"threshold_uncertainty_score":0.0050367117},"labels":[],"label_agreement":null},{"id":"W4282822260","doi":"10.1097/coc.0000000000000925","title":"A Real-World Study of the Incidence and Outcomes of Early-Onset Well-differentiated Neuroendocrine Neoplasms","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Foregut; Hazard ratio; Hindgut; Proportional hazards model; Internal medicine; Incidence (geometry); Midgut; Epidemiology; Confidence interval; Neuroendocrine tumors; Gastroenterology; Pathology; Biology","score_opus":0.05526594234614452,"score_gpt":0.4515410364582003,"score_spread":0.3962750941120558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282822260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957628,0.0014591502,0.00026652665,0.000165299,0.00001322506,0.000014359296,0.0018471554,0.000005178618,0.00046642692],"genre_scores_gemma":[0.99827886,0.00036669028,0.00012115282,0.000042541546,0.000024247416,0.000010111597,0.0011008453,0.0000012807607,0.000054126034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986785,0.00050826016,0.00017281633,0.00028306476,0.00023515464,0.00012219085],"domain_scores_gemma":[0.99354374,0.00096722116,0.0042225746,0.00029289498,0.00055610924,0.0004174263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001415254,0.00024250968,0.00027599052,0.00069319736,0.00022377945,0.0006622608,0.0003077812,0.0003577699,0.00087920483],"category_scores_gemma":[0.0049363286,0.00016493107,0.0003530323,0.0012026373,0.00025165855,0.0007259522,0.0005847558,0.0004751094,0.00017400246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033692402,0.000010242853,0.99904066,0.000015175265,0.00004807581,0.000029553019,0.000020754456,0.000027121727,0.000035407524,0.000013152261,0.00008654405,0.00063957524],"study_design_scores_gemma":[0.0000038246385,0.000047521586,0.999087,0.000014586362,0.000024354727,0.0002274632,0.00011276891,0.00014054865,0.000025217567,0.000018581875,0.0002957273,0.0000024583942],"about_ca_topic_score_codex":0.003110738,"about_ca_topic_score_gemma":0.0037539082,"teacher_disagreement_score":0.003110738,"about_ca_system_score_codex":0.00034846354,"about_ca_system_score_gemma":0.0003902897,"threshold_uncertainty_score":0.0074846745},"labels":[],"label_agreement":null},{"id":"W4295066538","doi":"10.1097/coc.0000000000000940","title":"Long-term Locoregional Control With Unilateral Radiation for AJCC-7 T1-2N2b Tonsillar Cancer","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"U.S. Department of Veterans Affairs","keywords":"Medicine; Tonsil; Radiation therapy; Surgery; Cancer; Retrospective cohort study; Clinical endpoint; Internal medicine; Randomized controlled trial","score_opus":0.06536051852036996,"score_gpt":0.46128078286753277,"score_spread":0.3959202643471628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295066538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935137,0.0034988874,0.0008570533,0.00006948427,0.000016558903,0.00002304473,0.00017612487,0.000018772202,0.0018263379],"genre_scores_gemma":[0.999326,0.00028172618,0.00014701093,0.000021226408,0.000013332974,0.000008147205,0.000108859225,0.000002930967,0.00009081193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996464,0.00009393816,0.00003542352,0.000060961687,0.00011405566,0.000049227896],"domain_scores_gemma":[0.9992106,0.0001664413,0.0004145686,0.000059033133,0.00006390739,0.000085402055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069945154,0.00011330935,0.00023500023,0.00025986243,0.00023389462,0.00037691052,0.00021519445,0.00012941778,0.0008848926],"category_scores_gemma":[0.0015678469,0.000047552232,0.00037441764,0.00034965354,0.0002647394,0.00031157144,0.00029166494,0.00017063979,0.000087584725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013034355,0.00027687007,0.8505234,0.00042490894,0.00022953005,0.00072210614,0.00018157235,0.0016232784,0.0119861765,0.00014545403,0.000613703,0.1319695],"study_design_scores_gemma":[0.00005758411,0.0035932423,0.98362225,0.000078935016,0.00016042012,0.0036487086,0.00019249295,0.0006318942,0.006017388,0.00010587784,0.0018736251,0.0000175627],"about_ca_topic_score_codex":0.0010586814,"about_ca_topic_score_gemma":0.0042793746,"teacher_disagreement_score":0.0010586814,"about_ca_system_score_codex":0.0005004021,"about_ca_system_score_gemma":0.0005569851,"threshold_uncertainty_score":0.0036990643},"labels":[],"label_agreement":null},{"id":"W4295904613","doi":"10.1097/coc.0000000000000942","title":"Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Colorectal cancer; Multivariate analysis; Neoadjuvant therapy; Univariate analysis; Receiver operating characteristic; Internal medicine; Oncology; Odds ratio; Cancer; Youden's J statistic; Stage (stratigraphy); Chemoradiotherapy; Retrospective cohort study; Breast cancer","score_opus":0.06226248890684994,"score_gpt":0.40464936423534253,"score_spread":0.3423868753284926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295904613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995352,0.00021353042,0.00009197186,0.0000338464,0.0000027843826,0.0000026547007,0.000032723437,0.0000033089777,0.00008402028],"genre_scores_gemma":[0.99980384,0.000030203219,0.000058957707,0.0000061147985,0.0000053177387,0.0000028147917,0.00006279925,8.7945807e-7,0.000028966842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997423,0.00010058416,0.000029167219,0.000029916875,0.00006746187,0.00003055034],"domain_scores_gemma":[0.9979164,0.00086692197,0.0008198546,0.000059137717,0.00011293991,0.0002247248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055955246,0.00016579658,0.00023971176,0.00039967307,0.00012313775,0.00027864316,0.00018350389,0.00025983344,0.0008866658],"category_scores_gemma":[0.0037256517,0.00013328395,0.00022399996,0.00027808928,0.00022423285,0.00024660828,0.0001895713,0.00025068698,0.00014255333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004037462,0.0000222492,0.9959617,0.00001012817,0.000025254145,0.00008830481,0.000030248062,0.0003994731,0.000647973,0.000009404495,0.00007768823,0.002323859],"study_design_scores_gemma":[0.000012985407,0.00026272892,0.996545,0.000006810946,0.000027319835,0.00063463335,0.00006921962,0.0019024017,0.00036224222,0.00003647694,0.00013493207,0.0000050792696],"about_ca_topic_score_codex":0.0004961698,"about_ca_topic_score_gemma":0.000729186,"teacher_disagreement_score":0.0008866658,"about_ca_system_score_codex":0.00015262987,"about_ca_system_score_gemma":0.00019426204,"threshold_uncertainty_score":0.0029662251},"labels":[],"label_agreement":null},{"id":"W4309648805","doi":"10.1097/coc.0000000000000955","title":"Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Anal cancer; Toxicity; Adverse effect; Oncology; Internal medicine; Cancer","score_opus":0.35342035971078095,"score_gpt":0.546357270421215,"score_spread":0.192936910710434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309648805","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29038903,0.044882726,0.5601454,0.003922488,0.0024615258,0.04854859,0.0129129095,0.002122151,0.034615126],"genre_scores_gemma":[0.64594316,0.0042742672,0.29354754,0.0016651991,0.00075525197,0.047005452,0.0046099285,0.00039551416,0.0018036923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.56120604,0.35694945,0.047963787,0.0052889627,0.02730954,0.0012823015],"domain_scores_gemma":[0.57574105,0.27610606,0.10197678,0.018356796,0.024689058,0.0031303165],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4084588,0.0020232804,0.0045042494,0.009086338,0.00080818334,0.0044902023,0.0019698648,0.0011574312,0.0023872184],"category_scores_gemma":[0.30910584,0.00064906204,0.0070228297,0.012922668,0.001391142,0.004295046,0.0035469632,0.003366843,0.00045338963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03607356,0.00095062976,0.44009197,0.011443537,0.037314747,0.00033549688,0.001208827,0.032766096,0.004260086,0.0138525525,0.011538978,0.41016346],"study_design_scores_gemma":[0.013028104,0.07254639,0.54554164,0.0036078289,0.01789185,0.0019733312,0.0011225659,0.21951663,0.018089825,0.040756036,0.06490575,0.0010201067],"about_ca_topic_score_codex":0.00060054037,"about_ca_topic_score_gemma":0.0013035608,"teacher_disagreement_score":0.5915412,"about_ca_system_score_codex":0.0042515597,"about_ca_system_score_gemma":0.0037454471,"threshold_uncertainty_score":0.7294756},"labels":[],"label_agreement":null},{"id":"W4310570503","doi":"10.1097/coc.0000000000000961","title":"Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Internal medicine; Odds ratio; Survival analysis; Anal cancer; Logistic regression; Pacific islanders; Oncology; Epidemiology; Confidence interval; Cancer; Population","score_opus":0.04224362162302379,"score_gpt":0.36978068598864433,"score_spread":0.3275370643656205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310570503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974874,0.0011130965,0.00009322037,0.00021497163,0.000018027302,0.000008678357,0.00036257683,0.0000042755187,0.0006976053],"genre_scores_gemma":[0.9993363,0.00016058167,0.00003346131,0.00002792791,0.000019732142,0.000005989158,0.00031192478,0.0000016775309,0.00010233508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993587,0.00022124845,0.00006880133,0.000090229776,0.00012947233,0.00013141833],"domain_scores_gemma":[0.994031,0.0018262096,0.0029443693,0.0001380054,0.00034950348,0.00071104674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009827076,0.00016947878,0.00030122974,0.00039600453,0.0002835674,0.0005773566,0.00025819492,0.0003107764,0.0025042063],"category_scores_gemma":[0.008247447,0.00009201205,0.000675831,0.0005196812,0.00016449353,0.00059687236,0.00044627712,0.00066150987,0.00018632611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008055224,0.00010210413,0.99301755,0.00003630355,0.00010673372,0.00007563221,0.000043929474,0.0002036032,0.00012825891,0.000021621083,0.00015454227,0.0053041596],"study_design_scores_gemma":[0.000021202917,0.0004468483,0.99846566,0.000019291121,0.000074930096,0.00022224526,0.00011625417,0.00035694515,0.00006328802,0.000029487517,0.00017932539,0.000004503096],"about_ca_topic_score_codex":0.0020296741,"about_ca_topic_score_gemma":0.0029830474,"teacher_disagreement_score":0.0025042063,"about_ca_system_score_codex":0.0004148378,"about_ca_system_score_gemma":0.000522669,"threshold_uncertainty_score":0.008377373},"labels":[],"label_agreement":null},{"id":"W4315436665","doi":"10.1097/coc.0000000000000975","title":"The Impact of Racial Disparities on Outcome in Patients With Stage IIIC Endometrial Carcinoma","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Carcinoma; Oncology; Endometrial cancer; Internal medicine; Outcome (game theory); Gynecology; Cancer","score_opus":0.09073136062926593,"score_gpt":0.4714907019835871,"score_spread":0.3807593413543212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315436665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993005,0.0002562601,0.000042423788,0.000071342496,0.0000042760375,0.0000022657684,0.00005727957,6.0370235e-7,0.00026508598],"genre_scores_gemma":[0.99982965,0.000051288407,0.000020097934,0.000018362154,0.000007088753,0.0000016841087,0.000035186393,5.189367e-7,0.0000361488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961853,0.00015943628,0.000022896018,0.00005135363,0.00006620262,0.0000814693],"domain_scores_gemma":[0.99879336,0.00026043216,0.0007005924,0.000048371403,0.000069078764,0.00012811898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006482457,0.00011347109,0.00018179855,0.0003504309,0.00032922835,0.00032766146,0.00011591701,0.00025107258,0.0012162455],"category_scores_gemma":[0.002979582,0.000073670824,0.0002519505,0.00037904567,0.00019880725,0.00024035691,0.00033337157,0.0002362117,0.000100055695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001434664,0.000018855093,0.99784076,0.0000047601175,0.00004235483,0.000035355486,0.00005073088,0.000042296222,0.00013630724,0.000024928391,0.000047770467,0.0016124186],"study_design_scores_gemma":[0.0000075674043,0.00009227157,0.99897146,0.0000075196,0.000035947498,0.00017546558,0.0001494233,0.00026109937,0.000070121496,0.0000483798,0.00017830986,0.0000025002316],"about_ca_topic_score_codex":0.0016819455,"about_ca_topic_score_gemma":0.002812629,"teacher_disagreement_score":0.0016819455,"about_ca_system_score_codex":0.00018909706,"about_ca_system_score_gemma":0.00023191849,"threshold_uncertainty_score":0.0040687323},"labels":[],"label_agreement":null},{"id":"W4317568116","doi":"10.1097/coc.0000000000000976","title":"Efficacy and Toxicity of Combined Inhibition of EGFR and VEGF in Patients With Advanced Non–small Cell Lung Cancer Harboring Activating EGFR Mutations","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine; Lung cancer; Hazard ratio; Oncology; Odds ratio; Epidermal growth factor receptor; Adverse effect; Clinical endpoint; Gefitinib; Cancer; Randomized controlled trial; Confidence interval","score_opus":0.051375962068259506,"score_gpt":0.4729018708173301,"score_spread":0.4215259087490706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317568116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016187083,0.9825326,0.00026741513,0.00013372599,0.000119902885,0.00018218833,0.00022588624,0.0000147334395,0.00033645157],"genre_scores_gemma":[0.4103534,0.5851925,0.0017103736,0.0008997388,0.00028668388,0.000566379,0.00046519274,0.000021506274,0.0005041874],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959793,0.0022200283,0.0009570764,0.00035814394,0.00037750902,0.000107869455],"domain_scores_gemma":[0.9944165,0.0038529586,0.0011675855,0.00012906508,0.0003432806,0.000090637404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066586095,0.0014718313,0.010018119,0.0026590582,0.00027361495,0.0016829459,0.0008919205,0.0015065445,0.001536264],"category_scores_gemma":[0.009136207,0.0008255592,0.019198455,0.002409769,0.0004583127,0.0010397428,0.00065633934,0.0013544493,0.00015961274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016193897,0.000096492586,0.0036080107,0.33832088,0.60184556,0.00017102523,0.00009024264,0.0009683391,0.0012936078,0.0001824515,0.0007149072,0.03651463],"study_design_scores_gemma":[0.004226191,0.0018032467,0.005712794,0.016702639,0.96765745,0.00020760369,0.000046837315,0.0003443134,0.00043791698,0.00023000178,0.0026028638,0.00002815098],"about_ca_topic_score_codex":0.0026143268,"about_ca_topic_score_gemma":0.007269151,"teacher_disagreement_score":0.010018119,"about_ca_system_score_codex":0.0014406774,"about_ca_system_score_gemma":0.0011990732,"threshold_uncertainty_score":0.035214543},"labels":[],"label_agreement":null},{"id":"W4317678583","doi":"10.1097/coc.0000000000000963","title":"The Effect of Biomarkers on Clinical Trial Risk in Gastric Cancer","year":2022,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cancer; Internal medicine; Oncology; Clinical trial","score_opus":0.07262873180167413,"score_gpt":0.49118693422079296,"score_spread":0.41855820241911884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317678583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.671581,0.17306025,0.10280683,0.019742295,0.0013745287,0.0043197814,0.0021580122,0.0010586863,0.023898637],"genre_scores_gemma":[0.98404133,0.0029174993,0.009218016,0.0014483371,0.0005958249,0.0007565577,0.00030122744,0.0001326394,0.0005886876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.6372653,0.2833962,0.031421576,0.013123052,0.031474583,0.00331931],"domain_scores_gemma":[0.152736,0.6497992,0.16353793,0.018057492,0.011042476,0.004826832],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.32452244,0.0011085628,0.0019534132,0.004437865,0.0010525575,0.00510319,0.0016758108,0.0033194402,0.0035276518],"category_scores_gemma":[0.61351305,0.00077615277,0.0038156845,0.004312865,0.002518816,0.0068625594,0.0032222283,0.0035904758,0.0007361686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019186115,0.0002698051,0.74008584,0.0020618786,0.0054053627,0.00035033052,0.0006181301,0.005189883,0.00081064785,0.004395082,0.003426999,0.21819994],"study_design_scores_gemma":[0.0021941026,0.022590695,0.87281924,0.002557057,0.010442273,0.005053694,0.00049985334,0.03917469,0.0059099616,0.014918725,0.023395991,0.00044369098],"about_ca_topic_score_codex":0.000405949,"about_ca_topic_score_gemma":0.00044166343,"teacher_disagreement_score":0.32452244,"about_ca_system_score_codex":0.0016911816,"about_ca_system_score_gemma":0.0023054555,"threshold_uncertainty_score":0.8329841},"labels":[],"label_agreement":null},{"id":"W4323535383","doi":"10.1097/coc.0000000000000992","title":"Population-based Long-term Outcomes for Squamous Cell Carcinoma of the Nasal Cavity","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Head and Neck Surgical Oncology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Positive Living North; University of British Columbia","funders":"","keywords":"Medicine; Nasal cavity; Surgery; Hazard ratio; Radiation therapy; Retrospective cohort study; Population; Basal cell; Adjuvant radiotherapy; Proportional hazards model; Internal medicine; Confidence interval","score_opus":0.10433245940342789,"score_gpt":0.4640535484684075,"score_spread":0.3597210890649796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323535383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986394,0.0003559885,0.00006000667,0.000023714196,0.0000035184025,0.000006607577,0.000576697,0.0000033022309,0.0003307627],"genre_scores_gemma":[0.9993181,0.000097633165,0.0000240159,0.0000118946755,0.0000029284067,0.0000046921114,0.0004989709,9.199749e-7,0.00004074492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996308,0.000057117697,0.000035750705,0.00007564557,0.00012591739,0.00007472236],"domain_scores_gemma":[0.9988961,0.00012663429,0.0004910094,0.000054689845,0.00024953627,0.00018196183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054958736,0.00015385581,0.00027635306,0.0010147778,0.00043380473,0.00063477916,0.00036176055,0.00029482975,0.0008410809],"category_scores_gemma":[0.0013609293,0.000118318145,0.00032595842,0.0013356165,0.0003486031,0.00027603735,0.00040160085,0.00034509442,0.00012545518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013755743,0.000006268154,0.9992617,0.0000044622216,0.000030327945,0.000026305688,0.000014932344,0.000029376131,0.000046319452,0.0000025841296,0.000031067142,0.00053298037],"study_design_scores_gemma":[0.0000010605194,0.000016339038,0.99966276,0.000003042494,0.000016687216,0.00009285173,0.00007347089,0.000039256855,0.000017490154,0.0000051834145,0.000070324175,0.0000014465063],"about_ca_topic_score_codex":0.08268667,"about_ca_topic_score_gemma":0.13131538,"teacher_disagreement_score":0.08268667,"about_ca_system_score_codex":0.0011227743,"about_ca_system_score_gemma":0.0011433406,"threshold_uncertainty_score":0.16441077},"labels":[],"label_agreement":null},{"id":"W4386252711","doi":"10.1097/coc.0000000000001039","title":"Geographic Disparities in Access to Cancer Clinical Trials in Canada","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Clinical trial; Medicine; Cancer; Cancer registry; Bladder cancer; Demography; Internal medicine","score_opus":0.8323996274990457,"score_gpt":0.763624699035733,"score_spread":0.06877492846331268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386252711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8880775,0.036237333,0.0012290785,0.017269218,0.00011279319,0.00027617303,0.013985247,0.00010154181,0.042711154],"genre_scores_gemma":[0.9922746,0.004396012,0.0004146097,0.00096396107,0.000037015765,0.000049653932,0.0010271892,0.000010578104,0.00082632265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994663,0.0010078115,0.0005736939,0.00068604114,0.0018760966,0.001193374],"domain_scores_gemma":[0.9794526,0.0050918325,0.007176749,0.0005485827,0.0038360117,0.0038941836],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0029412867,0.00015325828,0.00043213583,0.0025941299,0.001762035,0.0017288267,0.0007628367,0.0003392434,0.0044298097],"category_scores_gemma":[0.016509445,0.0001765713,0.00055522425,0.0073507754,0.0014090958,0.000524131,0.001315352,0.00052507134,0.00013642058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080266997,0.00008691824,0.8899983,0.0014538426,0.00067016645,0.00036745405,0.0032689928,0.0013563664,0.0005434002,0.005838075,0.010954083,0.08465967],"study_design_scores_gemma":[0.000068020774,0.000078752564,0.9814181,0.00048086818,0.00016186308,0.00023582451,0.0017982164,0.0003210319,0.00013265153,0.00058767904,0.014683069,0.0000338907],"about_ca_topic_score_codex":0.94291943,"about_ca_topic_score_gemma":0.962137,"teacher_disagreement_score":0.9970587,"about_ca_system_score_codex":0.020930283,"about_ca_system_score_gemma":0.053734496,"threshold_uncertainty_score":0.15186054},"labels":[],"label_agreement":null},{"id":"W4387563786","doi":"10.1097/coc.0000000000001049","title":"Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors","year":2023,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Trillium Health Centre; University Health Network; University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; Lakeridge Health","funders":"","keywords":"Medicine; Internal medicine; KRAS; Serous fluid; MEDLINE; Randomized controlled trial; Oncology; Ovarian cancer; Clinical trial; Meta-analysis; Cancer; Colorectal cancer","score_opus":0.2085496925214123,"score_gpt":0.5294789099811842,"score_spread":0.3209292174597719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387563786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030199513,0.99620026,0.000048691083,0.000119501376,0.000075501375,0.00012585598,0.00006882265,0.0000041835683,0.0003370908],"genre_scores_gemma":[0.05323717,0.9447606,0.0005863016,0.0005421147,0.00015414254,0.00034755166,0.00013323981,0.000003980037,0.00023487057],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976399,0.0010395505,0.0007473034,0.0001697552,0.00032310523,0.00008031365],"domain_scores_gemma":[0.9960257,0.0024982686,0.0010469193,0.000056889025,0.00030817772,0.00006420639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030785848,0.0006679342,0.004519687,0.0025202157,0.0003620844,0.0013976197,0.0009559123,0.001255598,0.0027626085],"category_scores_gemma":[0.009373939,0.00039541099,0.005444837,0.0017130784,0.00043938594,0.0010336274,0.00059301144,0.0009798893,0.0002432565],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00270351,0.00008913206,0.001063293,0.8389778,0.010412335,0.00021784702,0.00017217199,0.00025698752,0.00061580417,0.0002783833,0.0017670582,0.14344564],"study_design_scores_gemma":[0.0091974065,0.0073504313,0.014853441,0.7798867,0.11899767,0.0024236236,0.00078743784,0.00048544919,0.0023289197,0.0007638069,0.062815696,0.00010941733],"about_ca_topic_score_codex":0.0020652176,"about_ca_topic_score_gemma":0.0054767467,"teacher_disagreement_score":0.004519687,"about_ca_system_score_codex":0.0012522975,"about_ca_system_score_gemma":0.002681344,"threshold_uncertainty_score":0.016281307},"labels":[],"label_agreement":null},{"id":"W4389306890","doi":"10.1097/coc.0000000000001068","title":"Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2–Positive Metastatic Breast Cancer in Manitoba","year":2023,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"George & Fay Yee Centre for Healthcare Innovation; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Univariate analysis; Odds ratio; Cohort; Proportional hazards model; Oncology; Breast cancer; Cancer; Survival analysis; Multivariate analysis","score_opus":0.09528721805467023,"score_gpt":0.48239477823000837,"score_spread":0.38710756017533815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389306890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839336,0.0006930404,0.000041581567,0.000110019384,0.0000048065353,0.000007916826,0.0004097321,0.000003354472,0.00033626705],"genre_scores_gemma":[0.99858415,0.00062253553,0.000046702276,0.00005265074,0.0000057028706,0.000008540782,0.00042111377,0.0000013066525,0.00025723834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998702,0.000023165334,0.000009347492,0.000027682207,0.00002629787,0.000043349915],"domain_scores_gemma":[0.9995989,0.000040185427,0.00013117991,0.00001736661,0.00009157171,0.00012081519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003265052,0.0002300544,0.0001784851,0.00061063014,0.0006939751,0.000457244,0.00039070967,0.00019418889,0.0008436815],"category_scores_gemma":[0.0006433704,0.00020122719,0.00021668679,0.0008570371,0.0002706623,0.00020324241,0.00056254823,0.0003982742,0.00016330798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067866706,0.000017349957,0.99811006,0.000009248819,0.000029580646,0.00013148566,0.00012733166,0.000038983428,0.00025926577,0.000009257389,0.00012216158,0.0010774422],"study_design_scores_gemma":[0.000010865004,0.00006952538,0.9985796,0.000023094386,0.000046681715,0.00023418138,0.00042803696,0.00013053314,0.00007349313,0.000015007123,0.0003848235,0.0000040520217],"about_ca_topic_score_codex":0.30623877,"about_ca_topic_score_gemma":0.49715844,"teacher_disagreement_score":0.6937612,"about_ca_system_score_codex":0.002470963,"about_ca_system_score_gemma":0.0022922975,"threshold_uncertainty_score":0.6089125},"labels":[],"label_agreement":null},{"id":"W4391941149","doi":"10.1097/coc.0000000000001091","title":"Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Regimen; Radiosurgery; Radiology; Prostate cancer; Esophagus; Surgery; Cancer; Internal medicine","score_opus":0.06591625611906836,"score_gpt":0.47392068387247677,"score_spread":0.4080044277534084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391941149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649737,0.017062945,0.010455322,0.0011077333,0.000054819437,0.00020664328,0.00011081173,0.00009418705,0.005933814],"genre_scores_gemma":[0.98250824,0.008802703,0.0058643376,0.0009111459,0.00016561721,0.00008811648,0.0002627448,0.000055694967,0.0013414515],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99891186,0.0005006543,0.00009997179,0.00015125019,0.00020521547,0.00013109238],"domain_scores_gemma":[0.9976351,0.0010054581,0.0005218377,0.00021896132,0.0003258369,0.0002927769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026280133,0.0005236447,0.00029290613,0.0004342541,0.0003458465,0.000683674,0.0007526148,0.00070121646,0.0019021273],"category_scores_gemma":[0.0035094584,0.00017880824,0.0006934164,0.00061986846,0.00054811157,0.00053261546,0.00073587155,0.0008075344,0.00045689478],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003023044,0.0036404463,0.40200987,0.001411318,0.00082413986,0.007754603,0.005004972,0.0057194205,0.02673884,0.00079582137,0.002536279,0.5405412],"study_design_scores_gemma":[0.0015634989,0.053781357,0.70578027,0.0008323414,0.0008691259,0.12072958,0.0016867232,0.004200538,0.045796882,0.0010390723,0.06353353,0.00018704051],"about_ca_topic_score_codex":0.0013062821,"about_ca_topic_score_gemma":0.0029390415,"teacher_disagreement_score":0.0026280133,"about_ca_system_score_codex":0.00065881666,"about_ca_system_score_gemma":0.0006662018,"threshold_uncertainty_score":0.013898432},"labels":[],"label_agreement":null},{"id":"W4402356242","doi":"10.1097/coc.0000000000001143","title":"Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer","year":2024,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fulvestrant; Internal medicine; Oncology; Hazard ratio; Metastatic breast cancer; Breast cancer; Adverse effect; Combination therapy; Cancer; Confidence interval; Tamoxifen","score_opus":0.1099644072603908,"score_gpt":0.5343017928638563,"score_spread":0.42433738560346546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402356242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022795482,0.97490454,0.00023755072,0.0002542946,0.00013008415,0.00030183897,0.00026985622,0.000015501055,0.0010909808],"genre_scores_gemma":[0.42950895,0.56503016,0.0019279039,0.0013405995,0.00047355337,0.00056146795,0.000543395,0.000017383258,0.00059666974],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961333,0.0020177432,0.0009346357,0.00030750554,0.0005140877,0.00009267748],"domain_scores_gemma":[0.99497,0.002905063,0.0015751952,0.000107877575,0.00033702436,0.00010493492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057783807,0.00080797885,0.0060025854,0.0021263773,0.00026065917,0.0015832433,0.00076750445,0.0011013,0.002478777],"category_scores_gemma":[0.009854014,0.00044292727,0.008167489,0.0017867959,0.0005363822,0.0010286802,0.00052584114,0.0010785855,0.00020322767],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05365105,0.0005978835,0.0040780352,0.5401716,0.16340438,0.0002512038,0.00016494023,0.0012722269,0.0033292365,0.0004623931,0.0020896601,0.23052739],"study_design_scores_gemma":[0.044346124,0.030416694,0.03171509,0.12217076,0.7367808,0.0016165487,0.00035312964,0.001640758,0.004615623,0.0014446522,0.0246995,0.00020029054],"about_ca_topic_score_codex":0.0012344468,"about_ca_topic_score_gemma":0.0031566145,"teacher_disagreement_score":0.0060025854,"about_ca_system_score_codex":0.0010950597,"about_ca_system_score_gemma":0.001543534,"threshold_uncertainty_score":0.03055942},"labels":[],"label_agreement":null},{"id":"W4403701324","doi":"10.1097/coc.0000000000001150","title":"Efficacy and Safety of Lenvatinib in Combination With Other Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma","year":2024,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Lenvatinib; Medicine; Internal medicine; Renal cell carcinoma; Adverse effect; Oncology; Sorafenib; Hepatocellular carcinoma","score_opus":0.10550136030377723,"score_gpt":0.43960692323035616,"score_spread":0.33410556292657895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403701324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01670896,0.9807983,0.0005876516,0.00026987784,0.00021465996,0.00012062572,0.0006630522,0.000032821146,0.0006039932],"genre_scores_gemma":[0.611707,0.38175297,0.002139761,0.0010204316,0.0006210126,0.0004985205,0.0014198874,0.00006692106,0.00077353214],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.99038714,0.00510551,0.0018865129,0.0012605054,0.0010968875,0.00026332555],"domain_scores_gemma":[0.99160904,0.005846126,0.0016195771,0.00028524868,0.00048744155,0.00015255656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011738559,0.0025492837,0.013808936,0.004868048,0.00044239787,0.0033075002,0.0015208262,0.0018499434,0.0030202],"category_scores_gemma":[0.017182408,0.0011501741,0.047914185,0.0050768326,0.0004882253,0.0014372392,0.0010958032,0.0016883655,0.0003389912],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004403994,0.00002280158,0.0038175285,0.050100144,0.9331654,0.000055490465,0.00001853036,0.00080096634,0.00028739727,0.00004823818,0.00020675058,0.0070727817],"study_design_scores_gemma":[0.0009302796,0.0005159295,0.0043025073,0.004113476,0.98834074,0.00009276519,0.000016795244,0.00028394026,0.00016667253,0.00011722102,0.0011047133,0.000015047551],"about_ca_topic_score_codex":0.0036548108,"about_ca_topic_score_gemma":0.0061046225,"teacher_disagreement_score":0.013808936,"about_ca_system_score_codex":0.0018227674,"about_ca_system_score_gemma":0.0013260077,"threshold_uncertainty_score":0.062080145},"labels":[],"label_agreement":null},{"id":"W4404867374","doi":"10.1097/coc.0000000000001157","title":"Phase 2, Multicenter, Open-label, Nonrandomized Study of Neoadjuvant Chemotherapy Liposomal Irinotecan With 5-Fluorouracil, Leucovorin, and Oxaliplatin, Followed by Chemoradiotherapy in Patients With Rectal Cancer in a Watch-and-Wait Program","year":2024,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Irinotecan; Oxaliplatin; Internal medicine; Fluorouracil; Capecitabine; Phases of clinical research; Clinical endpoint; Colorectal cancer; Chemotherapy; Gastroenterology; Chemoradiotherapy; Neoadjuvant therapy; Surgery; Oncology; Cancer; Clinical trial; Breast cancer","score_opus":0.040096710341763916,"score_gpt":0.4576771838341635,"score_spread":0.4175804734923996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404867374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994926,0.00038167092,0.00048014408,0.00018310187,0.0001350965,0.003255759,0.00024263926,0.000037497917,0.00035812135],"genre_scores_gemma":[0.9822613,0.0006530798,0.0033425107,0.00076329615,0.0005511197,0.009409202,0.0011577237,0.000033706736,0.0018280939],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9976471,0.0016389535,0.00008192032,0.0002849533,0.00013978053,0.00020733659],"domain_scores_gemma":[0.99782604,0.00039399962,0.0005409263,0.00028029428,0.00014590636,0.0008126991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045687566,0.0031266208,0.0028010628,0.00067829323,0.0006475337,0.0010558134,0.0011265385,0.0016054895,0.0032594367],"category_scores_gemma":[0.0024267004,0.0012292232,0.0014026158,0.0005701546,0.0020594688,0.0014777249,0.00059794314,0.0029490006,0.00074169954],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87757593,0.09777621,0.0035811455,0.00018953411,0.00049616664,0.00008300373,0.00012697915,0.00079889665,0.009634351,0.000086971726,0.00051763863,0.0091332365],"study_design_scores_gemma":[0.652144,0.34299123,0.0027057074,0.000009461578,0.00014523964,0.00004558189,0.000024716734,0.0005848231,0.0009548886,0.000051057577,0.00033042175,0.000012828841],"about_ca_topic_score_codex":0.00076064636,"about_ca_topic_score_gemma":0.0019760102,"teacher_disagreement_score":0.0045687566,"about_ca_system_score_codex":0.0012307849,"about_ca_system_score_gemma":0.0026874025,"threshold_uncertainty_score":0.024162173},"labels":[],"label_agreement":null},{"id":"W4407300113","doi":"10.1097/coc.0000000000001171","title":"Efficacy and Safety of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Patients with Non-Hodgkin Lymphoma","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Internal medicine; Lymphoma; Neutropenia; Adverse effect; Nausea; Chimeric antigen receptor; Hazard ratio; Oncology; Incidence (geometry); Gastroenterology; Chemotherapy; Cancer; Immunotherapy; Confidence interval","score_opus":0.055866799719170517,"score_gpt":0.45606727496103683,"score_spread":0.4002004752418663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407300113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01713742,0.9812277,0.00018691557,0.0003395026,0.00014425213,0.00012184898,0.00024625374,0.000009982829,0.0005860879],"genre_scores_gemma":[0.5558293,0.43982074,0.0006992371,0.0016987291,0.0006716499,0.00034926017,0.00052429904,0.000017441618,0.0003894382],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933062,0.0036912942,0.0015340066,0.00050159654,0.0008125019,0.00015429968],"domain_scores_gemma":[0.9892315,0.0075636012,0.0022958985,0.00020220927,0.0005589458,0.00014783793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009864031,0.0008076594,0.0060296627,0.0018332694,0.00022350841,0.001776164,0.0009007535,0.0016822201,0.002380923],"category_scores_gemma":[0.01735072,0.0005118752,0.012617854,0.0020260226,0.00049315795,0.0012030195,0.00059714384,0.0016289816,0.00021700269],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054729205,0.0004957206,0.013326231,0.35129783,0.39291963,0.00022018678,0.00019029526,0.0016130261,0.0012169052,0.00045728718,0.0017912646,0.18174239],"study_design_scores_gemma":[0.02604082,0.017333139,0.039644152,0.053470932,0.84516746,0.0007559579,0.0002681457,0.0013204116,0.0013353042,0.0015221465,0.013048005,0.00009357897],"about_ca_topic_score_codex":0.0011756803,"about_ca_topic_score_gemma":0.002017702,"teacher_disagreement_score":0.009864031,"about_ca_system_score_codex":0.0011695832,"about_ca_system_score_gemma":0.0010543293,"threshold_uncertainty_score":0.05216664},"labels":[],"label_agreement":null},{"id":"W4407978994","doi":"10.1097/coc.0000000000001179","title":"Impact of Minimal Residual Diseases Status and Depth of Response on Survival Outcomes in Blinatumomab-Treated Acute Lymphoblastic Leukemia","year":2025,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Blinatumomab; Medicine; Lymphoblastic Leukemia; Internal medicine; Meta-analysis; Incidence (geometry); Chemotherapy; Acute lymphocytic leukemia; Malignancy; Leukemia; Oncology; Gastroenterology; Pediatrics","score_opus":0.06679622836495017,"score_gpt":0.5004555254595139,"score_spread":0.43365929709456374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407978994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007897128,0.9913924,0.00005118818,0.00014662268,0.000052603504,0.000041475,0.0001351941,0.000001997317,0.00028137933],"genre_scores_gemma":[0.21225831,0.78565276,0.00045458265,0.0005247281,0.0002942874,0.00021644455,0.0003749002,0.000005336861,0.00021864119],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99471575,0.0024773385,0.0015100236,0.00037524672,0.0008016089,0.000120069846],"domain_scores_gemma":[0.98624146,0.010226309,0.0025640954,0.00014009468,0.0006739087,0.00015418885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006606878,0.0005259246,0.0047011646,0.0025702715,0.00019388548,0.0016589684,0.00080064184,0.0009220594,0.0016301537],"category_scores_gemma":[0.018628579,0.00028353147,0.0055460287,0.0026161664,0.0004413089,0.0011845462,0.0005009173,0.00077519857,0.00012068773],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013487842,0.00020965749,0.017495474,0.56718504,0.08230432,0.00034335087,0.00038038724,0.0007167842,0.0012361166,0.0005177328,0.0017055938,0.3144177],"study_design_scores_gemma":[0.004759312,0.0103087425,0.12881644,0.2969546,0.5107244,0.0021985786,0.0009900343,0.00067550567,0.0018868755,0.0012559398,0.04125743,0.000172188],"about_ca_topic_score_codex":0.0011976126,"about_ca_topic_score_gemma":0.002228817,"teacher_disagreement_score":0.006606878,"about_ca_system_score_codex":0.001073881,"about_ca_system_score_gemma":0.001448245,"threshold_uncertainty_score":0.0349409},"labels":[],"label_agreement":null},{"id":"W4409281052","doi":"10.1097/coc.0000000000001199","title":"Efficacy and Safety of Pegylated Filgrastim as Primary Prophylaxis Following Pediatric Dose-intensive Chemotherapy","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Filgrastim; Medicine; Neutropenia; Chemotherapy; Febrile neutropenia; Adverse effect; Granulocyte colony-stimulating factor; Internal medicine; Surgery; Randomized controlled trial","score_opus":0.02644083628862164,"score_gpt":0.4228698651195398,"score_spread":0.39642902883091813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409281052","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38272366,0.60999525,0.0018336838,0.0009199236,0.0008400318,0.0005791718,0.0008889663,0.000109075125,0.002110241],"genre_scores_gemma":[0.96389383,0.033735614,0.00079783,0.0004784057,0.00029208645,0.00018078074,0.00032996282,0.000015341337,0.00027611578],"study_design_codex":"meta_analysis","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9957842,0.002787792,0.0004385714,0.00051892153,0.00033093838,0.0001394618],"domain_scores_gemma":[0.99199027,0.0053842682,0.0018919341,0.00029751545,0.00019201438,0.0002439012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005847662,0.000846268,0.004636284,0.0007476545,0.00016964611,0.0011807965,0.00084458117,0.0010242416,0.0020177816],"category_scores_gemma":[0.011914499,0.00037465003,0.009074231,0.0009804696,0.00037514698,0.0006190921,0.00041143075,0.0015428029,0.00011718566],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32256675,0.00063546223,0.030534487,0.04011883,0.47753033,0.0001860459,0.00009941391,0.005984969,0.0014810334,0.00044435135,0.002064396,0.118353985],"study_design_scores_gemma":[0.12916733,0.045405492,0.090756245,0.007623357,0.7081735,0.0004114064,0.000093228715,0.0065144743,0.0024330802,0.0012904017,0.008050016,0.000081471786],"about_ca_topic_score_codex":0.0012273302,"about_ca_topic_score_gemma":0.0014060289,"teacher_disagreement_score":0.005847662,"about_ca_system_score_codex":0.00088205613,"about_ca_system_score_gemma":0.0006825146,"threshold_uncertainty_score":0.03092575},"labels":[],"label_agreement":null},{"id":"W4410404180","doi":"10.1097/coc.0000000000001215","title":"Metabolic Plasticity in Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Sherbrooke","funders":"","keywords":"Warburg effect; Prostate cancer; Medicine; Cancer; Cancer research; Cancer cell; Anaerobic glycolysis; Glycolysis; Prostate; Oxidative phosphorylation; Internal medicine; Oncology; Biology; Metabolism; Biochemistry","score_opus":0.02541152604416668,"score_gpt":0.4167065186115824,"score_spread":0.39129499256741573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410404180","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3205529,0.5809999,0.008362732,0.015382145,0.0017282598,0.00015893918,0.0020518329,0.000463477,0.07029985],"genre_scores_gemma":[0.8213464,0.15871324,0.0024095709,0.0024550224,0.0012546522,0.00011848022,0.001104046,0.000060671762,0.0125379395],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998561,0.000031453583,0.0000071010663,0.000035708264,0.00003385449,0.00003567613],"domain_scores_gemma":[0.99988675,0.000014793404,0.000035581095,0.0000072910984,0.000023122368,0.000032370182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016272585,0.00026306696,0.00024991308,0.0004778493,0.00030287492,0.00079204154,0.00031195665,0.00035171214,0.0028392181],"category_scores_gemma":[0.0002864029,0.00008907702,0.00027736695,0.0007596934,0.00045087375,0.00033836823,0.00059881055,0.00081153406,0.00058611226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012514929,0.00051158824,0.042379905,0.0047727586,0.00026604533,0.0042856378,0.0011500401,0.0039269524,0.15402506,0.044266794,0.034627996,0.7085358],"study_design_scores_gemma":[0.00008305894,0.0012827185,0.22147296,0.0010209602,0.00022380643,0.018982222,0.0013822961,0.0018716123,0.047084536,0.027888244,0.6785407,0.00016682842],"about_ca_topic_score_codex":0.0011299714,"about_ca_topic_score_gemma":0.0013165477,"teacher_disagreement_score":0.0028392181,"about_ca_system_score_codex":0.0007290064,"about_ca_system_score_gemma":0.00070405565,"threshold_uncertainty_score":0.009498119},"labels":[],"label_agreement":null},{"id":"W4411093414","doi":"10.1097/coc.0000000000001221","title":"Impact of Sequencing of Treatment Modalities on Survival in Nonmetastatic Hepatocellular Carcinoma","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Systemic therapy; Liver transplantation; Liver cancer; Proportional hazards model; Cohort; Liver disease; Oncology; Sorafenib; Malignancy; Gastroenterology; Cancer; Surgery; Transplantation","score_opus":0.1830231610961523,"score_gpt":0.4386759174022137,"score_spread":0.2556527563060614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411093414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466467,0.0030353565,0.0007071561,0.00024665793,0.000045825283,0.000028410941,0.00017708761,0.000015988182,0.0010788705],"genre_scores_gemma":[0.9988306,0.00040986622,0.00032236398,0.000074891745,0.000021241678,0.000018019655,0.00020338476,0.0000038503695,0.00011583696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941146,0.00028888078,0.00006713109,0.00008619211,0.00008137974,0.00006504024],"domain_scores_gemma":[0.99857974,0.00058931904,0.00046085555,0.00006615773,0.00008020492,0.00022377566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001216015,0.00015396676,0.0003590346,0.0002160423,0.00014699493,0.0002845429,0.00018110026,0.00018936716,0.0013989606],"category_scores_gemma":[0.003853463,0.00006814755,0.00057498424,0.00020592473,0.0001014477,0.00039517795,0.0002775254,0.00031529047,0.00013624119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017811555,0.0010800539,0.60493946,0.0004513895,0.00090668455,0.00012360644,0.00015281551,0.013821954,0.0043338225,0.00033016774,0.001273669,0.35477477],"study_design_scores_gemma":[0.00065077224,0.015168877,0.95549077,0.00025855337,0.0012657174,0.00063677476,0.0002606919,0.018693117,0.0029740941,0.0012160392,0.0033617697,0.000022841303],"about_ca_topic_score_codex":0.0009044274,"about_ca_topic_score_gemma":0.0018979532,"teacher_disagreement_score":0.0013989606,"about_ca_system_score_codex":0.00041127016,"about_ca_system_score_gemma":0.00057576405,"threshold_uncertainty_score":0.006430924},"labels":[],"label_agreement":null},{"id":"W4413041068","doi":"10.1097/coc.0000000000001246","title":"Impact of Intensive Multimodal Treatment on the Outcomes of Patients With Anaplastic Thyroid Cancer","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Propensity score matching; Cohort; Cancer; Internal medicine; Radiation therapy; Anaplastic thyroid cancer; Clinical trial; Thyroid cancer; Surgery","score_opus":0.04054436259646686,"score_gpt":0.451152187052796,"score_spread":0.41060782445632915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413041068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216604,0.00427134,0.00013469603,0.0005918809,0.000041514533,0.000020931791,0.00046844478,0.000008113494,0.0022971677],"genre_scores_gemma":[0.99883276,0.00046549516,0.000051477902,0.000102714104,0.0000482123,0.000014062837,0.00036989726,0.0000016139513,0.0001136535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995683,0.00015924472,0.000047045363,0.000061868865,0.000078319215,0.00008525048],"domain_scores_gemma":[0.9986058,0.0003244257,0.00063028705,0.000055740762,0.00009748173,0.00028621242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006129929,0.000115352894,0.00025805243,0.0002043237,0.00022519422,0.00045442482,0.00018089333,0.00019254062,0.0019142258],"category_scores_gemma":[0.0033933064,0.000037391033,0.00052160694,0.00036690471,0.00015721364,0.00037878123,0.0005066055,0.00044782675,0.00011558953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005533515,0.00044937438,0.8706812,0.00034461546,0.0009043782,0.0001858532,0.00013164092,0.0012381796,0.001057395,0.0001950299,0.0015684332,0.11771036],"study_design_scores_gemma":[0.00019524638,0.0015079805,0.99482745,0.000101660626,0.0004171187,0.0002612381,0.000154701,0.00080009265,0.00017118354,0.00028725373,0.0012668277,0.000009270028],"about_ca_topic_score_codex":0.0016426671,"about_ca_topic_score_gemma":0.0031711406,"teacher_disagreement_score":0.0019142258,"about_ca_system_score_codex":0.0005725062,"about_ca_system_score_gemma":0.00056213845,"threshold_uncertainty_score":0.006403744},"labels":[],"label_agreement":null},{"id":"W4414084486","doi":"10.1097/coc.0000000000001253","title":"A Phase II Trial to Assess the Evolution of the KRAS Mutation Load by Liquid Biopsy in Patients With Resectable Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant NALIRIFOX","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"KRAS; Pancreatic ductal adenocarcinoma; Liquid biopsy; Neoadjuvant therapy; Adenocarcinoma; Biopsy; Mutation; Phases of clinical research","score_opus":0.04503807221140932,"score_gpt":0.43144048437396826,"score_spread":0.38640241216255894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414084486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982023,0.0004401029,0.00019326068,0.00012957658,0.000036739213,0.00053428556,0.00014865029,0.000020715532,0.0002943941],"genre_scores_gemma":[0.9957579,0.00034890455,0.001075245,0.00029159908,0.00010964037,0.0011860039,0.00061466935,0.000008181631,0.0006078983],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994823,0.00033354186,0.000024696392,0.00007459663,0.000032313976,0.000052651725],"domain_scores_gemma":[0.99876106,0.00030011428,0.00035346157,0.000105722414,0.000056891833,0.00042267918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016381401,0.0009948977,0.0013012437,0.00024491487,0.00022844701,0.0005386049,0.00047806112,0.00084052084,0.002142344],"category_scores_gemma":[0.0013059549,0.0004358665,0.00066939864,0.0002249601,0.0005885956,0.0006626542,0.00026703713,0.0017208781,0.0004060903],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91126037,0.024373755,0.0182157,0.00020286681,0.00049480895,0.00008614024,0.000107497064,0.000710941,0.0148690855,0.00004943986,0.000498361,0.02913111],"study_design_scores_gemma":[0.54891276,0.424301,0.022089418,0.000018012188,0.00025391873,0.00017750476,0.000039085247,0.0013896095,0.0020320145,0.00007673296,0.0006919184,0.000018040677],"about_ca_topic_score_codex":0.0003378074,"about_ca_topic_score_gemma":0.0007559129,"teacher_disagreement_score":0.002142344,"about_ca_system_score_codex":0.00050784834,"about_ca_system_score_gemma":0.00089809287,"threshold_uncertainty_score":0.008663416},"labels":[],"label_agreement":null},{"id":"W4417168166","doi":"10.1097/coc.0000000000001265","title":"Immunotherapy in Extensive Stage Small-Cell Lung Cancer in First-Line and Second-Line Setting","year":2025,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; BC Cancer Agency; London Health Sciences Centre; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Lung cancer; Immunotherapy; Stage (stratigraphy); Respiratory disease; MEDLINE; Neoplasm staging; Retrospective cohort study","score_opus":0.04850980863133062,"score_gpt":0.49210545852412857,"score_spread":0.4435956498927979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417168166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005106185,0.99416685,0.00012200967,0.00012202131,0.00009855564,0.00007169331,0.00009036507,0.0000049331516,0.00021736661],"genre_scores_gemma":[0.27180216,0.7246751,0.0010245137,0.001046166,0.00043298263,0.00040454217,0.00030064356,0.00000876333,0.00030508675],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702746,0.0016324726,0.0006363357,0.00030660734,0.00029546773,0.0001016276],"domain_scores_gemma":[0.9947055,0.003667859,0.0011993775,0.00010527344,0.00023688919,0.00008510332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048988345,0.00091230596,0.00732045,0.0017509268,0.00021063488,0.0016900621,0.00078371953,0.001265267,0.001843025],"category_scores_gemma":[0.010708215,0.0004289385,0.013403395,0.00154451,0.0003075058,0.0010021272,0.0005285658,0.0012467888,0.00012951938],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012037118,0.00017496811,0.00547987,0.49334386,0.3813602,0.0001910822,0.00009732992,0.0016841402,0.0011807515,0.00041968504,0.0011042791,0.102926746],"study_design_scores_gemma":[0.0091667315,0.004755134,0.016255978,0.10424925,0.85216546,0.0005902763,0.0001284033,0.0010016802,0.00080227735,0.0008747928,0.009951137,0.00005886844],"about_ca_topic_score_codex":0.0021051853,"about_ca_topic_score_gemma":0.006013586,"teacher_disagreement_score":0.00732045,"about_ca_system_score_codex":0.0012166313,"about_ca_system_score_gemma":0.0014909052,"threshold_uncertainty_score":0.025907815},"labels":[],"label_agreement":null},{"id":"W987760055","doi":"10.1097/coc.0000000000000205","title":"Defining Eligibility of FOLFIRINOX for First-Line Metastatic Pancreatic Adenocarcinoma (MPC) in the Province of British Columbia","year":2015,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; FOLFIRINOX; Adenocarcinoma; Metastatic adenocarcinoma; Oncology; Line (geometry); Internal medicine; Oxaliplatin; Cancer","score_opus":0.1317465678737183,"score_gpt":0.4785126894804782,"score_spread":0.3467661216067599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W987760055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954099,0.0003380625,0.00008801961,0.00029894104,0.000007125588,0.000053474436,0.0011337836,0.0000081724575,0.0026625313],"genre_scores_gemma":[0.99832326,0.00024137553,0.00013140817,0.00011114678,0.000003307532,0.000018966779,0.0006621408,0.0000026287187,0.0005056209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939466,0.000076469856,0.00006432963,0.00007317278,0.00018497654,0.00020638084],"domain_scores_gemma":[0.997776,0.00029752907,0.00047821237,0.000052940555,0.00085955794,0.00053577987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062138273,0.00015812651,0.00019563161,0.0010884902,0.0014473323,0.0007708428,0.0008702319,0.00035956505,0.001619036],"category_scores_gemma":[0.0032124643,0.00016239942,0.00011301303,0.0016913216,0.0004452233,0.0001794417,0.0006401513,0.00034381062,0.0001733356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001121143,0.000033948003,0.99239916,0.000039844956,0.0000101524865,0.00028077143,0.00037045896,0.000108903616,0.00029994044,0.000042293075,0.0012692219,0.0050331485],"study_design_scores_gemma":[0.000013813895,0.000033078893,0.9957196,0.00005944589,0.000013266195,0.00028312005,0.0017024545,0.00036373772,0.00015200046,0.000024619567,0.0016280271,0.0000067363303],"about_ca_topic_score_codex":0.92774856,"about_ca_topic_score_gemma":0.96765286,"teacher_disagreement_score":0.07225144,"about_ca_system_score_codex":0.007561659,"about_ca_system_score_gemma":0.011766859,"threshold_uncertainty_score":0.14535385},"labels":[],"label_agreement":null}]}